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Motivation 
!  Feedback loops are integral in biological networks, 
controlling oscillations and robustness.1 
!  Feedback loop detection requires i) cyclic graphs,  
ii) cascades, iii) multiple regulatory inputs per genes. 
!  Popular inference methods (e.g Bayesian Networks) 
can not detect feedback loops.2 
 Feedback loop detection can bring improvement 
1 Department of Bioengineering, 2 Department of Computing , Imperial Collage, London, UK 
Introduction 
Logic Programming Driven Framework for the inference of atheroprotective        
gene networks. 
Teaser: A declarative constraint-based approach for detection of complex network structures: enriches 
networks with feedback loops and competitive gene influences 
Methods 
Results 
Conclusion 
Hypothesis 
Due to the non-restrictive nature of a 
symbolic representation of gene 
influences, which enables the incremental 
detection of complex network structures, 
logic inference techniques based on 
abduction/induction are appropriate for 
detecting Gene Regulatory Networks 
(GRNs) with complex structures.  
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"  Competitive gene influences  
( S and C on A) 
"  Cyclic graphs (A-B-C-A) 
"  Gene cascades (A–B-C) 
"  Multiple regulatory inputs per gene 
(S and C on A) 
Figure 1: Requirements for feedback loop detection 
Gene expression Module Logic Driven Reasoning Module 
Sign Consistent Gene influences 
Competitive Gene influences 
Sign Consistent Regulators Criteria: 
!  Sign Consistency Check  
!  Regulatory potential  
!  Interactive potential  
Overpowered Regulators Criteria: 
!  Sign Inconsistent 
!  Never occurs in isolation 
!  Deterministic function predicting the state 
of (G1) should be consistent with data 
Influence(R) = Fold Change(R) * correlation(R, T) 
Figure 2: Overview of Integrative Declarative Modeling (IDM) platform. IDM consists of four main modules. The central reasoning module accepts input from expression studies as well as online biological 
databases. Following the inference of putative GRN networks, an iterative approach is set up for validation and further refinement of the networks.  
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Abstract
The prevalent pathology leading to high mortality from cardiovascular disease is arteriosclerosis. Despite 
strong evidence for the association of shear stress and the site-specificity of atherosclerosis initiation, there 
is a lack of treatment focusing on modulating shear stress-induced phenotypes in endothelial cells. The 
overarching theme of the thesis is to uncover the causal molecular networks that are activated by 
mechanical forces in endothelial cells. 
We present an integrated platform for gene network inference and validation, which integrates network 
inference from gene expression data with functional genomics within a single framework to set up  an 
iterative cycle of measurement and network refinement. In order to achieve this, a number of technological 
innovations were necessary and developed.
We present an approach, named ARNI, to logically model and construct through abductive reasoning, 
regulatory gene networks from gene expression profiles and background prior knowledge on gene functions 
and interactions. We demonstrate the improved predictive power and complexity of our inferred network 
topologies compared with those generated by other non-symbolic inference approaches.
A bioinformatics workflow for the integration of gene expression profiles across platforms and species is 
presented and applied for generating an integrated endothelial cell mechanoresponsive gene expression 
profile. The integrated dataset identified >1600 genes to be shear responsive, more than any other study, 
and in this gene set all known mechanosensitive genes and pathways were present. 
We also present the first high-throughput RNAi platform to demonstrate successful reverse electroporation of 
mammalian primacy cell lines and which couples RNAi screening with mechanotransduction studies. Each 
step of the assemblage is evaluated and effective loss-of-function is demonstrated for multiple gene targets. 
The tools presented in this thesis provide the basis for developing qualitative models and targeted therapies, 
in order to further our pursuit for shear-mediated atherosclerosis prevention.
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1Introduction
Chapter 1 Summary
The overarching theme of the thesis is to uncover the causal molecular networks that are activated by 
mechanical forces in endothelial cells. We propose a two-step approach, which integrates network inference 
from gene expression data with functional genomics within a single framework to set up an integrated 
platform for gene network inference and validation. The hypothesis driving the platform is that efficient 
network inference can be achieved based on symbolic representation for improved network inference, 
combined with automated and highly parallelised validation techniques to form an iterative cycle of 
measurement, validation and network refinement. Section 1.1 presents the motivation of the thesis and the 
evidence for the association of shear stress with atherosclerosis initiation, highlighting the need for treatment 
against shear-mediated atherosclerosis. Section 1.2 presents an overview of the methodological approach. 
Section 1.3 presents the aims of the thesis which include development of software packages, design and 
fabrication of experimental devices and optimisation of experimental protocols for live cell time-lapse 
imaging. Section 1.4 gives the outline for the rest of the thesis. 
Introduction
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1.1 Motivation 
1.1.1 Cardiovascular diseases: Clinical implications and current 
treatments
Oxygen is the most fundamental requirement for almost every known multicellular animal [Roberto10]. 
Oxygen and other essential molecules are supplied to each cell in the human body via the vasculature, a 
branching network of arteries and veins that transports oxygenated blood to the tissues and deoxygenated 
blood away from the tissues back to the respiratory organs in a continuous cycle. Similar to any other tissue 
within the body, the cardiovascular system (heart and blood vessels) is susceptible to disease. 
The most prevalent pathology is arteriosclerosis, in which areas of the arterial wall suffer a loss of elasticity, 
hardening and thickening. The commonest form of arteriosclerosis is atherosclerosis, in which calcified and 
cellular deposits (plaques) form on the vessel wall and enlarge, leading to stenosis of the vessel and 
impeding blood flow. Moreover, plaques can acutely rupture, causing rapid activation of platelets and the 
formation of a thrombus which can lead to an acute localised occlusion of the vessel and hypoxia, or the 
thrombus can break free and travel along the vessel resulting in occlusion at a downstream site, termed an 
embolus. Without timely restoration of blood supply, cells of the affected tissue undergo necrosis and die, 
termed as infarct [Libby13]. Atherosclerosis is the underlying pathological mechanism responsible for the 
majority of myocardial infarcts (i.e. heart attacks), ischeamic strokes (i.e. cerebral infarcts) and peripheral 
vascular disease (arterial insufficiency typically of the lower limbs), that can progress to ischemic ulceration 
and ultimately necrosis (i.e. gangrene). Atherosclerosis is also a significant cause of arterial aneurysms, in 
which a localised weakening of the arterial wall leads to a dilation (bulge) and carries a significant risk of 
rupture. The aforementioned diseases belong to a group of diseases collectively known as CardioVascular 
Diseases (CVDs). CVDs are the leading cause of mortality worldwide, responsible for 17.5 million deaths per 
year, accounting for 31% of all global deaths [WHO14]. The current trends in mortality are expected to 
remain the same in the next 20 years [Mathers06, WHO15]. In the period 2012/2013, CVDs were the second 
largest category of NHS (National Health System) expenditure in England costing 7.02 billion per year, with 
the total cost to the economy estimated at £19 billion per year [NHS14, BHF14]. 
A major area of focus of CVD treatment is the prevention and management of associated systemic risk 
factors, namely, smoking, hypertension, dyslipideamia (i.e. elevated blood cholesterol and lipids), diabetes 
(i.e. hyperglyceamia), central obesity and lack of physical activity [Rader08]. The continued improvement in 
identification and management of at risk populations has contributed to a significant decrease in CVD 
mortality in the last 50 years, especially from ischeamic heart disease, with an over 50% decrease in 
myocardial infarct mortalities [BHF11]. Interventions aimed at directly controlling these risk factors: lipid 
lowering drugs (e.g., statins), antihypertensive treatments, insulin-sensitising agents and strong antismoking 
campaigning, have been widely lauded as a crucial contributing factor in the declining incidence of CVD in 
high-income countries [WHO14]. 
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1.1.2 Need for treatment against shear-mediated atherosclerosis 
Atherosclerosis is a complex and active process, which involves the interplay of multiple cell types 
(endothelial cells, macrophages, smooth muscle cells). At the cellular level, atherosclerosis is an 
inflammatory process triggered by the free radical oxidation of low density lipoproteins (LDLs) and their 
infiltration of the arterial wall. Monocytes (a subtype of white blood cell) are recruited locally, and then 
differentiate into macrophages and engulf oxidised lipoprotein to form foam cells. This build-up of lipids, foam 
cells, smooth muscle cells, cellular debris, calcium, and extracellular matrix constitutes the atherosclerotic 
plaques [Libby02]. Atherosclerosis develops over many years and patients typically only present clinically at 
the later stages of disease progression. Current diagnostic tools can only detect relatively advanced stages 
of disease.
Due to high profile and expensive failures in drug development of preventative agents, pharmaceutical 
companies have increasingly been shifting their focus from preventative treatments to treatment of acute 
manifestation of the disease [Plump10]. However, preventative treatments lie at the heart of controlling the 
disease in the long term. An aspect of CVD prevention lies with the discovery of the mechanisms that directly 
prevent the initiation, or progression of atherosclerosis, which can lead to the design of treatments to 
“prevent atherosclerosis promoting events or shift them to anti-atherosclerotic ones” [Ramsey10].
However, not all arteries are ‘created’ equal. Despite the systemic nature of the associated risk factors, 
atherosclerotic plaques typically develop at specific well-defined locations of the arterial system; near 
branches and bifurcations, and the inner curvature of aortic arch [DeBakey85, VanderLaan04]. The site 
specificity of atherosclerosis is also observed across multiple species and experimental models of 
atherosclerosis [Chiu11]. The focal nature of atherosclerosis has been attributed primarily to disturbed blood 
flow patterns [Asakura90]. The geometric irregularities of these regions generate complicated flow patterns 
compared to that of straight vessels, characterised by lower average velocity, changes in direction (flow 
reversal) and stagnation. 
Amongst the leading hypotheses to explain the site-specificity of atherosclerosis is that the vascular 
endothelium is exposed to different biomechanical forces, which directly regulate endothelial cell function, 
gene expression and structure [Kwak14]. Vascular endothelium is the single layer of cells, endothelial cells 
(ECs), lining the luminal site of blood vessels and in direct contact with blood. ECs are constantly exposed to 
blood flow and as a result are subjected to mechanical forces induced by the flow and pulsatile blood 
pressure. The stationary endothelial surface experiences a tractive (frictional) force, called wall shear stress 
(WSS), due to the blood flow. Shear stress acts in parallel to the arterial wall and is determined by the flow 
pattern (blood velocity) and vessel geometry. Pulsatile flow in straight arterial vessel segments generates 
unidirectional WSS with a positive time average WSS of around 15-20 dyne/cm2 [Chatzizisis07]. 
Caro and colleagues in their seminal work on human cadavers put forward the notion of low time average 
WSS correlating to plaque formation [Caro69]. Low WSS is unidirectional but the periodic fluctuating 
magnitude results in a significantly lower time-average WSS (less than 10dyne/cm2) when compared to 
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straight vessel segments. The low WSS hypothesis was supported by a number of follow up  studies 
[Zarins83, Caro71, Ku85, Friedman81,  Gimbrone00, reviewed in: Peiffer13] and extended to include 
oscillatory shear stress following Ku et al. observation that artery thickening was strongly correlated to 
oscillatory shear index [Ku85, Moore94]. Oscillatory WSS is characterised by both changes in direction (flow 
reversal) and magnitude of WSS, generating a time-average WSS close to zero. In vivo rabbit and mice 
models, which use flow modifying devices (cuff [Cheng06] or partial ligation [Nam09] of carotid artery) that 
induce defined shear stress environments further support the causal relationship  between low and oscillating 
shear stress on the regional localisation of atherosclerosis. Despite recent debates regarding the validity of 
the findings and the relative importance of magnitude, frequency and oscillations [Peiffer13], the low and 
oscillatory shear stress hypothesis still has the predominant consensus of the research field [Davies09]. 
Disturbed flow is also believed to play a role in all stages of atherosclerosis: initiation, progression, 
remodelling, and rupture [Kwak14]. Specific heamatodynamic environments have been associated with 
plaque instability and rupture [Koskinas09, Chatzizisis08]. In addition, mechanical forces other than WSS 
also act on the ECs and contribute to atherosclerosis development. Blood pressure exerts a perpendicular 
force on the arterial wall, resulting in circumferential (tensile) stress. Tensile stress is believed to be important 
in the destabilisation and rupture of plaques [Pedrigi14].
It should be noted that there are other explanations for the focal nature of atherosclerosis. The mass 
transport theory states that shear stress affects transport of atherogens into the arterial wall. Initially it was 
thought that in areas of disturbed flow EC contact with lipids and other reagents is prolonged and therefore 
their uptake into arterial wall is enhanced [Caro71]. Later studies dispute the role of blood flow rate on 
atherogens uptake, and rather focus on the break down of the arterial wall’s transport system as the source 
of the enhanced uptake [Tarbell03]. Shear stress has been linked to increased EC leakiness  and increased 
wall permeability due to EC hypoxia [Tarbell10, Vincent14]. 
This project focuses on the direct effect of shear stress on endothelial cell function and its role on the 
initiation of atherosclerosis. Despite strong evidence for the association between shear stress and 
atherosclerosis initiation, there has traditionally been very little potential treatment focus on directly 
modulating shear stress. Shear stress environment can also affect the responsiveness of ECs to current 
drug treatments, highlighting the importance of taking into account biomechanical factors in the development 
of atheroprotective therapeutics, even for those interventions that do not directly address the issue of sheer 
stress. For instance, the effect of statins, one of the biggest blockbuster drug classes of recent years for the 
prevention of CVD, is enhanced in areas of undisturbed flow and impaired in atherosusceptible sites where it 
would be most beneficial [Ali09]. An exciting new avenue for shear-mediated atherosclerosis treatment is the 
developments of mechanosensitive liposomes that can target the delivery of drugs to most vulnerable sites 
[Saxer13]. Understanding the mechanism via which flow patterns are translated to biological effects and 
identifying the specific intracellular mechanoresponsive system activated by WSS can lead to the rational 
design of therapeutic interventions. 
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1.1.3 Complexity of endothelial mechanoresponses
Several studies, including both those at the reductionist level (i.e. identifying a discrete selection of genes), 
and those at the whole genome level (i.e. using microarrays), have started unravelling the molecular 
mechanisms involved in EC responses to shear stress. What is emerging is a highly dimensional complex 
response, consisting of 6-8 signalling pathways that regulate at least 8 acknowledged transcription factors, 
which control the expression of approximately 2000 genes [Frueh13, Chiu11, Tarbell14, Pan09, Bryan14]. 
Endothelial cells sense shear stress via receptors on their cell membrane, which activate mechanosensitive 
downstream signalling pathways (mechanotransduction). At least 10 different mechanoreceptors have been 
described including the glycocalyx, ion channels, adhesion molecules (e.g., PECAM1 and VE-cadherin), cell 
surface receptors (e.g., tyrosine kinase, G-proteins), membrane micro domains (e.g., caveola and primary 
cilia) and cytoskeleton components [Yamamoto11, Hahn09]. The diversity of mechanotransduction reflects 
the diversity of EC functions controlled by mechanical forces, both in healthy and pathological states. 
Mechanoreceptors are linked to a number of different signalling pathways including NFkB  pathway, MAPK 
pathway, Pi3K-Akt and nitric-oxide pathway. The integration of these signalling pathways is currently 
emerging and involves at least 8 transcription factors (e.g., NFkB, AP-1, BMP4 and atheroprotective KLF2, 
KLF4 and Nrf2). Bryan et al. reviewed the literature and described a mechanoresposnive inflammatory 
network of 25 genes focusing on the MAPK and NFB  signalling pathways and their interplay [Bryan14]. 
Davies et al. studied in vivo gene expression profiles under disturbed flow and revealed a network of 133 
genes involved in endoplasmic reticulum protein processing, which is hypothesised to push ECs into a state 
of chronic inflammation [Civelek09]. The studies of Davies et al. also revealed that in vivo atheroprotective 
and atheropromoting processes co-exist in EC regions of disturbed flow, further supporting the notion of 
atherosclerosis initiation as a highly complex network of interconnected components [Passerini04]. 
Historically drug discovery has been critiqued as the search for ‘magic bullets’; chemically designed highly 
selective ligands that act on a single target. However, the recent decline in pharmaceutical companies 
output, especially for CVDs, highlights the ineffectiveness of such an approach [Plump10]. The two main 
reasons for drugs failing at later stages of clinical development is lack of efficacy and clinical safety. This can 
be explained by considering the interconnectivity of cellular components, which implies that the phenotypic 
impact of altered gene expression can only be understood within the gene’s network context, since the 
alteration is spread along links and has widespread effects on multiple other genes. As a consequence, an 
emerging way to understand diseases is as ‘sets’ of up  and down regulated genes that interact in complex 
interconnected networks, which has given rise to the area of network medicine [Barabási11,Zanzoni09] and 
network pharmacology [Hopkins08,Arrell10].  
Network based drug discovery
Network pharmacology utilises a network perspective for drug discovery and attempts to identify the 
combinations of nodes in a given network that infer a desired therapeutic outcome, and then identifies drugs 
that match those profiles [DelSol 10]. In the context of CVDs, these could be the enhancement of 
atheroprotective pathways, and the blocking of atherogenic pathways. Multi-target approaches have been 
beneficial for treatment of cancer, depression and AIDS and are believed to act synergistically to improve the 
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efficacy of each of the agents involved, [Csermely05], reflecting the idiom ‘the sum is greater than the parts’. 
In the context of CVDs, statin is known for its pleiotropic effects, which extend beyond their originally 
ascribed function of inhibiting endogenous hepatic cholesterol synthesis [Antonopoulos12]. 
Network topologies can act as frameworks for optimal selection of drug targets taking into account the ability 
of the specific targets to control wider overall network behaviours [Liu11]. Such approaches also arguably 
have increased robustness, by taking into account redundancy of networks, thus avoiding or minimising the 
neutralisation of drug effects [Hwang08]. The topological position of targets can also help  inform and avoid 
adverse effects. WSS controls homeostasis and other fundamental cellular processes for EC physiology, 
therefore having a network might help  maintain the physiological phenotypes but still allow for a positive 
effect on controlling plaque development. 
In summary, the current understanding of regional differences in atherosclerosis initiation is that ECs in 
disturbed flow are sensitised to systemic risk factors via the activation of pro-thrombotic and pro-
inflammatory pathways by low and oscillating WSS. In contrast, unidirectional high WSS establishes an 
atheroprotective state characterised by anti-thrombotic and anti-inflammatory pathways, low EC turnover and 
low oxidative stress. Hence, treatment avenues include enhancement of atheroprotective pathways in areas 
of low oscillating shear or alternatively, EC priming reversal and/or stabilisation. In order to understand how 
distinct endothelial phenotypes become established and are maintained via different biomechanical signals a 
comprehensive description of the signalling networks regulated by biomechanical forces is needed. Over the 
past decades multiple mechanisms have been described to explain EC response to shear stress and 
hundreds of genes have been implicated in EC mechanoresponse. It remains largely unclear how these 
genes interact in space and time as part of a complex mechanoresponsive network. The ‘sheer’ number of 
mechanosensitive pathways and their complex interactions benefit from a systems biology approach to 
further our understanding of EC mechanoresponsive signalling networks. 
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1.2 Hypothesis and methodological approach
The overarching theme of this thesis is to uncover the causal molecular network that is activated by 
mechanical forces in endothelial cells. Of the high-throughtput (HTP) methods available, gene expression 
profiling and RNAi (RNA mediated interference) screening are the two most frequently and successfully used 
methods for the purpose of network inference. Gene expression profiles measure the mRNA abundance of 
all the genes in the cells, giving a compete view of the cell state under the experimental condition studied. 
RNAi screens (functional genomics) use siRNA molecules to experimentally knockdown a specific gene and 
measure the effect of the loss-of-function on a given biological phenotype. Biologists can then determine if 
the knockdown gene is involved in the process and whether it has an activating or inhibitory role. They each 
independently have been used for gene network inference and their limitations are reviewed in detail in 
Chapter 2. In this work we propose a two-step  approach, which integrates network inference from gene 
expression data with functional genomics within a single framework to set up an integrated platform for gene 
network inference and validation, (Figure 1.1). The hypothesis driving the platform is that efficient network 
inference can be achieved based on, symbolic representation for improved network inference combined with 
automated and highly parallelised validation techniques to form an integrative, repetitive cycle of 
measurement, validation and network refinement.
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Figure 1.1: Integrated platform for gene network inference and validation. 
The integrated platform consists of two components, a gene inference software and a bespoke RNAi 
platform, integrated through the design of informative experiments. The network inference method is based 
upon background knowledge and abductive reasoning, which applies a series of logic-based rules to infer 
gene networks that are guaranteed to explain the observations derived from high-throughput gene 
expression studies. The abductive reasoning used in this work is a complete inference process and therefore 
infers all networks compatible with the given data and prior knowledge. Consequently, the output consists of 
a list of gene networks, which could be in excess of 100. From this a large number of experiments need to 
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be performed to find the correct network. We tackle this problem with a combination of logic-based prediction 
of “informative”  experiments (to reduce the number of experiments needed) and an experimental platform 
capable of parallelisation (>600 independent experiments). The validation method is a robot driven high 
throughput siRNA platform incorporated within a flow device that enables the parallel execution of loss-of-
function experiments to validate the proposed networks. The outcome of these tests are used to prune those 
inferred networks that are not coherent with them, thus setting up an iterative cycle of validation and revision 
to obtain a fully validated network. 
1.3. Thesis Aims
Uncovering a fully validated mechanoresponsive network requires: (i) a gene expression dataset of 
endothelial cell transcriptome under the effect of mechanical factors, (ii) an accurate gene network inference 
method and (iii) a methodology to validate the networks. In order to achieve these, a number of technological 
innovations were necessary and developed within this thesis:
1. Development of software packages for gene network inference, integration of microarray datasets and 
imaging analysis;
2. Design and fabrication of experimental devices for coupling flow studies with high-throughput RNAi 
screening in primary mammalian cells; 
3. Optimisation of experimental protocols for live cell time-lapse imaging and high content imaged-based 
RNA quantification. 
Need for improved gene network inference (Chapter 2): The field of gene network inference has been 
very active in the last 8 years prompting the development of a community based program, Dialogue on 
Reverse-Engineering Assessment and Methods (DREAM), for defining challenges through which proposed 
inference methods can be benchmarked [Stolovitzky07]. Following five years of challenges and the 
evaluation of more than 40 inference methods, they published their findings in two seminal papers 
[Marbach12, Marbach10]. Current inference methods are capable of predicting approximately 60% of real 
networks, and the prediction rates drop  to 5% for complex eukaryotic organisms. Furthermore, these 
methods are limited as to their ability to infer causal networks and complex network motifs such as feedback 
loops and multiple inputs per gene. Methods that are capable of causal inference are restricted to 
interventional data, where the source of perturbation to the system is known in advance and cannot be 
applied to environmental signals such as shear stress. Hence, the need for an inference method for network 
inference of complex causal networks from observational data. 
Need for an integrated mechanoresponsive gene expression profile (Chapter 3): The inference of a 
mechanoresponsive network relies on the availability of comprehensive high quality input data. A review 
paper, undertaken by our group, reviewed the available microarray studies that exposed ECs to different 
shear stress regimes with the aim to determine a robust set of mechanoresponsive genes [Frueh13]. The 
key conclusion was that the lack of conformity of platforms and bioinformatics analysis and high variability in 
biological conditions (e.g., cell types, species, age, shear regimes) leads to high variability between reported 
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gene signatures and hinders the determination of a robust set of mechanoresponsive genes. Hence, the 
need for a systematic meta-analysis of the available microarray studies using consistent methods to 
determine a robust set of mechanoresponsive genes. 
Need for a bespoke RNAi platform (Chapter 4):  The proposed integrated platform can in principle be 
applied using any established method for RNAi screening. A systematic review by Doring et al. summarised 
the use of HTP techniques in atherosclerosis and revealed a lack of RNAi screening in the field [Doring12]. 
The primary reason for this is the lack of an HTP system capable of delivering RNAi molecules inside 
‘difficult to transfect’ primary cells such as endothelial cells. Transfection of primary cells is notoriously 
difficult, but it can be achieved with membrane electroporation, whereby electrical pulses temporarily open 
pores on the cell membrane and allow the siRNA to enter the cell [Luft15]. Existing cell electroporation 
techniques are either not HTP or not readily compatible with the application of flow which is essential for 
shear stress studies. Hence, the need to develop  an RNAi platform that incorporates an electroporator within 
a microfluid device, to carry out mechanotransduction studies. 
Need for High-content RNA quantification in live cells (Chapter 5): A successful RNAi screen requires a 
biological read-out to assess the biological effect of the loss-of-function. Most RNAi screens rely on 
phenotypic outcomes (e.g., cell division, cell shape) or they use plasmids encoding fluorescent proteins to 
monitor a single target (usually the transcription factor regulating the process under investigation). The 
informative experiments proposed as part of the integrated platform require that each spot on the RNAi 
platform consists of a unique pair of a knockdown gene and a readout gene. The arrayed design of the RNAi 
platform precludes the use of methods based on cell lysis and has to rely on microscopy based methods. 
Hence, the need to explore methods to parallelise the quantification of RNA levels on adherent live cells. 
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1.4 Thesis Outline 
This project has a multidisciplinary breadth that encompasses a range of research fields from both 
experimental and computational biology. Thus for clarity the thesis is presented in two parts. Each chapter 
addresses a different aspect of the overall platform, Figure 1.2.
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Figure 1.2: Thesis outline
Part I introduces a computational framework with a series of algorithms to transform transcriptional profiles 
into biological networks, starting from integration of multiple gene expression datasets and ending with 
design of informative experiments. 
- Chapter 2 introduces a novel algorithm, Abductive Regulatory Network Inference (ARNI), for causal 
network inference based on symbolic learning and demonstrates its expressive and predictive power 
using datasets from the DREAM consortium. The potential to use ARNI as a scientific assistant for 
designing experiments is also expanded upon. 
- Chapter 3 presents methods for the integration of gene expression profiles across platforms and 
species and their application for generating an integrated mechanoresponsive gene expression profile. 
which can be used for networks inference. 
Part II focuses on the development of new RNAi screening technologies and details the requirements for the 
validation platform to be used in the overall integrated platform.  
- Chapter 4 presents the fabrication of a high-throughput RNAi platform for mechanotransduction 
studies in primary mammalian cells. The RNAi platform consists of a number of components (highly 
efficient electroporator for mammalian cells, ultra-high precision robot dispenser, and a modular 
parallel plate chamber for experimental interventions) which are functionalised involving a series of 
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procedures (spotting, seeding and transfection and flow studies). Each step of the assemblage is 
evaluated and effective loss-of-function is demonstrated for multiple gene targets. 
- Chapter 5 details experimental protocols for quantifying mRNA expression in live cells. The usability 
and applicability of nanoparticles technology for live cell real time gene expression quantification is 
investigated. 
Chapter 6 concludes with a summary of the thesis and key contributions and discusses the future direction 
of the work. 
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Part I
Part I: Computational framework for gene 
network inference and analysis
Part I of the thesis presents a computational framework called Abductive Regulatory Network Inference 
(ARNI). ARNI integrates a logic-based model for gene regulation, heterogenous knowledge resources and 
a set of complementary bioinformatics methods for microarray data processing and feature selection. ARNI 
provides functionallity for data preprocessing, network inference and network analysis for automated design 
of follow up experiments. 
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Organisation of cellular responses and modelling 
constraints
Cells respond to the environment via the activation of signalling and transcriptional components to modify 
gene activity and define cellular functions [Barabási04, Jordan00]. External signals are coupled to internal 
molecular circuits (signalling networks), which consist of causal chains of protein-protein interactions that 
propagate the external signals from the cell membrane to gene expression regulators. Gene expression 
regulators (typically transcription factors) are part of transcriptional networks that modify the expression level 
of a gene (by up  or down regulation) and their downstream targets can affect any of the regulatory 
mechanisms mentioned above including the upstream signalling networks, thus creating feed back loops. 
The principles governing biological networks have been studied and certain characteristics have emerged. 
The basic unit of a biological network consists of two nodes connected via an edge. The nodes represent 
molecular components such as genes, transcription factors (TF) and proteins, while the edges represent the 
interdependencies between the nodes. Depending on the context of a given network, the interdependencies 
can be either physical interactions (e.g., protein-protein interaction networks) or functional dependencies 
(e.g., co-expression networks). These basic units are organised in network motifs, which represent recurrent 
patterns of connections. Dominant network motifs include feedback loops (positive and negative), which 
allow a gene to control its own expression, feed-forward loops (coherent or incoherent), whereby a gene has 
both direct and indirect connections to its target1  and fan-in motifs with multiple inputs per gene, which can 
be complementary or opposing to each other. Each of these motifs governs fundamental properties of the 
overall dynamic behaviour of the network such as robustness, oscillations, memory and bistability [Alon07, 
Milo02]. Finally, the network motifs are clustered into modules of highly connected nodes, and modules are 
interconnected to form the complete network. The global structure of the network is referred to as “network 
topology”. Networks can have directionality, in which case they are referred to as directed networks, as 
opposed to undirected graphs. Directionality indicates the flow of information through the network (i.e. there 
is distinction between upstream and downstream components), but it provides no information about the 
causality. Causality is captured by the sign of an interaction, which can be positive or negative. Unsigned-
undirected networks are suitable for analysing the networks topology characteristics, while signed-directed 
graphs also have predictive power. 
In this work we represent networks as activity networks, which are a qualitative representation of causal 
networks to represent the transfer (or flow) of information along paths. The edges are directed and signed. A 
pointed arrow between two genes, say gene x and gene y, represents the notion of “gene x activates gene 
y”. A blunt ended arrow between genes captures the relationship “gene x inhibits gene y”. Activity networks 
however lack detailed information on biochemical mechanisms. For example the statement “gene x activates 
gene y”, can have multiple interpretations at the biochemical level; gene x could affect the activation, 
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1 Feed forward loop motifs are either coherent, if the direct effect of the regulator is the same as its net 
indirect effect, or incoherent otherwise
production, degradation or stability of gene y. Hence, activity network edges can only be interpreted in terms 
of activation or inhibition. 
Biological network topologies have been shown to be sparse, scale-free and small-world, which means that 
there is a limited number of inputs per gene, but there are a small number of hub genes with a large number 
of connections [Barabasi04]. The modularity of the networks, together with hubs genes ensure that each 
gene can be connected to any other gene in the network via a small number of steps (small-world). 
Redundant, parallel and overlapping pathways ensure the adaptability to environmental fluctuation and 
robustness to failure. The inherent robustness of network topologies, however, imposes a considerable 
challenge in the identifiability and controllability of the networks since experiments designed to reveal the 
underlying structure of the networks cannot capture all the component of the network.
Proposed computational framework 
Systems Biology aims to build models that describe, at some level of abstraction, the underlying operation of 
a cell at the genomic and/or protein level. Our goal is to extract the regulatory network activated in 
endothelial cells following exposure to shear stress from high-throughput gene expression data, which 
provide a ‘molecular snapshot’ of the system under investigation.  An effective method for network inference 
should: 
(1) allow for causal network inference that covers signaling and transcriptional regulation,
(2) conform with known properties of biological networks including the detection of loops, chains and 
multiple inputs per gene,
(3) identify hidden components which are genes that are part of the network but in a particular 
experimental dataset there is no observable change in their state,
(4) employ feature selection wisely to maximise the gene domain considered by the inference tool, but 
at the same time reduce the search space sufficiently to ensure it does not exceed the 
computational resources available.
The central challenge is then how to choose an appropriate framework that would (i) enable the construction 
of a model from experimental data and (ii) empower such models with a predictive capability for new 
information beyond that used to construct the model. 
Part I of the thesis presents a computational framework called Abductive Regulatory Network Inference 
(ARNI). ARNI integrates a logic-based model for gene regulation, heterogenous knowledge resources and 
a set of complementary bioinformatics methods for microarray data processing and feature selection. ARNI 
provides functionalities for data preprocessing, network inference and network analysis for automated design 
of follow up  experiments. ARNI is implemented within the R/Bioconductor software environment 
[Gentleman04]. The architecture is illustrated in Figures 1.3. The R/Bioconductor interface communicates 
with a number of external data repositories and software environments for logic reasoning and network 
exploration.  A fully developed framework consists of four main libraries:
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Feature Extraction Library: Disease gene identification from domain specific gene expression data: 
The first step  in the network inference is the identification of shear responsive genes to include in the 
network inference. We have pursued a meta-analysis approach for the integration of available 
mechanoresponsive microarray datasets and set up  procedures to obtain a robust set of shear sensitive 
genes. This is accomplished by the Feature Extraction library, presented in Chapter 3.
Data Mining Library for interactome construction: Provides functions for communication with online 
databases and automatic retrieval and consolidation. The implementation of the data mining library is 
ongoing work. 
Network inference library: The core network inference library is presented in Chapter 2 and includes the 
logic program for abductive network inference which is expressed as a set of rules and integrity constraints 
written in ASP and Prolog representation languages. The R framework provides an interface for the inference 
tools and auxiliary functions for  preparing the input files and parsing the output into R structures.
Network Analysis library is presented in Section 2.4 and includes a logical model for abductive inference 
and prioritisation of informative experiments to couple the computational platform with the RNAi platform 
presented in Part II of the thesis. Section 2.4 also presents examples of ARNI assisted scientific discovery 
using ARNI’s state prediction and model checking capabilities.
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2Symbolic representation and inference of 
regulatory network structures
Chapter 2 Summary
Recent results have demonstrated the usefulness of symbolic approaches for addressing various problems 
in systems biology. One of the fundamental challenges in Systems Biology is the extraction of integrated 
signaling-transcriptional networks from experimental data. In this chapter, we present a general logic-based 
framework, called ARNI, where we formalise the network extraction problem as an abductive inference 
problem. A general logical model is provided that integrates prior knowledge on molecular interactions and 
other information for capturing signal-propagation principles and compatibility with experimental data. 
Solutions to our abductive inference problem define signed-directed networks that explain how genes are 
affected during the experiments. Using datasets provided by the dialogue for reverse engineering 
assessments and methods (DREAM)) consortium, we demonstrate the improved predictive power and 
complexity of our inferred network topologies compared with those generated by other non-symbolic 
inference approaches, showing the suitability of our approach for computing complete realistic networks. We 
also explore how the improved expressiveness together with the modularity and flexibility of the logic-based 
nature of our approach can support automated scientific discovery where the validity of hypothesised 
biological ideas can be examined and tested outside the laboratory. Work presented in this chapter has been 
published in Logical Modeling of Biological Systems (ISBN: 978-1-84821-680-8, pages 1:48) and reproduced 
here with permission (Appendix IV).
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2.1 Introduction
The complexity of biological systems has urged researchers to turn to high-throughput (HTP) techniques, 
which motivated the development of System Biology approaches to interpret, model and integrate the deluge 
of omics data available. A range of HTP techniques are routinely used to investigate the different levels of 
cellular biology (DNA, RNA and protein) and define genomes, methylomes, transcriptomes, miRNAomes, 
proteomes, kinomes, interactomes. The most established and mature technologies are those for RNA 
abundance and these form the focus of this work. 
Gene expression profiles measure the mRNA abundance of all the genes in the cells, giving a complete view 
of the cell state under the experimental condition studied. Gene expression profiles can be collected over a 
group  of similar samples under the effect of different environmental stimuli (e.g., different shear stress 
exposure) or disease states (e.g., cancer versus control patients). These kind of datasets are referred to as 
observational data, to distinguish them from interventional data, which are obtained by performing microarray 
analysis following a targeted perturbation (knockdown or over-expression) of a specific gene. With the 
exception of model organisms, high-dimensional interventional data are normally limited to a few 
experiments investigating the effect of key regulators of the process under investigation and are rarely 
associated with systematic RNAi screens which investigate large numbers of genes. Large scale RNAi 
screens often rely on imaged-based readouts such as high content morphological measurements or 
molecular readouts of one or two reporter genes. Large scale RNAi screens have been used for genetic 
screens to uncover genetic interactions maps [Horn11]. These approaches are discussed further in Chapter 
6. In this chapter we focus on methods using transcriptional data to infer gene regulatory networks. 
In recent years several studies have addressed the problem of network inference from experimental data. 
The tools available are very diverse but they can broadly be classified into two categories: those that derive 
network from experimental data alone, and those that incorporate prior knowledge in the inference. Our 
study falls under the second category. In the next section, we introduce each category and give an overview 
of available methods. Comprehensive reviews can be found in  [Rotival14, Markowetz07, DeSmet10, He09]. 
2.1.1 Data driven network inference
A number of approaches have been proposed in the literature to infer networks from interventional data 
[Markowetz10]. The Nested Effects Model (NEM) approach introduced by [Fröhlich08] is based on the 
assumption that the perturbation of an upstream gene affects genes also identified by the perturbation of a 
downstream gene. Thus, NEM searches for nested clusters of affected genes within the given microarray 
data to define the hierarchy of the perturbed genes. The problem of this approach and others that follow 
similar principles [Pinna10, Anchang09, Sachs05, Luo11] is that the genes taking part in the networks need 
to be known in advance since the inferred network only includes the perturbed genes. Furthermore, these 
methods require the systematic perturbation of all the genes in the network and therefore are not appropriate 
for large scale networks. For instance, in our particular area of interest, interventional data are only available 
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for a very small subset of the genes involved in endothelial cell shear responses and the large number of 
genes involved in mechanoresponsive pathways makes it economically and practically impossible to obtain 
microarray datasets for systematically perturbed datasets. Therefore we have to rely on observational data 
for the inference of shear responsive networks. 
Four categories of statistical methods have been proposed for the inference of networks from observational 
data: 1) correlation and partial correlation methods, 2) information theory based methods, 3) regression 
based methods, and 4) probabilistic Bayesian methods.
 A straightforward way to compute a co-expression network is to calculate the Pearson correlation coefficient 
between all pairs of genes, and choose a threshold for selecting significant interactions. Correlation based 
methods were one of the first methods used for gene network inference [Stuart03]. Correlation networks can 
be enhanced in several ways. [Kostka04] introduces the concept of differential co-expression to identify gain 
or loss of co-expression patterns between two conditions. WGCNA [Zhang05] uses the Pearson correlation 
coefficient to define a correlation measure for all pairs of genes. The correlation matrix is then converted to a 
topological overlap  score which considers each pair of genes in relation to all other genes and measures the 
interconnectivity between a pair of genes (i.e the commonality in their neighbours). Hence WGCNA can 
identify pairs of genes that are not directly connect to each other but still have a high topological overlap 
score. Correlation-based methods detect linear relationships in the data. Consequently, they are adversely 
affected by outliers and cannot capture non-linear dependancies. Information theory based methods have 
been proposed to overcome these limitations. The relevance network approach of [Butte00] computes all 
pairwise mutual information (MI) values between genes and uses a hard threshold to filter out weak 
interactions. Advanced implementations of MI-based methods include CLR [Faith07] and ARACNE 
[Margolin06], which include procedures for eliminating false correlations and indirect effects. CLR uses the 
empirical distribution of all MI scores to calculate the statistical likelihood of each MI value, while ARACNE 
employs Data Processing Inequality to process triplets of genes and removes the link with the minimum MI 
score within the triplet. Partial correlation based methods [Schäfer05] are based on graphical Gaussian 
models (GGMs) and can distinguish between direct and indirect interactions. Partial correlation represents 
the correlation between two genes without the effect of all the other genes. 
The above mentioned methods infer unsigned undirected co-expression networks. Such networks are 
suitable for analysing the structure (topology) of the networks (e.g., scale free parameters, hub 
identification), but they lack mechanistic insight and predictive power. Co-expression networks provide no 
information regarding dependency of one gene’s activity on another or information flow through the network. 
For instance, three genes that are found to be co-expressed, might be in a linear chain configuration, a fork 
configuration, where one gene regulates the other two, in a collider configuration, where the two genes jointly 
regulate the other gene, or they might all be regulated by some unknown gene that was not detected in the 
inference. 
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Directionality can be inferred using regression analysis to identify best predictors for each gene [Huynh-
Thu10, Küffner12]. GENIE3 [Huynh-Thu10] is based on the assumption that the expression pattern of each 
gene can be predicted by all the other genes, and formulates the network reconstruction task as a series of 
regression problems. For each gene, a function is learned and a ranking of all genes with respect to their 
importance in explaining the given gene is computed. The rankings are aggregated to provide a global 
ranking of interactions. 
An alternative group  of methods is that proposed in [Friedman00, Fröhlich08, Werhli08] which employ 
probabilistic graphical models to infer joint probability distributions over the observations. Bayesian networks 
capture the conditional dependencies between genes and therefore they are directed networks. A key 
limitation of Bayesian networks is their reliance on direct acyclic graphs, which cannot represent feedback 
loops, a key component of signaling networks. 
The inference of complex networks from experimental data is still an ongoing challenge. The difficulty of this 
task arises from the complexity of the networks and the nature of the data: they are typically noisy, high 
dimensional, and sparse. The DREAM evaluation report, following the assessment of 35 different inference 
methods, concluded that the best performing methods achieve a maximum of 60% recovery of networks, 
which drops to 5% for eukaryotic cells [Marbach12]. The authors advocate the integration of results from 
multiple inference methods to compute a community network and for methods that allow the integration of 
additional biological knowledges (also called prior knowledge) since they performed the best. 
2.1.2 Integrated approaches for network inference
Prior knowledge can be in the form of gene-wise information priors (node attributes) or structural priors (edge 
attributes). Node attributes most frequently include a predefined list of transcription factors that are then 
allowed to be involved in the inference, thus reducing the search space for the inference and reducing false 
positives. Interactome is the collective term used for molecular networks whose nodes are linked by physical 
interactions [Vidal11]. These include protein protein interactions (PPI) networks whose edges correspond to 
physical interactions between proteins (including enzyme-substrate relations); metabolic networks whose 
edges correspond to biochemical reactions; transcriptional networks whose edges correspond to physical 
binding of a transcription factors (TF) to DNA regulatory elements and RNA networks (microRNA networks) 
whose edges correspond to RNA-RNA or RNA-DNA interactions. PPI networks are undirected and unsigned 
while TF-DNA and enzyme-substrate networks are directed. There are numerous databases that attempt to 
curate, integrate and evaluate each of these networks including amongst others STRING [Szklarczyk11], 
HPRD [Stelzl05], PhosphoELM [Dinkel11], JASPAR [Mathelier13], IntegromeDB  [Baitaluk10].  Signaling 
pathways are the most informative kind of priors consisting of signed directed pathways of physical 
interactions, but this information is sparse, covering only around 10-20% of the protein-coding genes. This is 
the type of network, our inference approach aims to infer. Signaling pathways can be extracted from online 
databases (KEGG  [Kanehisa11], Reactome [Croft14], WikiPathways[Kelder12]). Signed directed 
relationships can also be extracted from PubMed literature using text mining software [Rebholz-
Schuhmann12 , Hoffmann04, Haibe-Kains12]. 
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The interactome provides a rich source of information for software tools such as Ingenuity Pathway Analysis 
(IPA) [Kramer13], Cytoscape [Shannon03] and STRING  [Szklarczyk11] that provide functionality to map a 
given list of hit genes onto the interactome. Users have the choice to get all the paths connecting the hit 
genes, or alternatively the search can be restricted to a specified neighborhood (e.g., paths two steps away 
from the given hit genes). The resulting networks are a mixture of unsigned-undirected and signed-directed 
edges depending on the source of the interaction. The networks are analysed for topological properties (e.g., 
topological modules and hub gene discovery). In situations where the fold changes for the hit genes are 
available, there are methods available, the most popular being jActiveModules, to discover subnetworks that 
are enriched in hit genes i.e groups of genes that are topologically close to each other and are functionally 
related (under the assumption that hit genes are functionally related) [Ideker02, Simeone14]. 
The above mentioned tools do not use the interactome as a tool to guide network inference, they simply use 
it as a scaffold on to which the gene expression data can be mapped. The gain of prior knowledge 
integration in gene networks inference has been reported by many authors [Olsen14, Vicente12, Chen12, 
Sirbu15] and it improves both the completeness and precision of networks. Vicente et al. assessed the gain 
in network inference by each of these types of priors and concluded that PPI incorporation showed 90% gain 
in sensitivity of networks (ability to detect true positive), while node attributes derived from GO  terms showed 
a gain in precision of the networks [Vicente12]. Integrative approaches can extend gene networks beyond 
the ones that are experimentally measured and are not restricted to gene pairs that exhibit co-expression 
behaviours. An integrated approach is particularly important for causal network reconstruction which cannot 
be accomplished solely from observational data. Djordjevic et al. demonstrated that ARACNE and GENIE 
are not able to infer causal networks from observational data, and known causation did not always lead to 
co-expression in the expression data [Djordjevic14]. In the absence of any available interventional data, prior 
knowledge incorporation can help convert correlation to causation.
Different formalisms have been suggested for incorporating priors in network inference [Tan08], including 
adaptations of Bayesian approaches [Mukherjee08, Djebbari08, Qin12], regression models [Vicente12] and 
differential equation based models [Greenfield13]. In these approaches, the resulting networks still represent 
statistical associations. Another series of works considers the network inference task in terms of 
reconstruction of flow networks [Berger13]. This set of algorithms build on the idea that established 
knowledge on cellular networks provides a scaffold for interpretation of new datasets. Flow networks aim to 
explain experimental observations on a template of protein-protein and TF-DNA interactions, by establishing 
causal chains between predefined set of genes in such a way that the resulting information flow satisfies 
signal propagation principles. The inferred flow networks are based on physical molecular interactions and 
as such they are easier to interpret than statistical associations and can reveal the underling biological 
mechanism of gene regulations. Flow networks are uniquely capable of identifying hidden network 
components which have not been identified due to noisy and incomplete datasets. A recent study concludes 
that flow networks have better prediction power for disease genes (i.e in discovering the hidden elements) 
since they take into account both topological parameters as well as functional information. [Navlakha10] 
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Many different formalisms have been explored for flow network reconstruction, which differ in terms of the 
input, output and flow optimisation algorithm used. In the work of [Yeang04] and [Ourfali07], given a set of 
source/target pairs, and a set of rules for flow propagation, the authors use maximum-likelihood and linear 
programming, respectively, to search for the most probable path to connect source to targets. The targets 
are identified via differentially expression analysis of expression data, following the knockdown of the 
perturbed gene. The output are possible causal networks of molecular cascades that could in principle 
explain the effect. Yosef et al. follows a global optimisation approach (Steiner tree algorithm) which considers 
all the affected genes concomitantly by defining a set of upstream regulators (e.g., hits from RNAi screens or 
differential expression analysis) and a common anchor point onto which all the regulators should converge. 
(e.g., a biological process) [Yosef09]. The method is used by [Silberberg12] to infer drug response networks 
whereby for each drug considered, the drug was defined as the common anchor point and it was connected 
to the rest of the network  via a set of drug responsive genes downloaded from the Connectivity Map 
database. The upstream regulators that have to converge onto the drug anchor were drug targets extracted 
from the DrugBank database. In these methods, causal inference is restricted to datasets where the source 
of perturbation is known and therefore they cannot be used for observational datasets such as the effect of 
shear on endothelial cells.
[Yeger-Lotem09] and [Huang09, Tuncbag13] relax the assumption on source-target pairs but require 
additional data types as input. The work of [Huang09] models genes and proteins as different entities and 
integrates gene expression data, proteomic data and the interactome. The authors implement a price 
collecting Steiner tree algorithm to connect a given set of seed genes, such that the sum of the cost of the 
chosen interactions and the price of the seed not included is minimised. The method proposed by [Yeger-
Lotem09] integrates the interactome, RNAi screen hits and gene expression profiles. The underlying 
assumption of this method is that RNAi screens identify upstream regulators, while gene expression profiles 
identify downstream regulators. The inference task is implemented as a minimum-cost flow optimisation 
problem, with the objective of maximising the flow between the upstream RNAi screen hits and downstream 
transcriptional changes, while minimising the overall cost. Hence, these setscxz of methods can only be 
applied to problems where additional RNAi screen data or proteomic data are available. 
In summary, the existing works on flow network reconstruction are limited in their applicability requiring either 
interventional data or additional datatypes (proteomic/RNAi screen). In this work, we address these 
limitations and extent the applicability of flow networks to observational gene expression profiles through a 
symbolic approach for network inference. 
2.1.3 Logical modelling in systems biology
The available prior knowledge is descriptive, qualitative rather than quantitative, and incomplete. It is then 
important to require a framework that is (a) high-level close to the human description of the phenomena, and 
(b) modular and flexible so that the models can easily be adapted to new information and other changes that 
might come about. Under these conditions and requirements for our language, a symbolic or logical 
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framework is particularly suitable. A symbolic representation allows for an extensive prior knowledge 
incorporation, which can integrate different kinds of datatypes within the same framework as relational data 
without the need of extensive pre-processing. Furthermore, within a logical approach we can employ 
abductive reasoning  to help in the process of building a theory from experimental data by making 
assumptions about facts that could be true and not directly observable. In a symbolic framework of the type 
to be considered here the models are qualitative models describing the underlying logical system that 
governs biological systems, and thus parameter estimation is not required. Computational effort is focussed 
on identifying the model structure, which typically requires data of both less precision and quantity than that 
required for identification of quantitative models. Qualitative models are of course not equivalent or as 
informative as quantitative counterparts but they can still be used for inference or simulation, and can be 
used as blueprints for quantitative model definition [LeNovere15, Feiglin12]. The suitability of logical 
modelling for addressing challenges in Systems biology is evidenced by an increasing number of 
publications addressing various challenges in Systems Biology [Morris10, Iyengar11,Cerro14]. 
The existing body of works is concerned with refining existing networks including detection of 
inconsistencies and computation of repairs  [Gebser11, Gebser10b], expansions and optimisation of existing 
biological models with combinatorial logic [Schaub09, Guziolowski13], and state-prediction [Gebser10b, 
Demolombe14, Folschette12,Tran09, Chaouiya12]. A number of logic-based software tools are already 
readily available to biologists to facilitate automatic reasoning on regulatory networks. CellNetOPt [Terfve12] 
provides multiple logic formalisms for training existing signalling pathways to context-specific 
phosphorylation data and learning their combinatorial regulation. BioQuali [Guziolowski09] implements the 
Sign Consistency Model presented in [Siegel06] for detection of inconsistencies between a given network 
and experimental data. The functionalities of BioQuali are expanded by the BioASP library 
[Gebser10,Kittas15] to computation of repairs and predictions. PathwayLogic [Eker04] provides methods for 
the simulation of signaling and metabolic networks following perturbations to given networks. The usability of 
these software tools is supported by tools that convert standard network representation formats (e.g., SBML, 
SBGN, metabolic molecular maps) available on online databases into logical representations [Chaouiya13, 
Rougny14, Demolombe14].
The series of contributions discussed above illustrate the potential of logic reasoning for applications in 
Systems Biology. Although very promising and effective in their computational tasks, none of these existing 
approaches can do de-novo topology inference. Several publications based on logic programming have 
addressed the problem of reconstructing metabolic networks [Ray08, Ray10, Tamaddoni-Nezhad06, 
King04]. Metabolic pathways are governed by different dynamics and mechanism of action; they are 
modeled as reaction graphs with reactants, modifiers and products. The same logic rules cannot be applied 
to signalling regulatory networks, which operate as influence graphs. More directly related to our domain is 
the work of [Papatheodorou05], which uses abductive logic programming to infer gene dependencies that 
explain the changes in gene expression levels. [Papatheodorou05] presents a method capable of feedback 
loop detection, which supports our hypothesis that the non-restrictive nature of symbolic representation 
allows for complex network structure detection. Our work advances that in [Papatheodorou05] in several 
ways, specifically by allowing the use of prior knowledge, modelling and reasoning about co-current gene 
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regulation and presenting a framework that can act as a scientific assistant to biologists for testing the 
validity of new hypotheses.
The results to be presented in this chapter tackle the issue of causal network inference from high-throughput 
observational data. We propose a new method called Abductive Regulatory Network Inference (ARNI) 
based on symbolic representation to address the limitations of current inference methods. ARNI is based on 
flow network models with links corresponding to molecular interactions from the knowledge base. Our 
construction of regulatory networks relies on abductive reasoning as an automated form of the scientific 
reasoning of rationalising high-throughput experimental data. The output of our abductive inference task are 
causal signed directed networks, in which the information flow along depth-bounded paths between seed 
genes satisfies signal propagation principles and the inferred causal relationships explain the experimental 
data and the known biological function of regulators. We demonstrate the improved performance of the 
approach through a series of evaluation experiments that test the effectiveness of the abductive network 
inference and explore the expressiveness of the logical framework. We also examine the usefulness of our 
abductive approach as scientific assistant and how this, together with the modularity of the approach, can 
support the further development and improvement of the initially constructed networks.
The rest of the chapter is structured as follows. Section 2.2 provides background theory on logic 
programming and presents the ARNI approach with its main components. Section 2.3 describes the results 
of evaluating the predictive power of our approach and demonstrates the increased expressive power of 
ARNI. Section 2.4 explores ARNI as a scientific assistant for biological hypothesis testing and presents initial 
results on the design of informative experiments to couple our inference platform with the validation platform 
presented in Chapter 4 and Chapter 5. Section 2.5 concludes the chapter with a discussion on the strengths 
and limitations of out ARNI approach and future directions.
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2.2 Abductive Regulatory Network Inference (ARNI) 
framework
In this section, after briefly introducing the basic syntax of logic programs and the basic notions and 
terminology from abduction, we study how the problem of inferring regulatory networks can be formalised as 
an abductive problem. We analyse the general biological features of the problem and develop  the underlying 
logical model over which the task of constructing regulatory networks from experimental data can be 
understood and computationally realised in terms of abduction. 
2.2.1 Logic programming background
In what follows we introduce the basic syntax of logic programs. An atomic formula (or atom in brief) is an n-
ary predicate P followed by an n-tuple of terms. A term can be a constant, a variable, or an expression of the 
form f (t1,...,tm) where f is a function of arity m and t1,...,tm are terms. A positive literal is an atom ϕ, and a 
negative literal is a negated atom, written as not ϕ, where not is the negation as failure operator. A normal 
clause is a rule of the form ϕ  :- ϕ1, . . . ,ϕn ,where ϕ  is the head atom and ϕi are the body literals. The 
connectives :- and , (comma), can be read as ‘if’ and the logical ‘AND‘ respectively. A normal logic program is 
a set of normal clauses. A clause is said to be definite if all its body literals are positive. A definite logic 
program is a set of definite clauses. A clause without a body (when n = 0) is called a fact. A clause without a 
head is a denial (also called integrity constraint). A clause is said to be ground if it contains no variables. A 
clause with variables is shorthand for all its ground instances. The standard semantics for a normal logic 
program are given in terms of its stable models, defined below in Definition 2.1. 
Definition 2.1 (Stable models):  Let Π be a ground logic program. Let X be a set of ground atoms. The 
reduct of Π with respect to X, denoted by Π X is obtained by removing from Π:
! - any clause containing a negative literal not A with A ∈ X;
! - all negative literals in the remaining clauses.
X  is a stable model of Π if and only if X is the minimal Herbrand model of Π X, where a Herbrand model is 
said to be minimal if it does not strictly include (in terms of set inclusion) any other model.
Normal logic programs may have no, one, or several stable models and it is usual to identify these models 
as the possible meanings of a program [Gelfond88]. By construction, the reduct Π X is a definite clause 
program. The minimal Herbrand model of a definite clause program is always well defined and is unique. 
Stable models are also called answer sets. Answer sets are also defined for a wider class of logic programs. 
For normal logic programs, answer sets and stable models coincide and the two terms can be used 
interchangeably. 
Abduction is a process of reasoning from observations to possible causes by making assumptions about 
facts that could be true in order to explain the observation. Formally, abduction is concerned with the 
construction of explanations, a set of facts Δ, that conform with given observations and prior knowledge, Π, 
and that, together with Π, are consistent with given integrity constraints, IC. Abductive explanations are 
Symbolic Representation and Inference of Regulatory Network Structures
40
usually restricted to ground atoms from a predefined set called abducibles. Intuitively, abducibles are 
undefined information in a given knowledge base, whose truth value can be assumed in order to (partially) 
complete the knowledge base. Instead of failing in a proof when a selected subgoal fails, this subgoal is 
viewed as a hypothesis. In logic terms, given a set Π of normal clauses, expressing prior knowledge and 
observations, a set IC of integrity constraints, and a set A of abducible ground atoms, an abductive 
reasoning problem consists of finding a set of abducibles Δ ⊆ A such that IC is satisfied in a canonical model 
of Π ∪ Δ. We assume as canonical models, the stable models of Π ∪ Δ. Such stable models are also 
referred to as generalised stable models of the abductive task [Kakas90].
Consider the logic program given in Table 2.1 as an example of an abductive problem. The program is a 
logical representation of family relationships and includes the concepts of uncle/2 and brother/2 
together with background facts on gender of individual people. The background knowledge is incomplete in 
terms of parent-child relations and therefore the abducible is the parent/2 atom. Our abductive task is to 
explain the observation that Jon is the uncle of Ann, in terms of parent-child relations. According to the 
definition of uncle/2, in order to prove uncle(jon,ann), it is necessary to prove brother(jon,Z) and 
parent(Z,ann). The set of possible ground instances for Z is {liz, tom, bob}. parent(liz,ann) is 
rejected because brother(jon,liz) cannot be proven, since it requires parent(bob,liz) to be 
abduced that violates the first integrity constraint. Similarly, parent(bob,ann) is rejected, because 
parent(jon,bob) violates the second constraint. Therefore, with abduction we can complete the family 
tree by deriving the following explanation: {parent(tom,ann),parent(bob,tom)}.
Table 2.1 Example abductive problem for the inference of parent-child relationships
Background  Π Abductive Solution Δ
uncle(X,Y) :- brother(X,Z), parent(Z,Y) 
brother(X,Y) :-  male(X), parent(Z,X), parent(Z,Y), X ≠ Y. 
male(bob).
male(tom).
male(jon).
female(ann).
female(liz).
parent(bob, jon).
Observation  :   uncle ( jon,  ann)
Assumptions:
parent ( tom, ann),  parent (bob, tom).  
jon$
bob$
tom$
ann$
liz$
Integrity Constraints  IC
% Bob does not have a daughter
:-  parent(bob, Y), female(Y).
% It is not possible to be both the parent and the child 
:-  parent(X, Y), parent(Y, X). 
% It is not possible to be both a parent and a brother to the 
same person
:-  parent(X, Y), brother(X, Y). 
Abducibles  A
parent(X,Y)
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In our domain of gene network inference, the same principles can be applied: the objects in the domain are 
are genes, the (incomplete) relations to be abduced are the relations between gene activators/inhibitors and 
their targets and finally the rules are a logical representation of the principles involved in gene regulation. 
The observations are the expression values of the genes, which we wish to explain in terms of their 
relationships with other genes. 
2.2.2 Logical Model of Signed-directed Networks
In our ARNI abductive framework, the abductive problem is to identify causal regulations (i.e. activating or 
inhibitory links) that form a regulatory network that consistently satisfies the observed data. Within ARNI, 
causal regulations can be of two types, compatible and competitive gene influences. Compatible links 
consist of regulators (i.e activators or inhibitors), whose expected effect on their target, as given by the sign 
consistency model presented later in the chapter, explains the observed experimental data. Hence, a 
network of compatible links is sufficient to explain how the observed experimental data came about. So why 
do we also need to infer competitive influences? Competitive influences consist of regulators that can also 
act on a given gene but in this particular dataset their effects have been masked/overpowered by the more 
dominant effects of a compatible regulator. For instance, assume node A is under the influence of two 
regulators, node B  and node C. These regulators have opposing powers on A; node B promotes the activity 
of A while node C inhibits the activity of A. As a result, in a particular dataset node A would have a specified 
activity level and only one of these influences will be compatible with the experimental data, while the 
competing influence would have been overpowered and thus the effect of one of the regulators on A is 
masked. The end result is enrichment of the learned network by possible competing interactions that could 
have been true but which were dominated by the competing influence.
It should be noted that the biological mechanism of action of compatible and competitive regulators is the 
same. Classification of regulatory links into compatible and competitive is data dependent and only valid 
w.r.t. the experimental data used to infer the network. The biological motivation for modelling competitive 
gene influences is in order to reflect the underlying structure of real biological networks, where crosstalk 
between signalling pathways, regulatory feedback mechanisms and redundancy are common aspects of a 
biological system. Three of the most frequent network motifs that occur in biological networks are feedback 
loops, feed-forward loops and fan-in motifs. In all these motifs, genes are under the effect of multiple inputs 
that might be opposing each other. For instance, the feed forward loop  (FFL) motif consists of a regulator 
that affects a target gene via two alternative paths: a direct path and an indirect path via other genes. In 
incoherent FFL the indirect path has an opposite effect to that of the direct path. Similarly, negative feedback 
loops consist of a gene negatively affecting its own production, and thus opposing the regulator that 
originally triggered its activation. While this setup  allows the cells to fine-tune the responses to a stimulus 
and ensure robustness to noise, it poses an issue with their detection. Any inference method aiming to detect 
such motifs needs either to rely on multiple experiments to expose each of the influences individually, or to 
model the concept of competitive gene influences explicitly, as done in our approach. The latter case has the 
added advantage that network motifs can be detected using less experimental data, and competitive gene 
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influences can be placed within the same network as their compatible counterparts. Including these 
regulations in the final solutions is important for the applicability of the networks within the scope of planning 
future experiments and network based drug discovery/repositioning. Following an experimental perturbation, 
competitive gene influences could compensate for the intended experimental response thus rendering the 
experiments non-informative. Similarly, competitive gene influences that are enhanced in the presence of a 
drug might lead to unforeseen side effects. Overlooking the problem of competitive gene influences can 
result in inconsistencies between the observed and predicted drug effects/experiment outcomes, hindering 
the process of knowledge discovery.
Computing a regulatory network that conforms with observed gene expression data means discovering those 
unknown compatible and competitive regulations between genes that cause the observed data, in a way that 
is consistent with given biological constraints. Our ARNI abductive framework is composed of a rule-based 
model, called formal model, an extensional knowledge, called prior knowledge, and information about 
experimental data. The first expresses biological principles on how interactions between genes are expected 
to affect the concentration of genes; the prior knowledge captures any known information about specific 
genes, including molecular interactions between two genes and functions of genes, which are normally 
available from online biological databases. We describe below each of the components of our ARNI 
framework.
2.2.2.1 Prior Knowledge 
The domain of genes considered in our abductive task is given by the set of genes that are present in the 
prior knowledge. We denote this set with G. Known potential interactions between genes are expressed in 
the prior knowledge as logical facts of the form interactive_potential(gj,gi), which state that “there 
is a form of interaction between genes gi and gj”. Gene interactions can be of two types, protein-DNA 
interactions (PDI) and protein-protein interactions (PPI). PDI are unidirectional links from a transcription 
factor to a regulated gene, whereas PPI interactions are undirected links between proteins. Therefore, our 
prior knowledge will include only one ground fact of the form interactive_potential(gj,gi), for any 
known potential PDI interaction, and for any known PPI interaction between pairs of gi and gj, two ground 
facts interactive_potential(gj,gi) and interactive_potential(gi,gj). We denote with 
IPprior the following set of ground facts:
IPprior = {interactive_potential(gi,gj) | gi ∈ G  and gj ∈ G }   (1)
It is important to note that the information of interactive_potential in the prior knowledge does not 
fully capture the regulatory effects between genes as it does not express the type of causal relationship 
between two genes. This information is expressed by our abducibles. It is possible, however, that for some 
pair of genes, say gi and gj in G, specific information exists about their signed-directed regulation. Any such 
knowledge is expressed as atoms of the form established_regulation(gi,gj,s) where gi and gj are 
different genes in G and s is again the type of regulation. For instance, a ground atom of the form 
established_regulation(gi,gj,1) states that gj is a known  activator of  gi, whereas  a ground atom 
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of the form established_regulation(gi,gj,-1) denotes  that gj is a known inhibitor of gi. Again, our 
integrity constraints guarantee that abduced signed-directed regulations between genes are consistent with 
any already known type of regulation. We denote with ERprior the following set of ground facts:
ERprior = {established_regulation(gi,gj,s)| gi ∈ G, gj ∈ G 
                                                  and s ∈ {—1,1}} (2)
Inferred regulations between genes also have to be consistent with any known regulatory functions of a 
gene. Known regulatory potentials for genes are extracted from online biological databases and expressed in 
our prior knowledge as ground facts of the form regulatory_potential(gi,s) where gi is a gene and s 
is the type of regulation, which can be 1 (for activator) or -1 (for inhibitor). For instance, the statement 
regulatory_potential(gi,1) (resp. regulatory_potential(gi,-1)) in the prior knowledge 
captures the fact that the regulator gene gi can only act as an activator (resp. inhibitor) of other genes. 
When no information about the regulatory potential of a gene is included in the prior knowledge (because 
unavailable), then that gene can be assumed to have either positive or negative effect on any other gene. 
Again our abductive inference process takes into account these two possibilities when reasoning about the 
effects of gene interactions. As explained later in this Section, integrity constraints will guarantee that such 
assumptions are made in a consistent manner. We denote with RPprior the following set of ground facts:
RPprior = {regulatory_potential(gi,s) | gi ∈ G and s ∈ {-1,1}} (3)
Finally, information about experimental data is also part of the prior knowledge. This includes the expression 
value of the genes measured in an experiment2, represented using ground facts of the form 
exp_data(gi,s), where gi is a gene and s is the state of the gene, which can be equal to 1 (resp. -1) to 
denote that the expression value of gi has increased (resp. decreased). Specific information about genes 
that have been potentially overpowered during the biological regulation process is also computed from the 
experimental data and added to the prior knowledge as ground facts of the form overpowered(g,gi,gj), 
where g, gi and gj are different genes. This fact captures the biological notion that the effect of gene gi on g 
has overpowered the effect of gene gj on g. For this to occur the degree of inter-dependency between the 
expression value of gi and g, multiplied by the degree by which the expression value of gene gi has 
increased, is higher than the inter-dependency between the expression value of gj and g, multiplied by the 
degree by which the expression value of gene gj has decreased.  
ExpData = {exp_data(gi,s) | gi ∈ G and s ∈ {—1,1} 
∪ {overpowered(g,gi,gj) | g ∈ G, gi ∈ G and gj ∈ G} (4)
The prior knowledge also includes the notion of a subset of genes, within the large pool G, that are 
considered to be seed genes. Typically, seed genes are all or a subset of the genes identified as being 
affected (i.e differentially expressed) in a given experiment. Seed genes allow biologists to specify what 
aspect of cellular biology they are interested in and therefore define the scope of the inferred networks. This 
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2 We assume in this work the logic-based modelling of regulatory networks from single experiments. The approach can 
be easily generalised to cross-experiments problems by extending the formalisation of our model with an extra argument 
to denote the name of the experiment 
information is represented using ground facts of the form seed(gi), where gi is a seed gene.  We denote 
with SeedGenes the following set of ground facts
!   SeedGenes = {seed(gi) | gi ∈ G} (5)
In summary, the prior knowledge of our ARNI's background knowledge, denoted with Bprior, is given by the 
union of specific subsets of the sets (1)-(5).
2.2.2.2 Rule-based underlying model
The core rules of our model seek to connect a set of genes (i.e. the seed genes), which have been affected 
in a biological experiment, to each other, either directly or indirectly by using the information on interactive 
potentials given in the prior knowledge, and to abduce signed-directionality between linked genes that are 
consistent with the (biological) integrity constraints explained later in this Section. ARNI is implemented as a 
two step procedure, Figure 2.1. 
ﬁndall	for	Query	
([connect_seeds(M)])	
STEP	1:		Extract	relevant	priors	
			Op)mise	
#maximize{explain(X)}.		
STEP	2:	Inference	of	causal	networks	
SeedGenes!
RPprior!
ERprior!
ExpData!
Rel_IPprior!
SeedGenes!
IPprior!
	
ASP	model	Prolog	program	 compa7ble/3	
compe77ve/3	
state/2	
STEP	1	 STEP	2	
Figure 2.1: Flow chart for ARNI inference approach.
Top  panel: ARNI seeks to connect a set of seed genes that have been affected in a biological experiment 
(yellow nodes) to each other, either directly or indirectly via non seed genes (grey nodes), by using the 
information on interactive potentials given in the prior knowledge, and to abduce causal relationships 
between linked genes. Each node of the inferred network is associated with an expression state (up-
regulation or down-regulation), also abduced by ARNI, that satisfies the signal propagation specified by the 
abduced casual relationships. Bottom panel: ARNI is implemented as a two step  procedure. The first step 
computes the set of relevant interactive potentials Rel_IPprior which is the subset of all available interactive 
potentials in the knowledge base (i.e. set IPprior) that connects any pair of the given seed genes. The 
second step  of the computation implements the abductive task formulated in terms of an Answer Set 
Programming (ASP) problem and infers causal relationships for the set of relevant interactive potentials 
which satisfy biological constraints based on the data (i.e. set ExpData) and the known biological function of 
regulators (given in sets RPprior, ERprior). The output of this step  is the final set of compatible and 
competitive gene influences together with the associated gene states. The sets IPprior, RPprior, ERprior, 
ExpData and SeedGenes refer to definitions (1)- (5) in the text. Predicates connect_seeds/1 and 
explain/2 refer to definitions (6) and (12) in the text. 
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The first step  computes all possible paths (within a given maximum length) that connect any two seed genes 
either directly or indirectly (via non seed genes), using information from the interactive potentials (IPprior) in 
the prior knowledge. The output of this step is a set of relevant interactive potentials, Rel_IPprior, defined 
as a subset of all the known interactive potentials links for some species (which can be in excess of 100,000) 
that are relevant for connecting the given set of seed genes. The notion of relevant interactive potentials 
allows us to constrain the search space of our regulation network in a biologically meaningful way thus 
making the computation process more manageable. Once computed within the first step  only the set of 
relevant priors are given as background facts in the second step  of the inference. The second step  of the 
computation is formulated in terms of an Answer Set Programming (ASP) problem, which infers causal 
relationships for the set of relevant interactive potentials based on the data (i.e. set (4) above) and the 
known biological function of regulators (i.e. sets (2) and (3)). The output of this step  is the final set of 
compatible and competitive gene influences that satisfy the signal propagation principles and fully define 
signed-directed networks. 
Full details for each of the steps are presented below. 
Step 1: Extracting relevant interactive potentials from knowledge base
The objective for this step  of the computation is to identify all the genes from a given pool G  that, according 
to prior biological knowledge, are biologically relevant to the specific application. The set of interactive 
potentials, IPprior , given as part of the prior knowledge covers all aspects of cellular biology across various 
cell types and is universal for a particular species regardless of the specific biological applications. For any 
given application, however, not all the information is relevant, e.g. neuron specific genes are not relevant for 
the working of cardiac cells. The set of seed genes given by set (5) above allows biologists to define which 
area of cellular biology they wish to investigate. Therefore, relevant interactive potentials define the domain 
of the inferred networks over all available knowledge, in terms of either direct or indirect paths between seed 
genes. 
The construction of paths between seed genes is implemented in Sicstus Prolog, in a version of the 
abductive system A-System, [VanNuffelen01, Kaka01], which has been developed in the Russo's research 
group  (available form http://www-dse.doc.ic.ac.uk/cgi-bin/moin.cgi/abduction). This consists of computing all 
possible paths that connect seed genes within a given maximum length, using the rule-based logic below 3. 
connect_seeds(MaxLength,Path) :- seed(G1),seed(G2), 
! ! ! ! path([G2],G1,0, MaxLength, Path).
(6)
path([H|T],G,CurrLength,MaxLength,[G,H|T]):-
CurrLength < MaxLength, relevant_ip(G, H).
(7)
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3 The notation [H | T] used in rules (6)-(9) refers to Prolog list structures. A list in Prolog is an ordered structure of the 
form [ t1, t2, ..., tn].  A term [H | T] denotes a list whose first element H is the head, while the rest forms the tail T which is a 
list. 
path([H|T],G,CurrLength,MaxLength,[NewH,H|T]) :-
! ! ! ! CurrLength<MaxLength, relevant_ip(NewH,H),
! ! ! ! not seed(NewH), member(NewH,[H|T]).
(8)
path([H|T],G,CurrLength,MaxLength,Path) :- 
! ! ! ! CurrLength < MaxLength, relevant_ip(G1,H), 
! ! ! ! not seed(G1),not member(G1,[H|T]),
! ! ! ! NewCL is CurrLength + 1, 
! ! ! ! path([G1,H|T],G,NewCL,Path).
(9)
Rule(6) has the effect of constructing a path within the maximum length boundary (MaxLength) that links 
two seeds genes (i.e. G1 and G2). The path is recursively computed by checking that no gene is revisited 
more than once (i.e. rule (8)), and that only relevant genes, according to the existing prior knowledge of 
interactive potentials between genes, are added to a path (i.e. rule (9)). The latter case is captured by the 
use of the abducible predicate relevant_ip(G1,G2), and the following integrity constraint:
 :- relevant_ip(G1,G2), not interactive_potential(G1,G2). (10)
The construction of paths between seed genes could easily have been implemented in any other 
programming language (e.g. c++, python). The formalisation of extracting relevant interactive potentials as 
an abductive task, however, allows for modular and flexible control over the definition of what is considered 
to be a ‘biologically’ relevant interaction. In the current implementation we consider as relevant the simple 
case of all interactive potentials that connect given seed genes. Depending on the particular interests of 
biologists additional constraints can be defined over other properties of interactive potentials, in order to 
further restrict the solution space. For instance, this could include restriction to high confidence and cell-type 
specific interactions or exclusion of complex interactions.  
Step 2: Inference of causal relationships
As mentioned at the beginning of this section, our abductive problem is to identify compatible and 
competitive gene regulations (i.e. signed-directed links) that form a regulatory network which consistently 
satisfies the observed data. Paths generated by the first step  of the inference are sequences of genes which 
are connected with each other according to the abduced relevant_ip(gi,gj) directed link 4 . But to 
generate a regulatory network the directed links have to be signed. The inference of the sign for each 
relevant interactive potential and the computation of alternative regulatory gene networks, in terms of 
collection of regulations between genes, is achieved by the second step  of our ARNI approach, which is 
formulated in terms of an Answer Set Programming (ASP) problem. The priors for the ASP program include 
only the set of domain specific relevant priors, thus avoiding the explosion of the search space.  
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4 Note that directionality of the link is expressed by the order of the arguments in the predicate.
Abductive Reasoning with Answer Set Programming 
The ASP paradigm provides an environment for efficient computation of abductive solutions, as it combines 
a logic programming language with high-performance problem solving computational capabilities [Gebser12]. 
ASP is based on stable model semantics [GEL88] (ref to Section 2.1 for a definition of a stable model). 
Within the ASP environment, a problem is expressed by formulating constraints as logic program rules such 
that the resulting stable models of the logic program are the solutions to the initial problem. Stable models 
are also referred to as answer sets. 
In order to encode an abductive problem as an ASP problem we make use of two constructs of the ASP 
language: choice statements and optimisation statements. A choice statement is an expression of the form 
{a1,...,am} :- b1,...,bm, where ai and bi are ground atoms. This expression informally means that any subset of 
{a1,...,am} can be included in a stable model (i.e. answer set) of the given ASP problem, provided the body is 
satisfied. For example, the logic program consisting of the three rules q, p:- q  and {s,t}:-p has four 
stable models (answer sets):  {p,q}, {t, p,q} , {s, p, q},  {s, t, p, q}. That is, if p is included in the answer set, 
the ASP solver can freely choose to include s and/or t in the final solutions. Further, the syntax allows for 
cardinality restrictions on the subset choice. The head of a choice rule can include upper and lower bounds 
of atoms to include in the stable model, forcing the subset cardinality to be within the lower bound l and 
upper bound u. For example, the statement 1{s,t,u}2:-p expresses the fact that if p is included in a 
stable model then at least one and at most two of the atoms s, t, u should be included, thus eliminating 
sets {p,q} and {p,q,s,t,u} from the the answer sets of the logic program.  
Abducibles can be seen as ground atoms whose truth value is not defined in the program, although they are 
constrained by integrity constraints. Therefore, within the ASP framework abducibles can be expressed as 
choice statements and the ASP solver is free to ‘choose’ the Boolean assignment (i.e false or true) for each 
abducible. The choice is restricted by the cardinality of the choice statement and the remaining other 
constraints defined in the program. In biological terms, our (abductive) problem of extracting a gene 
regulatory network assumes that information about regulations between genes is unknown and therefore 
“open”  to Boolean assignments. Computing a regulatory network that conforms with observed gene 
expression data means discovering the subset of signed-directed regulations between genes that imply the 
observed data, in a way that is consistent with given biological constraints. The main abducibles in our ARNI 
approach are therefore ground facts of the form compatible(gi,gj,s) and competitive(gi,gj,s), 
whose first two arguments are genes in G and whose third argument s is a value from the set {-1,1} denoting 
the causal effect of the interaction between the two genes gi and gj. An instance of the form 
compatible(g1,g2,1) (resp. compatible(g1,g2,-1)) means that gene g2 activates (resp. inhibits) 
gene g1. An instance of the form competitive(g1,g2,1) (resp. competitive(g1,g2,-1)) means that 
gene g2 potentially activates (resp. inhibits) gene g1 but that in this particular dataset this effect has been 
masked by a stronger compatible influence. The inference of the sign for each relevant interactive potential 
in the prior knowledge is generated by means of the ASP choice statement defined in (11) below: 
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0{compatible(X,Y,1),compatible(X,Y,-1),competitive(X,Y,1), 
competitive(X,Y,-1)}1 :- relevant_ip(Y,X).
(11)
where the five possible choices for the abducibles fully capture the notion of a signed-directed link between 
two genes. During the inference procedure these are restricted by the set of integrity constraints expressing 
signal propagation principles and biological knowledge as discussed later in this section. It is important to 
guarantee that a gene is not assumed to be at the same time a compatible and a competitive regulator of 
another gene. Similarly, a compatible (resp. competitive) link cannot be both activating and inhibiting 
another gene. This logical consistency of our ARNI model is ensured by the cardinality restriction of the 
choice statement (11), which forces the ASP solver to choose at most one compatible/competitive 
abducible fact for a given answer set. Hence, the interaction between two genes, say g1 and g2, can be 
classified as either absent (i.e not compatible with the given data and biological knowledge base) or present 
as either an activation (compatible(g1,g2,1) ), an inhibition (compatible(g1,g2,-1) ), an 
overpowered activation (competitive(g1,g2,1) ) or an overpowered inhibition (competitive(g1, 
g2,-1) ).
The cardinality of the choice statement given in (11) implies that for any given relevant_ip  pair, the ASP 
solver can freely choose to add or not add an abducible link in the final networks. In fact, the ASP solver 
returns many answer set solutions corresponding to different possible subsets (including the empty set) that 
are consistent with the constraints. In order to compute only solutions (i.e answer sets) that are relevant to 
our biological question, the ASP problem is augmented with optimisation rules, which define which answer 
sets (i.e which choice of subsets over the set of abducibles) are ‘optimal’ w.r.t. to some user defined criteria. 
An optimisation expression is of the form opt{l1= w1@p1,...,ln=wn@pn}, where opt ∈ {“#minimize”, 
“#maximize”} and wi and pi represent (optionally) the weight and the priority of the literal li. Informally, 
optimisation expressions are directives to instruct an ASP solver to compute optimal stable models by 
minimising (or maximising) a weighted sum of elements. If weights and priorities are omitted then the 
optimisation procedure simply counts the number of elements. 
In our ARNI approach, the final set of networks is obtained by maximising the number of seed genes (i.e 
experimental data) explained by each network. The use of the optimisation statement, as opposed to an 
approach that requires that all seed genes are included in a network, allows for inconsistencies and noise in 
the data that could result in no possible solutions. In this way possible networks can still be inferred by 
excluding some of the seed genes for which there are no consistent paths. This is achieved by extending the 
ASP problem to include the optimisation rule given in definition (12) below, which states that a seed gene is 
explained if it has an incoming compatible link. The abducible compatible(X,Y) in explain/1 needs to satisfy 
all the other constraints in the ASP problem, presented later in this Section, and thus it is guaranteed that a 
seed is considered explained only if eventually connected to another seed gene. 
! explain(X):-seed(X),compatible(X,Y) (12)
! #maximize {explain(X)}
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The optimisation score is calculated based on the number of seed genes explained, as opposed to the 
number of individual abducible links, and therefore network topologies with multiple incoming links for a 
given seed gene have the same optimisation scores. This formulation allows the detection of complex 
network motifs whereby genes are often involved in multiple interactions and their detection requires the 
inference of multiple explanations for a given observation, within the same network. The maximise 
optimisation statement in (12) would generate as optimal all possible answer sets that guarantee the 
maximum number of seeds to be connected within the same network. For examples, in the case that a seed 
gene can be explained via two parallel paths, path_1 and path_2, the ASP solver returns three optimal 
answer sets: one answer set including the abducible components of path_1, one answer set including the 
abducible components of path_2 and finally, a third answer set including abducible components of both 
paths together. 
The explain/1 rule is only defined in terms of compatible/2 abducibles. This is because competitive 
links are inconsistent with the data and therefore a seed gene with only an incoming competitive link cannot 
be considered to be explained (i.e the network does not contain a regulatory path that could have caused the 
seed gene to have the specified state). Networks with competitive gene influences have the same 
optimisation score as those without competitive gene influences and as such, the ASP solver returns as 
optimal both sets of solutions (i.e answer sets with and answer sets without competitive links). Therefore, 
competitive links can be thought of as an enrichment step  after the compatible networks have been 
computed and compatible links are never excluded from answer sets in favour of their competitive counter-
parts.
Integrity constraints
The inference of compatible(G1,G2,S) and competitive(G1,G2,S) has to comply with existing 
knowledge, experimental data and biological principles of sign propagation. These principles are expressed 
in our ARNI approach as domain specific integrity constraints. Integrity constraints over the abducibles are 
of four different categories: (a) constraints about compatibility of the signed-directed regulations with 
experimental data; (b) constraints about biological principles of gene regulation; (c) constraints that enforce 
signed-directed regulations to be compatible with existing/established knowledge, and finally category (d) 
that includes constraints that express logical consistency of the extracted model. 
Compatibility with experimental data
One of the key biological principles modeled in our ARNI approach is signal propagation principles. To 
specify these principles we make use of an additional predicate, called state, which takes two arguments, a 
gene and a state value. The state value of a gene can be 1 to signify the gene expression is increased, and 
value -1 to represent that the gene expression has decreased. A ground literal of the form state(g1,1) 
means that the expressive value of gene g1 has increased during the experiment. Since not all states of 
relevant genes are measurable in an experiment either because of redundancy in the network topology, 
experimental limitations, or post translational regulation, in order to guarantee full consistency of our 
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regulatory network, the state predicate is therefore considered to be an additional abducible and all nodes 
present in the final inferred network are forced to have a state by extending the ASP program with the choice 
statements given in (13)-(16). 
! 1{state(X,1), state(X,-1)}1:- compatible(X,Y,_). (13)
! 1{state(Y,1), state(Y,-1)}1:- compatible(X,Y,_). (14)
! 1{state(X,1), state(X,-1)}1:- competitive(X,Y,_). (15)
! 1{state(Y,1), state(Y,-1)}1:- competitive(X,Y,_). (16)
For genes that have an expression value specified in set (4), the abduced state needs to be consistent with 
the available experimental data. This is captured by constraint (17). For the remaining genes in our 
identified pool, called in this case hidden genes, any of the two states could be abduced provided that the 
overall set of of integrity constraints is satisfied. The cardinality restriction of the choice statements to exactly 
one state for a given node, i.e. upper and lower bound equal to 1, together with constraint (18) ensure the 
that a given gene in a given network can have only one unique state value, even if it participates in more 
than one compatible or competitive link. Modelling hidden genes allows for signal propagation, even if the 
observed signal flux is fragmented and can offer biologists novel candidate genes not previously associated 
with the process under investigation. 
! :- state(G,S1), exp_data(G,S2),S1≠S2.                              (17)
! :- state(G,S1), state(G,S2), S1≠S2.                                 (18)
Constraints for signal propagation consistency
The flow of information (i.e. the state of genes) along paths computed in Step 1 has to satisfy the sign 
consistency model for gene regulation. Sign consistency states that inferred gene interactions must satisfy 
two main gene dependency rules: compatible gene influence and competitive gene influence. The 
compatible gene influence rule postulates that the state of a target gene G1 is directly related to the state of 
an activator G2, expressed in constraint (19), and inversely related to the state of an inhibitor G2, 
expressed in constraint (20). Intuitively, if the expression value of an an activator increases, the state of its 
target gene is also expected to increase, and therefore the states of the two genes G1 and G2 in constraint 
(19) are not allowed to be different from one another. Similarly, if the expression value of an inhibitor 
increases, the state of the target gene is expected to decrease and therefore the state of the two genes G1 
and G2 in constraint (20) can not be the same 
    :- compatible(G1,G2,1), state(G1,S1), state(G2,S2), S1≠S2    (19)
    :- compatible(G1,G2,-1), state(G1,S1), state(G2,S1). (20)
Conversely, by definition competitive influences violate the sign consistency model and thus the reverse 
gene dependency rule holds for competitive regulators. In this case, the choice of abducibles checks for 
inconsistencies between the expected and the observed expression value of target genes (i.e the state of a 
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target gene G1 is inversely related to the state of an activator G2, expressed in constraint (21), and directly 
related to the state of an inhibitor G2, expressed in constraint (22)).
   :- competitive(G1,G2,1), state(G1,S1), state(G2,S1). (21)
   :- competitive(G1,G2,-1), state(G1,S1), state(G2,S2),S1≠S2. (22)
The incompatibility of the competitive gene inference with experimental data implies that the ASP solver 
could simply assume competitive links whenever a compatible link cannot consistently be abduced. The 
search space explosion in allowing the competitive regulators to be abduced without any constraints is 
practically prohibitive and hinders the usability of the inferred networks. Therefore, constraint (23) and 
related definitions (24)-(27) are included in our model to capture two typical cases of competitive 
regulators that bypass the sign consistency principle. 
:- competitive(G1,G2,S), not op_exception(G1,G2,S). (23)
op_exception(G1,G2,S):- overpowered(G1,G2,G3),compatible(G1,G3,W) (24)
Integrity constraint (23) guarantees that competitive regulators are only inferred if there is an exception that 
holds. A gene, say g1, can have an inconsistent state with respect to the state of its regulator, say g2 
provided that there exist at least one other compatible gene, say g3 that consistently regulates g1, hence 
overpowering the influence of g2. This principle is captured by rule (24). Exceptions of the above form are 
derived from the data by means of an overpowered influence function that determines the truth of the 
condition overpowered(g1,g2,g3). Once pre-calculated from the data, this information is added as fact to 
the prior knowledge to express the biological notion that the effect of gene g2 on gene g1 has overpowered 
the effect of gene g3 on gene g1.
Because of the way the overpowered facts are computed there is the additional implicit constraint that genes 
that can participate in competitive regulations must have been observed as either up-regulated or down-
regulated. Given the sparsity in the microarray data, where the signal is fragmented due to noise, and the 
abstraction of all biological regulation to gene regulation, such situations are not very common. In the 
absence of additional priors information (e.g., kinetic information, promoter affinities), that can give 
information on the relative impact of competitive influences, our model includes  an additional exception case 
based on the biological principle of how competitive regulators can participate in network motifs. Specifically 
we consider the case of competitive links within feed-forward loops (FFL). 
A three node FFL consists of three links and three nodes, where a target gene T is regulated by a regulator 
R via two alternative paths: a direct link from R to T, as well as an indirect path via regulator R2. A FFL is said 
to be incoherent if the overall effect of the indirect path is different from the effect of the direct link. There are 
four predefined incoherent FFL configurations, graphically illustrated in Figure 2.2, depending on whether the 
individual links are activations (pointed arrow) or inhibitions (round ended arrow). These cases are 
represented in our model by the predicate iff(S1,S2,S3) where S1 is the regulatory effect of the direct 
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path from R to T, S2 is the regulatory effect between the two regulators R and R2 and S3 is the regulatory 
effect of R2 on T. The regulatory effect is equal to 1 in the case of activation and -1 in the case of inhibition.
Figure 2.2: Configurations of incoherent feed forward loops.
For any one of the four incoherent FFL configurations, one of the three links is always a competitive link in a 
particular dataset and therefore involved in an overpowered exception. These exceptions are captured by 
rules (25)-(27) that correspond, respectively, to the three scenarios of incoherent FFL in Figure 2.3, 
where a different part of the FFL (dashed links) is a competitive influence link involved in overpowered 
exception. 
op_exception(T,R,S1) :- compatible(T,R2,S3),compatible(R2,R,S2),  
            ! !  iff(S1,S2,S3) (25)
op_exception(T,R2,S3) :- compatible(T,R,S1),compatible(R2,R,S2), 
! ! ! !   iff(S1,S2,S3) (26)
op_exception(R2,R,S2) :- compatible(T,R,S1),compatible(T,R2,S3), 
! ! ! !   iff(S1,S2,S3) (27)
Specifically, in (25) a competitive regulator between a gene T and its regulator R requires that there is a 
compatible indirect route from R to T, via another gene R2. In (26) a competitive regulator between a gene 
T and its regulator R2 requires that there is a compatible regulator gene R that regulates both T and R2. And 
finally in (27) a competitive regulator between a gene R2 and its regulator R  requires that there is a target 
gene T that both R and R2 consistently regulate. The configuration of the regulatory sign value of the three 
sign-directed links that are involved in these motifs have to satisfy one of the predefined incoherent feed 
forward loop cases.  
Figure 2.3: Network motifs for competitive influences.
A three node FFL consists of three links and three nodes, where a target gene T is regulated by a regulator 
R via two alternative paths: a direct link from R to T, as well as an indirect path via regulator R2. For a given 
incoherent-FFL configuration (illustrated in figure 2.2), there are three scenarios where a different part of the 
FFL  is a competitive influence link (dashed links) involved in overpowered exception. 
Conf1 = iff(1, 1, -1) 
R
R2 T
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Compatibility with existing knowledge
In addition to constraints (17)-(27), abduced signed-directed links have to be consistent with existing 
knowledge: for some pairs of genes the signed directed link might already be known. In this case the prior 
knowledge would include ground instances of the predicate established_regulation and any abduced 
compatible fact will have to be consistent with this prior. This is captured by constraint (28) below. Similarly 
the abduced type (i.e. activation or inhibition) of compatible or competitive influence that a gene has on 
another gene has to be consistent with the regulatory potential that a gene is known to have (if any). This is 
expressed in constraints (29)-(30) below. Constraint (31) instead guarantees that competitive 
regulations are limited to links with an already known regulatory effect. This is done to further limit the 
solution space for this abducible. Biologists could remove this constraint whenever they intend to pursue a 
more exploratory analysis:
! :- compatible(G1,G2,S), G1≠G2, ! !         !               
!    established_regulation(G1,G2,S1), S≠S1.
(28)
! :- compatible(G1,G2,S),G1≠G2, 
!    not regulatory_potential(G2,S). 
(29)
! :- competitive(G1,G2,S),G1≠G2, 
!    not regulatory_potential(G2,S).   
(30)
! :- competitive(G1,G2,S),G1≠G2,
!    not established_regulation(G1, G2, S).
(31)
  
Constraints for logical consistency
Given the constraints with existing knowledge and experimental data it is possible that for a given relevant 
interactive potential there is no compatible/competitive link that can be consistently abdused. Therefore, in 
order to guarantee the connectivity of the networks, it is necessary to ensure that fragmented paths that do 
not lead to seed genes are excluded from the final inferred networks. This property is expressed by clauses 
(32)-(34) below. Integrity constraint (32) guarantees that only compatible links that fall in a path between 
seed genes are inferred. A compatible link from gene Y to gene X is considered to be in a path if gene Y has 
an incoming compatible connection (i.e. it is regulated by something) and gene X has an outgoing 
compatible connection (i.e. it leads to somewhere). This is captured by the rules given in (33). In turn, the 
compatible abducibles in (33) need to themselves satisfy constraint (32) and thus eventually only 
complete paths between seed genes are accepted in the final answer sets. Seed genes are an exception 
and are instead assumed to be connected in and out by default. This is captured by the rules given in (34). 
! :- compatible (X,Y,_), not in_path(X,Y). (32)
! in_path(X,Y):-connected_in(Y),connected_out(X).
! connected_in(X):- compatible(X,Z,_).
! connected_out(X):- compatible(Z,X,_).
(33)
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! connected_in(X):- seed(X).  
! connected_out(X):- seed(X). 
(34)
The connectivity of competitive abducibles is implicitly guaranteed through constraints (23)-(27), whereby 
competitive links can only be inferred in a network in conjunction with their stronger compatible competitors.
2.2.3 Inferring signed-directed networks and explanatory reasoning
As mentioned in Section 2.1 in our ARNI approach we can employ abductive reasoning for both inferring a 
signed-directed regulatory networks from experimental data and enabling explanatory scientific reasoning 
about signal propagations over the generated network in order to help  biologists plan the next sets of 
experiments or improve their understanding of the phenomena at hand. The first abductive reasoning task 
makes use of the full logical model described in this Section. Specifically, it uses as background knowledge 
the model Π given by rules in clauses (11) - (16), and the prior knowledge Bprior, which includes sets 
(1)-(5). The set A of abducibles is the collection of all ground instances of the abducible predicates 
compatible, competitive, and state. The set of integrity constraints IC includes all the constraints (17)-(34) 
described above. Hence, the question that we are interested in answering in this first type of abductive 
reasoning task is: what is a realistic signed-directed regulatory network that has generated the given set of 
experimental data? An answer to this question is the abductive inference of a maximal set (w.r.t. to the 
number of seed genes explained) of signed-directed links between genes with relevant interactive potential 
that are consistent with the given integrity constraints and the genes' expression level described by the 
experiment data. The collection of all abduced compatible and competitive predicates, computed in this 
answer, formally describe such a signed-directed regulatory network. This abductive reasoning task can be 
formally defined as follows.
Definition 2 (Abductive inference of regulatory networks): Let the background knowledge B = Bprior ∪ 
Π but with IPprior = {interactive_potential(gi,gj)|relevant_ip(gi,gj)}, IC be the set of integrity 
constraints (17)-(34), A be the set of all possible ground instances of the abducible predicates 
compatible, competitive, and state. A signed-directed regulatory network inference is the abductive 
task  ⟨B, IC, A ⟩ with an abductive solution a set Δ ⊆ A such that: 
  B ∪ Δ ⊨  IC    (consistency with integrity constraints)
¬ ∃ Δ’ such that,  B ∪ Δ′ ⊨  IC and | S Δ′ |  >  | S Δ |    (maximality of the network w.r.t. explain/1)
where SΔ = { s | s is ground explain/1 atom in answer set of B ∪ Δ}
The second abductive reasoning task allows biologists to conduct explanatory scientific reasoning about 
signal propagations over the generated networks. We describe here how this is formally defined. Assuming 
that a signed-directed regulatory network has been computed, the question that we are interested in 
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answering in this second abductive reasoning task is what are the signal propagations that cause a given 
collection of seed genes to have certain states in an existing regulatory network?. The answer to this task is 
a maximal set of states of genes and compatible/competitive links in the given network through which signal 
propagation can occur to cause (i.e explain) a given set of seed genes to have a given state. This abductive 
problem assumes a population G to be all the genes that appear in a given regulatory network. The 
background knowledge B is given by the same logical model considered in Definition 2, but with the signed-
directed links that appear in the network, defined as ground instances of relevant_ip(g1,g2), and 
established_regulation(g1,g2,s) as they are now part of prior knowledge. The set IC of integrity 
constraints includes all the constraints (17)-(34) augmented with the following new constraint (35). 
! ! op_exception(G1,G2,S) ← compatible(G1,G3,S1)                         (35)
This constraint captures, together with constraint (23), a weaker case of biological consistency for 
competitive influence than that expressed in constraint (24), which does not require experimental data to 
compute the overpowered function. 
The additional concept in this abductive reasoning task is the notion of query, i.e. required state of given 
seed genes. The query is what our abductive reasoning task aims to explain in terms of sign propagations 
that cause the given seed genes to reach their given state. For a given query, the SeedGenes will include 
ground facts of the form seed(gi) for each gene gi in the query. A query can be formally defined as a 
conjunction of ground atoms of the form state(gi, si):
        n! ! !
Q = ∧   state(gi,si)! ! !           i  = 1 (36)
An abductive reasoning task AC for signal propagation, and abductive explanation for a query Q in AC can 
be formally defined as follows:
Definition 3 (Abductive inference of signal propagations): Let N be a regulatory network. Let Q be a 
query as defined in (36). Let B = BPrior ∪ Π but with SeedGenes = {seed(gi)| gi ∈ G, gi ∈ Q} and ERPrior 
given by the full set of signed-directed links present in N. Let IC be the set of integrity constraints (17) - (35) 
and let A be the set of all possible ground instances of the abducible predicates state, compatible and 
competitive. An abductive reasoning task AC for signal propagation is the tuple ⟨B, IC, A ⟩.  An abductive 
explanation for Q in AC is any subset Δ of A such that:  
  B ∪ Δ ⊨  IC    (consistency with integrity constraints)
B ∪ Δ ⊨ Q    (explanation of the query)
¬ ∃ Δ′ such that,   B ∪ Δ′ ⊨ IC ,  B ∪ Δ′ ⊨ Q  and 
| S Δ′ |  >  | S Δ | 
   (maximality of the network w.r.t. explain/1)
where SΔ = { s | s is ground explain/1 atom in Answer set of B ∪ Δ}
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The two abductive tasks together capture the notion of abductive inference of a network that explains 
experimental data. In the special case where the task in Definition 3 is given as input a network, N, 
generated by the inference task in Definition 2, with respect to the same set of seed genes, the state of the 
genes inferred through signal propagation will be the same as that given in the experimental data for the 
construction of N. In other words, the signal propagation on the abduced network N gives an explanation for 
how the observed experimental data came about. Definition 3 can be used to examine the validity of other 
biological hypotheses over a (given or constructed) regulatory network. Different queries may be formed 
allowing the biologists to investigate how a given set of gene states can be caused and through which 
specific signal propagations. Given the new assumption on the states of the genes (via the query), the 
relevant links are re-classified into compatible and competitive and their classification can help  biologists 
form hypotheses to then test in the lab. In addition, different domain-specific integrity constraints can be 
considered in order to analyse signal propagation under different biological principles. Examples of these 
possibilities are presented in Section 2.4 where we illustrate how our ARNI approach can be used to support 
automated scientific discovery where the validity of different biological hypotheses can be examined and 
tested outside the laboratory.
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2.3 Evaluation of the ARNI approach
This section describes the results of evaluating different aspects and properties of our ARNI approach. 
Specifically, in Section 2.3.1 we validate the predictive power of our abductive reasoning showing that our 
approach is capable of extracting the correct regulatory networks from in silico (incomplete) data, in the 
presence of both biological and experimental noise. The prediction shows a recall of approximately 80% 
where, instead, existing best network inference methods are capable of predicting approximately 60% of a 
network from datasets generated with the same in silico  method. In Section 2.3.2 we demonstrate the 
increased expressive power of our ARNI approach by evaluating its ability to extract regulatory networks 
with a range of complex network motifs structures, which are not detectable by other existing inference 
methods. 
2.3.1 ARNI Predictive Power
In this section we validate the predictive power of our ARNI approach in terms of its robustness against 
incomplete data and noise in the data. The choice of these two types of validations is due to the fact that, 
given our logical model, the ability of abductively inferring a gold standard network depends on the ability to 
retrieve as many of the gold standard links as relevant interactive potentials (which depends on the extent to 
which the given seed genes cover the gold standard network) and assign to them the correct signed-
directionality. Both of these ultimately depend on the given experimental data. Noise in the data may result in 
incompatibility between the underlying gene regulation model and the observations and thus affect the 
assignment of signed-directionality. Incompleteness in the data on the other hand requires special 
procedures to be able to extend the inferred networks with non-observed genes. The two types of validations 
are conducted in the following way. We consider a given gold standard network. We generate from it different 
in silico  noisy datasets, corresponding respectively to different types of perturbations that could occur in real 
biological networks, and we evaluate the recall rate (R) of the network that ARNI computes from each of 
these datasets. The recall rate is given by the number of correct signed-directed links that the abductive 
reasoning is able to abduce from the dataset with respect to the total number of signed-directed links present 
in the gold standard network. Intuitively, this measure expresses how much of a real underlying regulatory 
network the ARNI approach is able to extract from given datasets. The recall rate is also evaluated with 
respect to different degrees of sparsity of the dataset. It is shown that although it follows the expected trend 
of decreasing recall with the increase of sparsity of the data, even in cases of 80% of missing data, the ARNI 
system is able to correctly extract 80% of the links present in the gold standard. The same type of 
experiments are conducted for three different sizes of gold standard networks in order to evaluate how the 
robustness changes with respect to the size of the network. Detailed discussion of the findings are given 
later in this Section.
 
Datasets and Metrics
We have used in silico datasets generated using the DREAM (Dialogue for Reversed Engineering and 
Methods) project [Stolovitzky07]. DREAM is a systems biology initiative to provide mechanisms for objective 
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assessment of reverse engineering methods. The DREAM project defines annual challenges consisting of a 
set of in silico networks with realistic network structure of varied size and complexity and the corresponding 
simulated experimental data [Marbach09] .
In our experiments we have considered eleven different network topologies taken from the DREAM 3 
[Prill10] and DREAM 4 challenges [Marbach09b]. These include five 10-gene networks, three 50-gene 
networks and three 100-gene networks. Using the GeneNetWeaver simulator provided by the DREAM 
project [Schaffter11], we have generated three different datasets for each of the networks:
• The wild-type dataset contains the (steady-state) gene expression levels in the unperturbed network, and 
provides the control condition against which all other datasets are compared. 
• The external-response dataset contains the (steady state) gene expression levels in the network after all 
nodes with no incoming links have been activated. The external-response dataset corresponds, for 
example, to experimental data observed in the case of exposure to environmental factors which, via cell 
surface receptors, activate intracellular signalling networks. 
• The multifactorial dataset contains the (steady-state) gene expression levels obtained by applying random 
multifactorial perturbations to the wild-type network. Multifactorial perturbations are simulated by slightly 
increasing or decreasing the basal activation of all genes of the network simultaneously by different 
random amounts. This dataset can be thought of as experimental data observed in the presence of 
multiple perturbations in the network (e.g., multiple drug effects or individual patients). A total of 50 different 
multifactorial perturbations were obtained from the 10-gene and 50-gene networks, and a total of 100 
different multifactorial perturbations were obtained from the 100-gene networks. 
Two different types of noise were also considered when generating our in silico  datasets: biological and 
experimental noise. The former was simulated by adding a noise term in the dynamics of the networks. The 
latter was simulated by adding to the data generated after the simulation a measurement error derived from 
a noise model similar to that observed in microarrays [Schaffter11]. In the case of the external-response 
dataset, we have also considered a deterministic simulation with no added measurement noise. 
As per normal practice in real biological experiments, each dataset was simulated three times to obtain 
replicates needed for the application of statistical testing (described below). For each run, the set ExpData of 
experimental data is given by those genes with an observable change in their state as determined by the 
statistical testing. All genes with a significant (p-value < 0.05) difference between the wild-type level and the 
level observed in an experimental condition (i.e external-response or one of the random perturbations of the 
multifactorial dataset) were considered to be affected by the given perturbation to the network and thus 
included in ExpData.  All genes with observed change in their state were also specified as seed genes. In 
real world applications the biological priors are extracted from online databases, however since our 
evaluation was based on in silico datasets such information was not available. Therefore in order to generate 
the biological priors, for each link in the gold standard network an interactive_potential(gi,gj) fact, 
an established_regulation(gi,gj,s) fact and two facts regulatory_potential(gi,1) and 
regulatory_potential(gi,-1) were added to IPprior, ERprior, and RPprior, respectively.
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For each of the datasets considered, ARNI’s predictive power was evaluated by calculating the recall rate 
(R) with respect to the total number of signed-directed links present in the gold standard network and the 
relative recall rate (RR), which gives the recall rate with respect to only the relevant interactive potentials. 
Therefore, RR can be used to evaluate the second step of our implementations (i.e the ability to infer the 
correct causal relationships). The recall and relative recall were defined as follows. Let N be the number of 
signed-directed links present in the gold standard network. For each experiment run we have calculated the 
TP (i.e. true positive) number of links which occur in the gold standard network and have been abduced with 
correct sign and direction, and the RIP number of links, which occur in the gold standard network and have 
been abduced as relevant_ip in the first step  of the inference. Given these values, the recall is defined as 
(TP × 100)∕N and the relative recall as (TP × 100)∕RIP.
2.3.1.1 Prediction under biological and experimental noise
In this set of experiments we have validated the ability of our approach to infer networks in a noisy 
experimental setup. We have used the external-response datasets described above. Table 2.2 reports the 
recall rates and relative recall rates for the eleven networks considered and compares the results in the 
cases of no added noise and  experimental noise.  
Table 2.2 Predicting gold standard networks from noisy data
For each of the eleven networks provided by the DREAM consortium, we simulated an external-response dataset by 
activating all nodes with no incoming links (with and without added biological and experimental noise). We report the 
recall rate, and relative recall rates. Recall rate is given by the number of correct edges in the inferred networks with 
respect to the total number of  edges present  in the gold standard. Relative recall rate is given by the number of correct 
edges in the inferred networks with respect to links that have been abduced as relevant_ip/2
10 Node Networks 50 Node Networks 100 Node Networks
Size
No Noise
Recall
Relative Recall
Noisy Data
Recall
Relative Recall
Net1 Net2 Net3 Net4 Net5 Net6 Net7 Net8 Net9 Net10 Net11
15 16 15 13 12 77 160 173 176 249 195
100 87.5 93.3 100.0 100 68 70.0 70 82 34.9 52
100 93 93 100 100 98 91 94 92 90 86
100 68.8 93.3 100.0 100 55 67.5 58 72 29.7 39
100 100 93 100 100 98 90 97 96 80 84
The table shows that the relative recall rate is consistently higher than 80%, reflecting the fact that the 
majority of signed-directed links retrieved as relevant have a correct sign propagation causal effect. That is, 
the expected state of the genes and the experimental observations correspond, validating the sign 
consistency principle as an appropriate model for gene regulation in the presence of biological and 
experimental noise. As the size of the network increases it becomes progressively more difficult to infer the 
gold standard from the data derived from a single experiment, i.e. the recall rate decreases. But given the 
high relative recall rates, this decrease is primarily due to the inability of the seed genes to cover the whole 
network. Normally, biologists have at hand data for more than one experimental condition and thus in large 
scale networks the low coverage of the seed genes can be compensated by the higher number of 
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experimental conditions. In fact, the DREAM challenges request the inference of networks using a complete 
set of multifactorial experiments.
In order to validate this hypothesis, we have evaluated, for the multifactorial dataset, the consensus recall 
rate, which is the recall rate across all the 50 experiments for each of the eleven networks. This is defined in 
a similar way as the recall rate but with the TP parameter calculated from the union of the individual inferred 
networks across experiments. The results are reported in Table 2.3. The table shows that the consensus 
recall rate has a significant gain over the recall rate from single experiments and outperforms the published 
DREAM results. The most recent DREAM network inference publication [Marbach12], using the same 
datasets as the ones used for the evaluation of ARNI, concluded that the best inference methods are only 
capable of predicting approximately 60% of a given gene network, whereas our approach reports a 
consensus recall rate greater than 85% for all networks considered. Selected 100-node networks can be 
inferred with a consensus recall rate as high as 97%.
Table 2.3 Recall rate for the complete set of multifactorial experiments
For each of the eleven networks provided by the DREAM consortium, we generated 50 in-silico data (with added 
biological and experimental noise) under the effect of multiple random perturbations of the network.  We report the recall 
rate range for each individual datasets, and the consensus recall rate, which is the recall rate for the union of the 
individual inferred networks across experiments
10 Node Networks 50 Node Networks 100 Node Networks
Recall range of 
single expts.
Min:
Max:
Consensus Recall 
using all expts.
Net1 Net2 Net3 Net4 Net5 Net6 Net7 Net8 Net9 Net10 Net11
0.00 0.00 0.00 0.00 0.00 1.29 8.75 1.73 11.93 13.65 29.74
66.66 93.75 86.66 69.23 100.00 53.00 56.87 63.58 40.91 44.18 55.90
93.3 100 100 100 100 85.7 93 97 88.7 91 97
To qualify even further the impact that multiple experiments have on the consensus recall rate, we have 
taken two networks, one of the 50-node and one of the 100-node networks. We have measured the gain in 
the consensus recall rate per additional experiment considered in the inference, as plotted in Figure 2.4. In 
addition to the single and full (n=50 for 50-node network and n=100 for 100-node network) experiment 
datasets, seven bins of number of experiments were considered. For each bin, 100 different randomly 
selected samples of experiments were generated. Figure 2.4 shows that the gain in the consensus recall 
rate follows a non-linear trend with more significant gain in the smaller network versus the smaller 
incremental (but still non-linear) gain in the larger network. Increasing the sample size from a single 
experiment to 3 experiments (i.e. n = 3) results in a 2-fold increase in the consensus recall rate; a further 
increase in sample size to n = 5 results in a 1.16 fold change increase in recall. This is a highly desirable 
property given the costs of running biological experiments. For example, we see that with 20% of the 
experiments we can get between 70-80% recall. As discussed above, with further increases in sample size 
the prediction rate reaches a plateau which is much higher than that of the other approaches reported in 
[Marbach12]  for the same datasets used here.
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Figure 2.4: Recall rate relative to the number of individual experiments used.
The plots  show the impact that  multiple experiments have on the consensus recall rate, for two example networks. In 
addition to the single and full (n=50 for 50 node network, n=100 for 100 node network) multifactorial experiment datasets, 
seven bins of number of experiments were considered.  For each bin (x-axis), 100 different samples of experiments 
selected at random were generated and for each sample the consensus recall rate was calculated (y-axis). Each boxplot 
in the graphs shows the distribution of the  consensus recall rate over the 100 samples. 
2.3.1.2 Prediction under incomplete data
For a given network, a single experimental dataset normally reveals only a fragmented view of the underlying 
gene network. The sparsity of the experimental data is partly due to regulation at the protein level which is 
not captured in gene expression data. Statistical (thresholding) and experimental noise, as well as the 
inherent robustness and redundancy properties of biological networks that may mask changes in gene 
effects [Rotival14], also contribute to the sparsity of data. An inference method should be robust to missing 
non-observed genes and be able to retrieve biologically consistent information about their states. We 
validate here the ability of our ARNI approach to infer state information about genes that are not included in 
the given ExpData  set. We have done so by pooling all individual experiments in the multifactorial datasets 
creating a sample size of 700 points (50 experiments for each of the 10-gene and 50-gene networks and 100 
experiments for each of the 100-node networks). For each experiment, the percentage of non-observed data 
is given by the percentage of non-seed genes over the total number of genes in the gold standard network. 
For each of the 700 experiments, we have run ARNI and computed the recall rate, Figure 2.5.
Figure 2.5 shows a general trend of decreasing recall rate with the increase of percentage of missing data. 
For some percentage of non-observed data the recall rate varies quite a lot. This reflects that our approach 
is sensitive to the specific choice of seed genes. The random nature of the perturbation effects in the 
multifactorial datasets leads to some datasets performing particularly badly (i.e. the random effects chosen 
were inconsistent with the underlying topology of the network). The robustness of our approach to missing 
data depends on the topological location and the distribution of the seed genes. With an appropriate choice 
of seed genes recall rates can be in the range of 80%  for datasets with as high as 80% missing data. The 
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desired properties of seed genes is to be widely distributed across the networks and to include both 
upstream and downstream genes. In these experiments the choice of seed genes was not controlled. They 
were determined by the experimental noise in the data and the biological perturbations in order to be as 
close as possible to realistic scenarios in real world applications. So, we can only speculate that, under this 
scenario, the depth bounded paths between seed genes would allow the inference of a large proportion of 
non-observed genes. 
Figure 2.5: Recall rate under decreasing number of experimental observed genes.
The recall rate is plotted against the number of experiments used as input. For each of the individual experiments in the 
multifactorial datasets (700 experiments in total), the percentage of non-observed data (x-axis) was calculated as the 
number of non-seed genes over the total number of genes in the gold standard network. The percentage of non-
observed data is plotted against the recall rate achieved by ARNI for a given dataset sample. 
We have further assessed ARNI’s performance on real experimental data derived from a synthetic network 
introduced in yeast cells [Cantone09]. In such a synthetic network, the structure of the network is known a 
priori but since the network is functioning within a real cell it is subjected to the stochastic processes and 
noise that normally affect the reliability of experimental observations. ARNI was used to infer the network 
given in Figure 2.6.A using progressively increasing amount of experimental data. The data were obtained by 
systematically over-expressing each of the genes in the network using plasmids and measuring (with real-
time PCR) the effect on all other genes, Figure 2.6.B. The results demonstrate that ARNI outperforms both 
Graphical Gaussian Models and Bayesian approaches and is able to reconstruct 100% of the synthetic 
network using less experimental data.
In summary, in this section we have evaluated ARNI on synthetic and real world datasets and shown that our 
approach is robust to noisy and incomplete data and it can achieve higher recall rate than established 
techniques while requiring less experimental data.
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Figure 2.6: Abductive inference of a  synthetic network in S. cerevisiae.
(A) Synthetic network topology introduced by [Cantone09] in S. cerevisiae. (B) Experimental data obtained by over-
expressing each of the genes in the network (diagonal) and measuring the effect on all other genes (dark grey: up-
regulation,  light  grey: down- regulation.) (C) Average recall rate achieved by ARNI given progressively increasing number 
of experimental data. The error bars represent the standard deviation of the recall rate for different sets of  single, pair, 
triplet  experiments. The performance of Graphical Gaussian Models (GGMs) and Bayessian approaches as calculated 
and reported in [Cantone09] are shown with dashed horizontal red lines, where the reported recall corresponds to the 
recall rate after using all the data available (i.e all five experiments).
2.3.2 ARNI Expressive Power
In Section 2.1 we stated that the logical representation used in our ARNI approach overcomes the 
limitations of existing methods in two ways: it is more expressive, in the sense that it enables the inference of 
networks with more complex regulatory structures, and it is modular, as it allows the logic model to be easily 
adapted to new available information (e.g., by addition of new constraints). In this Section we substantiate 
these claims by a series of experiments that demonstrate the expressiveness and modularity of our 
approach.
2.3.2.1 Network motif representations 
Network properties and dynamics are determined by recurrent patterns of interactions known as network 
motifs. In Section 2.1 we have argued that an effective method of inference has to be able to extract from 
experimental data regulatory networks that incorporate such motifs. Network motifs can be of different 
structural complexity. In this work we consider motifs given by 3-node feedback loops (FL) and 3-node feed-
forward loops (FFL) which contain cascades, fan-in and fan-out components5. 
A regulatory network is said to exhibit a given motif type (or the motif type occurs in the network) when all the 
signed-directed links that comprise the motif appear in the network. Similarly, a regulatory network inferred 
by our ARNI approach is said to exhibit a given motif type (or the motif type occurs in the inferred network) 
when all the signed-directed links that comprise the motif are included in the abduced compatible and 
competitive signed-directed links. So given a gold standard network with n occurrences of a network 
motif, the ability of ARNI to detect a given motif is measured by the notion of motif detection rate. This is the 
percentage of occurrences of a motif in the inferred network with respect to the number of occurrences of the 
same motif in the gold standard network. As compatible and competitive links can only be abduced 
within the scope of the abduced relavant_ip that connect seed genes, we have also considered an 
additional measure, called  motif inclusion rate. This is the percentage of occurrences of a given motif within 
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5 These are among the most complex motif structures. 
the relavant_ip of an inferred network with respect to the number of occurrences of the same motif in the 
gold standard network 6. Given these two measures, a normalised detection rate has also been computed as 
the ratio between the motif detection rate and the motif inclusion rate. 
We have considered the gold standard networks described in Section 2.3.1 and for each of the four motifs 
shown in Table 2.4 we have calculated the number of its occurrences across all the gold standard networks. 
A total of 9 positive feedback loops, 4 negative feedback loops, 267 coherent feed-forward-loops and 342 
incoherent feed-forward loops were identified. Using the networks inferred in the multifactorial and external-
response experiments, we have calculated the three parameters motif inclusion rate, motif detection rate and 
normalised detection rate per each motif type. Results are shown in Table 2.4. The normalised detection rate 
of our approach is above 75% for all motifs considered. The nearly perfect detection rates observed for the 
consensus networks indicates that ARNI has no built-in assumptions that forbid the detection of any of the 
motif types considered, thus validating the hypothesis that ARNI can detect a range of complex network 
structures known to be present in biological networks. 
Table 2.4 ARNI's network motif detection profile.
The inferred networks in Section 2.3.1 were analysed for inclusion of specified network motifs. For each motif, we 
report the percentage of total number of motifs that were inferred by the ARNI approach. FL: feedback loo, FFL: feed-
forward loop.
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Table 2.5 ARNI's network motif detection profile.
The inferred networks in Section 2.3.1, were analysed for inclusion of specified network motifs. For each motif, we 
report the percentage of total number of motifs that were inferred by the ARNI approach. FL: feedback loo,  FFL: feed-
forward loop.
Multifactorial consensus 
network
Inclusion
Detection
Normalised Detection
a
External response 
networks
a
Inclusion
Detection
Normalised Detection
Positive FL Negative FL Coherent FFL Incoherent FFL
n = 9 n = 4 n = 267 n = 342
100 100 99 99
100 100 96 97
100 100 97 98
88 100 53 50
89 75 46 49
100 75 87 98
The lowest detection values are observed for the coherent FFL and incoherent FFL motifs. In these cases 
the network for the external response experiment has a detection rate below 50% but it still has high value of 
the normalised detection rate. This indicates that the low detection rate is due to the inability of the given 
seed genes to cover the whole network, instead of failure of the constraints for biological consistency, (20)-
(23) and (24)-(28). We have verified this hypothesis by re-running, for the incoherent FFL motif, the 
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7 Note that because of the biological consistency constraints these two measures do not necessarily give the same 
results.
8 The motifs were detected abductively using the logic program listed in Appendix 1
The lowest detection values are observed for the coherent FFL and incoherent FFL motifs. In these cases 
the network for the external response experiment has a detection rate below 50% but it still has high value of 
the normalised detection rate. This indicates that the low detection rate is due to the inability of the given 
seed genes to cover the whole network, instead of failure of the constraints for biological consistency. We 
have verified this hypothesis by re-running, for the incoherent FFL motif, the same experiments but without 
constraints (25)-(27) which specify the overpower exceptions under which competitive gene influences 
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6 ote that because of the biological consistency constraints these t o easures do not necessarily give the sa e 
results.
can be inferred. We have found a marked reduction in the detection rate of incoherent FFL motif but the 
same inclusion rate (inclusion= 49.41%, detection=5%). This is because, as shown in Figure 2.7, when these 
constraints are not considered the ability to infer complete networks is much reduced (i.e. both the median 
and maximum recall rate for each of the networks considered is lower when constraints (25)-(27) are not 
included in the model). This not only highlights the importance of modelling competitive gene influences in 
general, as it increases the recall rate, but it also shows the relevance of competitive influence for the 
detection of network motifs.
Figure 2.7: Effect of reasoning over competitive gene influences on recall rate.
ARNI inference was re-run on the multifactorial datasets for two selected networks without constraints (25)-(27) for 
competitive gene influences. The difference is recall rates across the networks is shown with the boxplots.  
As is the case for the recall rate, the motif detection rate depends on the set of seed genes given to the 
abductive inference task, as different choices of seed genes may lead to different proportions of missed 
signed-directed links. To test the possibility of a systematic error in the inference process we tested for over-
representation of motif links within the missed signed-directed links in order to answer the following question: 
‘is a motif edge more likely to be missed over a non-motif edge?'. Absence of systematic errors would be 
indicated by equal probability of missing a motif and a non motif link.
All links in the gold standard networks were classified as motif link or non-motif link, depending on whether or 
not they occurred in any of the four tested motifs. Then, the two worst performing (i.e. lower recall rate) 
multifactorial datasets (50-node Net-6 and 100-node Net-9 in Table 2.3) were considered, and for each of the 
multifactorial datasets we labelled the links that were abduced as inferred and the rest of the links in the gold 
standard as non-inferred. We then performed a chi-squared test on the two factors (motif link and inferred 
link) to test if there is an over-representation of a particular motif in the links not detected (i.e. false negative). 
Specifically, we tested whether the ratio of inferred over non-inferred links for motif edges was lower than the 
ratio of inferred over non-inferred links for non-motif edges. Out of the 150 networks tested, none of the p-
values was significant (i.e. p-value < 0.05). Hence, we have been able to conclude that the ability to infer a 
link is independent of its participation in a network motif further supporting the conclusion that ARNI is able to 
detect complex network structures. 
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These experimental results are also particularly promising in highlighting the advantage of our logic-based 
inference approach versus other existing inference methods for regulatory networks. Results published in 
[Marbach10, Marbach12] on similar network motif analysis for existing inference methods have 
demonstrated that these methods do indeed suffer from systematic errors in detecting feed-forward loops, 
cascades (i.e. incorrect prediction of shortcuts) and fan-in motifs (i.e. missed regulation between two genes). 
In our approach the use of prior knowledge on interactive potentials has helped in overcoming this shortfall. 
To substantiate even further the improvement that our logic-based approach provides in detecting network 
motifs versus existing approaches, we have compared our results with respect to those achieved using a 
benchmarking method in physical network inference, referred to as PNM [Yeang04]. In this case we have 
chosen a network, active in T-cells, that controls T-cell differentiation into two different subtypes 
[Mendoza06]. The T-cell network topology is illustrated in Figure 2.8.A. The network includes multiple 
feedback loops (positive and negative), feed-forward loops and cascades that lead to the regulation of a 
gene either via transcriptional regulation (triangles) or post-translational regulation (circles). We have applied 
our ARNI approach and the PNM method on simulated data obtained from [Mendoza06] with STAT4 and the 
three sources, INFƔ, IL4 and IL12, in diamond shape7 as seed genes. ARNI was able to infer the entire gold 
standard network Figure 2.8.B whereas the PNM approach was able to infer only a partial network Figure 
2.8.C.  
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Introduction 
The cellular response to perturbation is controlled by complex interconnected molecular interactions 
comprising of changes in signalling as well as transcri tional regulat ry compo nts. A fundamental 
challenge in systems biology is to extract the integrat d regulatory etw rk activated as part of such a 
response. Current inference methods have limited expressiveness and applicability, relying on cause-
effect pairs and systematically perturbed datasets. 
 
Methods 
We present a novel framework, Abductive Regulatory Network Inference (ARNI), for building integrated 
models of regulatory networks from measurements under the infl ence of a singl  enrivoromental factor 
or perturbation. We model the reconstruction problem s an abductive i fer nce procedure that 
integrates elements from model checking, state predictions and topology inference. Logical rules use 
prior knowledge from online databases, and a sign-co sistency odel to determin  how affected genes 
are organized in a signed-directed network. 
 
Results 
We evaluate our approach using in-silico datasets provided by the DREAM (Dialogue for Reverse 
Engineering Assessments and Methods) consortium. Comparing it t existing approaches, we show that 
ARNI achieves better coverage, enriching networks with feedback loops, competitive gene influences 
and coordinated regulation, while retaining scalability and robustness (Figure 1). W  pr sent a sensitivity 
analysis on the ability of ARNI to infer the correct n tw rk u der i) incre sing number f unobserved 
genes (influenced by the noise in the data), and ii) under decreasing availability of prior knowledge.  
 
Conclusions 
The wider applicability and improved expressiveness of ARNI is exp cted t  luc date more realistic 
networks, better capturing the dynamics of the syst m. 
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Figure 1: Inference of a Gold Standard (A) using ARNI (B) and PNM[1](C). The Gold Standard was inferred under 
two conditions, i) where all the genes were observed to be differentially expressed and ii) where only the input and 
the final effector gene were observed to be differentially expressed. Dark grey, light grey and white nodes are 
respectively upregulated, downregulated and un-observed following stimulation of the system (diamond node). 
Arrow type denotes the regulatory effect: regular (activator) or cut (inhibitor). Dashed lines denote protein-DNA 
interactions. Wavy lines denote incorrectly inferred links.  
A B C 
Figure 2.8: Inference of T-cell differentiation network.
The gold standard network (A) was inferred using ARNI (B) and PNM methods [Yeang04] (C). The seed genes were 
STAT4 (shown with black border) and three receptor binding genes (shown in diamonds).  The data used for the 
inference were obtained from [Mendoza06] following perturbation of the three diamond nodes. Diamonds denote source 
of perturbation, eclipses denote proteins,  triangles denote transcription factors. Arrow type denotes the regulatory effect: 
regular(activator) and cut (inhibitor).  Dashed lines denote overpowered influences. Wavy lines denote incorrectly inferred 
link
The missed and mislabeled links in Figure 2.8.C can be attributed to specific limitations of the PNM 
modelling. The PNM approach can only infer simple paths, so it does not support feedback loop  detection. In 
fact, five of the eight missed links are part of a feedback loop. In addition, the PNM modelling rules impose 
the restriction that the last link in a path from source to target should be a transcription factor (triangle). But in 
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7 The background knowledge in each case included complete knowledge of interactive potential and regulatory potential 
with the expressive level as depicted in Figure 2.8 (i.e. dark grey for up regulated and light grey for down regulated).
the gold standard the IL12R regulation of STAT4 is at the post-translational level causing the path linking 
IL12 to STAT4 to be missed in the PNM output network. This is clearly a limitation of the PNM, as post-
translational regulation has been shown to be an important component in integrated networks [Joshi10]. 
Finally, the mislabeled link between IL4 and IL4R demonstrates the inability of PNM to reason about 
competitive gene influences. IL4R is under the competitive regulation of IL4 and SOCS1, and in the 
particular dataset, SOCS1 overpowers IL4 to determine the required state of IL4R. As PNM does not make 
use of prior knowledge about regulatory potential, it ends up  inferring sign consistencies that are against the 
known IL4's regulatory potential. ARNI has correctly inferred the link between IL4 and IL4R as overpowered 
activation. 
In summary, we have shown that ARNI can infer complex regulatory structures, achieving improved 
expressiveness over existing methods. The non restrictive nature of the symbolic representation that allows 
for cyclic graphs, coupled with reasoning over competitive gene influences and prior knowledge are key 
features of our approach for the detection of network motifs.
2.3.2.2 Representing complex interactions
As it transpires from Section 2.2, the constraints of our logical model are grouped by categories of 
functionally related concepts. Constraints (17)-(34) form the core of our model and should therefore 
always be included in any of the two abductive tasks defined in Section 2.2.3. In order to tailor our abductive 
tasks to specific inferences required by the biologists, additional constraints and assumptions can be 
included in the model. For instance, in addition to the conventional gene regulation, a biologist might want 
the inference process to take into account co-ordinated regulations. This type of information is typically not 
available in online biological repositories, and it relies mainly on the knowledge of the biologist. We consider 
in this section how our model could be extended to allow for two types of co-ordinated regulations, called 
respectively, allosteric inhibition and protein complexes.
Allosteric inhibition occurs when the binding of one protein on a target prevents the action of another 
regulator on the same target. Specific instances of allosteric inhibitions could be expressed by constraints of 
the form given in (37) and (38) below where g1, g2 and g3 are named specific genes. In this specific case, 
g1 is the target gene and g3 is the binding gene whose activated influence stops the regulation of gene g1 by 
g2. Constraint (37) ensures that the activation of  g1 by g2 and the inhibition of g1 by g3 are never inferred 
within the same network since this is inconsistent with the notion of allosteric inhibition. It is not sufficient, 
however, to simply ensure that the two regulations cannot occur in the same network. In order to infer 
compatible(g1,g2,1) it is also necessary to ensure that there is a compatible path, which ensures g3 is 
inactivated within the same network (i.e. state(g3,-1) and compatible(g3,Y,S) had been consistently 
abduced for some gene Y and value of S). Constraint(38) and the given definition of inactivated enforce this 
notion of strong inhibition.
  :- state(g1,1), compatible(g1,g2,1), compatible(g1,g3,-1)            (37)
  :- state(g1,1),state(g2,1),compatible(g1,g2,1), not inactivated(g3)  (38)
  inactivated(X) ← state(X,-1), compatible(X,Y,S)
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A protein complex occurs when two genes bind to each other to form a complex, which then acts on another 
target gene. The effect of a complex on a target can be of either activation or inhibition. An activating protein 
complex is only important in explaining the up-regulation of a gene, whereas an inhibitory protein complex is 
important in explaining the down-regulation of a gene. In situations where one component of an activating 
(resp. inhibitory) complex is down-regulated, it is sufficient on its own to explain the down-regulation (resp. 
up-regulation) of its target irrespective of the state of the other component in the complex. The behaviour 
described can be expressed with constraints (39)-(40) below for activating complex and (41)-(42) for 
inhibitory complex, where g1, g2 and g3 are named specific genes. In the case of activating complex, 
constraints (39)-(40) ensure that the same type of interaction of both genes forming the complex are 
inferred (i.e. in this case g2 and g3 form a complex and they both have to have the same type of signed-
directed link with g1). The state of g1 has to be in this case up-regulated, since the activating effect of a 
complex is only important for up-regulation. Constraints (41)-(42) capture the case of inhibiting complex, 
where the down-regulation (i.e. state(g1,-1)) is instead relevant. 
  :- state(g1,1), compatible(g1,g2,1), not compatible(g1,g3,1)              (39)
  :- state(g1, 1), compatible(g1,g3,1), not compatible(g1,g2,1)             (40)
  :- state(g1, —1), compatible(g1,g2, —1), not compatible(g1,g3,-1)         (41)
  :- state(g1, —1), compatible(g1,g3, —1), not compatible(g1,g2,-1) (42)
Note that constraints (39)-(42) are conceptually different from constraints (37)-(38). The latter enforce 
the absence of a link, whereas the former enforce the presence of a link. Adding these additional co-
ordinated regulations may result in significant changes in the resulting networks. For instance, taking as an 
example a protein complex that controls cell cycle, we would need to express that cyclinE and cdk2 form a 
complex that leads to inactivation of retinoblastoma (rb) protein. This can be expressed using constraints 
(43)-(44) below. 
  :- state(rb,-1), compatible(rb,cyclinE,-1),not compatible(rb,cdk2,-1)  (43)
  :- state(rb,-1), compatible(rb,cdk2,-1),not compatible(rb,cyclinE,-1) (44)
Embedding  (43)-(44) within our logical model for the inference of a bigger network would exclude some 
scenarios that would otherwise be abductively inferred. In datasets where rb is a non-observable gene, 
constraints (43)-(44) would guarantee that only the correct state for rb is inferred, namely rb  is inferred as 
down-regulated in the context of datasets where both cdk2 and cyclinE are up-regulated.
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2.4 ARNI assisted scientific methodology
In this Section we show that our ARNI approach is not only advantageous for network prediction, but also 
for performing explanatory scientific reasoning about signal propagations. Specifically, in Section 2.4.1 we 
illustrate how ARNI can enhance scientific knowledge discovery. We present examples in which ARNI is 
used as a “scientific assistant” to help  experts rationalise their hypotheses and guide them in identifying 
further experiments to improve the biological accuracy of the inferred networks. Section 2.4.2 examines how 
a logical framework can also be used to infer discriminating tests to help  choose among alternative 
regulatory networks.
2.4.1 Testing biological hypotheses
The ARNI approach provides a general logical model of gene regulation that can be applied to any problem 
of interest. The flexibility and modularity of the logical framework allow biologists to set up  and perform 
different inference tasks (see Definitions 2 and 3 in Section 2.2.3). We examine in this section how our ARNI 
approach can be used as a scientific assistant in supporting biologists through an iterative, investigative 
process. Each iteration is composed of the following steps: (1) automated analysis of the correctness of a 
current network with respect to a desired biological property, (2) human-driven biological assumptions to 
address any identified counterexamples, and automated check that the new assumptions would eliminate 
the counterexamples and therefore establish the desired biological properties, (3) automated prediction of 
the effects that the additional biological assumptions would have on the existing network, and (4) automated 
verification of the correctness of the newly inferred network. We illustrate this process by using a regulatory 
network that is active in T-cells and controls T-cell differentiation into two different subtypes [Mendoza06]. 
This is the same network we have referred to in Section 2.3.2 to demonstrate the expressiveness of our 
approach. The four steps of a single iteration, applied to this example, are illustrated in Figure 2.9. The 
iteration starts from a given (potentially incomplete) network (Figure 2.9.A top-left) and it ends with a 
corrected network (Figure 2.9.A top-right). 
Before describing the single steps, we give the relevant biological context of this example. T-cells have been 
shown to exist in a bi-stable environment and are either in a state of high t-bet phenotype controlled by infɣ, 
or in a state of high gata3 phenotype controlled by il4. Once the network reaches one of these two states, its 
behaviour becomes irreversible independently of the stimuli subsequently received [Mendoza06]. Any 
network describing T-cell regulation should satisfy (i.e. ensure the correctness of) this bi-stability property. In 
order to verify the correctness of a given network with respect to this bi-stability property, the biologists verify 
the absence of the unstable cases:
 high il4 leads to low t-bet expression or high infɣ leads to low gata3
We can start from either of the two possible unstable cases: “high il4 leads to low t-bet expression” or “high 
infɣ  leads to low gata3”. Let's consider the first case. If the regulatory network were correct, this property 
would not be satisfied even in the presence of high infɣ. We have performed this exploratory analysis by 
using the abductive inference task given in Definition 3 to answer the question ‘Does the t-bet phenotype 
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become become unstable in high il4’ . This query is captured by the following logical query and new 
background knowledge facts:
Query: New assumptions:
state(il4,1), state(infɣ,1) 
state(tbet,-1) 
seed(il4), seed(infɣ) 
seed(tbet)
The system was able to infer an explanation of how il4 can down-regulate t-bet (Query 1 in Figure2.9.B.), 
which demonstrates lack of biological stability. Such an explanation can therefore be seen as a counter-
example to stability. It not only shows that the given topology is insufficient to explain the bi-stability 
behaviour, but it also provides an example behaviour of non-stability, competitive(il4R,socs1,-1). 
Reviewing this counter-example the biologist can formulate possible changes to the network. One such 
hypothesis is that socs1 should act as a strong inhibitor (known in biology terms as allosteric inhibitor) of il4R 
in order to block il4R signal propagation and establish stability. This additional assumption (i.e. dashed arrow 
between left and right network in the left box of Figure 2.9) can be expressed in our ARNI model by the 
addition of the integrity constraint (45) below, which states that “il4 has an effect on il4R, provided that 
socs1 is not unregulated”.
respect to Query 1 in Figure2.10.B. This query is captured by the following logical query and new 
background knowledge facts:
Query: New assumptions:
state(il4,1), state(infɣ,1) 
sta e(tbet,-1) 
seed(il4), seed(infɣ) 
seed(tbet)
T e system was able to infer an expl nation of how il4 can down-regulate t-bet, which demonstrates lack of 
biological stability. Such an explanation can ther fore be seen as a counter-example to stability. It not onl  
shows that the given topology is insufficient to explain the bi-stability behaviour, but it also provides an 
example be aviour of non-stability, compet tive(il4R,socs1,-1). Reviewing this counter-example the 
biol gist can formulate possible changes to the etw rk. One such hypoth sis is th t socs1 should act as a 
str ng inhi it r (known i  biology terms as allo teric inhibitor) of il4R in order to block il4R signal propagati n 
and stablish stability. This additional assumpti n (i.e. dashed arrow between left and right network in t  
model checking box of Figure 2.10 can  expressed in our ARNI model by th  addition of the integrity 
c n traint (44), which states that “il4 has an effect on il4R, provided that socs1 is not unregulated”. 
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Figure 2.10 Iterative  process used by ARNI to support  the scientific process of extraction of correct regulatory 
network structures from experimental data.
(A) A single iteration process, starting from a given (potentially incomplete) network (left) and ending with the correct 
network (right).  (B) Left: Automated analysis of the correctness of the current network with respect to the data (i.e. model 
checking task), Right: Reviewing of counterexamples by biologists can result in possible changes to the network to 
establish the correctness. (C) Automated prediction of the effects that the additional biological assumptions would have 
on the existing network can result in additional behaviours to be considered in order to guarantee correctness.
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Figure 2.9: Iterative process used by ARNI to support  the scientific process of extraction of correct regulatory 
network structures from experimental data.
(A) A single iteration process, starting from a given (potentially incomplete) network (left) and ending with the correct 
network (right). (B) Left: Automated analysis of  the correctness of  the current network with respect to the data (i.e. 
verifying the absence of  the unstable cases), Right: Reviewing of counter-examples by biologists can result in possible 
changes to the network to establish the correctness. (C) Automated prediction of the effects that the additional biological 
assumptions would have on the existing network can result in additional behaviours to be considered in order to 
guarantee correctness.
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  ! :- compatible(il4R,il4,1), activated(socs1) (45)
! activated(socs1) ←  state(socs1,1), compatible(socs1,X,S) 
The addition of the above constraint is easy to do because of the possibility of expressing in ARNI complex 
interactions as discussed in Section 2.3.2.2.
Repeating the same query as above, but now with constraint (45), ARNI returns no solution, which in 
logical terms means that the given network with the additional included hypothesis can no longer find 
consistent sign propagations that explain the query “high il4 leads to low t-bet expression”. Biologically this is 
because socs1 can be proven to be upregulated as one of its regulators, stat1, is upregulated. Hence, 
compatible(il4R, il4,1) cannot be abduced, removing the only possible path from il4 to t-bet. This 
second step  of model checking proves that a stable t-bet phenotype can be established in the given network 
under the assumption of allosteric inhibition at il4R, captured by constraint (45).
However the initial property of the network is bi-stability. So the added constraint should not affect gata3 
stability, which means that the property “high infɣ leads to high gata3” should succeed under the same 
constraint of allosteric inhibition at il4R (or socs1 strong inhibition). The third step  of our iterative process is 
then used to predict the effect that socs1 strong inhibition has on gata3 stability. We have used ARNI to 
predict the sign propagation that can explain the query gata3 stability, formalised below, with constraint (44) 
now part of the IC of our abductive task.
Query: New assumptions:
state(il4,1), state(infɣ,1) 
state(gata3,1), 
state(socs1,-1) 
seed(il4), seed(infɣ) 
seed(gata3),seed(socs1),
constraint(44)
In this case we seek an explanation that predicts socs1 as downregulated under the assumption that gata3, 
infɣ  and il4 are high. The only explanation is that stat1 cannot exert an effect on socs1 on its own, in 
conjunction with gata3 overpowering stat1's effect on t-bet and thus maintaining t-bet downregulation. The 
explanation generated by the ARNI system includes the two abducibles competitive(socs1,stat1, 
1) and competitive(t-bet,stat1,1), which are depicted with circled arrows in the network in Figure 
2.9.C. The biologist may use these predictions to infer a mechanistic biological hypothesis that t-bet and 
stat1 act on socs1 via a protein complex and that gata3  augments its own expression resulting into stat1 
overpowering. These are new biological hypotheses that can be further tested in the lab. 
In summary, we have presented two examples of how our ARNI abductive framework can be used as a 
scientific assistant for testing biological hypotheses.  Biologists can customise the set of seed genes, the set 
of constraints and/or add hypothetical biological priors in order to explore biological hypotheses by posing 
queries and identifying relevant unknown gene influences that consistently explain the given queries. We 
have illustrated these concepts by considering the combinatorial regulation of T-cell differentiation network, 
where the emphasis has been on the addition of specific domain-dependent integrity constraints. 
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2.4.2 Informative Experiments for Network Discrimination
The abductive algorithm of our ARNI software is a complete inference process capable of making 
assumptions about existing incomplete information. In all the experiments described so far we have 
assumed complete biological prior knowledge. If such knowledge were incomplete (e.g., 
established_regulation was incomplete), our ARNI abductive task would generate multiple regulatory 
networks (if any exist) that are consistent with the experimental data and integrity constraints. In real world 
biological applications, it is indeed often the case that biological knowledge available in online databases is 
not complete which implies that ARNI’s output is a long list of alternative networks. Such a complete 
inference approach is advantageous, in comparison to optimisation-based methods in that it is not subjected 
to local optima and can give a more complete insight of the process under investigation [Guziolowski13]. The 
large set of networks, however, poses a key challenge of how to decide which of the networks is the “correct” 
network. As biological experiments come with their own costs it is desirable to have a computational 
mechanism that identifies key lab  tests. In this section we examine how the established logical framework 
can be coupled with the experimental platform presented in Chapter 4 and 5 of the thesis. We introduce an 
ASP framework for the design of informative experiments to help  biologists navigate through the list of 
possible experiments and discriminate over the set of possible networks. 
As the initial set of inferred networks is complete w.r.t. the initial set of data and priors, the experiment-
planning task can be defined as a pruning process over the set of alternative networks in the fewest number 
of steps possible, avoiding computationally expensive revision operations such as those suggested in 
[Gebser10b] and  [Yeang05]. Our strategy for designing validation experiments will build upon notions of 
discriminatory index of an experiment [McIlraith94] and complexity index of a set of alternative networks 
[King04]. The former defines the number of networks that can be invalidated by the test outcome of a 
potential experiment.  Given a set of alternative networks, the complexity index defines the number of 
consecutive informative experiments required to eliminate all but one network. In a fully developed approach, 
at each cycle of our validation platform, we will compute informative experiments with maximal discriminatory 
index and proritise them, according to the complexity index of the alternative networks, preferring those that 
have minimal complexity index. 
A full detailed description of how we can formally define the task for network discrimination was not possible 
within the timeframe of this project.  We have, however, carried out a preliminary investigation to confirm our 
intuition that ASP and its optimisation mechanisms provide a suitable computational environment for 
representing the test generation problem and calculating the discriminatory index. The prior knowledge and 
formal model used is described below. 
2.4.2.1 Prior knowledge
Network Representation
Each of the alternative networks outputted by ARNI is represented by a count aggregate. A count aggregate 
is an atom of the form l #count {atom1,…,atomN} u where the count function is evaluated as true if the 
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number of true atoms inside the brackets is between the lower l and upper u bound. For instance, given the 
two alternative networks in (46) and (47) outputted by ARNI, the representation of these alternative 
networks within the test generation inference task is given in (48) and (49) respectively, where each 
instance of the compatible/3 abducible is now represented as a predicted_link/3 fact8. The meaning 
of the predicate predicted_link/3 is exactly the same as that of predicate compatible/3. During the 
inference, in order for the atom alt_net(1) in clause (48) to be evaluated as true, one of the ground 
predicted_link/3 predicates that make up alternative network 1 must be in the answer set. 
Answer 1: compatible(c,b,1), compatible(b,a,1). (46)
Answer 2: compatible(c,b,-1), compatible(b,a,-1), compatible(a,d,-1). (47)
alt_net(1):- 1 #count {predicted_link(c,b,1), predicted_link(b,a,1)} 1. (48)
alt_net(2):- 1 #count {predicted_link(c,b,-1), predicted_link(b,a,-1), 
! !      !! ! ! !   predicted_link(a,d,-1)} 1.
(49)
Test representation
The validity of a hypothesised network can be tested in two ways. The correctness of individual links in the 
networks can be tested experimentally by knockdown of one gene (using siRNA technology) and monitoring 
the response of another gene. Alternatively, the validity of a hypothesised network can be tested based on its 
ability to make predictions that can be checked against experimental observations. Within ARNI, the inferred 
networks already have predicted states (given by the state abducible) and therefore we can use both of 
these approaches to discriminate over the set of networks. In this preliminary work we only consider 
knockdown experiments, which are the kind of experiments that the experimental platform setup  in Chapter 4 
is able to perform. A knockdown test can be represented with the predicate ko_test(KoGene,ObsGene), 
where KoGene is a single gene to be knockdown in the pool G  covered by all the alternative networks and 
ObsGene is another gene in the pool of genes G whose expression value should be measured in the lab 
following the perturbation of KoGene. In the current implementation we only consider the inference of a 
single test per validation cycle and therefore the set of tests to be considered in the abductive task is given 
as a choice rule with cardinality 1, thus instructing the ASP solver to choose a single knockdown test for a 
given answer set. The set of possible tests can be the complete pool of genes that occur in the given set of 
alternative networks. For instance, the tests considered for the alternative networks in (48)-(49) are given 
by:  
! ! ! 1{ko_test(a,b),ko_test(b,c),ko_test(d,a)}1.
 Alternatively the tests available can be restricted based on practical constraints in performing the test in the 
lab  e.g. availability of reagents such as siRNA. For instance, the biologists can define a set of observable 
genes (i.e. genes whose state can directly be measured in the lab) and knockdown genes (i.e. genes that 
can be knockdown in the lab) and the predicate ko_test/2 can be restricted to only those sets via 
constraints (50) and (51). 
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8 In this pilot study only compatible gene influences are included since their interpretation w.r.t. new experiments to be 
conducted in straightforward. Once the feasibility of the approach has been established the model can be extended to 
include competitive gene influences. 
! :- ko_test(X,Y),  not observable(Y). (50)
! :- ko_test(X,Y),  not ko_gene(X) (51)
The outcome of these tests are used to prune those inferred networks that are not coherent with them. A 
given test, however, can only help  discriminate amongst alternative networks in which the tested gene 
occurs.  Therefore, the relevance of a tested gene w.r.t. to a network is expressed by ground facts of the 
form relevant_test(KoGene,NetworkID) where KoGene is s single gene to be knockdown and 
NetworkID is an integer in the set [1, totalNet] and totalNet is equal to the number of alternative 
networks. For instance, in the example given in (48)-(49) ko_test(a,b) and ko_test(b,c) are 
relevant for both network 1 and network 2, whereas ko_test(d,a) is only relevant for network 2 since 
gene d only occurs in network 2. In this case, the prior knowledge would include the following set of ground 
facts: 
  {relevant_test(a,1), relevant_test(a,2), relevant_test(b,1),relevant_test(b,2), 
relevant_test(d,2)}.  
In summary, the prior knowledge consists of a set of alternative networks and a set of possible knockdown 
tests that can be performed in order to discriminate between these networks, represented by the predicates 
alt_net/1 and ko_test/2, respectively. The auxiliary predicate relevant_test/2 specifies the 
relevance of a tested gene w.r.t. to a network. 
2.4.2.2 Formal model for informative experiment inference
Depending on the experimental results biologists can then determine if the knockdown gene is involved in 
the process under investigation and whether it has an activating or inhibitory role on the activity of the 
measured gene. A knockout test outcome can therefore be represented with the predicate 
ko_outcome(ObsGene,KoGene,Regulation) where Regulation  is a value from the set {-1,1} and 
represents the possible regulatory effect KoGene has on the ObsGene (i.e. either inhibition or activation). 
Hence, for a given knockdown test the ASP solver has to choose between two possible test outcomes: the 
tested gene will either be experimentally validated to activate or inhibit its target gene. This notion is 
captured by the choice rule given in (52). In the current representation we only consider the simple case of 
testing direct links between a pair of genes. Therefore, the test outcome can be used to set the sign of a 
predicted link between KoGene and ObsGene, as defined by rule (53).
1 {ko_outcome(ObsGene, KoGene,1), ko_outcome(ObsGene, KoGene,-1)}1 
! ! ! ! ! ! ! :-ko_test(KoGene, ObsGene).
(52)
predicted_link(ObsGene, KoGene,Reg) ← ko_outcome(ObsGene, KoGene,Reg). (53)
The inference of predicted_link(ObsGene,KoGene,Reg), enforced by (52)-(53), is consistent with 
some of the alternative networks in the prior knowledge but inconsistent with others. Since the ASP solver is 
forced to choose a singe test and a single test outcome, there can only be a single predicted_link/3 
atom in a given answer set, which can be used to evaluate the truthfulness of the alt_net/1 aggregate 
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atoms in the prior knowledge and classify networks as consistent or inconsistent. The definitions for 
consistent_network(Ni) and inconsistent_network(Ni) are given in (54)-(55) below, where Ni 
denotes the name of an identifier for an alternative network in the prior knowledge.
consistent_network(N) ← ko_test(Gko,GObs),  alt_net(N). (54)
inconsistent_network(N) ←! ko_test(Gko,GObs), relevant(Gko,N), 
! ! ! ! ! not alt_net(N).
(55)
As discussed above, in order for the atom alt_net/1 to be evaluated as true, one of the ground 
predicted_link/3 predicates that make up  the given alternative network must be in the answer set. 
Consequently, networks that are consistent with the chosen test outcome contain in their count aggregate 
set the predicted_link/3 atom inferred in (53), and the count aggregate is therefore evaluated as true 
and consistent_network/1 succeeds. Conversely, in the case of inconsistent networks there are two 
possibilities for the count aggregate to fail, either the inferred predicted_link/3 in the answer set 
contradicts that of the network inferred by ARNI (i.e. the compatible abducible has the wrong causal 
regulation) or the specific predicted link doe not occur in the given network at all. The use of the relevant/
2 predicate in definition (55) ensures that the latter case does not result in inconsistent networks. 
Intuitively, the ASP solver is instructed to choose a knockdown test and an associated test outcome and 
classify the set of alternative networks in the prior knowledge as consistent or inconsistent with the chosen 
test outcome.  Hence, the inference of a discriminating test can be specified as the task of inferring a test 
outcome that will maximise a given user-defined score. The simplest such score can be in terms of the 
number of inferred networks that the specific test outcome will be inconsistent with (i.e. rules out). This can 
be expressed by the optimisation expression given in (56) below: 
! ! ! # maximize {inconsistent_network(N)}. (56)
The additional constraint (57) is also included and expresses the fact that a test outcome should at least 
invalidate one alternative network (i.e. the set of consistent_network/1 atoms in the answer set cannot 
be equal to the total number of alternative networks given by parameter totalNet). 
:- totalNet[consistent_network(N)]totalNet. (57)
Figure 2.10 demonstrates an example of how the logic program defined by (48)-(57) can be used to infer 
informative experiments for the discrimination of six alternative networks. The set of alternative networks 
illustrated graphically in Figure 2.12 cover a range of scenarios we expect to encounter in a real-world 
application. Namely, it includes (i) regulatory links that occur across all the alternative networks with the 
same regulatory effect (e.g., inhibition of gene c by gene b); (ii) regulatory links that occur across all the 
networks but with different regulatory effect (e.g., the effect of gene c on gene d); (iii) regulatory links that 
occur only in a subset of networks with the same regulatory effect (e.g., activation of gene b by gene a and 
e) and (iv) regulatory links that occur only in a subset of networks and have different regulatory effects (e.g., 
effect of gene f on gene  e). The results of the inference in terms of the number of networks that are 
consistent and inconsistent for each test outcome are given in the table in Figure 2.10. The optimisation 
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expression as currently defined optimises the number of inconsistent networks and therefore the best 
scoring test would be to test if gene e inhibits gene b. 
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Figure 2.10: Abductive inference of informative experiments.
Given the six alternative networks illustrated on the left, there are five different knockdown tests possible.  The number of 
consistent and inconsistent networks for each assumed test outcome are shown in the table on the right. The 
optimisation expression as currently defined optimises the number of inconsistent networks and therefore the best 
scoring test would be to test if gene e inhibits gene b. 
Looking at the rest of the results in Figure 2.10, we can identify some of the limitations of the current ASP 
representation. Even though the test outcome that gene e inhibits gene b  refutes four networks, the opposite 
test outcome for ko_test(e,b) (i.e. testing for the activation of gene b by gene e) does not refute any 
networks at all. The biologists might indeed prefer to perform ko_test(c,d) which refutes three networks 
regardless of test outcome. These observations point to the fact that there are different types of test that can 
be defined, which are not currently fully represented in our ASP representation. Discriminatory tests can 
refute at least one inferred network independently of their empirical outcome [McIlraith94]. Namely, that for 
the outcome activation of the tested link there would be at least one inferred network Ni that is refuted, and 
that for the outcome inhibition of the tested link there would be at least another inferred network Nj that is 
refuted. In the example in Figure 2.10, ko_test(c,d) and ko_test(f,e) are discriminatory tests. On the 
other hand, some tests have partial discriminatory power whereby the number of networks invalidated 
depends on the experiment outcome and therefore it could be the case that none of the networks are 
invalidated (e.g. ko_test(a,b) and ko_test(e,b). Such tests are referred to as relevant tests.
In summary, we have described a prototype ASP framework for the design of informative experiments and 
showed how we can build upon the ARNI logic model to formally define a logical model for network 
discrimination. In a fully developed approach the convergence to a single network should formally be studied 
and the discriminatory index should be defined w.r.t. a given test, as opposed to test outcome to reflect the 
fact that once a test is performed in the laboratory the validity of both test outcomes is known. In addition, 
tests should be classified as discriminatory or relevant and the prioritisation protocol needs to be fully defined 
to take this into account and also consider the complexity index of the consistent set of networks. 
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2.5 Discussion
2.5.1 Summary of work
In this chapter, we have presented a general logic based framework, called ARNI, for Abductive Regulatory 
Network Inference, for the construction of biological networks from high-throughput experimental data. We 
formalise the network extraction problem as an abductive inference procedure that integrates topology 
inference with exploratory reasoning on signal propagations. A qualitative model is provided that exploits 
current prior knowledge of molecular interactions and gene functions, and implements rules for gene 
dependencies based on signal propagation principles and the concept of compatible and competitive gene 
influences. The solutions of our abductive inference task are causal signed-directed networks whereby the 
information flow along depth-bounded paths between seed genes satisfies signal propagation principles and 
the inferred causal relationships satisfy any given experimental data and the known biological function of 
regulators. ARNI can be used to address three kinds of question: (1) “what is a realistic signed-directed 
network that has generated the given set of experimental data”, (2) “given the signal propagation model 
within ARNI, is an existing network consistent with some given experimental data” and (3) “what are the 
signal propagations that can cause an existing regulatory network to have a certain state? ” 
Using in silico and real-world datasets provided by the DREAM consortium, we have demonstrated the 
improved predictive power and complexity of our inferred network topologies compared with those generated 
by other non-symbolic inference approaches, showing the suitability of our approach for computing complete 
realistic networks. Network predictions show a recall of approximately 80% where, instead, existing best 
network inference methods are capable of predicting approximately 60% of a network from datasets 
generated with the same in silico method. The inference method can be applied to datasets derived from a 
variety of experimental designs such as observational as well as interventional (knockdown) datasets and 
requires less experimental data than other methods. The networks also exhibit several important motifs 
including feedback loops (positive and negative), which allow a gene to control its own expression, and feed-
forward loops (coherent or incoherent), whereby a gene has both direct and indirect connections to its target. 
A comparative analysis with non-symbolic approaches showed that these motifs are not detectable by other 
existing inference methods. Key features of our approach for the detection of network motifs include: i) the 
multiple abductive explanations per seed gene enabled by the ASP implementation, ii) the non restrictive 
nature of the symbolic representation which allows for cyclic graphs and iii) reasoning over competitive gene 
influences. We have also explored how the improved expressiveness together with the modularity and 
flexibility of the logic based nature of our approach can support automated scientific discovery where the 
validity of hypothesised biological ideas can be examined and tested outside the laboratory. Lastly, we have 
examined how our logical model can be used to infer discriminating tests to help  choose among alternative 
regulatory networks.
In summary, our logical approach offers an improvement on predictive power, applicability and 
expressiveness of existing methods. 
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2.5.2 Comparison with symbolic and non-symbolic methods
The Answer Set Programming (ASP) environment used in ARNI provides a rich and simple modeling 
language together with intelligent search algorithms capable of solving NP-hard problems, which is well 
suited for the combinatorial complexity of network inference. Recent results have demonstrated the potential 
of ASP to address problems such as modeling, analysis and revision of complex biological processes. 
Although very promising and effective on their computational tasks, none of these existing approaches can 
do de-novo topology inference. The problem of training existing signalling pathways to context-specific 
phosphorylation data and learning their combinatorial regulation initially proposed by [Saez‐Rodriguez09] is 
revisited in [Videla12], which formulates the problem within an ASP environment and demonstrates a 
significant improvement on computation time. The work in [Fayruzov09] adapts an ASP framework for 
modeling cell cycle networks in [Dworschak08] to behave as a Boolean network. They conclude that the 
ASP framework outperforms Boolean networks both on expressiveness and scalability. In [Guziolowski13], 
ASP is used to exhaustively characterise all possible Boolean models of signalling pathways and the 
benefits of such a complete approach are demonstrated. The work in [Gebser10] proposes a new library, 
called BioASP, to analyse biological networks with respect to a large amount of high-throughput biological 
data. BioASP expresses the Sign Consistency Model presented in [Siegel06] which is closely related to our 
sign consistency constraints. Automated analysis tasks include detection and explanation of inconsistencies 
[Gebser11], computation of repairs and predictions [Gebser10b], and expansions of existing biological 
models [Schaub09]. More recently, abductive logic programming and ASP have been used in [Lazarou13, 
Papatheodorou12] to analyse the effect experiments have on established networks and help  biologists 
formulate new hypotheses and future experiments. In the context of metabolic networks, Ray et al. have 
shown in [Ray12] how ASP and a ASP-based symbolic learning can be use to model and revise (incorrect) 
metabolic networks. The approach is validated using a model of Aromatic Amino Acid (AAA) biosynthesis in 
the yeast S. cerevisiae [King04] and artificially generated growths in some hypothetical experiments. In all 
the above works, biological networks are assumed given or known. 
Abduction has already proved suitable for inferring signalling-transcriptional networks [Papatheodorou05, 
Inoue13]. Existing proposals however suffer a high number of false predictions. In [Inoue13] the nature of the 
data and hypotheses used differs from the one used here. The purpose of abduction is not to recover 
particular links, but rather to enumerate all possible additional links in prior networks to connect a target to a 
source node. The solutions are highly hypothetical, the inference process is not driven by experimental data 
and the logic-based inference about concurrent gene regulations works under the default assumption that an 
inhibitor always overpowers an activator. In [Papatheodorou05], gene dependencies are inferred to explain 
changes in the gene expression levels using a predefined set of regulators that are allowed to regulate any 
other gene, regardless of biological function of genes. No biological prior knowledge is considered during the 
inference process and the approach does not cater for non-observed hidden genes or concurrent gene 
regulation. ARNI builds upon the works of [Inoue13, Papatheodorou05] and addresses some of their 
limitations, specifically by allowing the use of prior knowledge, modelling and reasoning about competitive 
gene influences and presenting a framework that can act as a scientific assistant to biologists for testing the 
validity of new hypotheses. 
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A number of statistical approaches to gene network inference exist. These can be divided into three main 
groups:9  [Langfelder08, Schäfer05, Margolin06, Faith07] use various statistical dependency measures 
motivated from information theory to infer unsigned-undirected co-expression networks. The works in 
[Friedman00, Fröhlich08, Werhli08] employ probabilistic graphical models to infer joint probability 
distributions over the observations. Another group  of methods use regression analysis to identify best 
predictors for each gene [Huynh-Thu10, Küffner12]. A key advantage of the approach we have presented 
here, compared with statistical approaches, is the ability to incorporate background knowledge on interactive 
and regulatory potentials. Having a scaffold of interactions over which unknown networks can be inferred 
overcomes a number of problems: (i) the sparsity in the input data is addressed and genes in the inferred 
networks are extended beyond those experimentally measured, thus resulting in more complete networks, 
(ii) the systematic errors in network motifs representation, reported for statistical approaches [Marbach10, 
Marbach12], are not present in our method, thus resulting in more realistic networks, and (iii) the inferred 
networks are based on physical molecular interactions and as such are easier to interpret and can reveal the 
underlying biological mechanism of biological processes. The observed improvement of the performance of 
network inference algorithms by the integration of prior knowledge has also been reported by others 
[Olsen14, Vicente12, Chen12]. 
The approach taken in the ARNI system is based on flow networks, which aim to explain experimental 
observations on a template of protein-protein and TF-DNA interactions by establishing causal chains 
between pairs of genes in such a way that the resulting information flow satisfies signal propagation 
principles. Many different formalisms have been explored for flow network reconstruction, including statistical 
scoring of active subnetworks [Ideker02], maximum-likelihood [Yeang04], linear programming [Ourfali07], 
network flow optimisation [Yeger-Lotem09], and the Steiner tree approach [Huang09, Tuncbag13]. The 
existing works on flow networks approaches are limited in their ability to detect complex regulatory 
structures, Section 2.3.2.1, and the extent to which they can infer causal (signed-directed) networks. In 
[Yeang04, Yeger-Lotem09, Ourfali07] causal inference is restricted to source to target analysis which is not 
applicable to observational data where the source of perturbation is unknown. Methods that relax this 
assumption, [Ideker02, Huang09, Tuncbag13], can only infer unsigned undirected networks which have 
limited applicability for studying network dynamics and motifs. The formulation of the model, as presented in 
our ARNI approach, overcomes both of these limitations, allowing the inference of complex causal networks 
from observational and intervention data.
2.5.3 Factors affecting the performance of the integrated inference-
validation platform
The network pruning approach for network discrimination, which is part of the integrated inference-validation 
platform, relies on the initial set of networks to be as complete as possible with respect to the real ‘true’ 
network. False positives (i.e wrongly inferred edges) in the alternative networks can be eliminated with 
experimental validation using the high-throughput RNAi platform presented in Chapter 4. False negative (i.e 
Symbolic Representation and Inference of Regulatory Network Structures
80
9 For a comprehensive review of non-symbolic based approaches, see [Rotival14, He09]
true edges not inferred), however, cannot be retrieved since the informative experiments only test genes 
occurring in the initial set of networks. False negative edges in ARNI can be attributed to either not available 
molecular interaction in the priors or poor quality of seed genes. In this section, we briefly discuss strategies 
for addressing these two factors. 
2.5.3.1 Selecting a set of most informative seed genes
Under complete interaction potential priors, the results in Section 2.3.1 demonstrate that the main reason for 
incomplete network inference is the inability of the seed genes to cover the whole network as opposed to 
noise and inconsistencies in the gene regulation model. Seed genes should be as widely distributed across 
the networks as possible and to include both upstream and downstream genes. In addition, seed genes 
need to be as robust as possible (i.e. as few false positives as possible), since any given experimental data 
are assumed to be true, and all networks inferred have to be consistent with them. 
In order to address the issue of false positives in the seed genes we have pursued a meta-analysis approach 
for the integration of all available mechanoresponsive microarray datasets and set up  procedures to obtain a 
robust set of shear sensitive genes based on differential expression. The bioinformatics workflow  to 
generate an integrated endothelial cell mechanoresponsive gene expression profile and identify a robust set 
of mechanoresponsive genes is presented in Chapter 3. Differential expression analysis however is biased 
against the detection of differentially expressed genes with low fold changes and of weakly expressed genes 
due to the inherent noise in accurately measuring their expression value [Canales06]. Low expressed genes 
however are often involved in rate limiting steps in network dynamics and the importance of small fold 
changes has previously been reported [Laurent13]. In order to address this issue we propose to augment the 
seed genes identified from differential expression analysis with co-expressed genes identified via functional 
association methods to maximise information gain from the integrated mechanoresponsive gene expression 
profile. The set of co-expressed genes and differential expressed genes do not always overlap  as they 
capture different biological signals [Huan13]. Therefore by merging the two approaches the initial set of seed 
genes is as complete as possible and should result in improved network inference. To alleviate against false 
positives in the set of co-expressed genes, we have set up  procedures to generate a consensus co-
expression network which statistically integrates the results of multiple network algorithms. In recent years 
the benefits of a consensus approach to overcome the limitations of individual inference methods have been 
demonstrated and methods have been suggested to generate robust co-expression networks derived from 
multiple algorithms [Marbach12, Hase13, Fioretto15]. The work on consensus network construction from 
mechanoresponsive datasets was not fully completed. Preliminary results are presented in Appendix 2.   
In summary, the use of two complementary approaches, differential expression analysis and co-expression 
analysis, for seed gene identification maximised the information gain from the gene expression data and 
should generate high quality seed genes.
2.5.3.2 Addressing false negatives in molecular interaction priors
Incorporation of biological background knowledge is instrumental in overcoming the limitations of statistical 
approaches to gene network inference and improving the recall rate of the inference method. This, however, 
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introduces a bias in our ARNI approach towards interactions that have already been reported. Despite the 
growing body of available high-throughput interaction assays providing a vast amount of interaction data 
there are still unknown protein-protein or protein-DNA interactions that remain undiscovered. Our ARNI 
approach can be extended to complete networks with such previously unknown interactions. Logically and 
conceptually these can be accommodated very easily by introducing an additional abducible for interactive 
potentials and linking that to some constraints. Practically, one will need to drive the inference by integrating 
statistical approaches capable of detecting functional associations between genes, which might or might not 
correspond to physical interactions. Functional association networks have previously been used as priors for 
network inference and have been shown to improve the performance of the network inference [Olsen14, 
Studham14]. Functional associations can be retrieved from online databases that aggregate heterogenous 
data across diverse set of conditions. These associations are often not species or context specific and can 
be inaccurate. Alternatively, they can be computed in a context-specific manner from available data (e.g., 
from our mechanoresponsive microarray data). Studham et al. demonstrated that functional association 
priors have to be at 70% accuracy in order to show clear improvement in network inference [Studham14]. 
Our approach of generating a consensus co-expression network has the potential to meet this requirement. 
Integrating physical interactions and functional associations can result in causal networks enriched with 
novel interactions inferred by functional associations, overcoming the limitations of either approach alone. 
Any statistical associations that cannot be explained in terms of paths in our approach can be learned as 
new links in the networks. In this way  we can perform the task of adding new links as proposed by [Inoue13] 
but in a more realistic manner. For instance, two possible mechanistic explanations of a functional 
association between three genes are the following: the two genes could be targeted by the same regulator, 
or alternatively all three genes are involved in the same pathway. Under this scenario, directed signed 
interactions can be inferred in the absence of interactive potential by using the concept “guilty by 
association’. In a recent work, [Novershtern11] combines a Bayesian model describing modules of co-
expressed genes and their corresponding transcription factors, and a physical interaction graph 
(undirected,unsigned) that links the transcription factors together, thus providing partial mechanistic insight 
for gene regulation. The approach in [Novershtern11] is limited because of its inability to include feedback 
loops; the physical interactions are unsigned-undirected, and the genes are preprocessed into clusters of 
genes lacking edges between genes within clusters. We hope that an integrated approach, within our 
symbolic approach, can help overcome these shortcomings. 
2.5.4 Future work for the design of informative experiments
One of the advantages of our approach for network inference, in comparison to optimisation based methods, 
is that ASP solvers exhaustively enumerate all possible networks that are consistent with the given data. 
Reasoning over the complete solution space can lead to more robust insights by providing feasible solutions 
that would otherwise have been missed and allows for the identification of network components that are 
functional across all possible models or components that operate in a mutually exclusive manner. A complete 
approach however can result in a large number of plausible networks and therefore tools are necessary for 
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the automatic generation of informative experiments that are most discriminatory over the inferred gene 
networks. 
The results in Section 2.4.2. demonstrate how ASP can be used for the design of informative experiments 
and confirms our intuition that the ASP computational environment is suitable for test generation and well 
suited for the ASP implementation of our ARNI approach. Further work still needs to be done, in terms of 
definitions of informative experiments to formulate the network pruning task in such a way as to guarantee 
that the entire process eventually converges to a single gene network. An essential step is to extend the test 
definition to include discriminatory and relevant tests and implement the complexity index (i.e. the number of 
consecutive informative experiments required to eliminate all but one network). Further extensions include 
the adaptation of the inference task to consider multiple tests per iteration cycle. A set of high scoring 
experiments might be redundant with respect to each other, and therefore the test generation task should 
take into account that the experiments are going to be performed in parallel using the high-throughput RNAi 
platform. In such an approach, additional optimisation statements will have to be considered to maximise the 
diversity between the inconsistent networks [Szczurek09]. Advanced models for the design of informative 
experiments could make use of competitive gene influences and consider the identifiability of the test 
outcome given the network structure using concepts from control theory (e.g., existence of compensatory 
mechanisms that can mask the knockdown effect) [Liu11]. Lastly, the alternative networks could perhaps 
also be quantified probabilistically by incorporating our logic model in a framework that allows probabilistic 
abductive inference, e.g. [Turliuc13]. Such a framework would allow the representation of probabilistic 
abducibles whose probability value can be interpreted as the the strength of the knowledge that led this link 
to be inferred. The higher the probability the higher the chance that the signed-directed link is true. Using 
these probabilities it could be possible to evaluate the reliability of the inferred networks and therefore 
provide a means for prioritising alternative paths between two genes. 
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2.6 Conclusion
We have presented an approach, named ARNI, to logically model and automatically construct through 
abductive reasoning regulatory gene networks from experimental data and background prior knowledge of 
gene function and interactions. Through a series of evaluation experiments we have demonstrated the 
viability and potential of the approach. The logical approach and nature of the constructed network models 
gives these models not only predictive power but also a high degree of versatility in their further 
development. They can be modularly changed either with new information that has become available or with 
hypotheses that the scientists want to examine before carrying out in vitro experiments. We have shown how 
ARNI can be embedded within a general framework that supports automated scientific discovery where the 
validity of hypothesising ideas can be examined and tested outside the laboratory. 
The main challenges in gene network inference are often considered to be the under-determined nature of 
the data (more parameters than data sets), the noisy and sparse nature of high-throughput data and the 
complexity of network topologies. All available experimental or computational methodologies, including 
ARNI, have their strengths and weaknesses; no individual methodology can capture the full complexity of 
biological systems. Integrity constraints used in our work allow for incremental model refinement. We 
envisage that our logic based method can form a central platform for the progressive integration of diverse 
types of data and methodologies to improve the final network inference.
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3Integration of flow studies for robust 
selection of mechanoresponsive genes
Chapter 3 Summary
The clinical importance and motivation for studying mechanoresponsive networks in endothelial cells is fully 
discussed in Chapter 1. A review, undertaken by our group, of microarray studies that exposed endothelial 
cells (ECs) to different shear stress regimes concluded that the lack of conformity of platforms and 
bioinformatics analysis and high variability in biological conditions (e.g., cell type, specie, age, shear regime) 
leads to high variability between reported gene signatures and hinders the determination of a robust set of 
mechanoresponsive genes [Frueh13]. This chapter investigates whether a systematic meta-analysis of the 
available microarray studies using uniform methods can improve the consistency of available datasets. A 
bioinformatics workflow for the integration of gene expression profiles across platforms and species is 
established and applied for generating an integrated EC mechanoresponsive gene expression profile. 
Section 3.1 provides the background theory and principles for conducting integrative gene expression 
analysis and presents the objectives of the study. Section 3.2 gives details of the procedures used and 
Section 3.3 presents the results for the generation of an integrated EC mechanoresponsive gene expression 
profile. 
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3.1 Background
Since its introduction in 1995 by Schena et al. microarray technology has been adopted by a number of 
different vendors to become a standard tool for simultaneously interrogating the RNA expression of the 
whole genome [Shena95]. Whilst it is a very powerful technology, practical constraints restrict the number of 
samples that can be obtained reducing the discriminatory power of analyses. Data repositories such as 
Gene Expression Omnibus (GEO) maintained by National Centre of Biotechnology Information (NCBI) 
[Edgar02] and ArrayExpress maintained by European Bioinformatics Institute (EBI) [Brazma03], make it 
possible to address this issue by re-analysing and merging Microarray Gene Expression (MAGE) data. 
There is a strong motivation for cross-study analysis owing to the benefits of combining information from 
multiple studies. Integrative analysis is a relatively inexpensive way to gain new biological insight by making 
use of data accumulated through the years. Increased sample size and statistical power allows for the 
discovery of subtle differences in gene expression and result in more reliable and generalised findings, which 
are less likely to be due to study-specific artifacts [Ein-Dor06,van Vliet08, Xu08, Belcastro11, Lukk10, 
Schmid12]. In addition, each individual study addresses only a small part of the global solution, therefore the 
merging of diverse conditions on the same biological problem allows for the interrogation of a greater 
proportion of the “solution space” that is relevant to the biological problem under investigation [Lukk10]. For 
our application, a comprehensive and robust set of mechanoresponsive genes is essential for ARNI, since 
its performance depends on the initial set of seed genes (Section 2.3). 
3.1.1 Microarray integration approaches
Initial concerns on the reliability and reproducibility of MAGE experiments motivated the Federal Drug 
Administration (FDA) to set up  a community-wide MicroArray Quality Control (MAQC) project to evaluate 
cross-site and cross-platform concordance [Marshall04, Frantz05, Shi06]. The program was run in two 
phases. MAQCI tested six commercially available microarrays and three different sites and assessed intra-
lab  variability, inter-lab  reproducibility and cross-platform transferability. High reproducibility of results was 
demonstrated for differential expression gene lists (74% overlap  across platform) [Shi06, Guo06], as well as 
at the biological interpretation level (using GO  terms and gene set enrichment analysis) [Guo06, Zhang13a]. 
MAQCII evaluated the factors that are important for building classifiers (predictive models for clinical 
outcome based on training sets of MAGE data). It concluded that classifier’s performance was platform 
independent and dependents on the difficulty of the endpoint and the skills of the researchers [Shi10, 
Oberthuer10]. In addition, classifiers built on one platform could be used to predict the results from another 
platform [Fan10, Luo10]. The consensus derived from the MACQ project was that there is a high cross 
platform and cross laboratory transferability of results assuming the appropriate analysis procedures are 
followed, which encouraged researchers to pursue cross-study analysis.
A general workflow for microarray data analysis is illustrated in Figure 3.1.A. Microarray data analysis 
consists of four main steps. Imaging processing converts the image files into a matrix of numerical probe 
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intensity values. Each manufacturer provides specialised imaging processing software to segment individual 
spots and combine individual pixel values into probe intensity values [Dunning07, Arteaga-Salas08]. Probe 
intensity values are then processed to obtain normalised gene expression values. Pre-processing is an 
umbrella term used for: i) background correction to calculate the true signal from the technical noise ii) probe 
intensity summarisation to a single value per gene and iii) between-array normalisation to obtain similar 
distributions across samples. The methods are platform specific and is an area of active research with a 
plethora of alternatives proposed for each step [Ritchie07, Wu09, Schmid10]. The last step  of the workflow 
consists of  statistical analysis to obtain a list of differentially expressed genes (DEGs). Typically this involves 
choosing a fold change and p-value threshold at which the differences in the expression values between two 
conditions is considered significant. 
Integration of MAGE data can be achieved at multiple stages of the data analysis workflow. The choice 
depends on the type of available data and the purpose for undertaking the integrative analysis. Image files 
are very rarely available and most researchers use the manufacturer’s defaults as a black box. Pre-
processed gene expression values and published gene lists are the easiest data format to obtain, especially 
for early microarray studies for which there are no raw data available. They are, however, limited by 
differences in annotations, preprocessing algorithms and thresholding used. As a result they are rarely 
concordant between studies, as also demonstrated by our own review on mechanoresponsive studies 
[Frueh13]. Contrary, raw intensities allow for consistent handling of all datasets and it is the preferred data 
format to use for integration of MAGE studies. 
Integration methods starting from raw intensities can broadly be divided into methods that achieve 
integration at the interpretative level (meta-analysis) or methods that integrate expression values directly 
(integrative analysis), (figure 3.1.B). In meta-analysis each study is analysed independently to extract a 
summary statistic (e.g., fold change, p-value) and the merging is achieved by combining the results from 
individual studies. In integrative analysis the merging of datasets occurs at the gene expression value level 
to create a larger combined data matrix, which is analysed collectively.
The majority of studies, ~ 70%, pursue a meta analysis approach. [Tseng12, Rung13]. There are many 
different approaches proposed in the literature for the summary statistic used for combining studies. Rhodes 
et al., one of the first studies to apply meta-analysis at a large scale, followed a combined p-value approach 
and created the Oncomine consortium of cancer transcriptomes, one of the largest one to date [Rhodes05]. 
Gene-wise p-values calculated per study were combined into a single value based on the Fisher’s method 
that sums up  minus log-transformed p-values. The combined value was then used to detect consistently 
significantly disregulated genes. Choi et al. followed an effect size approach and developed GeneMeta 
software [Lusa08]. For each gene in each study, the effect size was calculated based on the t-statistic. The 
individual t-statistics for a gene were aggregated into an overall score using a model that accounted for inter-
study variability [Choi03]. Hong et al. proposed the rank product approach and developed the RankProd 
software [Hong06]. In this approach, fold changes for each dataset were calculated and ranked. The ranks 
for each gene across all the studies were combined using rank product. Genes that were consistently found 
among the most up-regulated (or down-regulated) genes in the majority of studies were ranked higher.
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Figure 3.1: Integration strategies for cross-study analysis of gene expression microarray data. 
A) Microarray data analysis workflow, stating from image files and concluding with the generation of differential 
expression gene lists. B) Integration methods starting from raw probe intensities can be divided into methods that 
achieve integration at the interpretative level (meta-analysis) or methods that integrate expression values directly to 
generate a larger single dataset (integrative analysis). The main difference between meta-analysis and integrative 
analysis is that in meta-analysis, each study’s expression value matrix is compressed into a single column of results, 
which are then merged, whereas in the integrative analysis the expression value matrixes maintain their dimensions. 
Integrative analysis offers a number of advantages over meta-analysis approaches. Meta-approaches 
analyse data in a study-by-study basis and therefore there is no increase in the sample size, resulting in 
reduced gain in statistical power. As a result subtle changes in gene expression, which are hypothesised to 
play important role in regulation of biological pathways are missed [Laurent13]. Further, lower expressed 
genes are under represented in the DEG lists due to the inherent higher noise associated with these [Tu02]. 
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A number of studies have demonstrated that aggregating the data prior to statistical analysis is more 
powerful with improvement observed in differentially expressed genes [Taminau14, Turnbull12], predictive 
power of classifiers [Xu08, Warmat05, Zhang07], and gene network inference [Steele08, Sirbu10]. For 
instance, Taminau et al. compared the biological insights gained by following a meta-analysis versus 
integrative-analysis approach on the same lung cancer MAGE dataset. Significantly more DEGs were 
identified via the integrative approach (102 DEGS compared to 25 DEGs via meta analysis) and all the 
DEGS identified via meta-analysis were included in the integrated analysis results [Taminau14]. 
3.1.2 Challenges for direct integration of gene expression datasets
The key challenge in microarray integration is the generation of optimal pipelines to achieve compatible data 
at the gene level across different platforms and laboratories.
3.1.2.1 Microarray platforms technologies
A major concern for successful cross-study analysis is the lack of a single experimental platform for 
generating the data. Microarrays consist of an ordered matrix of immobilised nucleic acid probes on a solid 
surface. Each probe can bind to a different target in a highly specific manner based on the principle of 
complementary binding of base pairs (hybridisation), first described by Watson and Crick in the 1950s 
[Schena95]. In a typical microarray experiment, RNA is extracted from cells or tissues, amplified and labeled 
with fluorescent dye. The labelled cDNA sample is then hybridised to the microarray. Target specificity is 
determined by the probe’s sequence and the binding of the labelled cDNA transcripts to a specific probe 
generates a fluorescent signal that can be used to quantify mRNA abundance in a sample. Target 
identification is resolved either spatially (i.e. probes have predefined coordinates on the array) or 
alternatively a barcode system is used. Available microarray platforms differ in terms of their fabrication, 
probe design, and signal detection methods, which results in data that are not numerically comparable and 
cannot directly be combined. The three main manufacturers are Affymtrix (AFFX), Illumina (ILUM) and 
Agilent (AGL). In addition, a large number of academic groups rely on in-house manufactured spotted 
microarrays. Table 3.1 details the properties of each of these platforms [Coller09]. 
An important consideration for cross-study analysis is the probe design for each platform. The genomic 
organisation of genes is illustrated in Figure 3.2. DNA is discontinuous with non-coding regions between and 
within genes. When the gene is transcribed from DNA into RNA, those non-coding areas (termed introns) are 
edited out. Such inta-gene non-coding regions are not used for the generation of the protein(s) that the gene 
is responsible for. The coding regions of the gene (termed exons) can be spliced together in multiple 
configurations. This allows a single gene (at the DNA level) to produce different protein products, termed 
alternative splicing. Microarray platform manufacturers chose different approaches for designing probes 
targeting a specific gene region. Figure 3.2. illustrates the design for Affymetrix and Illumina arrays.
Affymetrix GeneChip  arrays use a system of Perfect Match (PM) - Miss Match (MM) probes pairs, with each 
probe being 25 bases long. The PM probe perfectly matches the sequence of the target gene, whereas the 
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Table 3.1: Properties of available microarray technologies
Platform Probe Length Manufacturing Method
Target 
Identification Label Type
Detection 
Method
# Samples 
per array
Affymetrix
GeneChip 25
in-situ synthesised on solid 
waffer using photolithography
pre-defined 
coordinates Biotin
streptavidin-
phycoerythrin 
antibody
Single 
channel
Illumina 
Beadchip 50
Random placement of 
prefabricated beads loaded with 
cDNA probes, on a substrate 
with micro-wells
Decoding 
probe-specific 
barcode Biotin Streptavidin-Cy3
Single 
channel
Agilent 50 in-situ synthesised on glass substrate using ink-jet printing
pre-defined 
coordinates
Cy3 or Cy5 
dye Cy3 and Cy5
Single 
Channel
Spotted 
DNA array
Varied
(60-90)
Robotic deposition of 
presynthesised cDNA probes on 
glass slide
pre-defined 
coordinates
Cy3 or Cy5 
dye Cy3 and Cy5
Dual 
Channel
MM probe has a changed middle residue and is designed to detect non-specific binding for that probe. The 
probes are organised into probesets, with each probe pair measuring a different part of the mRNA, meaning 
no two probes are exact replicates. In earlier versions of the technology each gene was represented by a 
single probe set that targeted the 3′ end of the mRNA transcript. Later versions have evenly distributed 
probe sets along the entire length of the mRNA transcript, removing bias at the 3’ end [Lockhart96].
Genomic(Locus((DNA)(
of(Gene(x 
Transcript(Variant((RNA)(
of(Gene(x 
{ 
Aﬀymetrix*Array*
probe*design*
3’* 5’*
Illumina*Array*
single*probe*design* Probe* Probeset*
Figure 3.2: Microarray probe design against the genomic organisation of a gene.
DNA is discontinuous with non-coding regions between and within genes. The coding regions of a gene (termed exons) 
can be spliced together in multiple configurations.  In Affymetrix chips probes are evenly distributed along the entire 
length of the mRNA  transcript.  In Illumina beadchips each transcript is targeted by a single probe sequence, at the 3′ end 
of the mRNA transcript.
Illumina Beadchip  arrays consist of silica beads (each 3microns in diameter) randomly positioned on the 
chip. On average, each bead type is replicated 30 times on the array and each bead is bound with hundred 
of copies of a specific 50-mer oligonucleotide sequence. The technical replicates for each bead type are 
scattered randomly across the array to avoid spacial artefacts and probe identification is based on a barcode 
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decoding system [Kuhn04].  In contrast to affymetrix GeneChips, illumina arrays provide internal technical 
replicates and each transcript is targeted by a single probe sequence at the 3′ end of the mRNA transcript. 
The MAQC project demonstrated high reproducibility for the same platforms across sites, and high 
transferability of results across platforms. Transferability is very important in building classifiers for diagnostic 
purposes or testing robustness of DEGs lists but for systems biology approaches the data need to be 
analysed altogether in order to gain insights on the overall networks and processes driving a disease. The 
MAQC project did not attempt to directly integrate the expression data across platforms speculating that the 
”expression values generated on different platforms cannot be directly compared because unique labelling 
methods and probe sequences will result in variable signals for probes that hybridise to the same 
target”  [Shi06]. Therefore, there are two main challenges that need to be overcome for successful cross-
platform integration of MAGE experiments: 1) What does each probe represent and how does it relate to 
probes on other microarrays?, and 2) How to make data numerically comparable given the disparity in data 
format and scale?
3.1.2.2. Probe annotation and  cross-platform mapping
Probe annotations are an important factor in the reliability of biological interpretations derived from 
microarray experiments since incorrect probe to gene mapping can lead to misleading results. A substantial 
number of the manufacturer’s original probe groupings and mappings are known to be inaccurate  (~5% 
probes) or map  to intronic regions (~30% probes) [Okoniewski06, Perez-Iratxeta05, Risueño10]. Completion 
of genome’s sequencing and improved understanding of gene transcription and regulation allows for 
improved mapping of probe sequences to genetic identifiers. Several re-annotation efforts demonstrated an 
improved precision and accuracy in terms of DEG detection and improved cross-platform reproducibility 
[Carter05, Dai05, Mecham04, Sandberg07, Lu06, Risueño10]. Problematic probes include probes that match 
multiple gene loci, whereby their signal is derived from multiple unrelated transcripts, or probes that are 
targeting the not transcribed part of the gene and thus their signal does not reflect the abundance of the 
mRNA levels.  
Three problems need to be addressed. First, all probes within a platform are re-assigned revised genetic 
identifiers to reflect the latest understanding of genomic sequence and annotations (i.e. which part of the 
genome each probe is targeting and which gene that region is transcribing (genome annotations). Affymetrix 
arrays are particularly problematic because each probeset consists of 4 probes with different sequences, 
targeting a different region of the gene. Therefore, as new information on the genome annotation is available 
the individual probes need to be re-grouped into new probesets to better reflect the biology of the transcript 
been targeted. Several publications addressed these issues and generated custom annotation files [Liu07, 
Dai05 , Risueño10]. 
Second, the probes for each platform need to be mapped to a common identifier since no two platforms use 
the same sequences. There are a number of common identifiers to choose; transcript-centered identifiers 
(e.g., Unigene, RefSeq) or gene-centered identifiers (e.g., EntreZ ID, Ensemble Gene ID). In choosing the 
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best identifier there is a trade-off between coverage and accuracy. Mapping to more specific genomic 
locations results in improved expression value consistency since probe signal is sequence-dependent and 
the probes interrogate the same genomic locus. The mapping rates between platforms on the other hand, 
are greatly diminished since different vendors choose to target a different region of a gene [Carter05, Ji06]. 
Therefore, the most appropriate procedures should be set up  to maximise overlap  between platforms but 
also ensure compatibility between platforms. 
Third, given that the cross-platform analysis needs to be performed at the gene level, procedures need to be 
setup  to collapse probes mapped to the same gene into a single value. This problem is often referred to as 
‘many-to-one’ problem. Different approaches have been pursued in the literature, ranging from averaging 
over the individual probes to selecting the probe-pair with best sequence overlap between platforms. 
3.1.2.3. Cross-laboratory and cross-platform normalisation
When integrating multiple studies it is important to account for systematic biases, also known as ‘batch 
effects’. Systematic biases can be defined as “systematic technical differences between measurements of 
different MAGE experiments which are uncorrelated to any biological variation” [Leek10]. MAGE experiments 
are a multi-step  procedure consisting of tissue preparation, RNA processing, hybridisation and data 
acquisition. Each process is affected by different factors such as, different technician handling, 
environmental conditions, reagent batches, microarray platforms and equipment, and contributes to different 
extents to the observed variation in MAGE measurements [Lazar13, Kitchen11, Scherer09, Kitchen11]. 
Therefore, pre-processing procedures need to be applied to remove technology and laboratory variability, 
while retaining biological variability.
Uncorrected batch effects have been shown to greatly compromise experimental results. Batch effects 
increase the variability in the data and decrease power, thus masking the biological signal. Leek et al. 
examined the consequences of uncorrected batch effects in published data and raised serious concerns 
about the validity of the findings [Leek10]. In a comprehensive review of published data, 40-90% of genes 
showed strong association with processing date, regardless of biological phenotype, a finding also confirmed 
by Baggerly et al. where they showed that the results derived from an ovarian cancer cross-study analysis 
were mainly driven by run date rather than by clinical response [Baggerly08]. Batch effects not only affect the 
mean level of genes but also the correlations and ranking of genes [Leek10], which is important for 
application of MAGE experiments for networks inference and classifier training. Batch correction has been 
shown to improve cross-laboratory correlation (from 0.6 to greater than 0.9 [Shi08, George09]), cross-
platform consistency [Larsen14, Turnbull12, Sims08] and the predictive abilities of classifiers [Sims08, 
Luo10]. Despite the recognition of the importance of batch effect correction very few studies address these, 
with only 10% of MAGE studies performing batch correction [Chen11, Leek10]. 
In summary the full potential of direct integration of expression data is hindered by practical issues 
associated with disparity in data format and scale due to platform technologies, lack of common identifiers 
and laboratory specific effects, which result in data that are not numerically comparable. 
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3.1.3 Proposed workflow for direct integration of gene expression 
datasets
The shear stress studies considered in the integrative analysis consist of expression data from four different 
microarray platforms across four different species. Therefore, we had to tackle the issue of direct integration 
across platforms and species. Of the available software for cross-study integration of microarray experiments 
(Table 3.2) there is no tool currently available with the full functionality needed for this project. Software with 
extensive annotation functionality, lack the functionality to pre-process raw data (e.g., DSGeo, AMADMAN). 
Software with broad range of preprocessing functionality are limited to vendor annotations or assume the 
studies have the same gene identifiers (e.g., WebArray, insilicoMerging).  
Table 3.2: Available software for cross-study integration of microarray experiments
Software
Preprocessing* Probe 
Mapping
Cross-Study 
Analysis
Cross-study 
Normalisation
Software 
Type CitationAFFX ILUM AGL 2-Ch
AMDA ✔ ︎ ✔ ︎ ✔ ︎ - Vendor - - Local Kapetis13
MicroarrayRUS ✔ ︎ ✔ ︎ - - ✔ ︎ - - Local Dai12
WebArrayDB ✔ ︎ ✔ ︎ ✔ ︎ ✔ ︎ Vendor Integrative Discretisation Web-tool Xia09
ArrayMining - - - - - Integrative Multiple Web-tool Glaab09
VirtualArray - - - - Vendor Integrative Multiple R Heider12
InsilicoMerging - - - - - Integrative Multiple R Taminau12
AMADMAN ✔ ︎ - - - ✔ ︎ Integrative Quantile Web-tool Bisognin09
AnyExpress ✔ ︎ - - - ✔ ︎ Integrative Quantile Web-tool Kim11
DSGeo - - - - ✔ ︎ Integrative Quantile Web-tool Lacson10
InCroMAP - - - - ✔ ︎ Meta - Local Wrzodek13
iArray - - - - - Meta - Web-tool Pan06
INMEX - - - - ✔ ︎ Meta - Web-tool Xia13
MetaOmics - - - - - Meta - R Wang12
* AFFX: Affymetrix; ILUM: Illumina; AGL: Agilent; 2-ch: two-color array
The proposed workflow for integrative microarray analysis is illustrated in Figure 3.3. The workflow consists 
of five modules: data acquisition, platform annotation, data pre-processing, data merging and data discovery 
(derived from [Ramasamy08, Turnbull12]). Studies to be included in the analysis are identified via a series of 
inclusion/exclusion criteria within the Data acquisition module. The Data pre-processing module applies 
platform specific normalisation steps to generate normalised expression values for each study. The Platform 
annotation module links the probes between the different platforms and finds a subset of genes consistently 
measured across platforms. The Data merging module takes as input the study-wise gene expression data 
and the platform-wise annotation mappings and generates a merged cross-platform, cross-laboratory 
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normalsied gene expression dataset. Once the merged datasets has been generated, the Data Discovery 
module consists of identification of a robust set of differentially expressed genes, identification of co-
expressed genes based on community co-expression network analysis and abductive regulatory network 
inference to obtain a set of alternative mechanoresponsive networks. 
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Figure 3.3: Workflow for integration of endothelial flow studies.
The workflow consists of five modules:  data acquisition, platform annotation, data pre-processing, data merging and data 
discovery. The Data acquisition module identifies the studies to be included in the analysis. The Data pre-processing 
module applies platform specific normalisation steps to generate normalised expression values for each study. The 
Platform annotation module links the probes between the different  platforms and finds a subset of genes consistently 
measured across platforms. The Data merging module generates a merged cross-platform, cross-laboratory normalsied 
gene expression dataset. The Data Discovery module (not shown) consists of identification of a robust set of differentially 
expressed genes, identification of  co-expressed genes based on community co-expression network analysis and 
abductive regulatory network inference.
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The detailed steps for each module are listed in Table 3.3 and they are the objectives for this chapter.
Table 3.3 Detailed steps for cross-platform, cross-species integration of MAGE experiments. 
1. Data acquisition module, ! ! ! ! ! !      Section 3.2.1- 3.2.2, Section 3.3.1
1.1 Perform literature search: Systematic searching of PubMed, GEO and Array express to identify the 
studies to include in the cross- study analysis.
1.2 Study the experimental design: Detailed review of each study’s publication to identify experimental 
factors (technical and biological) to include in the analysis. 
1.3 Inclusion/exclusion of studies: Based on the following criteria a) biological relevance of factors used,b) 
compatibility of experimental factors with the other studies, c) coverage of platform used, d) sample size 
and e) raw data availability.
1.4 Download raw data and import into R/Bioconductor framework.
 2. Platform annotation module ! ! ! ! ! ! ! !           Section 3.2.4
2.1 Re-annotate each platform: Assign revised genetic identifiers to reflect the latest understanding of 
genomic sequence and annotations.
2.2 Map probes to common identifier: Identify a subset of genes consistently measured across platforms 
and map genes across species using homology information.
2.3 Collapse  many to one probes: Setup procedures for combining probes targeting the same gene into a 
single expression value.
 3. Data pre-processing module   ! ! ! ! ! !  Section 3.2.3, Section 3.3.2
3.1 Platform specific pre-processing: For each microarray platform, choose the best practices algorithm for 
background correction and normalistaion and apply the same protocol to all datasets. 
3.2 Outlier detection and Batch-effect correction: For each study, identify outliers based on standard 
quality control reports and apply batch-effect correction if necessary. 
 4. Data Merging module  ! ! ! ! !                   Section 3.2.5, Section 3.3.3 - 3.3.4
4.1 Merge  studies and inspect  clustering of studies: Run multidimensional visualisation techniques to 
identify study-specific and platform-specific effects.
4.2 Normalise  across studies and platforms: Run batch effect  correction to make data numerically 
comparable. Confirm results using positive controls.
4.3 Filtering: i) Filter out non-reproducible GeneIDs across studies and ii)  Filter out  non-informative genes 
(genes that are not changing by mechanical stimuli).
 5. Data Discovery   ! ! ! ! ! ! ! ! !           Section 3.3.2
5.1 Robust set of mechanoresponsive  gene: Implement linear mixed model analysis to identify 
mechanoresponsive genes. 
5.2 Community co-expression network: Identify co-expressed genes (Ref Appendix 2 for more details).
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3.2 Material and Methods
3.2.1 Study identification and acquisition
Studies were collected from three sources: PubMed search, Gene Expression Omnibus (GEO) database 
maintained by National Centre of Biotechnology Information (NCBI) [Edgar02] and ArrayExpress database 
maintained by European Bioinformatics Institute (EBI) [Brazma03]. A systematic search was conducted to 
find all studies whose abstract and/or title contained at least one keyword from each of the following three 
categories; endothelial cell studies, fluid mechanical forces studies and gene expression studies: 
• endothelial, endothelium, HUVECs, MAECs, BAECs, PAECs
• shear stress, flow NOT flow cytometry, laminar, disturbed, hemodynamics, mechanosensitive, 
mechanical force, atheroprotected, athero-protected, atherosusceptible, athero-susceptible, 
atherosusceptibility, atheroprone
• microarray*, expression profil*, transcriptome, whole-genome, transcript*, transcriptional analysis, 
Affymetrix, Illumina, transcriptomics
Figure 3.4 illustrates the flow chart for study collection and characterisation. In total, PubMed, GEO  and 
ArrayExpress returned 209, 142 and 60 studies, respectively. After removing duplicates and screening for 
relevance 82 studies were identified and further evaluated. Amongst these, 9 papers were review papers and 
16 studies had incorrect datatype (e.g., methylation or miRNA expression datasets) and therefore were 
excluded. The remaining 57 studies were formally reviewed and summarised resulting in a final set of 17 
studies considered for building the integrated mechanoresponsive gene expression profile. Exclusion criteria 
were:
• Studies with no raw data available
• Studies with sample size less than three
• Studies with incompatible factors (e.g., knockdown genes)
• Studies with first generation microarrays with low coverage 
The results were cross-referenced with papers manually accumulated in the research activities in the Krams 
group, to ensure they were all included. Full details on the experimental design of the final set of studies can 
be found in Section 3.3.
Raw data files were directly downloaded from the GEO  database. Affymetrix raw data consisted of .CEL files 
(one for each sample), which were read into R structures using the ReadAffy function of the affy package 
[Gautier04a]. Illumina raw data consisted of a single tab-delimited file per study, which included the output of 
the Beadstudio analysis software used to process Illumina images. Each sample was represented by two 
columns: average probe signal and detection p-value. Illumina raw data were converted to R structures using 
the lumiR function of the lumi package [Du08]. Agilent raw data consisted of tab-delimited files (one for each 
sample), which included 60 different columns on annotations, spot quality metrics and spot signal as 
outputted from the Agilent Feature Extraction Software. Agilent raw data were read into R structures using 
the ‘maimage’ function of the limma packages [Ritchie15]. The column “gMeanSignal” was used for the 
probe intensity value. 
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Figure 3.4:Flow Chart for study collection and characterisation. 
Studies were collected from three sources: PubMed, ArrayExpress and GEO database. Search commands used were: 
a microarray*,  expression profil*, transcriptome, whole-genome, transcript*,  transcriptional analysis, Affymetrix, Illumina, 
transcriptomics,   b : endothelial, endothelium, HUVECs, MAECs, BAECs, PAECs, c : shear stress, flow NOT flow 
cytometry, laminar,  disturbed, hemodynamics, mechanosensitive, mechanical force,  atheroprotected, athero-protected, 
atherosusceptible, athero-susceptible, atherosusceptibility, atheroprone. 
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3.2.2 Study factors
The primary factor considered in the analysis was shear stress pattern, which was characterised by three 
parameters: waveform, directionality and magnitude. 
• Shear stress waveform: Waveform describes the change in velocity of the applied flow over a cardiac 
cycle. The waveform factor has three levels: Steady, Pulsatile (Sinusoidal) and Pulsatile (Physiological). In 
vivo blood flow is always pulsatile with changing velocity during the cardiac cycle. In vitro flow systems, 
simulate pulsatile flow using either a sinusoidal velocity profile with define frequency or physiologically 
characterised waveforms derived from in vivo measurements. In vitro flow studies also use steady flow 
with constant velocity over time. Steady flow results to steady unidirectional shear stress with constant 
defined magnitude. 
• Shear stress magnitude: Magnitude refers to the time average wall shear stress. This is a numerical value 
ranging from 0 to 300 dyne/cm2. Magnitude was further categorised into a descriptive “Phenotype” variable 
with the following levels: low (< 10 dyne/cm2), moderate (10-50 dyne/cm2), and high (> 50 dyne/cm2) shear 
stress. 
• Shear stress directionality: Directionality was defined as either unidirectional (i.e. always remains positive) 
for steady and non-reversing pulsatile flow, or reversing for oscillatory shear stress. 
Secondary factors, which were considered include: 
• Species:  including human, mouse, bovine and porcine cells.
• Flow System: refers to the flow device used for generating the shear stress. The two flow systems used in 
the studies under investigation were parallel-plate flow chambers and cone–plate viscometers. In parallel-
plate flow systems, the cells are seeded on the bottom plate of a flow chamber and the liquid flows 
between the two parallel plates from the inlet to the outlet along the chambers length [Frangos85]. Cone-
plate viscometers consist of a coverslip  onto which cells are seeded and a cone which is placed above the 
plate. Spinning the cone moves the liquid between the plate and cone, generating a defined shear stress 
profile [Bussolari82, Dewey81]. 
• Platform: Platform refers to the microarray type used for generating the gene expression profiles. The 
following platforms were included: Affymetrix, Illumina, Agilent and custom spotted cDNA arrays.
• Study: refers to the Study ID, a given sample belongs to.
• Batch effect: Most studies collected their samples in independent experiments, whereby each experiment 
had a replicate for each experimental condition used. The batch for each sample was determined based 
on the information in the papers. 
3.2.3 Platform specific preprocessing
Data analysis remains one of the biggest challenges in microarray-based studies because of the availability 
of a number of different methods and the lack of consensus in the community regarding the capabilities and 
limitations of each. Methods are platform specific and depend on platform design and the error model of the 
labelling and scanner used [Wong08]. The contribution of different normalisation methods in cross-platform 
compatibility was investigated by the MAQCI project and optimised pipelines performed better than the 
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manufacturer’s recommendations [Guo06, Zhippy06]. The choice of algorithms to use for each platform was 
based on two factors: relative performance and track record. Performance was assessed by reviewing 
literature that compares methods’ performance on common datasets. Track record was assessed by 
reviewing the methods successfully used by other application articles, though a literature review of 93 
microarray meta-analysis publications. 
The subsections below give details of the methods used for each platform and motivates the choice over 
alternative methods. 
Affymetrix arrays preprocessing
Affymetrix datasets were normalised using the Robust Multiarray Analysis (RMA) algorithm [Irizarry03] 
implemented in the Affy R package  [Gautier04a]. RMA was chosen as it has consistently been shown to 
perform amongst the top  ranked methods in terms of sensitivity to biological variation [Bolstad03, Irizarry06, 
McCall12, Lim07]. In addition, it was shown to improve cross-platform comparability [Shippy06] and it was 
used by studies that successfully performed cross-platform integration of expression values [Turnbull12, 
Ruby11, Sirbu10]. 
RMA consists of four discrete steps: background correction, log2 transformation, quantile normalisation and 
probe intensity value summarisation. Background correction uses the “normexp” model, which assumes that 
the observed signal for each Perfect Match (PM) probe consists of the additive effect of the true signal and 
background, where the true signal has an exponential distribution and the background is normally 
distributed. The mean and variance parameters for the background distribution are estimated for each chip 
separately using the observed distribution of PMs. The background correction in RMA relies only on the PM 
probes, ignoring any signal from the Miss Match (MM) probes. The MM probes were originally designed to 
specifically detect not specific binding that contributes to background signal, but it has since been shown that 
they include biological signal, with 1/3 of MM probes having a higher signal than that of their PM pair. 
Therefore, methods relying on MM probes for background correction such as MAS5, which is the 
manufacturer’s recommendation, perform poorly [Bolstad03]. An improved implementation of RMA exists, 
called GCRMA [Wu04], which also considers the GC content of probe sequences in the background 
estimation step, however, it was shown to perform particular bad for network inference [McCall12, Lim07]. 
The purpose of the log2 transformation is to make the variance of the probes independent of the mean 
expression value, which is an assumption for downstream statistical analysis methods. The goal of the 
quantile normalisation step in RMA is to give the same empirical distribution of intensity values to all the 
arrays while maintaining the biologically driven differences between the arrays. The algorithm works as 
follows: 1) the probe intensities for each array are ranked in ascending order, 2) for each rank the 
background corrected intensity values are averaged across arrays and 3) the average for each rank is then 
used to replace the actual probe intensity values for that particular rank on all the arrays. Hence for every 
array, each rank has the same value, but this value corresponds to a different probe on each array, hence 
the biological information is still retained.
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Affymetrix arrays use multiple probes to quantify the same genomic locus, ref: Figure 3.2, therefore it is 
necessary to summarise the individual probe intensity values into a single expression value. The grouping 
for the probes is defined by the custom definition file (CDF) used. In our case, since we are using the 
Brainarray CDF file, the summarisation is done per Entrez ID (ref Section 3.2.4). Probes with different 
sequences have different probe affinities for their targets and therefore two probes targeting the same gene 
can have significantly different probe signal values. It has been reported that the variance of a given probe 
across arrays could be smaller than the variance of the given probe and the rest of the probes targeting the 
same gene on a given array. Given that on the Affymetrix Chips no two probes have the same sequence, it is 
important that these probe affinity effects are taken into account when summarising individual probe 
measurements. Probe affinities are highly reproducible and can be estimated using information across all the 
arrays. For each EntrezID to be summarised RMA fits a linear model defined as:  
Yij = µi + aj + εij              
where, Yij is the matrix of background-corrected, log-transformed, normalised probe intensity values targeting 
the same EntrezID, αj is the probe affinity for the jth probe and µi is the summarised expression value for the 
ith array. The parameters are estimated from the data using median polish, which is robust to outliers.
Illumina arrays preprocessing
Illumina datasets were normalised using methods implemented in the Lumi R package [Du08]. Raw data 
were log2 transformed and quantile normalised. No background correction was used. This approach has 
been shown to perform well over a variety of metrics studied by [Schmid10] and [Dunning10] who collectively 
compared 25 different pre-processing pipelines for Illumina arrays.  
Illumina raw data downloaded from the GEO  database consist of bead-summary data as outputted from the 
BeadStudio software provided by the manufacturer. BeadStudio implements background correction and 
summarisation steps. Starting from image files, for each bead, a local background value is calculated by 
averaging the five dimmest pixels of a 17x17  grid around the bead. The local background is subtracted from 
the foreground intensity, which is calculated as the weighted sum of the intensities in a 4x4 square around 
the bead centre. The background corrected bead values across replicate probes are then summarised into 
bead-summary data. The summarisation step  is different from that detailed above for Affymetrix arrays since 
Illumina uses one probe sequence per genomic location but includes technical replicates (on average 30 
bead per genomic location). Therefore, since the probes to be sumamrised all have the same sequence 
there is no need for probe affinity correction. Bead Studio implements a trimmed mean approach by 
removing replicate beads which are 3 median absolute deviations from the median. [Dunning08] showed that 
the summarisation method was robust for up  to 20% of replicate beads being outliers and concluded that the 
background subtraction and summarisation steps as done by BeadStudio, reduce biases and produce robust 
expression values.
Illumina recommends an additional background normalisation step, which consists of subtracting the 
average of the negative control beads on each array from the bead summary data. This method of 
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background subtraction however, is highly discouraged by others since it has been reported to increase false 
positives and introduce negative values in the data [Dunning08, Barnes05].
Agilent arrays preprocessing
Agilent datasets were normalised using methods implemented in the Limma R package [Ritchie15]. Raw 
data were background corrected using the ‘normexp’ model, discussed above for Affymetrix arrays, log2 
transformed and quantile normalised. Single channel Agilent arrays are the least popular amongst the single 
channel platforms available and therefore there are not very well studied. Agilent is more frequently used for 
its two-colour arrays, which allows the hybridisation of two samples on the same chip. The recommendations 
for two-colour arrays were used, since the error model for single channel Agilent arrays is expected to be 
very similar. [Zhu11, Diyagama, Ritchie07] recommend the use of the ‘normexp’  for background correction 
and strongly discourage the background subtraction method recommended by the manufacturer. There are 
no summarisation methods available for Agilent arrays. As discussed in the annotation section, replicate 
probes or probes mapping to the same Entrez ID were collapsed into a single value by taking their average.
!
3.2.4 Annotation of microarray platforms
The 17 studies considered for the integrative analysis were conducted on eight different array versions. Table 
3.4 contains a summary of the platforms, sorted by vendor. Each array version has been assigned an 
abbreviated name, displayed in Table 3.4. There are two Affymetrix arrays (Affy U133 and Affy Bovine), three 
Illumina arrays (Lumi HT12, Lumi Ref8, Lumi Mouse), one Agilent (Ag44k) and two custom design spotted 
cDNAs arrays (Duke, UPenn). In this work, we have focused on the analysis of single channel arrays 
(Affymetrix, Illumina and Agilent), and therefore the two dual channel arrays (Duke and Upenn) have not 
been annotated.
Table 3.4: Microarray Platforms included in the integrative analysis 
Array Version # Probes Abbreviated Name Vendor Type
GeneChip Human Genome U133 Plus 2.0 Array 54675 Affy U133 Affymetrix, Inc. Single
GeneChip Bovine Genome Array 24128 Affy Bovine Affymetrix, Inc. Single
BeadChip Human HT-12 v3 48793 Lumi HT12 Illumina,Inc. Single
BeadChip Human Ref-8 v2 22184 Lumi Ref8 Illumina,Inc. Single
BeadChip Mouse WG-6 v2.0  45281 Lumi Mouse Illumina,Inc. Single
Whole Human Genome Microarray 4x44K 41000 Ag44k Agilent,Inc. Single
Duke Operon Porcine 10.5K Oligo Array 10665 Duke Custum Dual
UPenn Porcine Oligo Microarray 1.0 12288 UPenn Custum Dual
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3.2.4.1 Overview of the annotations workflow
All probes were mapped at the gene level using human Entrez IDs as the common identifier. Entrez ID was 
selected since it is stable over time, well curated and has previously been shown to achieve high mapping 
rates between platforms [Allen11]. Mapping based on transcript IDs (e.g., Refseq or genbank accession 
number) is more accurate in terms of interrogating the same entity on the genome, however, the mapping 
rates are greatly diminished since different vendors choose to target a different region of the same gene.
For each array version the following general workflow was implemented. The specific details for each vendor 
are different and are described in detail in subsequent sections.
1. Annotation packages were used to associate individual probes on each array with Entrez IDs. Based on 
the mapping information individual probes were assigned a mapping count which indicated the number of 
Entrez IDs associated with a given probe.
2. Probes with a mapping count equal to 0 or > 1 were filtered out since they represented unmapped and 
bad quality probes with ambiguous mapping. 
3. For the remaining probes, in the case of cross species annotation, the species specific Entrez IDs were 
mapped to human Entrez IDs using information from NCBI homolog database and functions provided by 
the ‘annotationTools’ R package [Kuhn08]. 
4. For each array, a two column mapping table was created, which listed the human Entrez IDs covered by 
that array and their corresponding probe mapping index that indicated the individual probes targeting the 
specified Entrez ID. The probe mapping index information was used for merging the individual datasets 
and indicated which probe measurements had to be collapsed into a single gene value. 
A summary of the final mapping statistics is shown in Table 3.5, depicting the total number of Entrez IDs 
covered by each array, alongside the number of mapped and excluded probes. A probe was considered 
mapped if it was unambiguously mapped to a single Entrez ID. Figure 3.5 illustrates the process of mapping 
across species, including the percentage of annotated probes/Entrez IDs lost at each step. 
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Figure 3.5: Annotation process followed for  maping probes across species. 
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Table 3.5: Probe mapping results for each array version included in the integration analysis
# Entrez IDs
# Mapped 
Probes
# Excluded Probes
Total Targeted by single probe
Targeted by 
>1 probe Total Unmapped
Ambiguously
mapped
Affy U133 19702
19702 
(100%)
--- 34541 
(63%)
20134
(37%)
NA NA
Lumi HT12 18311
12197 
(67%)
6114 
(33%)
28064 
(57%)
20729
(43%)
6290 
(30%)
14439 
(70%)
Lumi Ref8 16288
13746 
(84%)
2542 
(16%)
19813 
(89%)
2371
(11%)
119 
(5%)
2252 
(95%)
Ag44k 17678
10151 
(58%)
7527 
(42%)
28223 
(69%)
12777
(31%)
11351 
(89%)
1426 
(11%)
* Mouse 15953
7659 
(48%)
8294 
(42%)
30378 
(67%)
14903
(33%)
14384 
(97%)
519 
(3%)
* Bovine 9202
9178 
(99.7%)
24 
(0.3%)
13784 
(57%)
10344
(43%)
NA NA
 * Mapping shown is for mapping to Human Entrez ID after cross-species annotations
Following the successful annotation of each individual platform, the coverage of the four human arrays (Affy 
U133, Lumi HT12, Lumi Ref8 and Ag44k) was compared. Collectively, the probes on the four arrays targeted 
a total of 22478 unique Entrez IDs, out of which 14030 were common amongst all four human platforms, 
(figure 3.6.A (left)). We refer to this set of probes as the “common-human” list. The individual mapping rates 
between the four human platforms is shown in Figure 3.6.A (right). The rate is calculated by obtaining the set 
of common Entrez IDs between the two platforms and dividing it by the total number of Entrez IDs in the 
source platform. Furthermore, there is an overlap of 7743 genes between human and bovine platforms and 
an overlap  of 12641 genes between human and mouse (figure 3.6.B). The 7743 genes common between 
bovine and human arrays captured 85% of the bovine array, but only 55% of the human arrays. This is 
because of the low coverage of the bovine array, which includes a total of 9902 genes. The mouse array had 
a more extensive coverage of human genes (a total of 15963) and therefore 90% of the common human list 
was captured by the mouse array. 
3.2.4.2 Platform specific annotation packages and quality control for annotations. 
Affymetrix arrays annotation
Affymetrix arrays were annotated using the BrainArray custom definition files (CDF) [Dai05]. As discussed in 
Section 3.1, Affymetrix arrays consist of probes that are grouped into probesets by the vendor. BrainArray 
regroups the full set of probes on Affymetrix arrays into redefined probesets, based on their genomic 
locations and associated identifier. BrainArray annotations are compiled through aligning the individual 
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probes to all individual UniGene sequences, all dbSNP sequences and to the genome sequence of the 
corresponding species. A series of seven different filtering steps excludes bad quality probes. The remaining 
probes are regrouped into probesets based on six different genomic locations. In our case we choose the 
Entrez ID annotations files whereby each BrainArray probeset maps to a single Entrez ID. Binary annotation 
packages for affy.hu133v2 and bovine.affy, Version.19.00 (November 2014), were downloaded from http://
brainarray.mbni.med.umich.edu/Brainarray/Database/CustomCDF/19.0.0/entrezg.asp
The main consideration for successful annotation is the coverage of the array in terms of the number of 
genes interrogated by the array. It has been reported that annotations based on re-definition files result in a 
significant reduction in array coverage, therefore, we checked the overlap  between the Entrez IDs obtained 
from BrainArray annotations and those provided by the vendor [Liu03, Leeuw08]. For the Affy U133 array, 
even though the two annotation lists had 52% different probe content, there was still a 93% overlap  in terms 
of their Entrez ID coverage (18360 in common; 1342 BrainArray only; and 1405 Vendor only). Similar results
Affy$U133 Lumi$HT12 Lumi$Ref8 Ag44k
Source
Affy$U133 555 0.81 0.76 0.83
Lumi$HT12 0.88 555 0.88 0.86
Lumi$Ref8 0.91 0.99 5555 0.91
Ag44k 0.92 0.89 0.84 5555
Target
Aﬀy$U133$ Lumi$Ref8$
Lumi$HT12$Ag44k$
A$
6287% 7743% 1459%
Common$$
Human$
Bovine$
1389% 12641% 3312%
Common$$
Human$
Mouse$
Affy$U133 Lumi$HT12 Lumi$Ref8 Ag44k
Source
Bovine 0.97 0.95 0.93 0.9
Mouse 0.93 0.92 0.92 0.86
Target
B$
Figure 3.6: Entrez ID overlap between the array versions included in the integration study. 
A) Overlap between the four human array. 14030 genes are common amongst all four arrays refereed to as the 
“common-human” list. The individual mapping rates between pairs of platforms are shown in the table on the right.  The 
rate was calculated by obtaining the set of common Entrez IDs between the two platforms and dividing it by the total 
number of Entrez IDs in the source platform. B) Overlap between the common human Entrez IDs and cross-species 
annotations.  Species specific Entrez IDs were mapped to human Entrez IDs using NCBI homolog information. Cross-
species mapping rates to individual human arrays are shown in the table on the right.
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were obtained for the bovine Affymetrix array, with 85% of the vendor Entrez IDs also represented in the 
BrainArray annotations.
The improved quality of the BrainArray redefinitions was confirmed by calculating the intraclass coefficient of 
variations (CV) for biological replicates. For each Entrez ID, the probes targeting the Entrez ID were pooled 
and the intraclass CV was calculated by taking the ratio of the standard deviation to the mean. CV captures 
the variability in the gene expression measurements; the lower the intraclass CV the higher the quality of the 
biological replicates (e.g. all static control samples). In the case of the Affy U133 array, the median intraclass 
CV across all Entrez IDs was reduced to 1.3% for BrainArray annotations, compared to 17.5% when using 
the vendor annotations. 
Illumina arrays annotation
Illumina probes were mapped to Entrez IDs using ReMOAT (Re-annotation and mapping for oligonucleotide 
Array Technologies) annotation packages, which are based on reports generated by sequence alignment 
tools such as BLAST [Barbosa-Morais10]. ReMOAT provides a quality grade for each probe, which was used 
for filtering out bad quality probes. Probes classified as “perfect” (a probe sequence which matches perfectly 
and uniquely to a transcript) or “good” (a sequence that is not completely complementary to a transcript but 
includes no more than 2 nucleotide mismatches) were retained, whilst those classified as “bad” (whereby a 
probe sequence has more than three mismatches or maps to multiple sequences) were excluded. In order to 
ensure that the filtering did not affect the coverage of the annotations, we compared the number of genes 
represented by the filtered set of probes and the entire set of probes. In the case of the Lumi HT12 array, 
which was most affected by the filtering, even though 30% (14439) of the probes were filtered out there was 
only a marginal decrease in the number of Entrez IDs covered by the filtered set of probes compared to the 
entire set of probes (18311 versus 19877, respectively). The same pattern was observed for both the Lumi 
Ref8 and the mouse arrays. 
We also compared the coverage obtained from ReMOAT annotations with that observed when using the 
vendor annotations [Du07], (figure 3.7). The total number of probes were categorised in five groups: probes 
with consistent annotations (labelled ‘common’), probes with inconsistent annotations (labelled ‘Different’), 
probes only mapped to an Entrez ID in the ReMOAT annotations (labelled ‘ReMOAT Only’), probes only 
mapped to an Entrez ID in the vendor annotations (labelled ‘Du et al. Only’), and probes not mapped by any 
method (labelled ‘None’). Very similar mapping was observed between the two annotation methods, with the 
majority of annotations being consistent between the two mappings. ReMOAT performed better for the 
mouse array with 7254 probes only mapped by ReMOAT, which increased the overall mapping rate across 
all arrays.  A small proportion of probes (2232 probes on Lumi HT12 array and 571 probes on Lumi Ref8 
array) had different Entrez mapping between ReMoat and vendor annotations. Manual checking of the lists 
did not indicate that this could adversely affect the results, since the majority of miss-matched annotations 
were between putative Entrez ID which changed their status over time and probes assigned to different 
subfamilies of the same gene. For instance, “DUSP22 dual specificity phosphatase 22” in ReMOAT versus 
“LOC651760 similar to dual specificity phosphatase 22’ in vendor annotation; “amylase, alpha 1B” versus 
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“amylase, alpha 2A”; and “protocadherin gamma subfamily A, 8”  versus “protocadherin gamma subfamily C, 
3”. In fact protocadherin variation attributed for 80 probe differences. In the current implementation we 
carried forward the ReMoat annotations. In future implementations these probes can be checked against a 
third source, for example Ensemble annotations [Ballister10], and resolved using a semi-automated 
approach. 
Figure 3.7: Comparison of ReMOAT Illumina annotations with those provided by the vendor. 
The total number of probes have been categorised in five groups: probes with consistent annotations between ReMOAT 
and vendor annotations (labelled ‘common’), probes with inconsistent annotations between ReMOAT and vendor 
annotations (labelled ‘Different’), probes only mapped to an Entrez ID in the ReMOAT annotations (labelled ‘ReMOAT 
Only’),  probes only mapped to an Entrez ID in the vendor annotations (labelled ‘Du et al. Only’),  and probes not mapped 
by any method (labelled ‘None’)
ReMOAT based annotations and probe quality grades for each of the Illumina platforms considered (Lumi 
HT12, Lumi Ref8 and mouse), were extracted from “illuminaHumanv3.db”, “illuminaHumanv2.db” and 
“illuminaMousev2.db” R libraries, respectively [DunningHT12, DunningRef8, DunningWG6]. Vendor 
annotations were extracted from “lumiHumanIDMapping.db” R library for the human arrays (Lumi HT12, 
Lumi Ref8) and “lumiMouseIDMapping.db” R  library for the mouse array using the “nuID2EntrezID” function 
implemented in the lumi R packages [Du07, DuHum, DuWG6, Du08]. 
Agilent arrays annotation
Agilent probes were mapped to Entrez IDs using AILUN (Array Information Library Universal Navigator) 
mapping [Chen07a]. AILUN is not a sequence based re-annotation method but it was the most recent 
annotations (generated in 2011) available for Agilent arrays. The vendor annotations dated back to 2007. 
Microarray platforms have an associated GEO entry, which includes a list of probe IDs for a given platform, 
along with other columns of external gene identifiers. The source of the external gene identifiers varies from 
vendor-provided gene identifiers to bespoke user lists. AILUN maps each column of the GEO external 
identifier to a Universal Gene identifier table (UGIT), which contains 73 million records that relate 90 different 
identifier types to Entrez ID, and retains the column that results to the largest mapping percentage for the 
platform. AILUN annotation files were downloaded from http://ailun.stanford.edu/gplIdSearch.php  (GPL: 
GPL6480).
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Collapsing probes targeting the same gene
Illumina and Agilent datasets required further processing before merging in order to collapse multiple probes 
mapped on the same Entrez ID into a single expression value. Affymetrix datasets did not require any further 
processing, since BrainArray annotations featured only one-to-one mapping between gene and probe ID. 
Following a comprehensive literature review of 93 papers the majority of studies (48%) used their mean or 
median to collapse the probes. In order to check the validity of this approach, for each array, we compared 
the median intraclass coefficient of variation (CV) of Entrez IDs targeted by a single probe with the median 
intraclass CV of Entrez IDs targeted by multiple probes. Based on the results of the MAQCI project, which 
reported a CV between 5 - 15% for intra-site variability for technical replicates, a threshold of 15% was used 
as an indicator of acceptable variability. [Shi06]. The median CV of genes targeted by multiple probes was 
higher than that of genes targeted by a single probe, but still remained below 15% (figure 3.8). Illumina 
arrays performed better than Agilent arrays, possibly reflecting the improved annotations used for Illumina 
arrays. Given the results on the intraclass CV, a collapse function was implemented that collapses probes 
targeting the same gene by taking the average gene expression of the individual probes. 
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Figure 3.8: Intraclass coefficient of variation for Entrez IDs targeted by a single probe or multiple probes. 
For each of Ag44k, Lumi HT12 and Lumi Ref8, the total number of Entrez IDs were divided into those that are targeted 
by a single probe and those that are targeted by multiple probes. The proportion of  each set is illustrated by the pie 
charts on the left. The boxplots represent the distribution of the intraclass coefficient of variation (CV) for each set. CV 
was calculated using the normalised data from a study conducted by the given array. 
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3.2.5 Systematic biases and cross-platform correction
Systematic biases and cross platform correction was performed using ComBat [Johnson07, Johnson09, 
Leek12]. ComBat was run twice, once on the individual studies to remove batch effects due to different 
experimental runs (using Batch effect factor), and it was also run on the merged datasets to remove cross-
platform biases (using Study factor). ComBat was run based on the implementation available in the SVA R 
package, using the non-parametric parameter estimation option [Leek12]. 
ComBat assumes that batch adjustment can be corrected by standardising the means and variances across 
batches. It also assumes that the gene expression value for each gene can be expressed as a linear model 
with known covariates (experimental conditions), addictive and multiplicative batch effects and a noise term. 
For each gene the batch effect is estimated from the data using an empirical Bayes method that borrows 
information across genes with similar expression patterns across batches. Once estimated, the batch effect 
is removed from the data. In all runs, the shear information (Phenotype factor) was given as a covariate to 
ensure the biological signal was maintained. 
ComBat was chosen based on its demonstrated ability to perform well in small sample studies [Johnson09, 
Lazar13] and the fact that it uniquely allows a design with multiple covariates (e.g., species, shear regime), 
which is very important for studies with imbalance design. Its ability to remove batch effects due to different 
experimental runs has been demonstrated in Affymetrix arrays [Johnson07,Chen11,Taminau14], Illumina 
arrays [Kitchen10] and two-colour arrays [Larsen14]. In all of the above papers, Combat improved the 
consistency of gene lists, suggesting that the biological signal was still intact. Combat also demonstrated the 
potential for cross-platform normalisation based on merging technical replicates [Ruby11, Turnbull12]. It 
performs better that a simple z-score standardisation, which fails to correct for cross-platform effects [Luo10, 
Zhang10], since batch effects are probe sequence dependent and therefore correction methods that perform 
gene-wise correction are preferred [Kitchen11]. Alternative methods, XPN [Shabalin] and DWD [Benito04], 
which also perform well in comparative analysis, require more than 25 samples per batch in order to work 
properly [Ruby11].
3.2.6 Quality control assessment
Array quality metrics: Individual studies were assessed for technical and biological outliers. Technical 
outlier detection was based on the report generated by arrayQualityMetrics [Kauffmann09], which provides 
box plots, density plots, MA plots and variance versus rank of the mean plots. Following successful 
normalisation, all the samples in a study are expected to have similar expression values distributions, since 
the majority of probes are not expected to be differentially expressed. In addition, the variance should be 
independent on the mean. arrayQualityMetrics implements automatic detection of outliers from each of these 
plots based on empirically calculated thresholds. arrayQualityMetrics were also computed for the author 
normalised data (downloaded from GEO databased) in order to ensure the normalised data were still in line 
with the published data. 
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Multidimensional scaling (MDS) plots: MDS plots were used to assess the uniformity of replicates and 
ensure that the samples were clustered by experimental condition. MDS plots are very similar to Principal 
Component Analysis (PCA) plots, with the x and y axis representing the two principle axis of expression 
variation. Biological replicates are expected to cluster together and away from other experimental conditions. 
In studies where batch effects were identified, batch correction was performed using ComBat. 
Principal variance component analysis (PVCA): The relative contribution of each factor to the overall 
variability was assessed using the principal variance component analysis (PVCA) method [Li09]. PVCA is a 
hybrid method between PCA and variance component analysis (VCA). First, PCA reduces the data into low 
dimensional principal components with maximal variability. VCA is then used to partition the variability in 
each of the principal components into known sources (factors) using classical linear mixed models. For each 
factor the weighted average of the variability explained by that factor, across all principals components, is 
calculated, and visualised as a bar chart. The weights used are the individual component’s eigenvalues. 
PVCA was performed using the pvca R package, with default parameters (variability threshold was set to 
60%).
Mean-mean expression scatter plots: Inter-study concordance was assessed through mean-mean 
expression plots. For studies with similar shear stress conditions (e.g., 15 dyne/cm2), the mean expression 
levels of samples from one study were plotted against the mean expression level of samples from another 
study. Under perfect conditions, the points on the mean-mean scatter should fall on the theoretical y=x line. 
The closest the points fall on this line, the better the agreement between the expression values across 
studies. The goodness of the line of best fit (r2) was calculated as a measure of inter-study concordance.
3.3.6 Differential expression and functional enrichment analysis
Differentially expressed shear responsive genes were detected using the moderated t-test of the LIMMA 
package. The moderated t-statistic has the same interpretation as an ordinary t-statistic except that the 
standard errors for every gene are adjusted using an empirical Bayes method, which takes into account 
information from all the genes. Shrinking the standard errors towards a pooled estimate makes the analysis 
more stable [Smyth04]. P-values were corrected for multiple testing using the Benjamini–Hochberg 
procedure. Functional enrichment analysis for Gene ontology terms, canonical pathways and transcription 
factor binding sites was performed with the online tool WebGestalt [Zhang05a]. Annotations were selected 
based on FDR p-value less than 0.05.
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3.3 Results
3.3.1 Endothelial cell gene expression flow studies 
A systematic search was conducted in PubMed, GEO and ArrayExpress databases to find all studies whose 
abstract and/or title matched keywords from each of the following three categories; endothelial cell studies, 
fluid mechanical forces studies and gene expression studies. A total of 57 studies were formally reviewed 
and summarised resulting in a final set of 17 studies, that were used to generate a database of endothelial 
cell (EC) flow studies. The studies were categorised into in vivo, Table 3.6 , and in vitro studies, Table 3.7. 
In Vivo studies investigating the role of different flow patterns on the endothelium
In total six different in vivo studies were identified. In vivo studies were conducted by the Davies [Civelek09, 
Civelek10], Friedman [Zhang08, LaMack10] and Jo laboratories [Ni10, Dunn14]. 
Table 3.6: Overview of in vivo flow studies included in the integrative analysis
GEO ID Array Type Vendor Cell Type Experimental Design Total #Samples
GSE20741
[Ni10] Single Illumina MAEC
Oscillatory, 30dyne/cm2 , 12 hours post-ligation
Oscillatory, 30dyne/cm2 , 48 hours post-ligation
Uniform, 100dyne/cm2 , 12 hours control vessel
Uniform, 100dyne/cm2 , 48 hours control vessel
12
GSE56143
[Dunn14]* Single Illumina MAEC
Oscillatory, 30dyne/cm2 , 7 days post-ligation
Uniform, 100dyne/cm2 , 7 days control vessel 6
E-CBIL-42 
[Civelek09] Dual Custom PAEC
7 athero-susceptible regions from coronary and non-
coronary bed (n = 52)
6 athero-protected region from coronary and non-
coronary bed (n = 46)
98
E-CBIL-43
[Civelek10]& Dual Custom PAEC
3 athero-susceptible regions: aortic arch, renal artery, 
abdominal aorta. (n = 18)
3 athero-protected region: descending thoracic aorta, 
carotid artery,renal branch (n = 18)
36
GSE10671
[LaMack10] Dual Custom PAEC
10 dyne/cm2 region of iliac artery
15 dyne/cm2 region of iliac artery
32 dyne/cm2 region of iliac artery
32
GSE10938
[Zhang08] Dual Custom PAEC
Proximal coronary (susceptible) 
Right illiac (protective)
Left illiac (protective)
12
* Dunn14 study also includes 6 arrays, following the treatment of DNMT inhibitor 5-Aza-2’deoxycytidine (5Aza), which 
were excluded from the integrative study due to incompatibility with the factors included in the analysis.
& Civelek10 also includes samples following high fat diet treatment of adult swine, which were excluded from the   
integrative study due to incompatibility with the factors included in the analysis. 
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The Davies and Friedman labs choose naturally occurring athero-susceptible or athero-protective sites in 
adult swine animal models. These animal models are appropriate for studying shear-mediated 
atherosclerosis since they spontaneously develop  atherosclerotic plaques [Skold66], and have similar 
haematodynamic environment and plaque localisation to that of humans [French63, Huo07, Asakura90]. 
Civelek et al. isolated endothelial cells from 7 athero-susceptible and 6 athero-protected regions from 
coronary and non-coronary bed to generate a large dataset of 134 samples [Civelek09, Civelek10]. Zhang et 
al. isolated ECs from the proximal right coronary (athero-susceptible) and left and right iliac arteries (athero-
protective). In a follow up  study, LaMack et al. characterised the shear environment of iliac arteries using 
casts and computational fluid dynamics simulations, and selected three regions characterised by low 
(10dyne/cm2), medium (15dyne/cm2) and high (32dyne/cm2) time averaged WSS [Zhang08, LaMack10]. 
The Jo lab use a partial carotid ligation mouse model to experimentally induce a shear environment  that 
promotes endothelial cell dysfunction [Nam09]. Computational fluid dynamic simulations determined that the 
non-ligated right carotid artery is exposed to a time average shear value of 110 dyne/cm2  (which is 
considered to be normal for the mouse model), and the ligated left carotid artery is exposed to a lower time 
average shear value (~30dyne/cm2) and distrubed flow pattern. The two studies of [Ni10] and [Dunn14] study 
the effect of disturbed flow at 12 hour, 48 hours and 7 days post ligation.
In Vitro flow studies investigating the effect of shear stress on endothelium
Eleven microarray studies investigating the effect of mechanical stimuli on endothelial cells were considered 
for building the integrated mechanoresponsive gene expression profile. In total there are 153 samples, 
featuring a wide range of shear stress levels (0 to 284 dyne/cm2) and waveforms (steady, pulsatile, 
oscillatory). Full details for the individual studies can be found in Table 3.7. Each study was assigned an ID, 
based on its citation, which is used for the rest of the chapter to refer to the studies. The sample size for 
individual studies is small, with three to four biological replicates per experimental condition. 
Figure 3.9, illustrates the different shear stress conditions across the studies considered, grouped by species 
and microarray platform. Studies have conducted analysis on Affymetrix, Agilent, Illumina and spotted cDNA 
platforms using human umbilical venous endothelial cells (HUVEC), porcine arterial endothelial cells (PAEC) 
and bovine arterial endothelial cells (BAEC). Shear stress conditions were grouped in a descriptive 
phenotype variable, which consists of five levels: static, low, moderate, high and complex shear stress. Low, 
moderate and high refer to the magnitude of shear stress used for steady uniform shear. Low shear includes 
samples from 1 to 10 dyne/cm2, moderate shear captures samples from 11 to 35 dyne/cm2 and high shear 
includes samples with shear between 75 and 284 dyne/cm2. The complex category includes all non-uniform 
shear stress waveforms (e.g., oscillatory, pulsatile). As it can be seen in Figure 3.9, there is no consistency in 
the shear stress conditions used across studies. The porcine studies predominately investigated complex 
shear stress waveforms while the human studies mainly investigated steady uniform shear stress conditions. 
There are no two studies that have been conducted in the same species and include the same experimental 
conditions. The closest experimental designs were those of Mun09 and Conway10, with both studies having 
static control samples together with 12 dyne/cm2 and 15 dyne/cm2  steady shear stress sample, respectively.
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Table 3.7: Overview of in vitro flow studies included in the integrative analysis
GEO ID Array Type Vendor Cell Type Flow System Experimental Design
Total #
Samples
GSE13712
[Mun09] Single Affymetrix HUVEC
Cone
plate
Static
Uniform: 12 dyne/cm2 6
GSE23289
[White11] Single Illumina HUVEC
Parallel
Plate
Uniform: 15 dyne/cm2 
Uniform: 75 dyne/cm2 8
GSE20739
[Ni11] Single Illumina HUVEC
Cone
plate
Uniform: 15 dyne/cm2 
Oscillatory: 0 ± 15 dynes/cm2  (1 Hz) 6
GSE16706 
[Conway10] Single Agilent HUVEC
Parallel
Plate
Static
Uniform: 1 dyne/cm2 
Uniform: 15 dyne/cm2 
Oscillatory: 1 ± 11 dynes/cm2  (1 Hz)
12
GSE52211
[Lorenz15] Single Agilent HUVEC
Cone
plate
Static
Uniform: 6 dyne/cm2 12
GSE29376
[Dolan12] Single Affymetrix BAEC
Parallel
Plate
Static
Uniform: 20 dyne/cm2
Uniform: 100 dyne/cm2 
9
GSE37127
[Dolan13] Single Affymetrix BAEC
Parallel
Plate
Uniform: 35 dyne/cm2
Uniform: 284 dyne/cm2
Gradient: 35 to 284 dyne/cm2
Gradient: 284 to 35 dyne/cm2
12
GSE26505
[Zhang12] Dual Custom PAEC
Parallel
Plate
static
Non.Revers.: 15 ± 15 dynes/cm2 (1 Hz) 12
GSE26513
[Zhang13] Dual Custom PAEC
Parallel
Plate Non.Revers.: 15 ± 15 dynes/cm
2 (1 Hz) 4
GSE30843
[Wallace] Dual Custom PAEC
Parallel
Plate
Uniform: 15 dyne/cm2
Non.Revers.: 15 ± 15 dynes/cm2 (1 Hz)
Oscillatory: 0 ± 15 dynes/cm2  (1 Hz)
12
GSE4281 
[Himburg07] Dual Custom PAEC
Parallel
Plate
Static
Uniform: 7.5 dyne/cm2
Uniform: 15 dyne/cm2
Oscillatory: 0 ± 15 dynes/cm2  (1 Hz)
Oscillatory: 0 ± 15 dynes/cm2  (2 Hz)
Oscillatory: 0 ± 15 dynes/cm2  (3 Hz)
Oscillatory: 0 ± 15 dynes/cm2  (Phys.)
Revers.: 7.5 ± 15 dynes/cm2 (1 Hz)
Revers.: 7.5 ± 15 dynes/cm2 (2 Hz)
Revers.: 7.5 ± 15 dynes/cm2 (3 Hz)
Revers.: 7.5 ± 15 dynes/cm2 (Phys.)
Non.Revers.: 15 ± 15 dynes/cm2 (1 Hz)
Non.Revers.: 15 ± 15 dynes/cm2 (2 Hz)
Non.Revers.: 15 ± 15 dynes/cm2 (3 Hz)
Non.Revers.: 15 ± 15 dynes/cm2 (Phys.)
60
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The two studies, however, have been performed using different experimental systems for application of 
shear stress (cone and plate in Mun09 and parallel-plate design for Conway10). The diversity in 
experimental conditions makes the comparison of the results difficult, since there is no common baseline. 
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Figure 3.9. Experimental factors in the flow studies considered for building the integrated dataset
Each study is represented by a different box, which is coloured according to the microarray platform used. The species 
and shear stress regime used is also indicated.  Shear stress conditions have been grouped in a descriptive phenotype 
variable,  which consists of  five levels: static,  low, moderate, high and complex shear stress. Low, moderate and high 
refer to the magnitude of shear stress used for steady uniform shear. The number in each box shows the specific shear 
stress value (in dyne/cm2) used. The complex category includes all non-uniform shear stress waveforms (e.g., oscillatory, 
pulsatile). 
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Figure 3.9 also demonstrates that there is no predominant species or platform type, which makes the 
normalisation steps very challenging, having to ensure the compatibility across species and platforms. For 
the purpose of this study, we focused on the analysis of single-colour arrays (Affymetirx, Agilent and 
Illumina). This allowed us to test the feasibility of the integrative approach without the additional complexity 
of combining data from two-colour arrays, which are technically different. In addition, all the two colour arrays 
have been conducted on custom designed arrays interrogating porcine cells with limited information on the 
annotations, sequences and pre-processing considerations. Consequently the in vivo studies and the in vitro 
studies conducted in PAECs were not pursued further. Of the remaining single colour arrays only a small 
number of samples was subjected to complex shear (e.g., oscillatory shear or shear with gradient). Hence, 
only samples with uniform shear were retained for integration. 
3.3.2 Integration of flow studies conducted in human endothelial cells
In order to test the effectiveness of the suggested pipeline, in the first phase of the integration we focused 
our effort on integrating the flow studies conducted in human endothelial cells. The five studies incorporated 
in the analysis were: Mun09, White11, Ni11, Conway10 and Lorenz15. These were performed on three 
different microarray platforms, Agilent, Affymetrix and Illumina. In this section, we first give details on the 
normalisation of each individual study, and then describe the results obtained from integrating the five 
studies listed above. 
3.3.2.1 Normalisation of individual studies
Prior to merging, the studies were checked for technical and biological outliers using exploratory clustering of 
samples with multidimensional plots (MDS) to asses the uniformity of replicates. In addition variance 
component analysis was performed using principal variance component analysis (PVCA) [Li09]. PVCA is a 
hybrid method between PCA and variance component analysis (VCA). First, PCA reduces the data into low 
dimensional principal components with maximal variability. VCA is then used to partition the variability in 
each of the principal components into known sources (variables) using classical linear mixed models. For 
each factor the weighted average of the variability explained by that factor, across all principal components, 
is calculated, and visualised as a bar chart. The weights used are the individual component’s eigenvalues.
The Mun09 dataset included samples subjected to 12 dyne/cm2 shear stress, with static cultures as controls. 
The authors also investigated the effect of cell senescence on the shear response. Sample clustering of 
normalised data revealed the existence of batch effects in the dataset, which contributed to 27.8% of total 
variation (figure 3.10 A-B). The MDS plot in Figure 3.10.B  demonstrates sample separation related to 
experimental run, with Run 1 (circles) forming a particularly distinct group. Following batch effect correction, 
the variation due to experimental run was reduced to 0%, with clear separation of samples by the four 
experimental conditions, (figure 3.10 C-D). Given that the young and senescence samples formed distinct 
groups, with 37% of variation attributed to the interaction of shear stress and passage, it was decided to 
exclude the senescent sample to ensure the compatibility of the Mun09 study with the rest of the datasets. 
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Hence, a trimmed dataset was created including only the young static and 12 dyne/cm2 samples. Following 
batch correction, the shear stress factor in the trimmed dataset contributed to 86% of total variation.
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Figure 3.10. Mun09 study: Sample clustering and variance component analysis
The bar charts show the proportion of  variance (y-axis) captured by each of the known study factors (x-axis), before (A) 
and after (C) batch effect  correction. Batch effects  define the experimental run of a given sample, Passage defines the 
age of the cells used, which were either young or senescent, and shear stress defines the shear environment the cells 
were subjected to. Sample clustering before (B), and after (D) batch effect correction is  plotted using multidimensional 
scaling plots. Each point on the plot is a sample, where colour corresponds to the shear stress environment and the 
symbol corresponds to the experimental run of the sample. 
The White11 dataset investigated the shear stress response at 15 dyne/cm2 and 75 dyne/cm2. Sample 
clustering of normalised data demonstrated consistent grouping of samples by shear stress magnitude (x-
axis direction in figure 3.11.B-C). There was a minor batch effect captured by the second principle 
component (y-axis direction in figure 3.11.B). Following batch effect correction, the proportion of variation in 
expression data relating to phenotype increased from 62.6% (figure 3.11.A) to 81.5% (figure 3.11.C), with a 
corresponding decrease in the variation linked to batch effects (from 7.9% to 1.3%). The samples clustered 
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more tightly together as it can be seen from the reduced range of the second principle component (y-axis 
direction in figure 3.11.D)
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Figure 3.11. White11 study: Sample clustering and variance component analysis
The bar charts show the proportion of  variance (y-axis) captured by each of the known study factors (x-axis), before (A) 
and after (C) batch effect  correction. Sample clustering before (B),  and after (D) batch effect correction is plotted using 
multidimensional scaling plots. Each point on the plot is a sample, where colour corresponds to the shear stress 
environment and the symbol corresponds to the experimental run of the sample. 
The study of Conway10 included three shear stress environments: static control, 1 dyne/cm2 and 75 dyne/
cm2. Initial clustering of samples indicated a batch effect that was quantified by variance analysis at 34.6% of 
the total variation (figure 3.12.A-B). Following batch effect correction, the samples of all shear stress levels 
formed three spatially distinct groupings, whose percentage of variation related to shear stress, increased 
from 48.5% to 86.1% (figure 3.12.C-D). There was still some interaction between shear stress and batch 
effect, quantified at 15%.
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Figure 3.12. Conway10 study: Sample clustering and variance component analysis
The bar charts show the proportion of  variance (y-axis) captured by each of the known study factors (x-axis), before (A) 
and after (C) batch effect  correction. Sample clustering before (B),  and after (D) batch effect correction is plotted using 
multidimensional scaling plots. Each point on the plot is a sample, where colour corresponds to shear stress environment 
and the symbol corresponds to the experimental run of the sample. 
Lorenz15 studied the gender-specific effects of shear stress response. HUVECs isolated from three female 
and three male donors were subjected to 6 dyne/cm2 shear stress or kept in static conditions, resulting in a 
paired experimental design. Exploratory MDS plots on the Lorenz15 dataset showed unexpected shifts in 
expression values in response to experimental conditions, which were unable to be corrected by batch 
adjustment. The inconsistent trends in the shear stress response have been highlighted in Figure 3.13 by 
pairing static and low sheared samples from each donor to emphasise the directionality of the response. 
Initial analysis of all samples in the dataset, (figure 3.13.A), indicated that two of the male samples (Run 4 
and Run 5) demonstrated no response to shear stress. Female and male samples were clustered separately 
to further interrogate the data. When clustered together (figure 3.13.B), one of the female samples (Run1, 
circles) demonstrated an enhanced response with a shifted distribution that was identified as a technical 
outlier by array quality metrics. Male samples, (figure 3.13.B), showed a diverse range of responses to shear 
stress, indicating underlying problems in the experimental data. Given the evidence of unreliability in the 
expression data the entire Lorenz15 dataset was eliminated from the pipeline. 
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Figure 3.13. Lorenz15 sample clustering
The study consists of three female and three male samples subjected to 6 dyne/cm2 shear stress or kept in static 
conditions,  resulting to a paired experimental design. Sample clustering of all samples (A), female samples only (B) and 
male samples only (C) is shown using multidimensional scaling plots. Each point on the plot is a sample, where colour 
corresponds to the shear stress environment and the symbol corresponds to the experimental run of the sample. The 
directionality of the response is indicated by connecting the static and low shear samples from each donor with a line. 
The final dataset considered for the integration of flow studies conducted in human endothelial cells was the 
Ni11 study, which included samples at 15 dyne/cm2 and oscillatory shear stress. For the purpose of this study 
only the 15 dyne/cm2 samples were retained. As we were unable to retrieve information on experimental runs 
from the publication associated with this study [Ni11], no variance component analysis was conducted. 
Sample clustering did not indicate the existence of batch effects; uniform sheared samples clustered 
together and away from the oscillatory shear stress samples (data not shown). 
In summary, the Mun09, Conway10, White11 and Ni11 studies were all consistently normalised and 
corrected for systematic biases. Variance within each expression set was shown to be largely influenced by 
shear stress environment, capturing more than 80% of total variation. One study, Lorenz15, was excluded 
from the integration pipeline due to poor quality.  
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3.3.2.2 Integration of studies to generate a merged human expression dataset
Following the successful normalisation of Mun09, White11, Ni11 and Conway10 studies, the datasets were 
merged into a single expression set to create an integrated human endothelial cell dataset. The integrated 
dataset consists of a total of 26 samples with shear stress phenotypes as shown in Table 3.8. 
Table 3.8: Shear stress phenotypes included in the integrated human endothelial cell dataset
Shear stress 
Phenotype Sample size
Shear stress 
Magnitude
# of studies including 
phenotype 
Static n= 6 0 2
Low n= 3 1 dyne/cm2 (n=3) 1
Moderate n= 13
12 dyne/cm2 (n=3)
15 dyne/cm2 (n=10)
4
High n = 4 75 dyne/cm2 1
Whilst the integrated datasets did not initially appear to demonstrate successful integration (figure 3.14) the 
concordance between datasets greatly improved after cross-platform normalisation (figure 3.15). Prior to 
cross-study normalisation, exploratory MDS plots projecting shear stress phenotypes and study IDs on the 
sample clustering, demonstrated a clear distinct groupings for Agilent (Conway10), Affymetrix (Mun09) and 
Illumina datasets (White11 and Ni11), (figure 3.14.B), with no evidence of separation due to phenotype 
(figure 3.14.A). This was supported by variance component analysis, which showed 82% of variance within 
the integrated dataset was influenced by study ID, with only 1.7% of variance attributed to shear stress 
phenotype, (figure 3.14.C). Expression value density distribution plots for individual studies showed a large 
amount of heterogeneity, with the distributions of the two illumina expression sets, different to the 
distributions of Affymetrix and Agilent datasets. 
Following cross-study normalisation sample distributions showed a great degree of similarity (figure 3.15.D), 
with a clear separation of samples into their respective shear stress phenotypes (figure 3.15.A). In variance 
component analysis, 66.2% of variation was linked to shear stress phenotype (figure 3.15.C). There was 
however, some study-effect remaining in the data as indicated by the 24% variation attributed to an 
interaction between phenotype and platform. This can also be interpreted in terms of the sample clustering 
shown in Figure 3.15.A and Figure 3.15.B: the red triangles in Figure 3.15.A, representing the static controls, 
clustered together and away from the green and blue triangles. Now, focusing on the red triangles and 
looking at Figure 3.15.B, it can be seen that Conway10 and Mun09 static samples are still slightly separated 
into two distinct sub-clusters. 
Four out of the 26 samples were identified as outliers and removed from further analysis. One of the White11 
15 dyne/cm2 samples clustered away from the rest of the moderate shear stress samples (figure 3.15.A). In 
addition the three low shear stress samples from the Conway10 study clustered with the moderate shear 
stress samples and therefore were removed as outliers (data not shown). A possible explanation for this is 
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that the low shear stress phenotype only occurs in a single study, hence, the imbalance design makes it very 
difficult to distinguish platform effects from shear stress effects  [Ruby11]. 
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Figure 3.14. Merging of human expression datasets. 
(A) Sample clustering of the merged human endothelial cell dataset.  For each study the normalised batch corrected data 
were used. Each point  on the plot is a sample, where colour corresponds to the shear stress environment. B) Visualises 
the same MDS plot  as in (A),  with individual samples coloured according to the different  studies instead of  shear stress 
environment.  C) The bar chart shows the proportion of variance (y-axis) captured by each of the known factors (x-axis). 
D) Density distribution plots for the expression values of each sample, coloured according to individual studies.
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Figure 3.15. Cross-study normalisation of the integrated human endothelial cell dataset
(A) Sample clustering of the integrated human endothelial cell dataset following cross-study normalisation. Each point on 
the plot is a sample, where colour corresponds to the shear stress environment. B) Visualises the same MDS plot as in 
(A), with individual samples coloured according to the different studies instead of shear stress environment. C) The bar 
chart  shows the proportion of variance (y-axis) captured by each of the known factors (x-axis).  D) Density distribution 
plots for the expression values of each sample, coloured according to individual studies. 
In order to explore further the concordance between the different studies, we analysed the agreement 
between the expression values of all the15 dyne/cm2 samples across studies. In total there are 9 samples, 
three samples from each of Conway10, Ni11 and White11 studies. Figure 3.16 shows the mean-mean 
scatter plots for all pairs of studies. Each plot shows the mean expression levels of 15 dyne/cm2 samples 
from one study, plotted against the mean expression level of 15 dyne/cm2 samples from another study. 
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Under ideal conditions these should be in perfect agreement and fall on the y=x line (shown in blue). Inter-
study agreement can be measured by calculated the goodness of fit (r2), of the data, which quantifies the 
fraction of variance explained by the line of best fit. The higher the r2 value, the better the agreement 
between the two studies. Prior to cross-study normalisation the average r2 value was 0.60 (figure 3.16.A), 
which increased to an average of 0.94 after applying cross-study normalistaion (figure 3.16.B), indicating the 
high agreement between studies from different platforms. Similar results were obtained for the concordance 
between the static samples in Conway10 and Mun09; following cross-study normalisation, r2 increased from 
0.70 to 0.96.
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Figure 3.16. Mean-mean scatter plots of 15 dyne/cm2 samples across studies. 
A) Mean-mean plots before cross-platform normalisation. B) The same pairwise comparisons after cross-platform 
normalisation.  Each plot shows the mean expression levels of 15 dyne/cm2 samples from one study, plotted against the 
mean expression level of 15 dyne/cm2 samples from another study. The axis labels indicate the studies compared. Under 
perfect conditions, the points on the mean-mean scatter should fall on the theoretical y=x line, plotted in blue. The red 
line corresponds to the line of best fit  to the data. The goodness of fit  (r2), is  shown under each plot and it quantifies the 
fraction of variance explained by the line of best fit. r2  is a measure of inter-study concordance. 
3.3.2.3 Identification of shear responsive genes.  
In order to verify that the biological variation was not affected by the normalisation steps, shear responsive 
genes were identified through differential expression analysis of the static and moderate shear stress 
samples in the integrated dataset. In total 3299 shear responsive genes were identified with a p  < 0.05 (1628 
after FDR correction was applied). A query for the most related diseases in the set of differentially expressed 
genes returned cardiovascular diseases with an enrichment score of 32.51 (p  < 0.0001). Enrichment 
analysis for transcription factor binding sites identified key transcription factors known to be involved in the 
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endothelial cell shear response including AP1, NFkB, p53, MEF2, NRF2 and PPARgama [Fledderus08, 
Heo11, Boon09, Boon07]. Amongst the top  unregulated genes were  KLF2 (fold change=5.2), KLF4 (fold 
change=16) and NRF2 (fold change=1.9), which have been attributed to regulate up to 70% of the 
atheroprotective endothelial cell transcriptional program [Boon09]. The list also included upstream regulators 
of these transcription factors including EKR5, MEF2, KEAP1,HDAC5 as well as downstream genes 
controlled by these transcription factors and which have been associated with shear stress responses and 
include eNOS, thrombomodulin, HMOX1, NQO1, CYP1B1, E-selectin, ICAM1 and plasminogen activator 
inhibitor type 1 [Clark11, García-Cardeña01,McCormick01, Wang10].
Functional enrichment analysis for Gene Ontology biological processes and KEGG/Wikipathway canonical 
pathways revealed a strong involvement of phospoproteins (p< 0.0001) with a widespread responses of all 
five MAPK pathways (enrichment score (ES)=2.88, p< 0.0001), and processes regulating cell communication 
(p  < 0.0001) including adherent junctions (ES = 4.12), focal adhesions (ES= 2.75), regulation of actin 
cytoskeleton (ES=2.39), tight junctions (ES=2.48), and integrin mediated cell adhesion (ES=3.49). Top 
enriched signalling pathways include Keap1-Nrf2 pathway (ES= 6.15), oxidative stress (ES= 4.36), Wnt 
Signalling (ES=2.44) and TGF-beta signalling pathways (ES=3.27). These findings are in line with current 
literature [Pan09, Chiu11,Chatzizisis07].
In summary, an integrated dataset for flow studies conducted in human endothelial cells was successfully 
generated. Variance within the integrated dataset was shown to be largely influenced by biological 
phenotype rather than original dataset. Differential expression and functional analysis suggests that the 
results are consistent with current literature regarding the atheroprotective transcriptional program induced 
by shear stress; further validating the biological relevance of the integrated human endothelial cell dataset. 
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3.3.3 Integration of flow studies conducted across species
In the second phase of the project we attempted to expand the set of integrated studies to cross-species 
datasets. Two additional studies were considered, Dolan12 and Dolan13, which subjected bovine aortic 
endothelial cells to a wide range of shear conditions (static controls, 20 dyne/cm2, 35 dyne/cm2, 100 dyne/
cm2 and 284 dyne/cm2). The integrated cross-species dataset consisted of a total of 37 samples with shear 
stress phenotypes as shown in Table 3.9. The range of shear stress magnitude for the moderate and high 
descriptive phenotype is much broader due to the diverse nature of the individual studies.
Table 3.9: Shear stress phenotypes included in the integrated human endothelial cell dataset
Shear stress 
Phenotype Sample size
Shear stress 
Magnitude
# of studies including 
phenotype 
Static n= 9 0 3
Moderate n= 18
12 dyne/cm2 (n=3)
15 dyne/cm2 (n=10)
20 dyne/cm2 (n=3)
35 dyne/cm2 (n=3)
6
High n = 10
75 dyne/cm2 (n=4)
100 dyne/cm2 (n=3)
284 dyne/cm2 (n=3)
3
The quality controls for the normalised studies are shown in Figure 3.17 and Figure 3.18, respectively. The 
Dolan12 and Dolan13 datasets were generated from the same laboratory and both used bovine Affymetrix 
arrays. Both studies demonstrated batch effects, which were successfully corrected for, resulting to clear 
separation of samples by shear stress magnitude. The Dolan12 dataset initially demonstrated 23.3% 
variability due to batch effects (figure 3.17.A-B), which was eliminated following batch effect correction, 
resulting to 93.7% of variation been attributed to shear stress magnitude (figure 3.17.C-D). Similarly in the 
Dolan13 dataset the percentage of variance explained by the shear stress phenotype increased from 44.2% 
prior to batch-effect correction to 82.5% following correction (figure 3.18.A-C). In tandem to this, the amount 
of variation associated with batch effects (originally at 37.8%) was completely removed. There is however, 
some remaining effect of the batch on shear stress, quantified at 17.5% of total variations. Based on sample 
clustering, one of the 284 dyne/cm2 samples was an outlier compared to the rest, but because of the small 
sample size, n=3, it was not removed. 
All six studies (Mun09, White11, Ni11, Conway10, Dolan12 and Dolan13) were merged to generate an 
integrated EC mechanoresponsive gene expression profile. Similar to the human integrated dataset, prior to 
cross-study normalisation the samples clustered in distinct groups based on the study of origin, as opposed 
to the shear stress phenotype (figure 3.19 A-C). Variance component analysis suggested that the key drivers 
of variability were the species factor, contributing to 34.9%, followed by study ID which contributed by 24.7%. 
A further 17.1% of variation was due to the interaction of study and species, with the shear stress phenotype 
only contributing to 1.6% of variation, (figure 3.19 E). The expression value distribution plots for the two 
bovine studies, were similar to the human Mun09 study, which also uses the Affymetrix platform, suggesting 
that the distribution of expression values depends on the  array platform used, (figure 3.19.D).
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Following cross-study normalisation, with the exception of one of the White11 samples, the distribution plots 
across studies became homogeneous (figure 3.21.D). Sample clustering demonstrated a broad clustering by 
shear stress phenotype (figure 3.21.A). The boundaries of clusters, however are not well-defined, with some 
studies still failing to separate into shear stress groups (e.g., Dolan13, dark red triangles in figure 3.21.C). 
Consistent with the findings of the sample clustering, 19.8% variability is due to the shear stress phenotype, 
and a further 42.8% variation is influences by the interaction of shear stress phenotype and study ID. There 
is 35% unexplained variations, that suggests the factors currently considered do not capture all the sources 
of variation (figure 3.20.E). Variance component analysis was also performed using the shear stress 
magnitudes as inputs (8 different levels as shown in Table 3.9), instead of the shear stress phenotype, to 
check whether it could result in a reduction of the residual variation. Considering the magnitudes in the 
variance analysis improved the variability due to shear stress to 27.5% and reduced the interaction between 
shear stress and study to 36.2%. The residual however, still remained at 35%.
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Figure 3.17. Dolan12 study: Sample clustering and variance component analysis
The bar charts show the proportion of  variance (y-axis) captured by each of the known study factors (x-axis), before (A) 
and after (C) batch effect  correction. Sample clustering before (B),  and after (D) batch effect correction is plotted using 
multidimensional scaling plots. Each point on the plot is a sample, where colour corresponds to sheared stress 
environment and the symbol corresponds to the experimental run of the sample.
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Mean-mean scatter plots for nine 15 dyne/cm2 samples (figure 3.21 A-B) and nine static samples (figure 3.21 
C-D), which are the only two conditions common across more than one study, demonstrated improved intra-
study concordance following cross-study normalisation. Prior to cross-study normalisation, the average r2 for 
15 dyne/cm2  and static samples was 0.58 and 0.53, respectively, which increased to 0.79 and 0.94, 
respectively.
Collectively, the evidence indicates a partially successful cross-species integration of endothelial cell flow 
studies, with improved concordance for experimental conditions, common across multiple studies. 
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Figure 3.18. Dolan13 study: Sample clustering and variance component analysis
The bar charts show the proportion of  variance (y-axis) captured by each of the known study factors (x-axis), before (A) 
and after (C) batch effect  correction. Sample clustering before (B),  and after (D) batch effect correction is plotted using 
multidimensional scaling plots. Each point on the plot is a sample, where colour corresponds to sheared stress 
environment and the symbol corresponds to the experimental run of the sample.
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Figure 3.19. Sample  clustering and variance component  analysis for the integrated mechanoresponsive 
endothelial cell dataset. 
(A) through (C): Sample clustering of the merged cross species endothelial cell dataset.  For each study the normalised 
batch corrected data were used. The plots visualise the same MDS plots using different colouring for each sample. A) 
colours individual sample by shear stress conditions, B) colours individual samples according to the species factor and 
C) colours individual samples according to the study Id. D) Expression value density distribution plots for each sample, 
coloured according to individual studies. E) The bar chart shows the proportion of variance (y-axis) captured by each of 
the known factors (x-axis).
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Figure 3.20. Sample  clustering and variance component  analysis for the integrated mechanoresponsive 
endothelial cell dataset. 
(A) through (C): Sample clustering of the merged cross species endothelial cell dataset.  For each study the normalised 
batch corrected data were used. The plots visualise the same MDS plots using different colouring for each sample. A) 
colours individual sample by shear stress conditions, B) colours individual samples according to the species factor and 
C) colours individual samples according to the study Id. D) Expression value density distribution plots for each sample, 
coloured according to individual studies. E) The bar chart shows the proportion of variance (y-axis) captured by each of 
the known factors (x-axis).
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Figure 3.21. Mean-mean scatter plots across studies with similar conditions. 
Upper box: Mean-mean plots of 15 dyne/cm2 samples before (A) and after (B) cross-platform normalisation. Lower box: 
Mean-mean plots of  static samples before (C) and after (D) cross-platform normalisation. Each plot shows the mean 
expression levels of  samples from one study, plotted against the mean expression level of  samples from another study. 
The axis labels indicate the studies compared. Under perfect conditions, the points on the mean-mean scatter should fall 
on the theoretical y=x line, plotted in blue. The red line corresponds to the line of best fit to the data. The goodness of fit 
(r2), is shown under each plot and it  quantifies the fraction of variance explained by the line of  best fit.  r2  is a measure of 
inter-study concordance.
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3.4 Discussion
3.4.1 Summary of work
This chapter introduced a microarray meta-analysis framework, able to normalise expression sets, annotate 
probes with Entrez ID’s, correct study-specific batch effects and conduct final integration of expression data 
across platforms and species. Implementation of the pipeline resulted in the successful construction of a 
merged human expression dataset relating to the effect of mechanical stimuli on endothelial cells. Variance 
within the integrated dataset was shown to be largely influenced by biological phenotype rather than original 
dataset. Differential expression and functional analysis suggests that the results are consistent with current 
literature regarding the atheroprotective transcriptional program induced by shear stress, further validating 
the biological relevance of the integrated human endothelial cell dataset. Similarly, a larger integrated 
dataset across species was generated, which was partially successful in cross-species integration of 
endothelial cell flow studies. While, sample clustering only demonstrated a broad clustering by shear stress 
phenotype with some study effects still present in the data, there was a demonstrated high agreement for 
experimental conditions, common across multiple studies.  
The pipeline presented in this chapter, provides an implementation of methods to integrate Affymetrix, 
Illumina and Agilent at the gene expression level, which has not been previously reported within the 
literature. Most existing compendia can be divided into studies that directly integrate single platform datasets 
or studies that indirectly integrate cross-platform experiments. As part of a survey to identify the best practice 
methods for successful integration of microarray experiments, 93 papers were reviewed, out of which only 43 
papers conducted direct integration of expression data; 67% were from a single platform and 30% (13 
papers) dealt with direct integration across platforms. There is increasingly more evidence demonstrating the 
successful merging of data from the same platform. For instance, [Lukk10] produced a global map  of human 
expression by integrating 5372 Affymetrix samples from 206 different studies, [Schmid12] merged 3030 
Affymetrix gene expression samples for a diverse set of tissues and diseases and studied the organisation of 
the samples into clusters. Combining data from a single platform eliminates issues with probe mapping and 
numerically incompatible data. In contrast, out of the 13 papers that conducted cross-study direct integration, 
3 papers proposed new cross-study correction methods, 4 papers evaluated existing batch correction 
methods, 3 papers used discretisation approaches and only 3 papers applied cross-platform integration for 
novel datasets: one paper integrated Affymetrix and Illumina [Turnbull12] and two papers integrated 
Affymetirx with two-colours arrays [Chen08, Lemmens09]. 
Having the ability to integrate studies across a range of platforms offers an alternative to current meta-
analysis approaches that convert gene expression matrixes to single vectors of summary statistics. 
Consequently, the information loss excludes gene network inference methods, since the algorithms assume 
gene expression data as input. Current, cross-study network inference has been limited to either 
development of specialised network inference methods to work on the discretised data [Belcastro11] or they 
rely on network biology techniques to compare the networks generated from the individual studies [Seo11]. 
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The results obtained on the integrated endothelial cell dataset are very encouraging for the application of 
ARNI. Inspection of the differentially expressed genes, mapped on KEGG pathways has demonstrated a 
wide distribution of seeds, which includes both upstream and downstream components. These properties of 
seed genes is a prerequisite for ARNI’s performance.
3.4.2 Evaluation of flow studies integration
There are a number of considerations specific to our datasets that makes integration of mechanosensitive 
microarray experiments particularly challenging. 
First, the studies were technically heterogeneous with no predominant choice of microarray technology; the 
six studies analysed, were conducted on 5 different arrays. As a consequence, the software developed had 
to cover a wide range of techniques and required in depth knowledge on the design and handling of the 
different microarray formats. The importance of following good practices has been highlighted by the batch-
effects identified in most of the studies analysed, which were not corrected in the original studies thus 
compromising the results [Leek12]. The work of [Lorenz15] was particularly affected by batch effects. In their 
publication, Lorenz et al. report a reduced shear responses in male subjects. The analysis carried out in this 
study, however, suggests inconsistencies in the response of the biological replicates, and non-
responsiveness of two of the male subjects. Without more details, it is not possible to determine if this is a 
biologically related observation, or an underling problem with the experiments, either in the flow application 
or the microarray labeling and scanning. 
Second, there was no predominant species, with a surprisingly low number of eligible studies conducted in 
human endothelial cells. The majority of in vitro studies in HUVECs (15 studies) were conducted on first 
generation arrays that suffer from low coverage and for which there were no available data. These include 
the seminal works of McCormick et al., Carcia-Cardena et al., and Dekker et al., which were one of the first 
groups to report the role of shear stress on regulating EC transcriptional profiles [McCormick01, Carcia-
Cardena01, Dekker02]. Over time, shear stress studies became more reliable due to the maturation of the 
microarray platforms in terms of coverage and repeatability of their responses; the early studies however 
have not been repeated resulting to the loss of that information. 
Theoretically, integration of datasets across different species should be possible. It is known that even 
dramatically different organisms often share similarities in the functioning of their biological systems and that 
many genes are conserved across species [Lu09]. It is these similarities, which have enabled patterns of 
gene network analysis in rats and mice to be used to gain insights into human diseases. Our results support 
cross-species compatibility with high concordance (r2 = 0.97) of static samples derived from human and 
bovine endothelial cells. Agreement in gene expression, however, is not the only consideration for study 
inclusion in the integrated dataset. Expanding the integration to further studies should carefully consider the 
trade-off between gain in statistical power (due to increased sample size) and the information lost due to 
incompatibility of annotations and not reproducible genes. The overlap  in annotations between human and 
bovine arrays reduced the eligible genes by 44% to only 7743, which is approximately only 30% of the whole 
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genome. In parallel, the experimental conditions in the bovine datasets are different to those of the human 
datasets, with only the three bovine static samples in common. Hence, the inclusion of bovine studies, might 
have limited benefits.
The third, and most important consideration is the small sample size of individual studies with only partially 
overlapping experimental conditions. Cross-study normalisation is most effective when all treatment groups 
are represented in both datasets. In the case of the integrated human endothelial cell dataset, which is more 
homogenous in terms of the experimental conditions used, we have demonstrated high agreement in the 
normalised expression data across studies ( r2 for static samples = 0.96, r2 for 15 dyne/cm2 samples = 0.94). 
The three 1 dyne/cm2 samples, however, that were the only low shear stress samples present in a single 
study, did not perform well, and had to be excluded. The importance of experimental conditions homogeneity 
is also evident in the cross-species integrated datasets. The human 15 dyne/cm2 samples demonstrated 
reduced agreement in the cross-species integrated dataset with an r2 = 0.79 compared to r2  = 0.94 in the 
human integrated dataset. These are the exact same samples, with the same initial input data, with the only 
difference being that the cross-study normaliation was performed in the presence of the variability introduced 
from the bovine samples. 
Hence, the inclusion criteria for studies should weight the impact on normalisation efficiency and reduction in 
annotations, against the increase in statistical power. While the inclusion of bovine studies might have limited 
benefits, porcine studies on the other hand, have more overlap  in terms of their experimental condition with 
that of the human samples. Successful integration will provide an additional 8 samples for each of the static 
and 15 dyne/cm2 conditions, providing a significant increase in power. Thus, current efforts are focused on 
incorporating two-colour arrays formats in the pipeline, as discussed below. 
The problem of imbalance design has been recognised in literature. Ruby et al. showed that current cross-
study normalisation methods are very limited as to their ability to normalise studies with inconsistent 
experimental conditions [Ruby11]. This was our main motivation in choosing Combat for cross-study 
normalisation since its uniquely able to incorporate study covariates in the normalisation and allows for the 
biological signal to be retained. Walker et al. further improved Combat with imbalance designs specifically in 
mind, but the method requires common reference samples [Walker08]. A collaborative effort across the 
mechanobiology community would be beneficial by ensuring future expression datasets studying the effect of 
mechanical stimuli on endothelial cells are more directly comparable by ensuring static controls are always 
included in the analysis to provide a common baseline. A common consensus on microarray platforms and 
protocols used would further improve the technical variability of studies. This strategy has already been 
adopted within the field of cancer genomics whereby several research groups have collaborated to form the 
Global cancer genomics consortium. These research groups are working together to ensure they use the 
same arrays, species and phenotypes in their work. 
A mechanobiology consortium could go beyond simply establishing standards. A crowd sourcing approach 
could be set up to investigate the same series of shear regimes across all common species (human, porcine, 
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bovine) and in vitro flow systems (e.g., parallel-plate, cone and plate systems). The shear regimes could 
systematically investigate differences in magnitude, pulsation waveforms and oscillations amplitudes, so as 
to capture the whole breath of mechanoresposnes. Such a dataset, not only will it provide valuable insights 
into the underling molecular mechanism of shear stress responses, but also it will provide an exciting 
opportunity to investigate the similarities of in vitro and in vivo environments. The studies of Davies and 
Friendman laboratories already provide a comprehensive dataset for Swine with over 200 samples. The 
Krams laboratory is currently performing new experiments in mice to obtain endothelial cell profiles from 
defined shear environments which would supplement the ones from the Jo laboratory. Once the merging has 
fully been achieved, classifiers can be used to determine the in vitro shear regime best at resembling specific 
in vivo environments and identify transcriptional profiles unique to in vivo or in vitro environments. 
3.4.3 Improvements and extension of the implemented pipeline
3.4.3.1 Preprocessing module
Incorporation of two-colour arrays
In order to enable the analysis of porcine samples the pipeline needs to be further developed to include pre-
processing steps for two-colour arrays. Two-colour arrays have fundamental technical differences to single 
channel arrays; they involve the hybridisation of two samples at the same time, each labelled with different 
fluorescent colour (green and red channel). It is common practice to use a common reference sample for 
one of the channels (e.g., universal RNA commercially available or pooled RNA from all the samples used in 
the study), which allows for within and between array normalisation.
A literature review has established the exact methods to implement: ‘normexp’ model for background 
correction, loess algorithm for within array normalisation and quantile normalisation for between array 
normalisation. The ‘normexp‘ model for background correction, which has already been used for Agilent and 
Affymetrix arrays, has been successfully applied in multiple two-colour array studies and been shown to 
outperform other applicable methods [Ritchie07, Larsen14, Peart05]. Two-colour arrays require an additional 
normalisation step, for within array normalisation to correct for dye differences between the two channels. 
The loess method [Yang02] was shown to perform well for this step, and demonstrated a particularly good 
performance when implemented in combination with the ‘normexp’ model [Zahurak07 Zhu11]. Finally, 
quantile normalisation should be used for between array normalisation, since it performs well and it has been 
used for the rest of the platforms in the pipeline [Bolstad03]. Using the same methods across platforms was 
shown to improve cross-platform compatibility [Klinglmueller11].
Once normalised, a method needs to be implemented in order for single and dual channel data to be 
merged. This is complex, as two-colour arrays represent gene expression as the log-ratio between the two 
channels (experimental condition and common reference) and can therefore not easily be compared to a 
single channel array’s expression intensities. There are three options proposed in literature, first single 
channel data can be merged with just one channel originating from the two colour data (i.e intensity-intensity 
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merging), alternatively single channel expression values could be converted into a log ratio and merged with 
the log-ratio of two-colour arrays (i.e ratio-ration merging), finally log-ratios and expression values can be 
merged (i.e ratio-intensity merging). Fan et al. demonstrated the importance of data equivalency in cross-
platform integration by comparing the performance of classifiers, for each of the three methods [Fan10]. 
Intensity vs ratio performed very poorly, while intensity-intensity and intensity-ration performed equally well, 
assuming cross-study normalisation was applied. Intensity-Intensity merging has also been successful within 
the context of network inference [Sirbu10], therefore it is reasonable to assume that such an approach can 
be used for our pipeline. Recently, complex separate channel analyses for two-colour arrays have been 
proposed which should be considered and evaluated relative to the more traditional approaches discussed 
above [Smyth12]. 
Implementation of filtering steps
Implementation of filtering steps can further improve the accuracy of the results. There are three levels of 
filtering proposed. Low expressed probes have lower correlation between platforms, partly because they are 
more noisy, and the noise models between the arrays are different [Barnes05, Canales06, Zhang10]. 
Filtering per platform prior to merging have been shown to improve the compatibility across studies 
[Turnbull12, Bosotti07]. In addition it has the added advantage of reducing the number of statistical tests 
performed, which reduces the impact of multiple testing adjustment [Bourgon10]. Larsen et al. further 
demonstrated that filtering out low variance genes can improve the intraclass correlation coefficient across 
platforms from 0.46 to 0.84 [Larsen14]. The final aspect of filtering proposed in literature is filtering out non-
reproducible genes across platforms. Chen et al. in their analysis of the MAQCI datasets concluded that 
patterns of expression across platforms (measured by the gene-wise correlation) are generally consistent 
(coef. correlation ~ 80%) but there are around 30% of genes that demonstrate inconsistent patterns across 
the five platforms considered and should be filtered out [Chen07]. A proposed filter is integrated correlation, 
which uses the correlation of correlations to identify genes that are not reproducible across platforms 
[Parmigiani04]. For each gene, its correlations to all other genes on a given platform is calculated. The same 
is repeated for all the platforms, resulting to multiple vector of correlations for each gene. Then the 
correlation between the gene correlation vectors is calculated (called integrated correlation). Genes with low 
integrated correlation should be filtered out. Prior to applying this method to our pipeline it should be tested, 
whether the different experimental conditions in each study, could affect the performance of the integrated 
correlation approach, since it is unclear if the correlations between genes will be reserved under different 
experimental conditions (e.g., static/moderate shear versus moderate/high shear). 
3.4.3.2 Platform annotation module
Sufficient coverage of the genome and high mapping rates between arrays are necessary for the usability of 
the integrated datasets. The lack of continuity in work was a major obstacle we encountered in setting up the 
annotation pipelines. Many of the software build to provide sequence matched probes are not supported by 
institutes and lost support through the years. Therefore we had to develop  bespoke software to consolidate 
and reannotate microarrays. Collectively, the four human platforms in this study target 22478 genes. While 
the two newer generations of arrays, Affy U133 and Lumi HT12, mapped to 19952 and 18523 genes 
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respectively, the coverage of older generation arrays, LumiRef8 and Ag44k is reduced, affecting the overall 
number of genes eligible for the integration study. The mapping rates achieved in this study are in agreement 
with those reported in literature. Allen et al. reports 0.71 mapping rate between Affy U133 and Lumi HT12, 
and the MAQCI project found 12651 genes common across five platforms [Allen1, Shi06]. In this study, the 
common human reference lists had 14030 genes, and the individual mapping rates between arrays were 
around 0.80. 
Following cross-species annotation, the mapping of the human arrays to the mouse array, remained high at 
90%. The mapping of the human to the bovine array however, was only 55%. Hence, the reduction in 
mapping rate does not appear to be due to the specific methods used to achieve cross-species mapping, but 
rather a property of the specific species considered. Bovine and porcine model organisms are not widely 
studied and thus their corresponding arrays suffer from low coverage and are not as technologically 
advanced as those of the most commonly used mouse and rat arrays. As a result, we had very limited 
options for improving the bovine annotations. 
Cross-species mapping requires more advanced annotation protocols to be considered. Manual checking of 
the annotation lists revealed that a significant proportion of excluded probes were targeting subfamilies of the 
same gene or were due to the miss matched database versions. As a result, the same gene had a different 
Entrez IDs. The choice of Entrez ID was motivated by the fact that these annotations are stable over time, 
but there is still a small proportion (~ 4% [Chen07a]) that changes over time. Therefore, extending the 
annotation matching function to also include string matching for the gene symbol and/or gene name can 
further improve the mapping rates. 
Within the scope of this project, averaging of probes targeting the same gene, resulted to an acceptable level 
of variation for the analysis to continue. There is, however, scope for improvement in the accuracy of the 
data. The improved intra-class correlation observed in BrainArray annotations (coef. variation = 1.3%, 
compare to 17.3% for vendor annotations), is partly due to the improved mapping, with probes grouped in 
such a way to accurately represent the same gene entity. In addition, BrainArray annotations were 
incorporated into the analysis from the raw data stage, and were used as input to the RMA pre-processing 
step. RMA implements advanced models for summarisation of probe signals, which are robust to outliers and 
take into account the varying probe affinities arising due to different sequences. A similar approach can be 
followed for Agilent and Illumina to further improve the results.  
3.4.3.3 Data merging module
Prior to applying the dataset for gene network inference using our ARNI approach, we are currently working 
to generate a final integrated dataset that will provide a robust set of shear responsive genes, specifically 
investigating the differences between static and moderate shear (12-15 dyne/cm2) conditions. The final 
integrated dataset will consist of 17 static samples and 20 moderate sheared samples across three species, 
a significant increase in power from any individual study. In order to achieve this, we are extending the 
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integrated dataset to two colour arrays and re-running the bovine integration dataset, including only the static 
samples to ensure the compatibility in the samples considered. 
In parallel, we are developing a linear mixed effect model (LMe) with random factors, to further explore the 
complete set of shear stress conditions available. Within an LMe model we can model shear stress as a 
numerical (as opposed to categorical) variable. In that way we can set up regression models for shear 
responses over the complete range of shear magnitudes ( 0 - 284 dyne/cm2). In addition, LMe models are 
more effective to handle high variability and correlations between sample (including species effects, study 
effects, and platform effects), and thus we hope to further improve the integrated cross-species dataset and 
correct for the remaining study effects  [Sung11].  
3.5 Conclusion
The work presented here makes key contributions to both the field of bioinformatics and endothelial cell 
mechanobiology. We have demonstrated that direct integration of Agilent, Affymetrix and Illumina platforms is 
possible following consistent normalisation methods. We have further demonstrated that cross-species 
integration is possible with high agreement between static samples derived from human and bovine species. 
The generated integrated endothelial cell gene expression profile has the potential to greatly advance the 
study of mechanoresponses in endothelial cells and the pursue for treatment. In the context of the integrated 
platform for gene network inference and validation, we have identified a robust set of shear responsive 
genes, which can be used as seed genes for our ARNI method presented in Chapter 2.  
In the future the pipeline could be adapted to be able to pre-process two channel arrays to expand the 
diversity of the data that can be used. As RNA sequencing becomes mainstream the current methods can be 
extended to include RNAseq data. There are already theoretical papers being published on the integration of 
microarrays and RNAseq data [Xu13]. Finally, it may be beneficial for the mechanobiology research 
community to make a collaborative effort to collect datasets, across shear regimes, in vitro models, and 
species, to inform the direction of the field for the coming years. 
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Part II
Part II: Experimental platform for network 
validation
Part II of the thesis presents experimental devices and protocols for establishing a high-throughput RNAi 
screening platform that specifically meets the requirements for uncovering mechanoresponsive gene 
networks in primary endothelial cells using our ARNI approach. These are, parallel high efficiency 
transfection with hundreds of siRNA molecules in conjunction with simultaneous read-out of multiple resulting 
molecular phenotypes under flow conditions.
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Experimental system requirements
In order to fully realise the potential of symbolic learning it is imperative that the network inference platform is 
coupled to a high-throughput screening platform. One of the advantages of an abductive approach for 
network inference is that ASP solvers exhaustively enumerate all possible networks that are consistent with 
the given data. Reasoning over the complete solution space can lead to more robust insights; it imposes 
however a considerable challenge for discriminating over them. Our ARNI approach provides tools for the 
automatic generation of informative experiments that are most discriminatory over the inferred gene 
networks. As an approach to validate the topology of these networks and discriminate over alternative 
networks, one needs to be able to manipulate genes either through activation or inhibition in order to 
decipher the function of genes. Given the large number of tests that need to be performed, the experimental 
platform has to be capable of parallelisation. 
Two discoveries made in 2001 have revolutionised the way functional genomics is done. Elbashir et al. 
demonstrated that small interfering RNA (siRNA) molecules can be used for silencing genes in mammalian 
cells [Elbashir01]. siRNA are small (20-25 base pairs long) double stranded RNA molecules that are able to 
experimentally knockdown the expression level of a gene by taking advantage of the cell’s innate machinery 
for gene regulation. Once inside the cells the siRNA molecules bind to the mRNA of specific genes in a 
sequence dependent manner and initiate its enzymatic degradation. The recognition of RNAi as a powerful 
tool for functional genomics has since credited its discoverers, Craig Mello and Andrew Fire, with the Nobel 
Prize in Physiology or Medicine in 2006 [Fire98]. In parallel, Ziauddin and Sabatini succeeded in fabricating 
the first reverse transfection cell array which allows for the parallel delivery of nucleic acids at the microarray 
scale, allowing the screening of loss-of-function effects in a high-throughput manner [Ziauddin01]. In this 
format, the siRNAs are first spotted onto a glass slide. The cells are subsequently seeded on the glass slide 
and then reverse transfected with the siRNAs already immobilised on the glass slide surface.
Successfully knocking down a gene is not sufficient for RNAi screening. An RNAi screen also requires a 
read-out to assess the biological effect of the loss-of-function on cell biology. Within the scope of the 
informative experiments discussed in Section 2.4.2 the RNAi platform should enable to inhibit one gene and 
monitor the response (mRNA and protein levels) of another gene. Therefore each spot on the array should 
contain a unique pair of a knockdown gene and a readout gene as dictated by the informative experiments. 
Current techniques suffer from low dimensionality of the readout, which is usually limited to high content 
morphological measurements or molecular readouts of one or two reporter genes [Berthuy15, Morh14]. 
Recent developments in live cell arrays combined with advances in fluorescent reporter technology allows to 
address these limitations. 
Part II of the thesis presents experimental devices and protocols for establishing a high-throughput RNAi 
screening platform based on reverse transfection arrays that specifically meet the requirements for 
uncovering mechanoresponsive gene networks using our ARNI approach. The two main parameters to 
consider for setting up  an RNAi screening platform are, the RNAi delivery method to achieve high 
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transfection efficiency and the RNAi screening format which needs to be compatible with the biological 
question. In this study, in order to carry out mechanotransduction studies, the platform needs to: 
(1) incorporate a microfluidics device for application of flow;
(2) be compatible with high-throughput transfection of primary mammalian cells;
(3) be compatible with microscopy imaging for automated monitoring of RNAi effects;
(4) be coupled with a molecular assay that allows for simultaneous quantification of multiple genes.
The central idea is to obtain different expression profiles for each array spot, detected via automated 
imaging.
Chapter 4 presents a high-throughput reverse transfection cell array based on electroporation that can be 
coupled to a parallel-plate chamber for mechanotransaction studies.
Chapter 5 focuses on the development of an assay for quantifying the biological effect of siRNA knockdown, 
with an emphasis on the role of RNA hybridisation probes as a modality for real-time quantification of 
endogenous RNA levels in live cells under flow conditions. 
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4High throughput RNAi cell array for 
mechanotransduction studies 
Chapter 4 summary
This chapter describes the design, fabrication and evaluation of a high-throughput RNAi platform for 
mechanotransduction studies in primary mammalian cells. Transfection of primary cells is notoriously 
difficult, but it can be achieved with membrane electroporation, whereby electrical pulses temporarily open 
pores on the cell membrane and allow the siRNA to enter the cell. Existing cell electroporation techniques 
are either not high-throughput or not readily compatible with the application of flow, which is essential for 
shear stress studies. The RNAi platform consists of a number of components (highly efficient electroporator, 
ultra-high precision robot dispenser, and a modular parallel plate chamber for experimental interventions), 
which are functionalised involving a series of procedures (siRNA spotting, seeding and transfection and flow 
studies). An optimised protocol for the generation of spotted arrays has been established and evaluated in 
terms of homogeneity and immobilisation of the siRNA on the spots. Effective loss-of-function was 
demonstrated for multiple gene targets at the mRNA, protein and phenotypic level with 64% transfection 
efficiency. Further, the cell array and the in-house build flow system has been demonstrated to be suitable 
for the application of flow studies with cell alignment to the direction of flow and minimal cell loss. All 
components are compatible with standard microscopes enabling automatic screening and high resolution 
imaging at a single cell level.
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4.1 Introduction
The discovery of the human genome has unveiled new fields of genomics, transcriptomics and proteomics, 
which has produced paradigm shifts on how to study disease mechanisms, wherein a current central focus is 
the understanding how gene signatures and gene networks interact within cells. These gene networks often 
consist of more than 1000 genes with a huge amount of interactions between them. As an approach to 
understand the topology and complex interactions of these gene networks, one needs to be able to 
manipulate genes either through activation or inhibition in order to decipher the function of genes.   
4.1.1 Electroporation for high efficiency transfection in primary 
mammalian cells.
Functional genomics studies require the introduction of exogenous molecules into cells in order to perform 
gain-of-function or loss-of-function studies. The cell membrane naturally acts as a barrier to these 
macromolecules and various techniques have been developed (such as lipofection, viral transduction, and 
electroporation) to allow the delivery of exogenous material inside cells in a process known as transfection. 
Lipid-based transfection reagents deliver molecules to the cell by means of a liposome that easily merges 
with the cell membrane [Felgner87]. Despite numerous efforts the efficiency of this method is low in primary 
mammalian cells, reporting a maximum of 30% transfection efficiency [Hunt10]. In viral-based methods, 
transfer of molecules is mediated by encapsulation in viral vectors such as lenti- or adeno-virus, which can 
achieve high transfection efficiency [Lindemann09]. This technique, however, is limited due to insertional 
mutagenesis and immunogenicity, high safety requirements and complex viral purification protocols, which 
make viral transduction impractical in a high-throughput setting [Bonetta05, Slivra15]. For electroporation, an 
electric pulse is applied to the cell to permeabilise the cell membrane and allow uptake of external 
molecules. Under optimised pulse parameters, the membrane returns to its intact state. Recent studies have 
shown that electroporation can achieve high transfection efficiency in a wide range of primary cell lines, 
including primary human endothelial cells [Luft15, Hernández04, Yockell-Lelièvre09, Gresch12, 
Ovcharenko05, Bonetta05]. Hernández et al. report 85% transfection of HUVECs using electroporation and 
no associated functional impairment in terms of cell morphology, migration or attachment. 
Electroporation is a simple and versatile transfection method well suited for customisation and high 
throughput applications. There are reported commercial systems for parallel electroporation of siRNAs in 
multi-well plates [Luft15]. Amongst the disadvantages of these instruments is that they rely on sequential 
processing of samples (siPorter96, Nucleofector) with large time-lag between processing of the first and last 
samples. Some systems allow for parallel processing of 96-well plates (Cellaxess and Primax) and 384-well 
plates (Cellaxess and Nucleofector 4D), however, the costs associated with the commercial parts limits their 
use for high-throughput studies. As a result, various academic laboratories have pursued the task of building 
their own high-throughput electroporators. Ovcharenko et al. developed a 96-well electroporation device 
consisting of two gold-plated electrode plates, the lower with 96 concave sample wells and the upper with 96 
convex protrusions [Ovcharenko05]. Huang et al. fabricated a microchip  consisting of multiple patterned 
micro-electrodes and well overlays for parallel electroporation of 96-well plates [Huang09]. Both studies 
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demonstrate high transfection efficiency and cell viability for multiple primary cell lines including HUVECs, 
fibroblasts, T-cells and astrocytes. These systems however, have a limited scale of 384 samples per plate 
and rely on manual preparation and loading of cell suspensions, which increases variability and is not 
compatible with high-throughput studies.
An emerging format for RNAi screening which can overcome these limitations is the use of reverse 
transfection microarrays for the parallel delivery of nucleic acids at the microarray scale. In this format, the 
nucleic acids are first spotted onto a glass slide. The cells are subsequently seeded on the glass slide and 
reverse transfected with the siRNAs already immobilised on the glass slide surface. Reverse transfection 
microarrays were first described by Ziauddin and Sabatini in 2001 who printed over-expression plasmid 
DNA together with gelatin on glass slides. The slides were subsequently exposed to chemical transfection 
reagents and seeded with HEK293 cells [Ziauddin01]. The method was later adopted by several groups for 
gene knockdown reverse transfection arrays [Mousses03, Silva04] and further improved by spotting 
transfection reagents and other additives together with siRNA to enhance transfection efficiency  [Erfle04, 
Yoshikawa04, Erfle07, Onuki-Nagasak08]. The methods employed by the above mentioned studies result in 
transfected spots of cells in an otherwise non-transfected monolayer of cells. In order to improve intra-spot 
contamination, assist automated image analysis and prevent the migration of already transfected cells to 
neighboring spots, the methods were later modified to generate a cell array of spatially confined spots, 
where the area outside of the spots was free of cells. [Rantala11, Fengler12]. 
The main shortcoming of established reverse transfection arrays is the use of chemical transfection 
reagents, which prevents their application to hard-to-transfect cells lines and primary cells. Previous attempts 
to couple reverse transfection with electroporation have only been demonstrated in cell lines (Hela and 
HEK293 cells) and they use complex micro patenting and lithography techniques to create microwells, which 
would intervene with fluid dynamics in shear stress studies [Jain12, Fujimoto10]. 
In this chapter, we seek to resolve these issues by developing an RNAi screening platform for primary 
endothelial cells that incorporates an electroporator in reverse transfection arrays, in such a way that is 
compatible with flow.  
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4.1.2 Reverse electroporation arrays for mechanotransduction studies
Several techniques and devices have been developed to expose in vitro cultured cells to fluid flow, including 
parallel–plate flow chambers, orbitally shaken dishes, cone–plate viscometers, and tubular capillary tubes 
[Chiu11]. In this study we chose to work with parallel-plate chambers since they are relatively simple to 
design and assemble and fit well with the rest of the components and requirements of the RNAi platform. In 
a parallel-plate flow chamber the cells are seeded on the bottom plate of a flow chamber and the liquid flows 
between the two parallel plates, from the inlet to the outlet, along the chambers length [Frangos85].  The use 
of glass slide in reverse transfection arrays naturally provides a flat surface which is compatible with parallel 
plate flow chambers for the application of flow. Further, the design of a custom build electroporator only 
requires two electrodes embedded in the cell medium and a pulse generator; a format that is analogous to 
the design of a parallel-plate flow chamber. Therefore, incorporation of an electroporator in a parallel-plate 
flow chamber is an efficient way to couple electroporation and flow studies. 
The requirements of the project (Table 4.1) demanded a highly bespoke RNAi platform. A scheme of the 
approach followed is shown in Figure 4.1. Central to our methodology is the use of a robotic system to 
develop an electroporation-ready siRNA array with multiple siRNA species, onto which endothelial cells are 
seeded for reverse electroporation. Following successful reverse electroporation the glass slide is 
assembled together with a parallel plate chamber, which is subsequently connected to a peristaltic pump for 
the application of flow. 
Gold%plated**
ﬂow*chamber*
Conduc5ve**
glass*slide*
%ve*electrode*
Inlet Outlet 
+ve*electrode*
Figure 4.1 Highly modular, high-throughput RNAi platform for mechanotransduction studies
The first  step in the assembly is the spotting of desired siRNA samples on a semi-conductive, optically transparent and 
biocompatible substrate. In the second step  the cells are seeded on the spotted array to form a cell array of spatially 
separated spots. In the third step electric pulse is applied for reverse transfection of the spotted agents into the cells.  In 
the fourth step, the glass slide is  assembled together with a flow chamber to form a parallel-plate flow chamber, which is 
subsequently connected to a peristaltic pump for the application of flow.
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The spotting slides act as: i) the substrate for immobilisation of siRNAs, ii) one of the electrodes for 
electroporation and iii) the lower plate of the parallel-plate flow chamber. Therefore, to create such an array, 
an electroporation-compatible substrate is needed that is biocompatible and transparent to allow for 
automated live-cell time-lapsed imaging. In this work we use indium tin oxide (ITO) hot coated glass slides 
which are semi-conductive, optically transparent and biocompatible. 
The rest of the chapter describes the detailed design, fabrication and operation of a reverse electroporation 
cell array on ITO coated glass slides. The requirements for each step  in the assembly are listed in Table 4.1 
and constitute the objectives of this chapter. 
Table 4.1 Requirements for reverse electroporation array for mechanotransduction studies
1. Array fabrication ! ! ! ! ! !    
1.1 Precise spotting with regular spot shape and uniform inter-spot siRNA concentration
1.2 Spot homogeneity with uniform intra-spot siRNA distribution
1.3 Sufficient immobilisation of siRNA on slides following the addition of cell suspension
 2. Cell Seeding
2.1 High cell viability and normal cell morphology
2.2 Preferential cell attachment on spots to generate a cell array of spatially separated spots
 3. Reverse transfection
3.1 High transfection efficiency for primary endothelial cells
3.2 High cell viability
3.3 Uniformity in the applied electric field and homogeneity of gene knockdown
 4. Flow studies   ! ! ! ! ! ! ! ! !         
4.1 Design and fabrication of a wide flow chamber with uniformity of shear stress profile over all spots
4.2 Minimal cell loss, following twenty-four hours of flow exposure
4.3 Compatibility with live-cell time lapsed microscopy
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4.2 Material and Methods
4.2.1 Array Printing
Arrays were printed onto Indium tin oxide (ITO) hot coated glass slides (Diamond coatings, UK), 28.5 mm × 
78.5 mm × 0.7 mm with 5-8 Ohms/Sq resistance. ITO  glass slides are semi-conductive, optically transparent 
and biocompatible, rendering them suitable for electroporation and live cell imaging. For performing 
experiments the slides were placed in 4-well cell culture treated polystyrene plates with rectangular wells 
(Nuclon flat bottom 128x86mm with lid, sterile). The resistivity of the ITO coated side was determined using a 
voltage meter.
Slide preparation
ITO slide washing
Prior to spotting, ITO slides were washed successively for 5 minutes with acetone (Sigma Aldrich, 24201), 
ethanol and miliQ  water in ultrasonic water bath. The slides were then rinsed 3 times with miliQ  water, dried 
under nitrogen stream and stored at room temperature in slide boxes until further use. 
ITO slide surface treatment
During the optimisation period slides were either left untreated, treated with oxygen plasma or treated with 
hydrogen peroxide (H2O2) solution. Oxygen plasma treatment was performed using Oxygen Plasma Prep 
Cleaner (Gala instrument). Washed slides, were placed in 4-well plates (with the ITO  coated side facing 
upwards) and placed in the oxygen plasma device chamber. The chamber was flushed with oxygen gas 
twice prior to treatment. The parameters for treatment were: 0.2 mbar, 300 W for 5 min. For H2O2 treatment, 
slides were immersed in a solution of H2O2: Ammonia: water at a ratio of 1: 1: 5 and incubated in the dark for 
30 minutes. Following H2O2 treatment the slides were washed with miliQ water and dried under nitrogen 
stream [Yang05]. Hydrogen peroxide (30%) and Ammonia (28%) were purchased from VWR (Catalogue 
number: 23615.261, 21190.246 respectively). Slides were stored in 4-well plates in sealed bags until use. 
3-Amino Propyl Triethoxy Silane (APTES) total coating was performed as follows: oxygen plasma treated 
slides were placed in a glass petri dish, immersed in 2.5% APTES solution in toluene and incubated at room 
temperature overnight on an orbital shaker. Subsequently, the slides were washed twice with fresh toluene (5 
minutes each wash), followed by ethanol wash for 5 minutes. Then, the slides were rinsed twice with ethanol 
and dried in nitrogen stream. Anhydrous APTES was purchased from Fisher Scientific (catalogue number 
10668429). Toluene (99.85%, Extra Dry over Molecular Sieve) was purchased from Acros Organics 
(catalogue number 364410025). APTES and toluene solutions were prepared under nitrogen, to ensure they 
remained anhydrous. 
For Poly-L-lysine (PLL) coating, slides were incubated in 5% PLL (0.1%) in water for one hour, followed by 
miliQ water rinsing. PLL was purchased from Sigma Aldrich (P4707). 
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ITO slide spotting
Spotting was performed using a non-contact automatic pipetting system (Nano-Plotter NP 2.1 (GeSim)) 
using a nano litre-dispensing tip  (NanoTip  A-J purchased form Analytik Ltd (A070-503)). The spotting solution 
was prepared in 384-well plates (Hibase polystyrene microplates, Greiner-bio-one) as follows: 6µl siRNA 
(100µM in nuclease free water), 12µl OptiMEM and 2µl APTES (50% in miliQ  water) were incubated for 20 
minutes at room temperature, and then mixed with 8µl fibronectin solution (1µg/µl). During spotting the 
samples were kept on a cooling plate at 12°C to avoid evaporation of the solution. The row and column pitch 
was set to 1.0mm (spot centre to centre distance). For flow experiments the row pitch was increased to 
1.4mm to prevent cross-contamination. Spot size was set to 15 or 20 droplets. Spotted slides were stored in 
a vacuum desiccator (Sigma Aldrich, Z119024-1EA) containing hydrogels and left to dry overnight. 30min 
prior to seeding the desiccator was placed under vacuum conditions. 
For APTES layered spotting, solutions with the required APTES concentration were prepared in toluene or 
ethanol and spotted (50 droplets per spot) on oxygen plasma treated slides. The spots were dried at room 
temperature for at least two hours and siRNA/fibronectin spots were spotted on top  of the APTES spots (15 
droplets per spot). Where possible, the slides were not removed from the Nano-Plotter spotting area 
between the spotting sessions, in order to ensure the overlap  between the two spotting layers. A similar 
approach was used for PLL spotting. 
OptiMEM-I Reduced Serum Medium was purchased from Life technologies (51985026). Fibronectin from 
bovine plasma was purchased from ThermoFisher Scientific (33010-018). Fluorescent labelled scramble 
negative control siRNAs (20 nmol) were purchased from Qiagen: Alexa Fluor 488 conjugate (1027292), 
Alexa Fluor 555 conjugate (1027294), Alexa Fluor 647 conjugate (1027295). AllStars Hs Cell Death Control 
siRNA (20nmol) was purchased from Qiagen (1027299). siRNA against cop-GFP was made to order 
(sequence: CCCAAUGGGAGACAACGUU) from Sigma Aldrich. siRNAs were reconstituted to 100µM in 
nuclease free water and stored as 10µl aliquots at -20°C. esiRNA against human KLF4 (13.8 µM) was 
purchased from Sigma Aldrich (EHU151801) and stored as 10µl aliquots at -20°C.
Immobilisation testing
Fluorescent-labelled siRNAs were used to monitor spot dissolving following the addition of culture medium 
(warmed at room temperature). Spots were imaged prior to the addition of medium and immediately after 
addition. Following successful siRNA immobilisation the fluorescent intensity remained constant after adding 
medium, otherwise the spot dissolves and the fluorescent intensity was reduced. 
Contact angle measurements
The contact angle of the slides was measured using an optical contact angle-measuring device (of the 
DataPhysics OCA Series (DataPhysics Instruments GmbH, Filderstadt)). Contact angle is defined as the 
angle a liquid droplet creates when in contact with a solid surface and is a measure of a surface’s 
hydrophobicity. Measurements were done by Miss Dk Ayesha Pg Hj Mohd Salleh.
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4.2.2 Reverse transfection of human endothelial cells
Electroporation system setup 
Design and manufacturing of the electroporation setup was performed by Dr Leila Towhidi. The design of a 
custom build electroporator requires two electrodes embedded in the cell medium and a pulse generator, 
(figure. 4.2.A). In order to connect the lower electrode (the ITO  slide) to the ground terminal of the pulse 
generator, a gold plated stainless steel electrode was designed and manufactured with the dimensions 
shown in Figure 4.2.B. Similarly, the upper electrode was made of gold plated stainless steel with the 
dimensions as shown in Figure 4.2.C. The electrodes connected to a pulse generator (ECM 830, BMX) 
through wires. The separation between these two electrodes was two layers of adhesive PCR film (Thermo 
scientific, AB-0558), with the thickness of 200 µm each, resulting in a distance of 400 µm between the two 
electrodes. The area inside the PCR film was 1.2 × 5 cm and the PCR well wall thickness was 2 mm.
As the ITO  coated slide is a semi-conductor the distribution of electric field following the application of pulse 
is not as uniform as that of a conductive electrode. Therefore, the optimal lower electrode geometry, in order 
to obtain a uniform electric field over the whole slide area, was determined using simulations. Simulations 
were performed using COMSOL software package with the following parameters: a semi-conductor 
electrode with size of 30mm x 80 mm and resistance 5 Ohm/sq and an upper electrode (conductive copper) 
with the size of 85% of the lower electrode. Different geometries for conductive connectors on the semi-
conductor electrode were simulated. Figure 4.2.B  (top row), shows the simulated distribution of electric field, 
3µm above the slide for four different connections configurations: a single point connection, a four point 
connection, two busbars positioned on either side of the ITO  slide, and a busbar around the perimeter of the 
ITO  slide. The distribution of electric field on a conductive slide is also shown for comparison. Figure 4.2.B 
(lower row), plots the value of electric field along a horizontal line on the slide. The relative variation of 
electric field values is shown below the graphs. A busbar around the perimeter of the ITO slide demonstrated 
the lowest variation and was thus chosen for manufacturing the lower electrode. 
During the optimisation stage a sloped electrode was used which generated a gradient of electric field values 
along the length of the slide. This is achieved by adjusting the distance between the electrodes using varied 
height of PCR film layers, which were attached to the underside of the sloped electrode. The height on one 
side was equal to two PCR layers, 400 µm, and on the other side it was equal to ten PCR layers, 2000 µm. 
The connector to the ITO slide is the same as indicated in Figure 4.2.B. Figure 4.2.E illustrates the 
configuration of the sloped electrode and the distribution of electric field along the ITO slide. The graph on 
the right plots the gradient of electric field achieved along a horizontal line on the ITO  slide for two different 
voltages. A voltage of 15 volts results to an electric field range of 8000V/m to 36000V/m, while a 5 volts pulse 
results to a range of 3000 V/m to 12000V/m.  
Stainless steel sheets (300mm x 300mm x 1mm) were sourced from Smiths Metal Centres Ltd., 
Biggleswade, UK (770-2961). Manufacturing of electrodes was done in the Mechanical workshop at 
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Bioengineering department, Imperial College London. Gold plating was done at the electrical engineering 
workshop, Imperial College London. BTX ECM® 830 pulse generator was purchased from VWR (732-0038). 
Figure 4.2 Electroporation system setup
A) Design of custom build electroporator with two electrodes separated by two layers of PCR adhesive film with a total 
height of 400 µm. The lower electrode (B) connects the ITO slide to the ground terminal of the pulse generator.  Similarly, 
an upper electrode (C) connects to the positive terminal of the pulse generator. D) The optimal geometry for the lower 
electrode was determined using COMSOL simulations. Upper row shows the simulated distribution of electric field, 3µm 
above the slide for each of  the connections configurations considered. The lower row plots  the value of electric field 
along a horizontal line on the slide. The relative variation of electric field values is shown below the graphs. E) Electric 
field simulation along the length of  a sloped electrode,  resulting to a gradient of  electric filed values. The graph on the 
right,  plots  the gradient  of electric field achieved along a horizontal line on the ITO slide for two different pulse 
applications,  15V  (green) and 5V (blue). The red line represents the electric field for optimised electroporation 
parameters for direct electroporation of pig aortic endothelial cells, previously described in our laboratory [Kis14]. Data 
provided by Dr Leila Towidi.  
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Cell culture and transfection protocols
Cell culture
Human umbilical vein endothelial cells (HUVECs) and human umbilical vein endothelial cells expressing 
green fluorescent protein (GFP-HUVECs) were obtained from commercial vendors and cultivated in a 
controlled incubator at 37°C in 5% CO2. Cells were used at less than six passages in order to avoid 
phenotypic changes. Full details for cell culture protocols can be found in Materials and Methods section of 
Chapter 5. Briefly, for seeding purposes cells were harvested, centrifuged at 220g for 5 minutes and the 
resulting cell pellet was re-suspended in 1ml of endothelial cell growth medium (ECGM) per 25 cm2 of cell 
growth area. Cells were counted using a hemocytometer and the desired volume of cell suspension was 
calculated based on the desired seeding density. 
The spotted ITO slides were placed in 4-well plates, and artificial wells were created on the ITO slide by 
using PCR adhesive film ((Thermo scientific, AB-0558). Two PCR films were attached together, and a well 
(with 2mm wall thickness) was created using a medical scalpel. The well area was determined by the follow 
up  experiment to be carried out: for transfection optimisation an area of 1.2 × 5 cm was used, for flow 
experiments, the area was the same dimensions as the flow chamber (1.5 cm × 6.8 cm). The adhesive film 
was sterilised with 254 nm UV light for 2 hours. Working under sterile conditions, the adhesive film was 
attached on the spotted ITO slide. Prior to adding the cell suspension, slides were washed once with cold 
OptiMEM (~ 800µl) to release the surface tension and allow the cell suspension to spread evenly over the 
spots.
Reverse electroporation of human endothelial cells
Cells were harvested as normal with the exception that the final re-suspension step  was done in endothelial 
cell medium kept at room temperature (instead of at 37°C). Cells were seeded at a concentration of 1200 
cells/ µl (i.e 400 000 cells in 400µl) and allowed to adhere on the spots for 10 minutes at room temperature. 
Slides were checked with light microscope to ensure the cells were evenly distributed over the spots. After 
10 minutes, the lower and upper electrodes were attached on the slide, as shown in Figure 4.2.A. In order to 
ensure the lower electrode was in direct contact with the ITO slide, two clamps were used to push it firmly 
onto the slide. The optimised pulse setting for HUVECs was determined to be a double pulse of 15V for 1ms. 
Following pulse application the cells were incubated for 10mins at 37°C and 5% CO2, washed once with PBS 
and fresh antibiotic free ECGM warmed to 37°C was added (400µl per well). Further washing with PBS was 
performed after 30 minutes and after two hours. The washing steps were necessary to generate a cell array, 
and to remove any dissolved APTES, which might be harmful for the cells [Rantala11, Fengler12]. The cell 
array was usually fully formed after 4-5 hours. Cop-GFP cells transfected with siRNA against GFP, were 
imaged 5 days after transfections [Fujimoto08]. HUVECs transfected with death control siRNA were imaged 
2 days after transfection. HUVECs transfected with siKLF4, were imaged 24 hours after transfection. 
Direct electroporation of human endothelial cells
For direct electroporation on a monolayer of cells, ITO slides were coated with fibronectin (1µg/µl), cells were 
harvested as normal, seeded at a seeding density of 16 000 cells/cm2 and allow to grow into a monolayer. 
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After 24 hours the cells were washed with PBS, and ice cold PBS containing 40µg/ml  propidium iodide (PI) 
was applied over the cells. The electrodes were assembled as discussed above and a pulse of 15V for 5ms 
was applied. Cells were allowed to incubate at 37°C and 5% CO2 for 10 minutes, followed by PBS wash and 
addition of fresh antibiotic free ECGM without PI. The cells were kept at 37°C and 5% CO2  and imaged after 
2 hours. 30 minutes prior to imaging, cells were stained with calcein to detect live cells. 
For direct electroporation on spotted slides, fibronectin spots were dispensed on the ITO  slides, cells were 
harvested as normal, seeded at a seeding density of 12 000 cells/ cm2 and incubated overnight. In these 
experiments only fibronectin was used in the spotting solution, since in direct electroporation siRNA 
molecules are applied on top  of the seeded cells. After 24 hours ice cold PBS containing 5µM cell death 
control siRNA was added to the cells and pulse was applied (15V, 5ms). The cells were allowed to incubate 
at 37°C and 5% CO2 for 10 minutes followed by a PBS wash and addition of fresh antibiotic free ECGM. The 
cells were kept at 37°C and 5% CO2 until imaging. Cells transfected with cell death siRNA were imaged 48 
hours after pulse application. Dead cells were detected using PI staining applied half an hour before imaging. 
Cell staining
Cell viability was determined using propidium iodide (PI) or Calcein AM staining. PI is a red-fluorescent 
nuclear and chromosome stain, not permeant to live cells and therefore only dead cells are stained. Calcein 
is a green fluorescent cell marker for detecting live cells. The non-fluorescent derivative of calcein (calcein 
AM), is transported inside cells and gets hydrolised by intracellular esterases into a highly negatively 
charged green fluorescent protein (calcein). As dead cells lack active esterases, only live cells are labelled. 
For PI staining, half an hour before imaging, cells were incubated with ECGM containing 0.5 µg/ml of PI for 
30 minutes, followed by PBS wash and addition of fresh ECGM. For calcein staining, 20 minutes prior to 
imaging, cells were washed once with PBS and incubated for 10 minutes with ECGM containing Calcein AM 
at a final concentration of 1µg/mL (1:1000 dilution). The ECGM was then aspirated, the cells were washed 
once with PBS and fresh ECGM was added without any calcein. Propidium Iodide (1.0 mg/mL) was 
purchased from Life technologies (P3566). Calcein AM (1.0 mg/mL) was purchased from Invitrogen (C3099). 
KLF4 mRNA was detected in live cells using Smartflare RNA detection probes. Full details of this method 
can be found in Chapter 5. Briefly, fresh media containing 200pM of KLF4 Smartflare was prepared in ECGM 
and added to the cells sixteen hours before imaging. Smartflare probes consist of gold nanoparticles, which 
can enter the cells via endocytosis. The nanoparticles are conjugated with a specific target sequence against 
KLF4 and a complementary reporter sequence, which contains a fluorophore that is quenched by its 
proximity to the gold nanoparticle. Upon target binding, the fluorophore is released in the cytoplasm and 
emits a fluorescent signal.  
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4.2.3 Design and operation of microfluidics device
Microfluidics device design and fabrication
Design and fabrication of the microfluidics device was performed by Dr Leila Towhidi. The modular parallel 
plate flow device comprises of a polycarbonate flow chamber, a glass spotted ITO  slide with a 400µm height 
seeding well, and a complementary clamping–holding equipment with six screws which hold the glass slide 
together with the flow chamber (figure 4.3). 
Figure 4.3 Design and fabrication of modular parallel plate flow device
The modular parallel-plate flow device comprises of a polycarbonate flow chamber,  a glass spotted ITO slide with a 
400µm height seeding well, and a complementary clamping–holding equipment which holds the glass slide together with 
flow chamber. The dimensions of the flow chamber (top) and clamping device (bottom) are also shown.
The centre of the bottom metal plate contains an 80 mm × 30 mm slot where the ITO slides are placed. In 
order to enable live cell imaging, the bottom metal plate has been designed to fit into a standard microscope 
stage holder, and a 70x15 mm hole has been cut into the centre of slide fitting slot. This is the same size as 
the channel of the flow chamber. The flow chamber design has been chosen to generate a uniform 
distribution of shear stress along the length of the chamber (figure 4.4). Three different geometries were 
designed to determine which one results in the most uniform shear stress profile, while providing a larger 
surface area for the spotted array. The shear stress at the bottom of each chamber was simulated using 
COMSOL Multiplysics (performed by Dr Leila Towhidi). Figure 4.4.A shows the simulated shear stress map 
for four different geometries: a 5mm narrow commercial chamber, a wider rectangular 15mm chamber, a 
modified 15mm width chamber with round edges and finally, a 15mm width chamber with blocks. Figure 
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4.4.B  compares the shear stress along the length and across the width of the flow chambers geometries. 
The 15mm chamber with the blocks demonstrated the most uniform shear stress and thus was chosen for 
manufacturing. The chamber was manufactured from polycarbonate with the dimensions shown in Figure 
4.3. Lexan Polycarb  Sheet (polycarbonate) was purchased from Direct plastics (PCCLS10001). The 
clamping–holding equipment was manufactured by cutting from aluminium alloy purchased by Smiths Metal 
Centres (H30 6082T651).
Figure 4.4 Design of a wider flow chamber for flow studies. 
The optimal geometry for the flow chamber was determined using COMSOL Multiplysics simulations. A) Upper row 
shows the flow chamber geometries considered. The lower row shows the shear stress map  at the bottom of the flow 
chambers.  B) Shear stress plotted along the length and across the width of the floor of the chambers. Data provided by 
Dr. Leila Towhidi.
Microfluidics device operation
The normal procedure was followed for seeding the chamber. First, the PCR well (1.5 cm × 6.8 cm), 
consisting of two PCR layers, was attached to the spotted slide. In order to ensure that the PCR well 
perfectly aligned to the flow chamber, the position of the chamber was demarcated on the slides before 
spotting and the PCR well was perfectly aligned to this. Then, the cells were harvested as normal and 
seeded at a concentration of 1200 cells/µl (if performing reverse transfection) or 12 000 cells/cm2 for flow 
experiments without reverse transfection. Seeded slides were incubated at 37°C in 5% CO2 with regular 
washing after 30 minutes and after 2 hours. 
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Prior to setting up  the flow device all equipment (polycarbonate flow chamber, metal holder with screws, 
media reservoir and platinum-cured silicone tubing) was sterilised by autoclaving at 135 °C for 5 minutes in a 
MLS-3751L Sanyo autoclave. The culture medium for flow experiments was pre-equilibrated at 37°C in 5% 
CO2 for two hours. Once the cell array was formed and the cells firmly adhered on the spots, the ECGM was 
aspirated, leaving behind a small amount of liquid to prevent cell drying. The slides were removed from the 
4-well plates using tweezers and placed in the base of the metallic holder. Next, the flow chamber was 
mounted on top  of the glass slide, the top  clamp  plate was positioned above the flow chamber and 6 steel 
screws went through the top aluminium plate and screwed into the bottom plate to seal the channel, taking 
care to apply even torque to avoid differences in the height of the chamber. The flow chamber was filled up 
with fresh media and the tubing of the media reservoir, containing the pre-equilibrated media, was connected 
to the flow chamber avoiding air bubbles. The pump head tubing was connected to a peristaltic pump  and 
the flow setup  was placed in the cell culture incubator. The pump  remained outside the incubator. Cells were 
primed for 2 hours at 5 dyne/cm2 with gradual increase in the flow rate over the next two hours to yield a final 
shear stress level of 15 dyne/cm2. The cell array was subjected to 15 dyne/cm2 for 24 hours. Full details of 
the materials used for flow experiments can be found in the Material and Methods section of Chapter 5. 
4.2.4. Microscopy imaging and analysis
Imaging acquisition
Microscopy imaging was performed in the Facility for Imaging by Light Microscopy (FILM) at Imperial College 
London using a Zeiss Axiovert 200 inverted fluorescent microscope with a fully motorised stage, controlled 
by Improvision Volocity software (Perkin Elmer). Spots were imaged using Zeiss EC Plan-Neofluar 10x 0.30 
Ph1 objective in combination with the appropriate filters. Alexa Fluor 488 conjugated siRNA, calcein-AM 
staining and GFP-HUVECs were imaged with Zeiss Filter Set 10 (FITC, green channel). Alexa Fluor 555 
conjugated siRNA, propidium iodide staining and Cy-3 tagged Smartflare nanoparticles were imaged with 
Zeiss Filter Set 15 (TRITC, orange channel). Finally, Alexa Fluor 647 conjugated siRNA (red channel) was 
imaged using CY5 (Chroma Filter Set 31023). If necessary, tile acquisition was used for imaging the entire 
ITO  glass slide, using 10-20% overlap  between tiles. The microscope stage was calibrated and the region of 
interest was defined using a rectangular selection area equal to the size of the spotted slide. In order to keep 
the spots/cells in focus, a focus map was created using 20-30 randomly selected spots scattered across the 
selected area. Following acquisition the raw tiles were stitched using default settings provided by Improvision 
Volocity software.  
Time-lapsed acquisition was used for spot immobilisation testing. The stage was first calibrated and the 
desired xy coordinates, each corresponding to a single spot, were added in the acquisition points list. Points 
were imaged once prior to adding culture media, and then media was added over the spots without removing 
the 4-well plate from the microscope stage to ensure that the positions remained the same. The points were 
refocused and time-lapse imaging was started at 5-minute intervals. 
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Imaging analysis to determine array printing quality
The acquired images were processed in ImageJ v.2.0 software environment using customised macros 
[Schindelin12, Abramoff04]. Fluorescent images of spots were thresholded to generate a binary mask and 
individual spots were segmented using ‘analyse particle’ function in ImageJ. 
Inter-spot variability was determined by calculating the coefficient of variation of four parameters: spot width, 
spot height, spot circularity and spot intensity value. For each parameter, the standard deviation over all 
spots (n= 616) was calculated and divided by the average over all spots. Spot circularity, width and height 
were calculated using shape descriptors available in ImageJ. Width and height correspond to the dimensions 
of the smallest rectangle that can bind the circular spot region of interest (ROI). Circularity is defined as 
4pi(area/perimeter^2). A circularity value of 1.0 indicates a perfect circle. For each spot’s ROI, the fluorescent 
intensity was measured by averaging over all pixels in the ROI. Background correction was based on 
calculating a local background signal around the spot ROI and subtracting this from the average pixel 
intensity. Local background was calculated by averaging the intensity over four rectangular areas (150 µm x 
100 µm each), positioned just outside each of the four quarters of the circular spot ROI. 
In order to calculate the siRNA concentration intra-spot variability in siRNA distribution, the area containing a 
given spot was duplicated into a new image and binned to produce an image with pixel width equal to 75 µm 
(pixel width in the original image was 2.5 µm). Hence, following binning the spot was segmented into a 7x7 
matrix of individual pixels. Each pixel roughly corresponds to the area occupied by 2-3 cells. The intra-spot 
variability was calculated by taking the coefficient of variation of the fluorescent signal across the 49 
individual pixels. 
Spot intensity profiles were plotted using ImageJ’s plot profile function. These plots, display the intensities of 
pixels along the horizontal distance of a selection area. A rectangular selection area through the centre of the 
spot was used. The x-axis represents the distance (in macrons) through the selection and the y-axis the 
averaged pixel intensity (of a vertical line with 100 µm length) at each location. 
In immobilisation tests, a mask was created for a given spot prior to adding culture media, and the same 
mask was used for all subsequent time frames. The relative signal of a spot was calculated by normalising 
the background corrected signal at a given time-point, to the background corrected spot intensity prior to 
adding culture media.  
Quantification of transfection efficiency
Percentage of GFP positive cells: Fluorescent images of GFP-HUVECs were set at the same fluorescent 
intensity range (minimum= 5450 units, maximum = 12890 units). The thresholds were determined based on 
the control condition, to retain the strong nuclear signal. Total number of cells (based on the phase contrast 
image) and GFP positive cells (based on the green channel image) were counted manually using Cell 
Counter plugin in Fiji (http://rsbweb.nih.gov/ij/plugins/cell-counter.html). Representative images of cell 
counting can be found in Appendix 3. The analysis was based on seven individual spots from each 
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experimental condition. Statistical significance for differences in percentage of GFP positive cells between 
conditions was determined using the student t-test and p-value < 0.05. 
Number of cells on spots transfected with cell death siRNA: Total number of cells was counted manually 
using Cell Counter plugin in Fiji. The areas corresponding to spots were determined based on the 
fluorescent signal of Alexa Fluor conjugated siRNA, which was included in the spotting mixture. The area 
counted for each spot was kept constant using a circular ROI with 650µm diameter. Statistical significance 
was determined using the student t-test and p-value < 0.05. Three spots were analysed for each 
experimental condition.
Single cell analysis of KLF4 mRNA signal: Cells were segmented based on thresholding of the phase 
contrast images (ref: Chapter 5 for more details) and the average fluorescence signal for each cell was 
measured by taking the average over all pixels that make up the cell. Fluorescence images were background 
corrected by manually selecting six regions in the phase contrast image with no cells present, and 
calculating the average fluorescent signal for these regions. The averaged background signal was then 
subtracted from the fluorescence image. For each experimental condition, the single-cell measurements for 
three spots, were pooled and represented as density distribution plots that display the fluorescent signal 
across the whole population of cells considered in the analysis. 
Transfection efficiency and cell viability based on PI and calcein staining: Fluorescent images for PI 
(transfected) and calcein (live) stained cells were set at the same fluorescent intensity range and thresholded 
to generate a binary mask. Transfected live cells were obtained by combining the individual PI and calcein 
mask (using AND operation). The resulting mask only contains pixels that occur in both masks and thus 
represent double-stained cells. Total number of cells was obtained by combining the individual PI and calcein 
masks (using OR operation). The masks were then segmented using the ‘analyse particle’ function available 
in ImageJ (size= 50µm-infinity, circularity= 0.01 - 1), to obtain the number of cells in each group. Transfection 
efficiency was calculated as the percentage of transfected live cells over the total number of live cells. Cell 
viability was calculated as the percentage of live cells over the total number of cells.
Quantification of cell alignment to flow
In order to determine whether the application of shear stress had an impact on cell alignment, cells were 
segmented based on thresholding of the phase contrast images. The segmentation was done using a series 
of filtering steps available in ImageJ (ref: Chapter 5 for more details). Once segmented the individual ROIs 
were saved, imported in MathWorks Matlab  and converted to binary mask. The binary mask was used to 
extract the ‘orientation’ measurement (using Matlab built-in ‘regionprops’ function) that specifies the angle 
between the x-axis (i.e direction of flow) and the major axis of region of interest (i.e individual cell). For each 
experimental condition the single-cell angle measurements for four spots were pooled and represented as 
density distribution plots. A uniform distribution of cell orientation angle demonstrates that the cells have no 
predominant directionally and the cell orientation is random. A distribution centered on zero degrees, 
demonstrates that the majority of cells are aligned to the x-axis and thus to the direction of flow.
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4.3 Results and Discussion
The RNAi platform consists of a number of components (highly efficient electroporator for mammalian cells, 
ultra-high precision robot dispenser, and a modular parallel plate chamber for experimental interventions), 
which are functionalised involving a series of procedures (surface treatment and spot-printing, cell seeding 
and transfection and flow studies). Setting up  the RNAi platform was an iterative process. The optimised 
protocol for establishing a high-throughput RNAi cell array for mechanotransduction studies is given in 
Figure 4.5. The rest of the chapter describes the optimisation process, presents an evaluation of each step 
of the assemblage and provides a rationale for selection of the final protocol. 
4.3.1 Fabrication of biocompatible, electroporation-ready siRNA arrays
The first step  in the assembly of the RNAi array is the spotting of desired siRNA samples on ITO  coated 
glass slides. In order to establish siRNA reverse transfection, we aimed for the optimal spotting solution and 
surface treatment protocol, in order to achieve: i) uniform intra-spot siRNA distribution, ii) uniform inter-spot 
siRNA concentration, iii) regular spot shape, iv) preferential cell attachment on spots and v) immobilisation of 
siRNA on slides following the addition of cell suspension. There are five procedures involved in slide 
preparation and printing, which all affect each other. During the optimisation stage different parameters were 
tested, listed in Figure.4.6. Evaluation of the spotting was based on fluorescent siRNAs mixed in the spotting 
solution. Fluorescent microscopy was then used to monitor the spatial distribution of siRNA on spots and 
siRNA immobilisation on the surface following the addition of cell culture medium.
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Figure 4.6. Parameters tested during optimisation stage
There are five procedures involved in array printing. Washing removes impurities from the surface, improving the quality 
of spots. The combination of surface treatment, ageing and coating with polymers (PLL or APTES) modifies slide 
characteristics and improves siRNA retention. Spotting solution is important for cell viability and attachment and the 
uniformity  of  spot siRNA  distribution. Robot dispenser parameters were also optimised for droplet size,  speed and 
distance between spots. 
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! !
Mix 12µl OptiMEM, 6µl siRNA (100µM in nuclease free water) and 
2µl APTES (50% in miliQ water) in a 384-well plate!
Cool plate to 12°C during spotting!
Cut PCR well (two layers of PCR film, wall thickness of 2mm, internal 
area 1.5 × 6.8 cm) and sterilised with 254 nm UV light for 2 hours!
Slide aging for 4-5 days (store in sealed bag)!
5 min acetone wash in ultrasonic water bath!
5 min ethanol wash in ultrasonic water bath!
5 min milliQ wash in ultrasonic water bath!
Rinse 3 times with miliQ water!
Dry under nitrogen stream!
Oxygen plasma treatment for 5min at 0.2 mbar, 300 W!
Incubated 20 min (RT)!
Add 8µl fibronectin (1µg/µl) and mix well!
Print onto ITO slide with NanoPlotter (use nanolitre dispensing tip, !
20 droplets per spot, spot pitch of 1.0mm)!
Dry slides at RT in a desiccator with hydrogels, for at least 12hr !
Desiccate slide for 30min and attach PCR well under sterile conditions!
Seed 1200 cells/ µl (400 000 cells in 400µl)!
Wash slides with 800µl of cold OptiMEM!
Incubate for 10 min (RT)!
Connect electrodes and apply pulse: 15V, 1ms, 2 pulses!
Incubated for 10mins at 37°C and 5% CO2!
PBS wash, followed by addition of 400µL antibiotic free media!
PBS wash after 30 min followed by addition of 400µL media!
PBS wash after 2 hr, followed by addition of 400µL media!
After 24 hours assemble flow chamber and apply 15 dyne/cm2 !
Live cell imaging and quantification!
Slide Preparation!
Array Printing!
A
B
Cell seeding and transfection!C
Flow studies and Live cell imaging!D
! ! ! Figure 4.5 Protocol for RNAi cell array for mechanotransduction studies
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Washing procedure optimisation
The washing step  removes dust particle and impurities (introduced during slide manufacturing) that can 
affect the spotting quality. Inadequate washing of the slides, resulted to poor attachment of spots on the slide 
and peeling off following the addition of cell suspension (Figure 4.7.B). Hence, ITO  slides were thoroughly 
washed with acetone, ethanol and water prior to spotting.  
Figure 4.7. Optimisation of spotting solution for uniform distribution of siRNA
Images represent the signal of fluorescent siRNAs mixed in the spotting solution. A) Spot  intensity profiles for gelatin 
(top) and fibronectin (bottom) spots. The x-axis represents the distance (in pixels) through the selection and the y-axis 
represents the average pixel intensity at each location. B) Spotting on non-washed ITO slides, results to spot peeling off 
after the addition of cell culture medium. C) and D) Fibronectin spots on washed untreated ITO slides (C) and washed 
PLL treated slides (D),  dissolve following the addition of cell culture medium. Images show the fluorescent intensity 
before and immediately after addition of  medium. Relative signal quantifies the siRNA signal retained within the same 
spot  area following addition of medium. E) siRNA immobilisation on ITO slides, coated with APTES. Enlarge image 
shows a spot immediately after addition of medium. (F) ITO slides were first spotted with APTES, followed by fibronectin/
siRNA spotting on top of the APTES spots. Images show the fluorescent intensity before and immediately  after addition 
of medium.  Enlarge image shows spot morphology after spotting. 
Spotting solution optimisation
Spotting solution is important for cell viability and attachment and the uniformity of spot siRNA distribution. 
Cell attachment on bare ITO  slides was very poor and therefore it was necessary to include an adhesion 
matrix in the spotting solution. We have investigated the use of gelatin and fibronectin, which have previously 
been used for manufacturing reverse transfection arrays [Erfle07, Onuki-Nagasak08, Silva04]. Spotting 
solutions containing fluorescent siRNA and either gelatin or fibronectin were spotted onto washed ITO slides 
and intra-spot variability was evaluated by plotting the intensity profiles along the horizontal distance of a 
rectangular selection area through the centre of the spots, Figure 4.7A. In order to ensure that all the cells on 
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a spot are exposed to similar concentrations of siRNA molecules, it is essential that siRNA distribution on 
each spot is uniform. Using gelatin in the spots, results to donut shape spots with no siRNA in the centre of 
the spot, whereas fibronectin results in uniform intra-spot intensities. Hence, fibronectin was chosen based 
on intra-spot uniformity and the fact that it has been shown to improve transfection efficiency [Yoshikawa04].
Slide coating optimisation
In order for reverse transfection to be effective, siRNA needs to remain attached to the slide for a long 
enough period so that cell attachment can occur prior to pulse application. Therefore, we next tested siRNA 
immobilisation following the addition of culture medium. siRNA immobilisation was evaluated by measuring 
the siRNA signal retained within the same spot area following addition of medium. Fibronectin spots on bare 
ITO  slides completely dissolved following the addition of medium, Figure 4.7.C. Therefore it was necessary 
to introduce positively charged molecules that can interact with negatively charge siRNA molecules and 
increase siRNA retention. We have investigated Poly l lysine (PLL) and 3-Aminopropyltriethoxysilane 
(APTES), which have previously been used in this context [Baghdoyan04, Mannherz05, Yoshikawa04, 
Jain09, Jain12]. PLL coating did not improve siRNA immobilisation, resulting to 84% of the siRNA signal 
being lost immediately after adding media (Figure 4.7.D). 
Three different APTES coating approaches were tested: total coating of slides with 2.5% APTES (Figure 
4.7.E), sequential spotting of APTES followed by fibronectin/siRNA spots (Figure 4.7.F) and finally spotting a 
mixture consisting of APTES, fibronectin and siRNA (Figure 4.8). All three methods significantly increased 
the siRNA retention on the surface (relative to the signal before adding medium) to 66%, 58% and 78%, 
respectively. APTES total coating, resulted in siRNA binding on the surface outside the spot area, thus 
increasing the chance of cross-contamination between different siRNA spots (Figure 4.7.E). In the absence 
of APTES total coating, no significant siRNA attachment on the slide was observed (Figure 4.7.E, Figure 
4.8.A). Layered APTES resulted in non-uniform spots and non-overlapping APTES and siRNA spots (Figure 
4.7.F). Hence, spotting with a mixture of APTES, fibronectin and siRNA was carried forward in the analysis. 
Surface treatment optimisation
Further surface treatment was necessary in order to strengthen APTES attachment on the surface and 
prevent spot peeling off, which was sometimes observed following the addition of medium (Figure 4.8 (lower 
panel)). For this purpose, we functionalised the surface by introducing hydroxyl groups [Bermudez06]. 
APTES reacts with the hydroxyls groups, through a salinisation reaction, resulting in a positively charged 
amine-terminated surface. This positively charged surface, then electrostatically binds negatively charged 
siRNA. While the binding of APTES on the surface is a covalent stronger bond, the siRNA binding is 
electrostatic and thus siRNA can still be released from the surface for transfection purposes. Hydroxyl 
groups were introduced on the surface either through chemical treatment with hydrogen peroxide (H2O2) or 
through oxygen plasma treatment. Both H2O2 and oxygen plasma treatment, significantly improved siRNA 
immobilisation with respectively 88% and 78% of the siRNA signal still retained after 20 mins, (figure 4.8). 
Neither method resulted to long-term immobilisation, beyond 2 hours, possibly due to the hydrolysis of 
APTES [Zhu11a].
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Figure 4.8. Optimisation of ITO slide surface treatment for effective siRNA immobilisation
Immobilisation of siRNA on oxygen plasma treated slides (top panel), oxygen plasma treated slides (middle panel) and 
untreated slides (lower panel) was monitored with time lapse microscopy, following the addition of culture media. The 
percentage of siRNA fluorescence intensity retained at each time point has been quantified relative to the 0 minute (top 
row) signal. Scale bar equal to 100µm.
Cell attachment optimisation
We further explored the two treatment options by comparing their surface characteristics, (figure 4.9). Cell 
attachment of untreated, H2O2 and oxygen-plasma treated slides was determined, twenty-fours hours after 
seeding. Cells were seeded at a density that results in the formation of a monolayer of cells on gelatin-
coated slides. There was no cell attachment on oxygen plasma treated slides, while cells were able to grow 
on H2O2 treated slides. Seeding on oxygen plasma treated ITO slides, spotted with APTES-fibronectin-
siRNA spots results to a cell array of spots, fulfilling the requirement for preferential cell attachment on 
siRNA spots, (figure 4.10). Each spot diameter is approximately 560µm, accommodating around 100 HUVEC 
cells.
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Figure 4.9. Surface characteristics of hydrogen peroxide and oxygen plasma treated ITO slides
A) Cell attachment on untreated, hydrogen peroxide treated and oxygen plasma treated slides twenty-four hours after 
seeding.  HUVECs were seeded at a concentration that normally results in the formation of a monolayer of cells on 
gelatin coated plates. B) Effect of ageing on spot morphology. Ageing refers to the time between oxygen plasma 
treatment  and spotting. At each day, the contact angle of the surface was also measured. Contact angle is defined as the 
angle a liquid droplet creates when in contact with a solid surface and is a measure of a surface’s hydrophobicity.
Ageing optimisation
The final parameter that was optimised was the effect of ageing on spot morphology. Ageing refers to the 
time between oxygen plasma treatment and spotting. It was observed that the shape of the spots depended 
on ageing; in early days, spots were large and irregular, while uniform spots were obtained when spotting 4 
days after oxygen plasma treatment, (figure 4.9.B). This can be explained in terms of the effect of oxygen 
plasma treatment on the measured contact angle of treated slides. Contact angle is defined as the angle a 
liquid droplet creates when in contact with a solid surface and is a measure of a surface’s hydrophobicity. 
Following treatment the contact angle decreases from 113° of untreated slides to 6.1° for Day 1 treated 
slides. This is due to the formation of hydroxyl groups and the removal of carbon contamination from the 
surface. As a result the surface becomes more hydrophilic, resulting in irregular spots. The contact angle 
gradually increased over a period of 4 days from 6.1° to 19.5°. This is either due to a decrease of oxygen 
atomic concentration during ageing as previously described [Yun04], or due to contamination by dust in the 
environment. In fact, the contact angle keeps increasing over a period of 17 days to reach 69.4° degrees. 
Four days following treatment, the contact angle is at an optimal value for the generation of uniform spot 
shapes. It should be noted that the immobilisation time-lapse results, shown in Figure 4.8, were performed 
on Day 4 spotted slides and therefore represent the siRNA immobilisation profile of our final optimised 
protocol. 
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Figure 4.10. Cell array of APTES-fibronectin spots on oxygen treated ITO coated glass slides.
Evaluation of the final optimised protocol
Following the optimisation of slide washing, surface treatment, ageing, slide coating and spotting solution, 
best results were obtained by oxygen plasma treatment, followed by four days of ageing and spotting with an 
APTES, fibronectin, siRNA solution. An array of 616 spots was spotted for assessing the quality of the final 
optimised method (figure 4.11.A). Inter-spot variability was determined by calculating the coefficient of 
variation (CV) for four parameters: spot intensity value (CV 7%), spot width (3.5%), spot height (4.3%), and 
spot circularity (2.0%), (figure 4.11.B). Coefficient of variation below 5% is considered to be within the error 
margin of the spotting machine. Further, intra-spot variability of siRNA intensity was evaluated to determine 
the uniformity of siRNA concentration on each spot. Each spot was binned into a 7x7 matrix of individual 
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pixels and the coefficient of variation of the fluorescent signal in all the individual pixels was calculated. The 
median intra-spot coefficient of variation was 8.3% with range of 1.8% to 18.8%. Representative images and 
intensity profiles across the length of the spot are shown in Figure 4.11.C. Intra-spot variability in siRNA 
concentration can mainly be attributed to different fibronectin patterns that are spontaneously formed when 
the spots are drying.
In summary, the combination of oxygen plasma surface treatment, four days ageing and spotting with a 
solution consisting of APTES, fibronectin and siRNA results to a cell array of uniform circular siRNA spots 
with sufficient siRNA retention to enable reverse transfection. 
Figure 4.11. Intra-spot and inter-spot variability of APTES-fibronectin/siRNA spots on oxygen treated ITO glass 
slides.
A) Tile scan of spotted array with 616 spots used for assessing the quality of the final optimised method. B) Inter-spot 
variability was determined by calculating the coefficient of variation (CV) for four parameters: spot intensity value, spot 
width, spot height,  and spot circularity. For each parameter, the standard deviation over all spots was divided by the 
average over all spots. Width and height correspond to the dimensions of the smallest rectangle that can bound the 
circular spot. A  circularity value of 1.0 indicates a perfect circle. C) Intra-spot variability was evaluated by binning each 
spot  into a 7x7 matrix of individual pixels  and calculating the coefficient of variation of  the fluorescent signal in all the 
individual pixels.  Representative spot images with different intra-spot variability values are displayed, together with their 
intensity profile along the horizontal axis of the spot’s width. 
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4.3.2 Reverse transfection of primary endothelial cells
Having established the spotting procedure that results in uniform and immobilised spots we next optimised 
the reverse transfection of primary endothelial cells. For this purpose, we used human umbilical endothelial 
cells (HUVECs) at less than six passages, to avoid phenotypic changes. Electroporation experiments were 
carried out in a custom setup  using a square wave electroporator. Given the limited conductivity of ITO, we 
have designed electrodes for uniform application of electric field across the length of the slides (Figure 4.2 in 
Material and Methods section). 
We first tested the experimental setup  using direct electroporation of propidium iodide (PI) on a monolayer of 
cells (figure 4.12). PI is normally used for dead cell detection. At lower incubation times, it can also be used 
for transfection efficiency optimisation [Jai09]. Since PI stained cells included both, live cell that had been 
transfected, as well as dead cells, calcein staining was used to determine cell viability. ITO slides were 
coated with fibronectin, seeded with cells and after twenty-four hours PBS containing 40µg/ml propidium 
iodide was added over the cells. A pulse of 15V for 5ms was applied using a specially designed sloped 
electrode to apply a range of 8mV/m to 36mV/m electric field values across its length. Cells were allowed to 
incubate at 37°C and 5% CO2 for 10 minutes, before washing away the PI and adding fresh media. 
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Figure 4.12. Direct electroporation of primary endothelial cells using propidium iodide
Direct electroporation of propidium iodide (PI) (40µg/m) on a monolayer of cells using a pulse of 15V for 5ms. A  specially 
designed sloped electrode was used to apply a range of electric field values from 8000V/m (low filed) to 36000V/m (high 
field).  Cell viability was determined using Calcein staining. Transfection efficiency and viability was quantified, defined 
respectively as, the percentage of transfected cells over live cells and percentage of live cells over total number of cells.
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Transfection efficiency and viability was quantified, defined respectively as, the percentage of transfected 
cells over live cells and percentage of live cells over total number of cells. As expected, at higher electric field 
values the cells were killed by the pulse (11% cell viability), however at lower electric field values 99% cell 
viability was observed with 93% transfection efficiency. Cell death occurred at the expected electric field 
values, additionally indicating that our electroporation device delivers the computed electric field values.
In order to validate that the transfected siRNA is functional inside the cells, we used phenotypic death control 
siRNA which includes a blend of siRNAs targeting ubiquitous cell survival genes. Direct electroporation of a 
cell array of primary HUVECs with 5µM of cell death siRNA resulted to 118 dead cells, compared to only 11 
cells on spots transfected with mock siRNA (figure 4.13). 
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Figure 4.13. Direct electroporation of a cell array of primary human umbilical endothelial cells
Direct electroporation of a cell array of primary human umbilical endothelial cells  with 5µM of cell death siRNA (5µM). 
Forty-eight  hours after transfection, cell death was observed by microscopy. Dead cells were detected using PI staining 
(0.5 µg/ml of PI for 30 minutes) applied half an hour before imaging.
We next proceeded, with reverse transfection of primary endothelial cells on siRNA spotted arrays using the 
spotting method optimised in Section 4.3.1. Validation of target silencing and quantification of transfection 
efficiency was based on phenotypic death siRNA, and the use of HUVECs stably expressing green 
fluorescent protein (GFP) together with complementary siRNA targeted against GFP. ITO slides were 
washed, oxygen plasma treated and after four days of ageing, they were spotted with fibronectin/APTES 
spots containing siRNA targeted against GFP or death siRNA. Cells were seeded on the spotted arrays, and 
reverse transfected with a double pulse of 5V for 1ms. The effect of transfection was quantified by manually 
counting the number of GFP transfected cells per spot or, in the case of death siRNA the total number of 
cells per spot. Reverse transfection achieved 64% of transfection efficiency, with a significant reduction of 
GFP positive cells (p-value < 0.0001), from 77% to 28%, (figure 4.14.A). Similar results were obtained for 
reverse transfection of death siRNA, with a significant reduction (p-values = 0.0034) in the total number of 
cells on death siRNA spots compared with mock siRNA transfected spots, (figure 4.14.B). 
The final test for reverse transfection on cell arrays, was performed using a novel live cell RNA quantification 
method, which is discussed in full in Chapter 5. siRNA targeted against KLF4 mRNA was reverse transfected  
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Figure 4.14. Reverse transfection of primary endothelial cells on cell array
A) Primary human endothelial cells stably transfected with green fluorescence protein (GFP) were seeded on spotted 
arrays consisting of APTES, fibronectin and siGFP. A  double pulse of  15V  for 1ms resulted to successful transfection and 
knockdown of GFP, p-value < 0.001. Quantification was based on manually counting the percentage of transfected cells 
for seven control and seven siGFP spots. B) HUVECs were seeded on spotted arrays consisting of mock siRNA or death 
siRNA, on alternate columns. A  double pulse of 15V for 1ms was applied, and cell death was observed by light 
microscopy 48 hours after transfection. Quantification was based on manually counting the percentage of transfected 
cells  for three control and three death siRNA spots. C) HUVECs were seeded on spotted arrays consisting of KLF4 
siRNA and a double pulse of 15V  for 1ms was applied. Intracellular KLF4 mRNA concentration was measured using 
Smartflare nanoparticle probes with a specific target sequence against  KLF4. Quantification was based on segmenting 
individual cells and measuring the average fluorescence signal associated with each cell. For each experimental 
condition the single-cell measurements for three spots were pooled and represented as density distribution plots that 
display the fluorescent signal across the whole population of cells. 
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in cells, and the KLF4 mRNA concentration was measured after twenty-four hours using KLF4 Smartflare 
nanoparticle probes. The nanoparticles are conjugated with a specific target sequence against KLF4 and a 
complementary reporter sequence, which contains a fluorophore that is quenched by its proximity to the gold 
nanoparticle. The probes can enter the cells via endocytosis and upon target binding, the fluorophore is 
released in the cytoplasm and emits a fluorescent signal. The fluorescence signal is proportional to the 
concentration of KLF4 mRNA molecules in the cell. Effective KLF4 knockdown can be seen qualitatively in 
Figure 4.14.C (top  panel), with transfected spots having a much lower fluorescence signal compared to non-
transfected controls. Knockdown effect has been quantified by segmenting individual cells and measuring 
the average fluorescence signal associated with each cell. For each experimental condition the single-cell 
measurements for three spots, were pooled and represented as density distribution plots that display the 
fluorescent signal across the whole population of cells, (figure 4.14.C (lower panel)). The cell associated 
fluorescence distribution of siKLF4 transfected cells was shifted to the left, with a significant reduction of 
KLF4 positive cells;  60% of the non-transfected control population has a cell-associated fluorescence higher 
than the highest expressing (95 percentile) siKLF4 transfected cells.
In summary, we have demonstrated that the spotted cell array can be used for effective reverse transfection 
of ‘hard-to-transfect’ primary endothelial cells, with successful gene knockdown for multiple gene targets at 
the mRNA (KLF4), protein (GFP) and phenotypic (death) level.
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4.3.3 Development of a flow system for the RNAi cell array
The final step  in the assembly of the RNAi cell array was to couple the spotted slides with a system that is 
suitable for the application of flow. A modular parallel plate flow system was setup  consisting of the ITO 
spotted slide, a 15mm wide flow channel and complementary clamping–holding equipment, which holds the 
glass slide together with the flow channel, (figure 4.15). The flow channel has been designed to maximise 
the area available for spotting, while maintaining the uniformity in the shear stress applied along its length 
and across its width. Section 4.2.3. in the Material and Methods includes more information on the simulation 
studies for designing the flow channel. All components are compatible with standard microscopes enabling to 
perform automatic screening and high resolution imaging at a single cell level.
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seeding densities along the surface of the cell seeding area. Cell seeding in the bottomless 
channel, would have had yielded high cell densities in the high channel height region, where 
the height of the cell suspension volume is high, and low cell densities in the low channel 
region, where a lower cell suspension volume and cell amount would be present per unit area. 
Twenty-four hours after cell seeding, this cell seeding well was replaced with the bottomless 
flow channel. Cell seeding was not possible directly in the channel since the varying height 
would have yielded non-uniform cell seeding densities along the length of the channel, high 
cell densities in the low shear region and low cell densities in the high shear region, would 
have had been obtained. 
 
Figure 3.13. Complementary equipment and the assembly of the flow device. A. Illustration 
of the device parts. From the bottom: microscope holder and bottom clamp plate; microscopy 
glass slide on which cell are seeded and which constitutes the bottom of the flow channel; 
A 
B 
i)##
ii)##
iii)##
iv)##
Figure 4.15. Assembly of in-house build flow system for flow studies on spott d arrays
Components that make up the modular parallel-plate flow device. From top to bottom: i) 15 m wide flow channel, ii) 
PCR adhesive file with height of 400µm which acts as a seeding well, iii) ITO slide with spotted array and iv) 
complementary clamping–holding equipment which holds the glass slide together with flow channel. 
The flow system was first tested on a monolayer of cells. ITO slides were coated with 1% gelatin and 
HUVECs were seeded at their normal seeding density of 16 000 cells/cm2. Following the formation of a 
confluent monolayer of cells, the slides were transferred into the in-house build flow system and sheared at 
15 dyne/cm2 for a period of twenty-four hours. Recorded microscopy images are shown in Figure 4.16.A. As 
it can be seen the cells were uniformly aligned to the direction of flow and no leakage was observed. 
Next, we carried out flow experiments using spotted arrays to determine whether the RNAi cell array is 
suitable for flow studies. The main concerns were, first, whether the spots will be able to withstand the shear 
stress and second, whether the experiments could be conducted without contamination for 48 hours. For 
this, HUVECs were seeded on spotted arrays and twenty-four hours after seeding, following the formation of 
the cell array, the slide was transferred into the in-house build flow system. The flow experiment was started 
by running the pump  at 5 dyne/cm2 for two hours to allow the cells to adjust to the flow conditions. Over the 
course of the following two hours, the flow rate was increased to a final shear level of 15 dyne/cm2. The cells 
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were imaged after twenty-four hours of flow exposure, (figure 4.16.B). As it can be seen cells on spots were 
present after 24 hours of flow exposure at around 70% confluence of their initial cell numbers. There was 
however, some observed spot loss at the entrance of the flow chamber. As expected the cells were aligned 
to the direction of flow. Cell alignment on spots was quantified by segmenting individual cells and measuring 
the angle between the x-axis (i.e direction of flow) and the major axis of individual cell, Figure 4.16.B (lower 
right). A cell orientation angle equal to zero indicates perfect alignment to flow. 55% of the sheared cell 
population had an angle between +20° and -20°, compared to only 20% of the static population. The majority 
of spots were still present at around 70% confluence of their initial cell numbers. 
Figure 4.16. Application of flow on cell array
A) HUVEC alignment to the direction of flow (from left to right) following exposure to 15 dyne/cm2 shear stress for 24 
hours using the in-house build flow chamber. B) Phase contrast microscopic images of  HUVECs exposed to 15 dyne/cm2 
shear stress for 24 hours. Direction of flow is from left to right. Cells were seeded on spotted arrays and exposed to 
shear stress using the in-house build flow system. Cell alignment on spots was quantified by segmenting individual cells 
and measuring the angle between the x-axis  (i.e direction of flow) and the major axis of individual cell. For each 
experimental condition the single-cell angle measurements for four spots were pooled and represented at density 
distribution plots. A uniform distribution of cell orientation angle demonstrates that  the cells have no predominant 
directionally and the cell orientation is random. A  distribution centered on zero degrees demonstrates that the majority of 
of cells are aligned to the x-axis and thus to the direction of flow.
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4.4 Summary and Future Work
In this chapter we have described the fabrication of a high-throughput RNAi platform, for 
mechanotransduction studies in primary mammalian cells. For siRNA array printing, a programmable robot 
dispenser was acquired. Homogeneity and immobilisation of the spots are very important for the success of 
the platform. These were strongly dependent on cleaning methods, coating materials and spotting solution 
reagents. Best results were obtained by washing with acetone, ethanol and water in an ultrasonic bath, 
followed by hydroxylation of the slide using oxygen plasma and four days ageing, before spotting with a 
solution consisting of APTES, fibronectin and siRNA. The optimised protocol for generation of spotted arrays 
on ITO glass slides resulted in regular spot shape with uniform siRNA concentration on spots; inter-spot 
width variation: 3.5%, inter-spot height variation: 4.3%, intra-spot siRNA signal variability: 8.3%. The 
combination of oxygen plasma treatment, fibronectin in spotting solution and washing steps enabled the 
formation of a cell array for spatial separation of different siRNA species reducing the risk of inter-spot 
contamination and cell migration during flow studies. The spot diameter achieved is approximately 550 µm, 
which can accommodate 80-100 HUVECs. The use of functional amine groups (APTES coating) enhanced 
siRNA retention on the slide, resulting in successful reverse electroporation of surface bound siRNAs with 
64% transfection efficiency of primary endothelial cells, with very high cell viability. Effective gene knockdown 
was demonstrated for multiple gene targets at the mRNA (KLF4), protein (GFP) and phenotypic (death) 
level. Finally, a modular parallel plate flow system was setup, consisting of the ITO spotted slides, a 15mm 
wide flow channel and complementary clamping–holding equipment to assemble the flow system. The flow 
channel has been designed to maximise the area available for spotting, while maintaining the uniformity in 
the shear on all the spots. The cell array and the in-house build flow system has been demonstrated to be 
suitable for the application of flow studies. The cell array was able to withstand twenty-four hours of 15 dyne/
cm2 shear stress exposure with 30% cell loss on spots, and 55% of the cells, perfectly align to the direction 
of flow (-20° < orientation angle > +20°). 
The work presented in this chapter is, to our knowledge the first study to demonstrate successful reverse 
electroporation of mammalian primacy cell lines. The first attempt for reverse electroporation was performed 
on HEK293 cells and involved a layered by layered approach of loading plasmid DNA on a gold electrode, 
using sequential coating with PEI (poly-ethyleneimine) polymer and plasmid DNA loading [Yamauchi04]. The 
method was later adopted for siRNA, where the sequential absorption of PEI and siRNA had to be repeated 
five times to obtain sufficient siRNA loading [Fujimoto10]. It is unclear how this method can be used in a high 
through-put setting; the use of non-transparent gold electrode precludes the use of microscopy imaging, and 
the siRNA solution is loaded manually on spots. The work of Jain et al. improves on this method by 
proposing an in situ electroporation setup  for HeLa and HEK293 cells, using microwells [Jain12]. That study 
shares a lot of similarities to our approach; ITO slides are used for their conductive and optical transparency 
properties, oxygen plasma treatment and APTES is used to enhance siRNA retention, and reverse 
electroporation is achieved, through application of pulse immediately after seeding (1 minute post-seeding in 
Jain et al. compared to 10 minutes post-seeding in our approach). A different approach, however, is used to 
overcome the problem of non-uniform electric field on the semi-conductive ITO  surface. Jain et al. used 
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deposition of Ti/Au by sputtering in vacuum to generate an electrode grid on the ITO slide. Most importantly, 
Jain et al. do not demonstrate transfection of primacy cells. Further, spatial separation is achieved by a 
complex procedure of two photolithography steps to create microwells; an approach that is not compatible 
for flow studies.  
The requirements of the project demanded a highly bespoke RNAi platform. Despite the relatively high 
number of publications on reverse transfection RNAi platforms [reviewed in Weise14 and Sturzl08], we faced 
considerable difficulties on siRNA immobilisation on ITO slides. Efforts were focused on using different 
spotting regimes, successfully used by other studies [Erfle07, Silva04, Baghdoyan04, Mannherz05, 
Yoshikawa04, Onuki-Nagasak08, Wheeler04, Mousses03, Neumann10]. These however, did not work for 
our setup. Different cleaning methods (iso-propanol, ethanol, acetone, methanol, sonication water bath and 
Oxygen plasma), different coatings (gelatin, fibronectin, PLL, and APTES) in different conditions (anhydrous, 
room temperature, high temperature and aging) and various spotting solutions (gelatin, fibronectin, sucrose, 
PBS, OptiMEM, DMEM and their combinations) were tested, compared and optimised. There are two main 
differences in our setup  that could explain the different outcome. First, ITO  slides have different surface 
characteristics to normal glass and polysterene slides used by other studies, which can potentially affect the 
surface interactions of the reagents. Second, all the above studies rely on chemical reagents whereby 
siRNA first forms a complex with lipofectamine, before being mmobilised on the surface. Compared to naked 
siRNA, the lipofectamine complex might be easier to be immobilised on the surface. The challenge of siRNA 
immobilisation is also evident by the methods employed in Jain et al and Fujimoto et al. In the study of 
Fujimoto et al. six layers of PEI and siRNA loading were necessary, while Jain et al. resorted to early 
electroporation, as also pursued in our study. An additional difficulty we faced was the specific use of 
HUVECs. Diluting siRNA in PBS as done by the others [Jain12, Fujimoto10], resulted to low HUVEC viability. 
Further, in the other studies electroporation was performed in PBS [Fujimoto10, Kis14] or OptiMEM solution 
[Jain12]; HUVECs however were not viable and therefore we had to use culture medium for electroporation.
The reverse transfection experiments are currently being repeated to assess the reproducibility of the RNAi 
platform. The experimental design consists of alternate spots of mock transfected and siGFP transfected 
HUVECs expressing GFP. The quality of the screen is being accessed in terms of homogeneity in 
knockdown, within and between spots. The expected coefficient of variation of cell based assays is around 
15%-30% [Ang04]. The alternate spot design also allows to systematically quantify cross-contamination 
between spots. The cell array of spatially restricted cell adhesion employed in this work, coupled with the 
washing steps have been shown to protect against cross-contamination [Rantala11, Fengler12]. Further, the 
use of fibronectin increases the adherence of cells to the spots reducing the risk of migration after they have 
been transfected especially when conducting flow studies [Weise14]. In fact, based on fluorescent siRNA 
signal, we have qualitatively observed minimal cross contamination between spots. This, however, should 
systematically be assessed at the biological level, since traces of siRNA could be sufficient to cause a 
biological effect. This work is currently being undertaken by Ms. Aliah Abuammah, a PhD student in Krams 
laboratory. Her work involves an application study of the RNAi platform to investigate the role of MAPK 
signalling pathways in the endothelial cell shear stress response. The pilot screen will determine the 
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variance of the screen and thus inform the number of replicate spots needed. The optimal timing for flow 
onset is also being investigated for optimal gene knockdown. Normally mRNA is depleted within 12-24 hours, 
with protein depletion occurring at around 48-72 hours [Morh14]. The exact dynamics, however, depend on 
the protein kinetics of the targeted gene. Chapter 5 presents experimental protocols for time-lapsed 
microscopy of flow studies, which enable the detection of gene knockdown onset and analysis of the data at 
the appropriate time point to match the protein kinetics of the targeted gene. 
In parallel, practical aspects of the screen need to be addressed including arranging liquid handling facilities 
and procedures for preparing the transfection mixture in a high-throughput manner. A major challenge has 
been the unavailability of a microscope suitable for high-throughput screening at the local imaging facility at 
Imperial College London. An optimal microscope for the RNAi platform is one that can image individual spots 
at predefined distances, taking advantage of the cell-array design of the platform, thus reducing the 
acquisition time and data size. Automatic shading correction, and if possible automated focusing are also 
desirable properties. This would eliminate the problems we faced regarding sub-optimal focus maps, with 
spots out of focus, and inaccurate stitching of tiles that introduced artificial shading rendering the 
segmentation of spots impossible. Having individual images, as opposed to a 1.3 gigabit sized stitched 
image makes data management easier and allows for the imaging analysis workflow to be parallelised. In 
addition, it avoids imaging the empty space between the spots, reducing the acquisition time, which currently 
is at two hours per slide. In larger stitched images, some spots were derived from four individual images, 
each from a different area of the field of view of the camera, with uneven illumination, making background 
correction very challenging. 
Due to these limitations we have mainly resorted to manual imaging of a handful of spots, and only 
qualitatively verified the reproducibility of the results over all spots, using the microscope eyepiece. It should 
be emphasised that automated single-cell-based analysis of large image datasets is feasible and has been 
applied to reverse transfection cell arrays [Rajan11, Neumann06, Neumann10, Jones06, Matula09]. All these 
studies, however, used automated high-content scanning systems. A new high-throughput microscope has 
since been purchased by the local imaging facility, which we hope can address most of these issues. We are 
working closely together with the staff to ensure the compatibility between the RNAi platform the microscope 
hardware and the imaging analysis software being developed (presented in Chapter 5). 
In conclusion, we have optimised a protocol for the generation of reverse transfection cell arrays based on 
electroporation. The proposed platform demonstrates high transfection efficiency for ‘hard-to-transfect’ 
primary endothelial cells, and has been shown to be suitable for the application of flow studies. Due to a 
number of technical difficulties regarding siRNA immobilisation and imaging, we have not been able to fully 
characterise the cross-contamination profile and reproducibility of the RNAi platform. The work presented 
here is a proof-of-principal approach, which has demonstrated that high efficiency of reverse transfection of 
endothelia cells is possible and presents the first described system that can couple RNAi screening with 
mechanotransduction studies. 
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5Exploring mechanisms for high content 
live-cell RNA quantification
Chapter 5 Summary
Gene network discovery requires technologies that allow for parallel transfection with hundreds of siRNA 
species, in conjunction with simultaneous analysis of multiple molecular readouts. The RNAi platform 
presented in Chapter 4 satisfies the first of these requirements. This chapter explores recent advances in 
fluorescent gene reporter technologies for establishing a high-content molecular readout for quantifying the 
biological effect of siRNA knockdown. Specifically, we test the feasibility of using fluorescent RNA 
hybridisation probes (SmartFlare), in conjunction with time lapse microscopy, to continuously monitor mRNA 
in live cells and decipher the gene expression dynamics under flow conditions. A key contribution of this 
chapter is the optimisation of experimental protocols for time-lapsed flow studies and implementation of 
associated software for single-cell imaging analysis. We present results on SmartFlare probe transfection 
efficiency and stability in HUVECs and demonstrate a statin concentration-dependent shift in endogenous 
KLF4 RNA levels. These results extend the use of SmartFlare probes beyond the detection of marker genes, 
and demonstrate their applicability for relative quantification of endogenous RNA levels. We also test the 
SmartFlare probe’s ability for real-time quantification of RNA dynamics based on the hypothesis that over 
time the probe measures the synthesis rate of a gene and therefore, gene up-regulation and down-regulation 
can be inferred by detecting changes in the rate of increase in SmartFlare signal. 
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5.1 Introduction
RNAi screens require the development of robust assays for assessing the biological effect of gene 
knockdown. There are three broad requirements for successful read-outs: i) they need to be sensitive with a 
large dynamic range, ii) they need to be reproducible with a low variability, and robustness (i.e. have a high 
signal to noise ratio) and iii) they need to be compatible with high throughput processing of samples [Ang04, 
Morh14, Sharma09]. A variety of assays have been used in the literature, ranging from phenotypic responses 
such as proliferation, viability, apoptosis and cytoskeleton arrangement, to reporter assays that measure the 
level/activity of specific mRNA/protein [Simpson08, Neumann06, Neumann10, Díaz‐Martínez14, Laufer13, 
Li06, Boutros04, Bakal07]. 
While phenotypic high-content assays based on morphological analyses of images are progressively 
becoming more common, reporter assays suffer from low dimensionality, typically limited to a small number 
of proteins/genes [Berthuy15, Morh14]. Gene network discovery, however, requires technologies that allow 
for parallel transfection with hundreds of siRNA, in conjunction with simultaneous analysis of multiple 
molecular readouts. The RNAi platform presented in Chapter 4 satisfies the first of these requirements. In 
this chapter, we explore recent advances in molecular reporter technologies for establishing high-content 
molecular readouts for RNAi screening. 
Section 5.1.1 presents available methodologies for studying gene/protein expression levels focusing on their 
evaluation within the scope of the RNAi platform presented in Chapter 4. Sections 5.1.2 and 5.1.3 expand 
further on the high-content potential of live-cell gene/protein reporters. Section 5.1.4 summarises the aims of 
the work presented in this chapter and presents the detailed objectives.  
5.1.1 Available methodologies for studying gene/proteins expression
There are a number of established techniques for acquiring the protein/gene expression measurements. 
These can be broadly divided into three classes: methods based on cell trypsinisation, methods based on 
fixing cells and methods based on live-cell imaging using reporter genes/proteins. The design of the RNAi 
platform has a number of implications in the choice of assay; desirable properties include single-cell 
resolution of adherent cells and continuous monitoring of the biological effect. The ability of available 
methods to meet each of these requirements is listed in Table 5.1.
Trypsinisation methodologies present significant and intrinsic problems to being used in this study. The RNAi 
platform is based on a cell array of spots without physical separation of different siRNA species. 
Consequently, cells cannot be pooled together and specific spots are difficult to extract. Hence, within the 
scope of the RNAi cell array we need a readout that works on adherent cells, excluding the use of 
quantitative polymerase chain reaction (qPCR) [Heid96, Higuchi93], mass spectrometry [Zhang10a], and 
fluorescence-activated cell sorting (FACS) [Herzenberg02]. Furthermore, in the above mentioned methods 
quantification is based on pooling entire population of cells, which fails to capture the cell-to-cell variability. In 
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recent years the importance of cell-to-cell variability arising due to the inherent stochasticity in gene 
expression has been highlighted [Raj08, Blake03]. There are many instances in the literature where single 
cell analysis was beneficial in the interpretation of RNAi screens, especially due to the incomplete 
transfection efficiency that reduces the signal from pooled cells [Snijder12, Rajan11, Liberali15]. 
Methods based on Immunohistochemistry [Warford04, Schacht15] and in situ hybridisation [Levsky03], 
improve on the above limitations and allow for single-cell resolution of RNA/protein expression in an imaging 
context which is compatible with a cell array format. These methods, however, require that cells are fixed 
and permeabilised to allow for cellular entry of antibodies. Consequently, only single point readout can be 
obtained at the end of the experiment and information on the temporal control of gene/protein expression is 
not available. In a time-resolved RNAi screen analysis, Zhang et al. demonstrated that each of the positive 
controls had unique kinetics and different timing for when the maximum effect was reached, highlighting the 
importance of monitoring gene dynamics for RNAi screening [Zhang 11].
In conclusion, within the scope of the RNAi cell array, we need readout with single-cell resolution that works 
on adherent cells, and also provides temporal information in a high-throughput manner. Live cell imaging 
provides an exciting opportunity to study cell-to-cell variation, spatial distribution of transcripts and capture 
the dynamics of cellular response. To achieve this, technologies have been developed for imaging protein 
and RNA expression in live cells, which are discussed in the next section.
Table 5.1 Summary of methods for quantifying gene or protein expression
Method MolecularLevel Class
Single-Cell 
Resolution Adherent cells
Continuous 
monitoring
Immunohistochemistry protein fixation ✔ ︎ ✔ ︎ -
In situ hybridisation mRNA fixation ✔ ︎ ✔ ︎ -
Mass Spectrometry protein lysis - -
Real time PCR mRNA lysis - -
Flow Cytometry mRNA/protein trypsinisation ✔ ︎ -
Fluorescent protein 
reporters protein live cell ✔ ︎ ✔ ︎ ✔ ︎
Oligonucleotide 
hybridisation probes mRNA live cell ✔ ︎ ✔ ︎ ✔ ︎
Fluorescent protein based 
RNA probes mRNA live cell ✔ ︎ ✔ ︎ ✔ ︎
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5.1.2 Live cell imaging reporters
Fluorescent microscopy is currently one of few methods that allow the visualisation of molecular processes 
inside cells. [Verveer08, Itzkovitz11]. There are two broad methodological approaches: fluorescent protein 
(FP) based methods, and RNA hybridisation probes.
Fluorescent protein methodologies
The primary method used for monitoring gene expression in live cells is fluorescent protein reporter genes, 
whereby the activity of an auto-fluorescent protein, e.g., green fluorescent protein (GFP), is placed under the 
control of the promoter for the gene of interest by cloning the promoter upstream of the open reading frame 
of the reporter protein. Activation of a signalling pathway that regulates the gene of interest drives the 
production of the FP, in addition to driving the expression of the endogenous gene. Therefore activity the 
gene can be measured by accumulation of fluorescent signal. Alternatively, fused fluorescent protein 
constructs can be used, whereby the protein of interest is fused with the fluorescent protein. Once expressed 
inside the cells the protein of interest can be detected due to its association with FP. Fused fluorescent 
proteins allow both the spatial detection as well as the quantification of a protein of interest [Crivat12]. 
Fluorescent proteins have also been used for intracellular detection of RNA molecules. The GFP-MS2 
system utilises both fluorescent proteins and RNA binding proteins isolated from bacteria. In this method, the 
target RNA is tagged with an RNA binding motif for the MS2 coat protein and GFP is modified to include the 
MS2 protein at one of its terminals. Therefore, once inside the cell the MS2 protein on the GFP binds to its 
corresponding RNA binding motif, on the target RNA, resulting to a high local concentration of signal being 
detected [Bertrand98]. In this method the unbound GFP is still fluorescent, creating a high background 
signal. An improved variation of this approach has been proposed based on RNA mediated construction of 
GFP. With this method, the GFP protein is split into two fragments, neither of which is fluorescent. Each 
fragment is tagged with a different RNA-binding protein and the target RNA is modified to include two 
complementary RNA binding motifs. Upon binding of the GFP fragments to their corresponding motifs, the 
functional GFP protein is re-constructed and the signal is generated [Valencia-Burton07]. Both these 
approaches require that RNA is tagged with RNA binding motifs, and therefore cannot be used to detect 
endogenous RNA. Consequently, they require the transfection with two components, modified RNA with 
RNA binding motifs and GFP/RNA binding protein constructs, which can be very challenging in primary 
mammalian cells.  
RNA hybridisation probes for detection of endogenous RNA
Oligonucleotide hybridisation probes are fluorescent label antisense probes specific for a gene of interest, 
whose fluorescence properties change upon binding to their complementary RNA molecule. They are 
available in a number of variants employing different strategies for signal quenching and generation, namely 
contact-mediated quenching or Fluorescence Resonance Energy Transfer (FRET) [Bao09, Tyagi09]. The 
most widely used RNA probes are molecular beacons, which consist of a dual labelled probe labelled with a 
reporter flurophore on one site, and a quencher on the other site. In the absence of the specific targeted 
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RNA, molecular beacons are designed to form a stem-loop  hairpin structure, which brings the 5‘end and 
3‘end of the probe close together and results to the quenching of the fluorophore. Upon hybridisation with the 
target mRNA the hairpin structure unfolds into a linear probe, allowing the fluorophore to emit a fluorescence 
signal [Tyagi96, Wu12]. FRET based probes consist of two individual probes targeting adjacent regions of 
the same RNA molecule. The probes are labelled with either a donor or an acceptor fluorophore. Upon 
binding to their complementary RNA sequences, the two probes are brought into proximity to each other, 
which leads to the excitation of the acceptor fluorophore by the donor fluorophore and produces a FRET 
signal that can be detected by fluorescence microscope [Bao09]. Dual FRET molecular beacons exist that 
combine both technologies and result in improved target specificity and lower background signal 
[Santangelo04].
Requirements for high content, dynamic live-cell imaging reporter
The two main objectives of this work are to establish a high-content molecular readout, which also allows for 
determining gene/protein dynamics using time-lapsed imaging. In order to satisfy the high-content 
requirement, the reporters need to be able to be produced and transfected in a high-throughput manner (i.e. 
different read out per spot). Therefore, desirable properties are their ability to be immobilised on solid arrays 
and be transfected using standardised parameters that are independent of the specific gene being targeted. 
Satisfying the second requirement requires: i) reporters with high intracellular stability that allow monitoring 
for a period of at least 24 hours, ii) reporters  that preserve functionality of endogenous genes with minimal 
cell toxicity and iii) reporters with fast association/dissociation kinetics (in the case of RNA probes) or  fast 
degradation times (for fluorescent proteins) to enable the detection of RNA/protein dynamics. A comparison 
of FP based methods and RNA hybridisation probes in terms of the above mentioned properties can be 
found in Table 5.2. We envision that both methods have the potential to be immobilided on the glass surface 
of our RNAi platform (owning to their similar charge and properties with siRNA). 
In parallel projects within the Krams laboratory, fluorescent protein reporter genes encoded in plasmids or 
lentiviral vectors are been investigated as potential assay readouts. In this study we explore an alternative 
approach based on RNA hybridisation probes, in order to address some of the limitation associated with FP 
reporter genes. Plasmid constructions can be a laborious and time intensive process, requiring several 
attempts for optimal positioning of the core promoter and finding a fusion protein configuration that does not 
affect the natural folding and function of the targeted protein [Giraldez05]. Further, there are intrinsic issues 
around plasmid design in terms of unknown promoter sequences, lacking co-regulation components and 
potentially unknown activity of the promoter, that can lead to false positives and negative fluorescent protein 
signals. The varied size of the gene constructs can also affect transfection efficiencies and makes 
standardisation of reverse transfection protocols that perform well across multiple reporter genes difficult. 
Moreover, fluorescent protein reporter genes do not measure endogenous protein and rely on promoter 
activity to drive the expression of the fluorescent protein. The introduction of the exogenous plasmids within 
the cellular milieu can have adverse effects on the normal function of the targeted genes; while promoter 
only fluorescent proteins can compete with the normal regulation of the targeted genes leading to down-
regulation, fusion protein vectors can result in over-expression that can influence the cellular dynamics.
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Table 5.2 Comparison of fluorescent protein methods and RNA hybridisation probes for live cell imaging 
Fused fluorescent proteins RNA hybridisation probes
Production x
Lengthly preparation, unknown promoter, 
non-functional fusion proteins
✔ ︎ Commercially available
Immobilisation ✔ ︎ Similar to siRNA ✔ ︎ Similar to siRNA
Delivery x Large and varied size ✔ ︎ Small, similar to siRNA
Endogenous x NO ✔ ︎ YES
Stability ✔ ︎ Prolong transfection x Broken down inside cells
Dynamics ✔ ︎
Short half-life allows for dynamic 
detection of up and down-regulations
x
irreversible binding or probe makes 
monitoring of dow-regulation difficult
RNA hybridisation probes can target endogenous unlabeled RNA molecules, providing the opportunity for 
live cell detection of gene expression without the need for engineering plasmid constructs. These probes are 
small RNA molecules, with standardised size, very similar to siRNA and therefore, utilising the reverse 
transfection protocol in Chapter 4, should require minimal changes. Contrary to FP reporter genes however, 
which have a proven record for intracellular stability and ability to dynamically detect gene dynamics, RNA 
probes have not been used in this context before [Rajan11, Ang04,Morh14, King07, Tian10]. This chapter 
presents a feasibility study on using RNA hybridisation probes as a modality for dynamic quantification of 
gene responses in live cells
5.1.3 SmartFlare nanoparticle probes for endogenous RNA detection
Successful RNA probes should demonstrate good cellular uptake and stability, respond to their target nucleic 
acid sequence in a highly specific and sensitive manner and display a high signal to background ratio. 
Molecular beacons suffer from limitations that prevent their widespread use in live cells, Table 5.3. These 
include nuclear sequestration, whereby the probes accumulate in the nucleus, instability within cells due to 
degradation by nucleases, and non-specific opening of the hairpin structure [Chen09,Wu12]. Collectively this 
results to high background signal and false positives. In addition, they require active transfection into cells 
(e.g., with electroporation techniques) and have strict guidelines for their design in terms of melting 
temperature and secondary structures, so as to ensure the formation of the hairpin structure and maintain 
integrity within cells [Chen07b]. 
A novel technique based on gold nanoparticles, termed NanoFlares, is promising to overcome some of these 
limitations. NanoFlares were originally conceived by the Mirkin lab  and subsequently developed 
commercially by Merckmillipore, under the trade name SmartFlare [Prigodich09, Seferos07, SF15]. 
SmartFlare probes consist of a gold nanoparticle core, conjugated with multiple copies of oligonucleotide 
probes (capture strand) that are complementary to the RNA target of interest. A shorter probe, called reporter 
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strand, binds to the capture strand via base pairing and contains a fluorophore, which is quenched by its 
proximity to the gold nanoparticle. In the presence of sequence specific target, the fluorophore is displaced 
from the capture stand, released in the cytoplasm and is free to emit a fluorescent signal, Figure 5.1. How do s it w rk? 
Single incubation, single reagent, overnight detection 
5 
Using the cells own machinery  
1. SmartFlare enters the cell (endocytosis) 
2. Detects the RNA of interest 
3. Exits the cell (exocytosis) 
allowing further experimentation 
Probe 
enters cells 
Target 
binding 
Probe 
release 
Probe exists 
cell 
Gold 
particle 
Gold-quenched 
dye 
Capture/
reporter 
strand duplex 
Figure 5.1 SmartFlare probes for endogenous RNA detection
SmartFlare probes consist  of  a gold nanoparticle core, conjugated with multiple copies of oligonucleotide probes (capture 
strand), that  are complementary to the RNA target of interest. A  shorter probe, called reporter strand, binds to the capture 
strand via base pairing and contains a fluorophore, which is  quenched by its  proximity to the gold nanoparticle. 
SmartFlare probes enter the cell through receptor mediated endocytosis, and once released from the endosomes are 
able to detect sequence specific RNA. In the presence of  sequence specific target, the fluorophore is displaced from the 
capture stand, released in the cytoplasm and is free to emit a fluorescent signal; adopted from [SF15]. 
SmartFlare probes have a better profile than molecular beacons, in terms of cellular uptake, biostability and 
signal detection, Table 5.2. These advantages are inferred from their design. The 3D architecture of the 
nanoparticles promotes binding to class A scavenger receptors and cellular uptake via endocytosis without 
the need for transfection reagents [Choi13]. Highly efficient uptake (99%) has been demonstrated in multiple 
cell lines (HeLa, Jurkat, and MCF-7, SKBR3, C166), embryonic stem cells, human iPS-derived 
cardiomyocytes and Purkinje neurons [Seferos07, Rossi06, Halo14, Kratz14, Khare14, Lahm15, Krönig15]. 
Further, the gold core is a potent quencher resulting to lower background signal [Seferos07]. Hence, the 
combined effect of lower background signal and improved stability results to a better signal to noise ratio for 
the detection of RNA gene expression. Specific to our application domain, nanoparticles have been shown to 
be non toxic in endothelial cells [Fede15], did not cause altered gene expression between nanoparticle 
transfected and not transfected HUVECs [Renata14], and there is a reported case of successful 
immobilisation of gold nanoparticles on a glass slide which is encouraging for coupling this technology with 
the existing RNAi platform presented in Chapter 4 [Yamada09]. 
Table 5.3 Comparison of SmartFlare probes and molecular beacon probes 
Property SmartFlare Molecular Beacons
Biostability
High stability in cells due to local enzymatic 
inhibitions of nucleases by particle [Rossi06]
Low biostability (degraded 4.5 times faster 
than SmartFlare) and nuclear sequenstation 
[Seferos07, Chen07b]
Cell entry
HIgh uptake (99%) without transfection 
reagents [Rossi06, Choi13]
Require transfection reagents [Chen09]
Signal Detection
Background signal from scramble control molecular beacons probes is 1.9 times greater than 
scramble control SmartFlare probes [Seferos07]
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In summary, SmartFlare probes were chosen for the pilot stage of the work over other hybridisation based 
methods because of i) increased stability compared to molecular beacons, ii) no specialised probe delivery is 
required and iii) they are commercial available, no laborious probe design, synthesis and amplification 
needed. 
5.1.4. Aims and Objectives
Aim: This chapter explores RNA hybridisation probes as a modality for RNAi screening assays. Specifically 
we test the feasibility of using SmartFlare probes, in conjunction with time-lapsed microscopy, to 
continuously monitor mRNA in live cells and decipher the gene expression dynamics under flow conditions. 
RNA hybridisation probes can target endogenous unlabeled RNA molecules, providing the opportunity for 
live-cell detection of gene expression without the need for engineering plasmid constructs. Successful 
application of RNA probe technology could enable the methods established in Chapter 4 to be applied for 
reverse transfection of RNA probes and establish high-content RNAi screening based on spots with unique 
siRNA/readout pair.
Objectives 1: Establish SmartFlare probes uptake and kinetics in human endothelial cells (HUVECs) and 
implementation of associated imaging software for single-cell analysis. 
Objectives 2: In current literature, SmartFlare probes have only been used to distinguish cell populations 
and detect RNA of marker genes. i.e. detection not quantification. Therefore, we test Smartflare ability to 
quantify gene expression in live-cells, and detect a graded response to Simvastatin drug treatment.
Objectives 3: Test SmartFlare probe ability for real-time quantification of endogenous RNA dynamics. RNA 
hybridisation probes constantly detect new mRNA molecules and due to the irreversible binding of the 
mRNA to the probe, the signal always reaches saturation over time. This poses a problem especially in 
detecting down-regulation of genes. We hypothesise that over time the probe measures the synthesis rate of 
a gene and therefore following intervention (gene up-regulation or down-regulation) the rate of increase in 
the SmartFlare signal (i.e. the slopes of the curves) should change. Hence, temporal information on gene 
expression levels can be detected through changes in slope. 
Objectives 4: Setup  experimental protocols for time-lapsed flow studies and investigate SmartFlare probe 
functionality in conjunction with flow. 
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5.2 Materials and Methods
5.2.1 Culturing of human umbilical vein endothelial cells
Sub-culturing procedure
Human umbilical vein endothelial cells (HUVECs) were purchased from Promocell (C-12200, lot# 
4061601.1) as a frozen 1ml vial at passage 0. Green fluorescent protein (GFP) expressing HUVECs (GFP-
HUEVCs) were purchased from AngioProteomie (cAP-0001) as a frozen 1ml vial at passage 3 [Koffler11]. 
Cells were cultivated in an Incusafe incubator (Sanyo) at 37°C in 5% CO2 and grown in Corning® polystyrene 
cell culture flasks with 25 cm2 (T25) or 75 cm2 (T75) cell growth surface area (FisherScientific, 734-1712, 
734-1713). The same culturing protocol was used for HUVECs and GFP-HUVECs. HUVECs were cultured 
using commercially available endothelial cell growth medium (ECGM) (Promocell, C-22010B) and the 
corresponding supplement mix (Promocell, C-39215). ECGM was optionally supplemented with antibiotics 
(100 units/ml penicillin with 100 μg/ml streptomycin (Sigma Aldrich, P4333)). Due to the low concentration of 
FCS (2%) in ECGM, DMEM supplemented with 10% FBS was prepared and used for neutralising the trypsin 
reaction at subculturing. All cell culture experiments were carried out under sterile conditions in a 1.5 Topsafe 
(Bioair) cell culture hood. 
Prior to passaging all solutions were pre-warmed to 37°C in a bead-bath kept at 37°C. The volumes used for 
sub-culturing are listed in Table 5.4. For passaging, cells were washed twice with 1x PBS (phosphate 
buffered saline), and incubated with 0.25% trypsin (containing 0.02% (0.53 mM) EDTA) for 3 minutes. Next, 
DMEM supplemented with 10% FBS was added to neutralise the trypsin and the solution was centrifuged at 
220g (rcf) for 5mins. The resulting cell pellet was re-suspended in 3ml of ECGM, mixed and distributed in 
flasks (1ml of cell suspension in each flask) already containing ECGM (T25: 6ml, T75: 9ml). HUVECs were 
passaged at 1:3 ratio every 3 days. For all experiments cells were used at less than six passages, to avoid 
phenotypic changes. DMEM (D5546), PBS (D8537), FBS (F7524), Trypsin-EDTA solution (T4049) and 
Penicillin-Streptomycin solution (P4333) were purchased from Sigma Aldrich. 
Table 5.4 HUVEC sub-culturing solution volumes
T25 flask T75 flask
Culture medium volume 7ml 20ml
Trypsin volume 1ml 3ml
Trypsin neutralisation volume 7ml 15ml
Trypsin neutralisation solution DMEM supplemented with 10% FBS
Centrifuge setting 220g (rcf), 5 min
Flask Coating None
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HUVECs were received from the supplier as a frozen 1ml vial of 500 000 cells. Once thawed in a single T25 
flask, passage 1 cells were grown to confluence (~ 2-3 days) and sub-cultured in three T25 flasks. Similarly, 
passage 2 cells were grown to confluence and each T25 flask was sub-cultured into one T75 flask, resulting 
to a total of three T75 flasks. Finally, the resulting passage 3 cells were grown to confluence and frozen in 
liquid nitrogen. Frozen cell stocks (in total 27 cryovials) were used for up  to 3 months. During the initial 
growth period, until freezing, the DetachKit from Promocell (C-41200) was used. Hence, instead of PBS, 
cells were washed with 2.5 ml (7.5 ml for T75) HepesBSS solution. For cell detachment, 2.5ml (7.5 ml for 
T75) of the provided Trypsin/EDTA solution was used and the reaction was neutralised using 2.5 ml (7.5 ml 
for T75) of Trypsin Neutralising solution (instead of DMEM supplemented with 10% FBS). 
Endothelial cell freezing procedure 
DMEM supplemented with 10% FBS and 10% DMSO  (Sigma Aldrich, D8418) was prepared and placed on 
ice. Cells were washed with PBS, trypsinised and pelleted as detailed above. The pellet was re-suspended 
in the required volume of ice-cold DMEM/DMSO  solution (T25: 3 ml, T75: 9 ml) and mixed well. 
Subsequently, 1ml of cell suspension (~2 x 105 cells) was distributed in each cryovial (Thermo Fisher 
Scientific, 12567501). Cryovials were placed in Mr.FrostyTM Freezing Container (Thermo Fisher Scientific) 
which contained 250 ml of isopropanol pre-chilled to 4°C. The freezing box was kept at -80°C for 24 hours 
and then transferred in a cryotank filled with liquid nitrogen.
Endothelial cell thawing procedure
A beaker was filled with lukewarm water and placed in the bead-bath, to reach 37°C. Cryovials of cells were 
removed from the liquid tank and transferred to a dry ice container for transport to the tissue culture 
laboratory. The cryovials were placed in the pre-warmed water beaker, avoiding the water to reach the cap 
area in order to prevent contaminations. As soon as the cell solution melted (no more than 3 minutes), it was 
added to a T25 flask, containing 9ml of ECGM pre-warmed and incubated for 30 minutes at 37°C and 5% 
CO2. According to the supplier’s advice, the cells were not centrifuged to remove the DMSO since HUVECs 
are sensitive to centrifugation. The day after thawing, the cells were observed under a brighfield microscope 
to verify that they were adhering and presenting the expected morphology of HUVEC cells. The cells were 
washed with PBS, fresh ECGM was added and allowed to grow to confluence.
Endothelial cell seeding
For seeding purposes, cells were harvested, centrifuged at 220g for 5 minutes and the resulting cell pellet 
was re-suspended in 1ml of endothelial cell growth medium (ECGM) per 25 cm2 of cell growth area. Cells 
were counted using a hemocytometer and the desired volume of cell suspension was calculated based on 
the seeding density. The seeding density for HUVECs was determined to be 18,000 cells per cm2. All live cell 
time-lapsed experiments were conducted in Ibidi μ-Slide VI 0.4 flow chambers since they provided excellent 
optical qualities for image analysis and they required smaller volume of SmartFlare probes, which were 
costly. The seeding of the chambers is described below, in Section 5.2.2. 
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Simvastatin experiments
Cells were incubated with ECGM containing 10% (v/v) of Simvastatin at the desired concentration. 
Simvastatin was used at a final concentration of 10µM, 1µM or 0.1µM. Dilutions were performed in PBS, 
which was also used as the vehicle control for untreated samples. Gene expression was normally measure 
24 hours after statin treatment, unless otherwise stated. 10mM solution of already activated Simvastatin was 
purchased from Merck Millipore (567022). Simvastatin was stored at 10µl aliquots at -80°C. Once thawed, 
each aliquot was used only once.
5.2.2 Flow experiments
Equipment and materials
The flow setup, shown schematically in Figure 5.2.A, consists of a flow chamber, a media reservoir, a 
peristaltic pump and platinum-cured silicone tubing. 
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Figure 5.2 Flow experiment setup 
A) The flow setup  consists of a chamber, a pump  and a media reservoir connected in a circuit. The medium flows from 
the media reservoir, through the flow chamber and back into the media chamber. B) Connections for μ-Slide VI 0.4 flow 
chambers. Individual channels were connected in a series using 7cm long connecting tubes. 
The flow chamber was either a commercial μ-Slide VI 0.4 from Ibidi (80606) or the in-house designed flow 
systems (described in Chapter 4). The media reservoir was a 150ml glass beaker with a tight fitted lid 
modified to include media inlet and outlet connections. It was made to order from Cambridge Glassblowing, 
UK; the design specifications can be found in Appendix 3. All live-cell time-lapsed flow experiments were 
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conducted using a peristaltic pump  from Atto Bioinstrument Corp (Perista SJ-1220). For flow experiments 
conducted on the RNAi cell array, a peristaltic pump from COBE Laboratories (03600-001) was used, since 
the Perista pump could not produce sufficient shear stress levels. Each pump  was calibrated before initiation 
of flow experiments (measured flow rates and associated shear stress values can be found in Appendix 3). 
The pump  head was 3.17mm inner diameter platinum-cured silicone tubing purchased from Cole Parmer 
(WZ-95802-04), which was replaced after 3-4 flow experiments. Each pump required different pump  head 
tubing length: 33cm long tubing for the Perista pump  and 36cm long tubing for the Cobe pump. The rest of 
the components of the flow setup  were connected using 2.4mm inner diameter platinum-cured silicone 
tubing (WZ-95802-03). The pump head tubing was connected with the rest of the tubing using barbed 
straight connectors (2 mm x 39 mm x 13 mm) from Cole Parmer (WZ-06288-10). Autoclave tape was 
wrapped around the pump head connectors to ensure a tight fit with the pump and prevent tube folding 
during flow. Individual flow channels of the 6-channel Ibidi chamber were connected using a series of 7cm 
long pieces of tubing (2.4mm inner diameter), with 3.2 mm inner diameter male luer to 200 series barb  elbow 
connectors at either site (Cole Parmer (EW-45551-36)). The same connectors were used for connecting the 
media reservoir tubing to the flow chamber. 
Flow chamber seeding
Ibidi μ-Slide IV chambers consist of six individual channels. The optimal seeding density for 80% confluence 
within 16 hours was 37 000 cells per channel in a volume of 30µl. Each channel was coated with 100µl of 
1% gelatin solution and incubated at 37°C and 5% CO2 for 30 minutes. Cells were harvested, as described 
above, centrifuged at 220g for 5 minutes and the resulting cell pellet was re-suspended in 1ml of endothelial 
cell growth medium (ECGM) per 25 cm2 of cell growth area. Cells were counted using a hemocytometer and 
the desired volume of cell suspension was calculated based on the seeding density. The required volume of 
cell suspension was transferred to a new 1.5ml autoclaved ependorf tube and centrifuged for 20 seconds 
using a minicentrifuge. The resulting cell pellet was re-suspend in 30µl culture medium per channel. The 
gelatin was aspirated from the channels, and 30µl of cell suspension was seeded in each channel, taking 
extra care to avoid forming bubbles. Seeded chambers were incubated at 37°C and 5% CO2 for one hour, 
after which the channel reservoirs were topped up with 60µl of culture medium each. 
Flow setup
Prior to setting up the flow system, all equipment was sterilised by autoclaving at 135°C for 5 minutes in a 
MLS-3751L Sanyo autoclave. The media reservoir was filled up  with 80ml of culture medium and pre-
equilibrated at 37°C and 5% CO2 for two hours. Individual channels of the ibidi μ-Slide IV chamber were 
serially connected using a 20ml syringe filled up  with equilibrated media. Bubbles from the syringe media 
were removed over some tissue, the connecting tube was fixed on the syringe and any residual bubbles 
were pushed out. The connection tubes were connected to the outlets of the individual channels, as shown 
in Figure 5.2.B. The syringe was connected to the inlet of the first channel by gently dripping media into the 
inlet, avoiding any bubbles. Next, media was pushed very slowly through the channels, attaching each 
connecting tube as the liquid moved along the tubing. Care was taken not to introduce any bubbles into the 
system. Channels for static control conditions were not connected to the circuit and were kept sterile with the 
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use of tubes connecting the channel inlet and outlet. In order to ensure the cells were provided with enough 
nutrients, the connecting tubes for static controls was filled up  with media. Once all the channels were 
connected in a series, the syringe connecting tube was removed and the first channel was connected to the 
media reservoir inlet. Similarly, the last connecting tube was detached from the flow channel and the media 
reservoir’s outlet tubing was attached. The connected chamber and media reservoir was transferred inside 
an incubator, the pump head tubing was attached to the pump and the flow experiment was started. Cells 
were primed for two hours at 5 dyne/cm2, gradually increasing the flow rate over the next two hours to yield a 
final shear stress level of 15 dyne/cm2. The cells were subjected to 15 dyne/cm2 for 24 hours. In the case of 
the Perista pump, the pump  was also placed in the incubator. In the case of the Cobe pump, the pump 
remained outside the incubator. 
5.2.3 Live cell detection of mRNA using SmartFlare probes
SmartFlare probes were reconstituted in 50µl of nuclease free water to yield a stock solution of 100nM. 20µl 
aliquots of 5nM working solution (1:20 of stock) were prepared in nuclease free water. Reconstituted 
SmartFlare probes were stored at room temperature. The final concentration was prepared in culture 
medium and directly added to the cells. All experiments were conducted using 200pM concentration, unless 
otherwise stated, and imaging acquisition settings were kept constant across all experiments. In each 
experiment a positive control, which is constitutively fluorescent, was included. In addition, a scramble 
negative control, which does not have any specific cellular target, was included to determine the background 
signal. For endpoint experiments, cells were imaged 16 hours after the addition of SmartFlare probes. For 
live-cell time-lapsed experiments, imaging was started 30 minutes after the addition of SmartFlare probes. 
The following SmartFlare probes were purchased from Emdmillipore: Uptake-Cy3 (SF-114), Uptake-Cy5 
(SF-137), Scramble-Cy3 (SF-103), Scramble-Cy5 (SF-102), KLF4 Hu-Cy3 (SF-918), HPRT1 Hu-Cy5 
(SF-132). Custom KLF2 SmartFlare probes (SFC-544) were designed with sequence: ‘ACCGGCCATT-
CCAGTGCCATCTGTGCG’. Four different sequences where designed using the online tool provided by 
Emdmillipore: https://customSmartFlare.emdmillipore.com/customflare, with the KLF2 (NM_016270.2) 
sequence as input. The sequences were evaluated for specificity using Blast sequence alignment analysis.   
5.2.4 siRNA experiments and transfection
In this chapter, conventional electroporation of cells in suspension was used for HUVEC transfection with 
siRNA. The NeonTM transfection System with 10µl electroporation reaction tips (Life Technologies, MPK5000, 
MPK1096) was used, following the manufacturer’s instructions. Each electroporation reaction consisted of 
50,000 HUVECs in 10µl of Resuspension Buffer R (provided by manufacturer) containing siRNA at the 
appropriate concentration. The final siRNA concentrations for Alexa Fluor 488 conjugated siRNA (Qiagen, 
1027292), death control siRNA (Qiagen, 1027299), and esiRNA against KLF4 (Sigma Aldrich, EHU151801), 
were 5µM, 500nM and 500nM, respectively. Before harvesting the cells, the NeonTM Pipette Station was 
prepared by mounting a NeonTM Tube pre-loaded with 3 ml of Electrolytic Buffer E (provided by the 
manufacturer). Cells at 70-80% confluency were harvested as normal, and the resulting cell pellet was re-
suspended in PBS for cell counting. The desired number of cells was pelleted, by centrifuging for 20 seconds 
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using a minicentrifuge, and resuspended in Buffer R containing siRNA at the appropriate concentration. The 
siRNA did not exceed 10% (vol/vol) of the electroporation mixture. Next, 10µl of the prepared electroporation 
mixture was aspirated with the NeonTM Pipette and a pulse was applied using the NeonTM Pipette station and 
the NeonTM pulse generator. After each electroporation reaction the 10µl of electroporated cell suspension 
was transferred to a 1.5ml tube containing 820µl of antibiotic free growth medium. Once all the reactions 
were performed, the cell suspensions were seeded in 48-well plates coated with 1% gelatin, at a seeding 
density of 18,000 cells/cm2. Following cell attachment to the surface (approximately 4 hours after seeding), 
fresh culture medium was added and cells were imaged twenty-four hours after transfection. The optimised 
electroporation parameters for HUVECs were a double pulse of 1000V for 30ms, which resulted to 74% 
transfection efficiency, (figure 5.3.A). The functionality of the transfected siRNA was tested using phenotypic 
death control siRNA, which resulted to significant cell death after 72 hours of transfection, (figure 5.3.B).  
Figure 5.3 Optimisation of siRNA electroporation in HUVECs, using NeonTM transfection system
A) Transfection efficiency for fluorescence-conjugated siRNA electroporation in HUVECs using a range of pulse 
parameters.  Representative brighfield and fluorescent images for the negative control (no pulse) and the optimised pulse 
(1000V, 30ms, double pulse) are also shown. B) Brighfield images of mock (500nM) and death siRNA (500nM) 
transfected HUVECs, 24 hours and 72 hours following electroporation. Scale bar = 100µm.
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5.2.5 Live cell time-lapsed microscopy 
Microscopy imaging was performed in the Facility for Imaging by Light Microscopy (FILM) at Imperial College 
London using Zeiss Axiovert 200 inverted fluorescent microscope with a fully motorised stage, controlled by 
Improvision Volocity software (Perkin Elmer). The microscope is equipped with an incubation chamber with 
temperature control and CO2 supply. In order to minimise focus shift during the experiment, the microscope 
stage was pre-heated at 37°C for 2 hour prior to the start of imaging and the flow chamber was taped on the 
microscope stage holder. For all live cell time-lapsed experiments, the endothelial cell growth medium was 
supplemented with 2% Hepes buffer (Life Technologies, 15630-056), since the microscope’s CO2 supply was 
not sufficient to maintain the cells for long term imaging. Cells were imaged using Zeiss EC Plan-Neofluar 
10x 0.30 Ph1 objective in combination with the appropriate filters. Cy-3 tagged SmartFlare nanoparticles 
were imaged with Zeiss Filter Set 15 (TRITC, orange channel), using 500ms exposure time with 2x binning 
of the signal. Cy-3 tagged SmartFlare nanoparticles were imaged with CY5 (Chroma Filter Set 31023). In 
order to ensure consistency across different experiments, for all time-lapsed experiments the flow chamber 
was positioned at the same location on the stage and a well overlay with predefined acquisition points was 
used. For each experiment, a focus map  was generated manually for each point at the start of imaging and 
revised as needed during the course of the imaging. Finally, the software was programmed to acquire 
images at 30-minute intervals from each saved XY point on the flow chamber.
For time-lapsed flow studies the flow circuit was connected in the tissue culture laboratory under sterile 
conditions and transferred to the imaging facility, where it was placed in an incubator for 30 minutes to allow 
the cells to recover from the movement. The flow chamber was fixed on a microscope slide holder and 
placing on the microscope stage. The media reservoir was placed inside the microscope’s incubation 
chamber, while the pump was kept outside. The inlet and outlet tubing were taped on the microscope stage 
to prevent movement during imaging that resulted to focus drift. During the optimisation stage it was 
observed that placing the CO2 supply tube directly over the flow chamber had minimal effect on cell survival 
for sheared samples. This was because, as the culture medium was flowing through the circuit, it was 
exposed to optimal CO2 levels for too short period of time for sufficient perfusion. Therefore, in order to 
perfuse the media supply to the cells, the CO2 tube was instead inserted into the media reservoir and sealed 
with parafilm foil. 
For time-lapsed studies without flow the flow chamber was taped on the microscope stage and the CO2 
supply chamber was placed directly over the flow chamber. In order to prevent medium evaporation wet 
cotton was placed around the CO2 supply chamber. The culture medium in the flow channel was topped up 
after around 16 hours of imaging. 
Cy5-tagged SmartFlare were also imaged using a confocal microscope (DMI 6000 CS inverted microscope, 
Leica). The cells were imaged using 10x dry objective in combination with 10mW HeNe laser with excitation 
wavelength of 633nm and signal acquisition from a range of 650nm to 750nm. The laser power was set at 
30% and imaged with 800V gain and 0% offset.
Exploring mechanisms for high content live-cell RNA quantification
187
5.2.6 Single cell imaging and data analysis
Imaging analysis 
Improvision Volocity library files (‘.mdv2’ file), were loaded in ImageJ using the Bio-Formats plugin 
[Linkert10]. Each saved file represents an image sequence (stack) of two channels, for t1 ... tN timeframes at 
a specific XY coordinate of the flow channel. Each channel was imaged at three regular intervals along its 
length and the XY coordinates for each point were kept constant throughout the experiments to exclude 
biases due to the selection area. The first step in the analysis was to manually inspect all the images and 
exclude poor quality images (e.g., out of focus frames, significant cell loss, and shading) from further 
analysis. ImageJ macros were implemented to extract the specified timeframes from each stack and split the 
stacks for each XY point into individual time points. An overview of the imaging analysis workflow is shown in 
Figure 5.4. There are three main steps: cell segmentation of phase contrast images, background correction 
of the fluorescent image and extraction of single-cell associated fluorescence and other morphological 
parameters. Cell segmentation and background correction was implemented in ImageJ. Once generated, the 
cell’s region of interests (ROIs) were imported in MathWorks MATLAB and Statistics Toolbox Release 2014b, 
for extraction of single-cell measurements and subsequent data analysis.
Figure 5.4 Overview of imaging analysis workflow
Grayscale phase contrast images (Channel 1) were first  thresholded to create a binary mask. The binary mask was 
processed in a series of filtering step  and finally segmented to detect individual cells,  coloured as different colours in 
lower left image. The cell’s regions of interests (ROIs) were overlaid on the phase contrast and background corrected 
fluorescent image to extract single-cell morphological parameters and single-cell associated fluorescence, respectively. 
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Cell segmentation
Segmentation of individual cells was based on the phase contrast images, following an eleven-step  routine 
implemented in an ImageJ macro. First, the contrast was enhanced using histogram equalisation and a 
smoothing operation was performed by using mean filtering. Mean filtering replaces each pixel with the 
average of its 3x3 neighbourhood, making edge detection easier. Next, the cumulative density distribution of 
the image was calculated and the image was thresholded to create a binary mask based on the 15th 
percentile value (i.e assign a value of 1 for values less than the 15th percentile, and 0 otherwise). The mask 
was processed by filling in the holes, dilating (adding pixels to the edges of the objects), and median filtering 
with radius 6 pixels to despeckle the binary image. The mask was further dilated and any touching regions 
were separated using the watershed segmentation algorithm. The last step  in the segmentation routine was 
to detect the boundaries of individual cells. For this purpose the ‘analyse particle’ tool within ImageJ was 
used with input parameters: circularity = 0.10-1, size= 100 pixels - Infinity. This operation works by tracing 
the pixels within the binary mask to find connected components. Finally, the segmented regions were 
expanded in all directions by 5µm. The last step  was essential to ensure the fluorescent signal in the 
cytoplasm was accurately captured. 
Following segmentation each cell was associated with a region of interest (ROI) tracing along its boundaries. 
Representative images of the segmentation are shown in Figure 5.5. The accuracy of the segmentation was 
quantified by calculating the percentage of the fluorescent signal captured by the cell masks. For this 
purpose, background corrected fluorescence images were thresholded at the 90th percentile to generate a 
binary mask representing fluorescent signal. The 90th percentile was found empirically to capture the 
fluorescence signal in the cells, while excluding the background signal. Following the analysis of 143 
individual images the median overlap  between the binary fluorescent mask and cell ROIs was 81% ± 5%. 
Segmentation overlap percentages were plotted for all the experiments analysed and used for quality 
assessment. Lower overlap  percentages were indicative of problems with the segmentation either due to 
shading in the phase contrast images or uncorrected uneven illumination of the fluorescent signal.
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Figure 5.5 Cell segmentation and signal detection accuracy
Representative phase contrast image and SmartFlare uptake control probe fluorescence. Derived cell contours are 
overlaid on the images. The accuracy of the segmentation was assessed by calculating the percentage of  the fluorescent 
signal,  defined as the 90th percentile of  the background corrected fluorescent image, that is also captured by the cell 
masks. 143 images were included in the analysis, pooled from across different experiments presented in Section 5.3. 
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Background correction
Fluorescence images had to be corrected for uneven background illumination (figure 5.6.A (left)) to generate 
a fluorescent image with homogenous signal across the field of view of the camera (figure 5.6.A (right)). For 
this purpose, the illumination correction function was implemented as described in [Singh14], which has 
been shown to work well in practice for cell array experiments. In this approach, each individual image is 
corrected by dividing it by an estimated background signal image. A different background image was 
estimated for each well (i.e flow channel) by averaging all the individual timeframes and replicates images, 
followed by smoothing using the morphological opening function implemented in ImageJ [Sternberg83]. 
             
Figure 5.6 Uneven illumination correction for fluorescence images
A) Representative fluorescent images of raw (left) and background corrected images (right). Scale bar=  100µm. B) 
Different rolling ball sizes were assessed for homogeneity of background signal by thresholding the lowest 10th 
percentile of the image. The rolling ball specifies the area over which a local background signal should be estimated. An 
even background illumination should result in a uniform distribution of the lowest  10th percentile of the signal,  across the 
image.  C) Spatial distribution of  high and low ranked cell-associated fluorescent values before (left) and after (right) 
background correction. In these plots, single cells were segmented as described above, and the coordinates of all cell 
centroids were plotted in an x-y plane. Each point is coloured according to the rank of its  cell associated fluorescence 
value.
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The morphological opening function takes as input the rolling ball size, which specifies the area over which 
to calculate a local background value. Different rolling ball sizes (20-150 pixels) were assessed for 
homogeneity of background signal, by thresholding the lowest 10th percentile of the background corrected 
image, (figure 5.6.B). An even background illumination should result in a uniform distribution of the lowest 
10th percentile of the signal. A rolling ball size of 100 pixels, still contained some spatial artifacts, while a 
rolling ball size of 30 pixels resulted to loss of cell specific signal. Therefore a rolling ball size of 50 pixels 
was chosen as the optimal one, (figure 5.6.B). Background correction with a rolling ball size of 50 pixels did 
not affect the signal, since positive and negative SmartFlare controls had the expected response (discussed 
in full in the results section). The spatial distribution of high and low ranked cell-associated fluorescent 
values before and after background correction are illustrated in Figure 5.6.C. In these plots, single cells were 
segmented as described above, and the coordinates of all cell centroids were plotted on an x-y plane. Each 
point is coloured according to the rank of its cell-associated fluorescence value. Prior to background 
correction (right), the highest ranked fluorescent values (blue) are all centered in the middle of the image 
with clear spatial artifacts. Following background correction (left), the ranks are uniformly distributed across 
the x-y plane. Uneven illumination correction is particularly important for the imaging analysis of the RNAi 
cell array, since the spots only occupy a fraction of the field of view, and they are not always positioned at the 
same location.
Data analysis
The background corrected images, together with their associated cell segmentation region of interests 
(ROIs), were imported into Matlab  and single-cell parameters were extracted using the build-in ‘regionprops’ 
function. The ‘orientation’ parameter was used for determining cell alignment. Orientation specifies the angle 
between the x-axis (i.e. direction of flow) and the major axis of a region of interest (i.e. individual cell). The 
average fluorescence signal for each cell was measured by taking the average background corrected 
intensity over all pixels that make up the cell (as defined by the ROIs produced during the segmentation). 
Follow-up  analysis was performed on the calculated cell-associated fluorescent values. Density distribution 
plots were employed to display the fluorescent signal and cell alignment across the whole population of cells. 
The three replicates from each flow channel were processed individually to generate three sets of cell-
associated fluorescent values. The data were then assessed for reproducibility by comparing their density 
distribution plots at regular time intervals (every 3 hours). Any samples with a response that deviated from 
the rest, were removed and the remaining samples were merged into a single largest dataset. Due to the 
behaviour of the data, whereby the increase in the signal was characterised by both a change in the shape 
and the spread of distributions, Kolmogorov–Smirnov (KS) test was used to perform statistical analysis for 
differences in the fluorescence signal between two experimental conditions. KS test takes into account the 
whole distribution of the data rather than just the mean and/or median as done by traditional tests. 
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5.3 Results
5.3.1 Time-lapsed flow studies. 
Before loss-of-function studies can be investigated using the RNAi platform, the experimental protocol for 
time-lapsed flow studies had to be optimised. For this purpose, flow chambers were seeded, cells were 
allowed to grow to confluence and then connected to a flow circuit. The setup  was transferred to the imaging 
facility and cells were exposed to 15 dyne/cm2 of shear stress for 24 hours. It is known that endothelial cells 
align to the direction of flow when exposed to more than 15 dyne/cm2 for 12 hours, therefore cell alignment 
was selected as a quality control read out for successful time-lapsed flow experiments [Davies95]. In order to 
quantify cell alignment, imaging analysis software were set up  to measure the orientation of individual cells, 
which is specified by the angle between the x-axis (i.e direction of flow) and the major axis of the cell 
contour. The suitability of the orientation angle parameter to quantify cell alignment was benchmarked using 
images with well-defined alignment to flow, (figure 5.7). The angle measurements for three static and three 
sheared samples are represented at density distribution plots. A uniform distribution demonstrates that the 
cells have no predominant directionality and thus the cell orientation is random. A distribution centered on 
zero degrees, demonstrates that the majority of cells are aligned to the x-axis and thus to the direction of 
flow. As it can be seen in Figure 5.7, the sheared samples’ density distributions demonstrate a clear peak at 
the zero angle, with 81% of the sheared cell population having an angle between +20° and -20°, compared 
to only 28% of the static population.
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Figure 5.7 Quantification of cell alignment
Representative phase contrast images for cells exposed to 15 dyne/cm2 for 24 hours, or kept under static conditions. 
Direction of flow is from left to right. The segmented cell contours are also overlaid on the images (green boundaries). 
Cell alignment was quantified by measuring the angle between the direction of flow and the major axis  of individual cell 
contours.  For each experimental condition the single-cell angle measurements for three static (red) and three sheared 
(black) samples are represented as density distribution plots. A  uniform distribution demonstrates that the cells have no 
predominant  directionality and thus the cell orientation is random. A distribution centered on zero degrees demonstrates 
that the majority of cells are aligned to the x-axis and thus to the direction of flow.
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Initial time-lapsed flow experiments were not successful. The two main problems encountered were focus 
drift and cell loss of the sheared cells after around 12 hours due to insufficient CO2 supply. Following a series 
of optimisation steps to the flow set up  (cf. to Section 5.2.5 for full details), successful application of flow 
under time-lapsed conditions was possible. Figure 5.8.A displays representative images for sheared cells at 
0, 4, 8, 12, 16, 20 hours. The cell counts over 23 hours of shear exposure, for six static and six sheared 
samples are shown in Figure 5.8.B. For the first 16 hours of flow, there was no observable difference 
between the cell count of static and sheared samples, while a minor cell loss for the sheared samples can be 
observed after 18 hours of flow. The effect of shear exposure on cell alignment was quantified as described 
above, and displayed graphically in Figure 5.8.C. The cell alignment results demonstrate that sheared cells 
are progressively aligned to the direction of flow with maximum alignment occurring between 14 and 18 
hours. 58% of the sheared cell population has an angle between +20° and -20° at 18 hours, compared to 
only 27% at the start of the experiment. Contrary, the cell orientation angles for static conditions are 
uniformly distributed for the entire measured period, with cell alignment remaining between at 25% and 29%.
Figure 5.8 Time-lapsed imaging of endothelial cells exposed to 15 dyne/cm2. 
A) Representative phase contrast images of cells exposed to 15 dyne/cm2 for 24 hours. The images show the same 
position on the flow chamber at 0, 4, 8,  12, 16, 20 hours. Direction of  flow is from left to right.  B) Cell count (y-axis) over 
23 hours of flow exposure (x-axis), for six static (red) and six sheared (black) samples. C) Quantification of the effect of 
flow exposure on cell alignment. Cell alignment was quantified by measuring the angle between direction of flow and the 
major axis of  individual cell contours.  For each experimental condition,  the single-cell angle measurements for six static 
and six sheared samples were pooled and represented as density  distribution plots. Each distribution plot represents the 
cell alignment values at a specific time-point. The plots are progressively coloured from light orange to black, 
representing 2 hours and 18 hours of 15 dyne/cm2 exposure, respectively.  
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5.3.2 SmartFlare probe uptake and kinetics in endothelial cells
In parallel to optimising time-lapsed imaging protocols, SmartFlare RNA probes were investigated for live cell 
gene expression monitoring in HUVECs. Smartflare probes consist of gold nanoparticles, which can enter 
the cells via endocytosis. The nanoparticles are conjugated with a specific target sequence against the gene 
to be monitored and a complementary reporter sequence, which contains a fluorophore quenched by its 
proximity to the gold nanoparticle. Upon target binding the fluorophore is released in the cytoplasm and 
emits a fluorescent signal.
An initial setup  experiment was designed to test SmartFlare probe uptake and stability in HUVECs. For this 
purpose, HUVECs were imaged following twenty-four hour incubation with SmartFlare control probes. For 
each of the available fluorophores (Cy3 and Cy5), two control probes were used. The uptake positive control 
probes are constitutively fluorescent and hence were used to assess transfection efficiency and signal 
detection. The scramble negative control probes do not have any specific cellular target and hence were 
used to determine the background signal and the dynamic range of the probes. The fluorescence signal was 
quantified based on segmenting individual cells and measuring the average fluorescence signal associated 
with each cell. In the figures that follow, the cell-associated fluorescence values are represented as density 
distribution plots that display the fluorescent signal across the whole population of cells. 
Figure 5.9.A shows the signal detected, after a twenty-four hour incubation period with 200pM of Cy3-tagged 
SmartFlare probes. Treatment with SmartFlare probes resulted to high transfection efficiency (98%) in 
HUVECs and an excellent dynamic range for the analysis, with the negative control population clearly 
separated from the positive control population. Specifically, 98% of uptake control cell population had a cell-
associated fluorescence higher than the 95th percentile of the negative control cell population. The Smartflare 
probe signal, however, is characterised by a broad distribution of cell-associated fluorescence values due to 
variation in the rate of probe uptake and degradation [Prigodich12].  
The SmartFlare uptake dynamics were also explored, in order to test the time-lapsed acquisition protocol 
and ensure the imaging analysis workflow retained the biological signal. For this purpose, 200pM of uptake 
and scramble control SmartFlare probes were added to the culture medium of cells and time-lapsed imaging 
was started after 30minutes. The results obtained are shown in Figure 5.9.B. The effect of time on the 
fluorescence signal for each probe has been visualised by continuous plotting of the interquartile range of 
the cell-associated fluorescence values (y-axis) over time (x-axis). At each time point the upper boundary of 
the shaded area is the 75th percentile value and the lower boundary is the 25th percentile value. The probes 
remained stable inside the cells for the duration of the imaging, with minimal increase in the scramble 
negative control signal. The uptake control probe demonstrated the expected behaviour (as characterised by 
the manufacturer), of gradual increase in the signal, which reaches a steady state after a period of 16 hours. 
Hence, it can be concluded that the background correction and segmentation steps do not introduce artifacts 
in the analysis. Further, a good dynamic range was observed after 4 hours of probe incubation, with the 
uptake control signal consistently above that of the scramble negative control.
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Figure 5.9 Cy3-tagged SmartFlare probe uptake and stability in HUVECs
A) HUVECs were imaged following twenty-four hour incubation with either Cy3-tagged uptake control or Cy3-tagged 
scramble control probes at 200pM concentration. Quantification of signal was based on segmenting individual cells and 
measuring the average fluorescence signal associated with each cell. For each experimental condition, the single-cell 
measurements are represented as density distribution plots that display the fluorescent signal across the whole 
population of  cells. The uptake control distribution has been gated at the 95th percentile of the scramble control 
distribution,  black: scramble negative control, green: uptake control.  B) SmartFlare probe uptake kinetics were 
investigated through time-lapsed imaging, started immediately after the addition of 200pM of uptake or scramble control 
probes.  The effect of time on the fluorescence signal for each probe has been visualised by continuous plotting of the 
interquartile range of the cell-associated fluorescence values (y-axis) over time (x-axis). At each time point the upper 
boundary of the shaded area is the 75th percentile value and the lower boundary is the 25th percentile value. 
The detection of the Cy5-tagged SmartFlare probes, however, was problematic. There was no detectable 
signal after twenty-four hour incubation with 200pM of probes. Following twenty-four hour incubation with 
400pM of Smartflare probe, the maximum recommendation by the manufacturer, specific signal could be 
detected with 5-second exposure time, and 4 times binning of the signal, (figure 5.10). The overlap  between 
positive and negative control probes was much higher than that observed for the Cy-3 tagged probes, 
resulting to only 34% of the uptake control treated cell population having a cell associated fluorescence 
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value higher than that of scramble control probes. Further, even with 5 second exposure time and signal 
binning, there was no detectable signal for the first 15 hours of probe incubation. The lack of signal was due 
to hardware limitation of the microscope, since the signal was detectable at higher magnifications (20x), 
which however did allow for cell segmentation. Hence, due to the difficulties in imaging Cy-5 tagged 
Smartflare, the Smartflare feasibility study was continued with Cy3-tagged Smartflare. 
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Figure 5.10 Cy5-tagged SmartFlare probe uptake and stability in HUVECs
HUVECs were imaged following twenty-four hour incubation with either Cy5-tagged uptake control or Cy5-tagged 
scramble control probes at 400pM concentration. Quantification of signal was based on segmenting individual cells and 
measuring the average fluorescence signal associated with each cell. For each experimental condition, the single-cell 
measurements are represented as density distribution plots that display the fluorescent signal across the whole 
population of cells. The uptake control distribution has been gated at the 95th percentile of  the scramble control 
distribution, black: scramble negative control, red: uptake control.
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5.3.3. Sensitive detection of endogenous RNA levels in live cells
Next, a series of experiments were designed to test the SmartFlare probe ability to detect and quantify 
endogenous RNA levels in live cells. For this purpose, KLF4 specific probes were chosen due to their 
established role in shear-induced responses in endothelial cells. Initially, KLF2 and eNOS probes were also 
investigated, but due to technical difficulties in imaging Cy-5 tagged probes, they were not pursued further. 
First the specificity of KLF4 SmartFlare probes was tested by employing siRNA targeted against KLF4. In 
these experiments HUVECs were transfected with either mock siRNA or siRNA targeted against KLF4. 
Twenty-four hours after transfection KLF4 or Scramble control probes were incubated with the cells for 16 
hours. The cell-associated fluorescence values for each condition are represented as density distribution 
plots in Figure 5.11. KLF4-specific signal in the siKLF4 transfected cell population (yellow line) was 
significantly (p  < 0.0001) reduced compared to that of mock-transfected cells (blue line), and shifted towards 
background control signal (red line). The observation was confirmed in two independent experiments.
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Figure 5.11 Validation of KLF4 SmartFlare probe specificity.
HUVECs were transfected with either mock siRNA or siRNA targeted against KLF4. Twenty-four hours after transfection, 
Cy3-KLF4 or Cy-3-Scramble SmartFlare probes were incubated with the cells for 16 hours. Single-cell associated 
fluorescence values for each condition are represented as density distribution plots. red line: SmartFlare scramble 
control (67 cells), yellow line: KLF4 SmartFlare signal for siKLF4 transfected cells (74 cells), blue line: KLF4 SmartFlare 
signal for mock siRNA transfected cells (70 cells).
In current literature, SmartFlare probes have only been used to distinguish between cell populations, based 
on marker gene detection. SmartFlare ability to quantify relative gene expression levels has not been 
demonstrated. Therefore, in this work the sensitivity of SmartFlare probes to detect graded responses to a 
stimulus was investigated using KLF4 specific SmartFlare probe and Simvastatin drug treatment. 
Simvastatin induced up-regulation of KLF4 gene expression in endothelial cells has previously been 
described and associated with statin’s pleiotropic effects on vascular protection [Zhou09, Villarreal10, 
Ohnesorge10, Maejima15]. In this experiments, cells were either left untreated or treated with different 
concentrations of Simvastatin (0.1µM, 1µM and 10µM) for twenty hours. KLF4 Smartflare probes were then 
added to the culture medium in the presence of statins and cells were imaged after 16 hours. A significant (p 
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< 0.001) statin concentration-dependent shift in the fluorescence of untreated, 1µM statin treated and 10µM 
statin treated cell populations was observed, Figure 5.12. No significant difference was detected between 
untreated and 0.1µM statin treated cells. 
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Figure 5.12 Detection of statin concentration-dependent shifts in endogenous KLF4 RNA levels. 
HUVECs were either left untreated or treated with different concentrations of Simvastatin (0.1µM, 1µM and 10µM) for 
twenty hours. KLF4 Smartflare probes were then added to the culture medium in the presence of statins and cells were 
imaged after 16 hours. For each condition, representative fluorescence images are shown, together with cell-associated 
fluorescence density distribution plots; black line: untreated cells, red line: 0.1µM Simvastatin, green line: 1µM 
Simvastatin and blue line: 10µM Simvastatin treated cells. Each distribution plot pools data from around 500 cells. 
Statistical significance was determined by Kolmogorov–Smirnov (KS) test, p-value < 0.05.
In a different experimental setting HUVECs were pre-incubated with different statin concentrations (1µM or 
10µM) for 16 hours, followed by the addition of KLF4 or scramble negative control Smartflare probes and 
starting time-lapsed imaging immediately after probe addition, Figure 5.13. This experiment was designed to 
test if the rate of increase in the KLF4 Smartflare signal correlates with the gene synthesis rate in the cells. 
The statin pre-incubation period should bring the cells at different steady states for KLF4 expression, and 
therefore the probe signal for each experiment condition should increase at different rates. The effect of time 
on the KLF4 fluorescence was visualised by continuous plotting of the interquartile range of the cell-
associated fluorescence values (y-axis) over time (x-axis), Figure 5.13. As it can seen from the plots, the 
slope of the curves are steeper for higher concentrations of statin treatment, which suggests different 
synthesis rates for KLF4 gene.
In summary, SmartFlare probes have been established in HUVECs, and have demonstrated high 
transfection efficiency and stability. Furthermore, KLF4 SmartFlare probes have been successfully used for 
live cell detection of endogenous RNA levels in a sensitive and specific manner.
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Figure 5.13 Time-lapsed imaging of statin effect on endothelial cell KLF4 expression 
HUVECs were pre-incubating with different statin concentrations (1µM and 10µM) for 16 hours, followed by the addition 
of KLF4 or scramble negative control probes and time-lapsed imaging for 8 hours immediately after adding the probes. 
The effect of time on the fluorescence signal of different  experimental conditions is visualised by continuous plotting of 
the interquartile range of the cell-associated fluorescence values (y-axis) over time (x-axis). At each time point the upper 
boundary of the shaded area is the 75th percentile value and the lower boundary is the 25th percentile value. Panel (i) 
displays the range of  KLF4 fluorescence (light brown) and scramble negative control (gray) for untreated cells. Panel (ii) 
displays the range of KLF4 fluorescence (light green) and scramble negative control (gray) for statin (1µM) treated cells. 
Panel (iii) displays the range of KLF4 fluorescence (purple) and scramble negative control (gray) for statin (10µM) treated 
cells. Panel (iv) overlays the range of KLF4 SmartFlare probe for all three experimental conditions.
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5.3.4 Evaluating SmartFlare probe potential for flow studies 
Having established SmartFlare functionality and sensitivity, we next investigated the ability to detect changes 
in gene responses in real-time under flow conditions. The expectation is that the rate of increase in 
Smartflare signal should change during the course of the experiment, as shear stress unregulates KLF4 
expression. Using the optimised time-lapsed protocol for flow studies, multiple conditions were tested 
simultaneously using commercial multi-channel chambers. Due to the large volume of medium used in the 
flow circuit (60ml), it was not possible to add SmartFlare directly in the circulating medium. Therefore, for 
flow studies, the SmartFlare protocol was modified to pre-incubate cells with probes (200pM) for 16 hours, 
before the start of flow. Following the pre-incubation period, SmartFlare containing medium was removed, 
and the flow channels were serially connected in a flow circuit. For static conditions, SmartFlare containing 
medium was removed, and fresh media was added without any SmartFlare. Figure 5.14 and Figure 5.15 
display the results for pre-incubating cells with either uptake control, scramble negative control or KLF4 
probes, followed by time-lapsed imaging for 20 hours under static or flow conditions (at 15 dyne/cm2). 
Quantification of signal was based on segmenting individual cells at each time-point and measuring the 
average fluorescence signal associated with each cell. The data for each time-point have been pooled from 
cell-associated fluorescence values in three different images along the length of the flow chamber, covering 
approximately 600 cells. 
For all probes included in the analysis (uptake, scrambled and KLF4), the cell-associated fluorescence 
intensities at the start of the experiment were comparable between sheared and static sample, (figure 
5.14.A). Following the initiation of flow, however, the probes behaved differently under sheared and static 
conditions. Figure 5.14.B  focuses on the effect of 20 hours of flow exposure on the uptake control signal. The 
signal from uptake control probes is expected to remain stable during the experiments, since they are 
constitutively active and do not respond to any specific cellular targets. As shown in Figure 5.14.B  (lower 
panel), there was an unexpected loss of signal under flow conditions. The cell-associated fluorescence for 
sheared cells is progressively diminishing, shifting towards the signal observed in scramble negative 
controls. Contrary, static control conditions have no associated loss of signal, excluding the possibility that 
this is due to photobleaching, (figure 5.14.B  (top)). Further, the loss of signal was not associated with 
reduction in cell numbers and was also confirmed in experiments performed in a cell culture incubator, 
excluding the possibility that the observation was due to the environmental conditions under the microscope. 
The effect of time on the fluorescence signal of sheared samples was further explored, in order to investigate 
whether correcting for the flow-induced signal reduction can derive shear specific effects on KLF4. 
Specifically, if the KLF4 response were decreasing at a slower rate than that of the uptake control, it would 
suggest that there are specific shear stress induced changes in the KLF4 probe. To this effect, Figure 5.15.A 
plots in a continuous manner the interquartile range of the cell-associated fluorescence values for different 
probes (y-axis) over time (x-axis). The reduction in the signal over time was also quantified by calculating at 
each time-point, the area under the curve (AUC) that falls into the interquartile range of the 1st time-point, 
(figure 5.15.B). The definition of AUC is illustrated diagrammatically in Figure 5.15.C. The AUC parameter 
measures the consistency between two distributions. If two distributions overlap, the AUC is expected to 
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remain stable at around 0.5. On the other hand, reduction in the AUC value is indicative of the distribution 
shifting to the right or left.
Figure 5.14 Effect of 20 hours of flow exposure on SmartFlare uptake control signal
Cells  were pre-incubated for 16 hours with three different probes (uptake control, scramble negative control or KLF4 
probes),  followed by time-lapsed imaging for 20 hours under static or flow conditions (at 15 dyne/cm2). Measurements 
were taken every 30 minutes.  Quantification of signal was based on segmenting individual cells and measuring the 
average fluorescence signal associated with each cell. For each experimental condition, the single-cell measurements 
are represented as density distribution plots. Each distribution plot represents the cell-associated fluorescence values for 
approximately  600 cells at a specific time-point. A) Cell-associated fluorescence intensities at  the start of the experiment 
(0 hours), for sheared (solid line) and static (dashed line) samples; uptake control (red), scrambled control (black) and 
KLF4 (blue)). B) Representative phase contrast and fluorescence images of SmartFlare uptake control for static (top) 
and sheared cells (bottom) at 0 and 10 hour after the start of the experiment. C) Effect of time on the cell-associated 
fluorescence intensities of the uptake control probe under static and sheared conditions. The plots are progressively 
coloured from black to light orange, representing 0 hours and 20 hours after the start of the experiment, respectively. 
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The largest loss of signal for the uptake probe occurs in the initial 5 hours of flow onset (Figure 5.15.A). 
During the same period the KLF4 probe only shows minimal reduction of signal (Figure 5.15.B). The KLF4 
probe, however, exhibits a steeper slope between 5 to 8 hours, resulting to the same overall loss of signal 
relative to the signal at the 1st time-point (figure 5.15.B, 5.15.A (right panel)). The plots in Figure 5.15.B  also 
confirm the observation that the signal in the static controls, for both uptake control and KLF4 probes 
remains stable. Given the current data, it was not possible to conclude whether there were shear induced 
effects on KLF4 expression.
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Figure 5.15 KLF4 SmartFlare probe response under flow conditions
Cells  were pre-incubated for 16 hours with three different probes (uptake control, scramble negative control or KLF4 
probes),  followed by time-lapsed imaging for 20 hours under static or flow conditions (at 15 dyne/cm2). Measurements 
were taken every 30 minutes. A) The effect of time on the fluorescence signal of sheared samples is visualised by 
continuous plotting of the interquartile range of the cell-associated fluorescence values (y-axis) over time (x-axis). At 
each time point the upper boundary of the shaded area is the 75th percentile value and the lower boundary is the 25th 
percentile value.  The left panel displays the range for uptake control (light brown) and scramble negative control (gray). 
The middle panel displays the range for KLF4 probe (purple) and scramble negative control (gray). The right panel, 
overlays the range of all three different SmartFlare probes. B) At each time-point, the reduction in the signal was 
quantified by calculating the area under the curve (AUC) that falls  into the interquartile range of the 1st time-point. 
Dashed lines represent static conditions, solid lines represent sheared conditions; uptake control probe (red), scrambled 
control probe (black), KLF4 probe (blue)). The definition of  AUC is illustrated diagrammatically in (C) by the green area.  If 
two distributions overlap, the AUC is expected to remain stable at 0.5. Reduction in the AUC, indicates that the 
distribution has shifted to the left.
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5.4 Discussion
5.4.1 Summary of work
In this chapter we have focused on the development of an assay for quantifying the biological effect of 
siRNA knockdown, with an emphasis on the role of SmartFlare nanoparticle technology as a modality for 
real-time quantification of endogenous RNA levels in living cells. A key contribution of this chapter has been 
the optimisation of experimental protocols for time-lapsed flow studies and implementation of associated 
software for single-cell imaging analysis. Cell alignment to flow under time-lapsed conditions was confirmed 
with 58% of the sheared cell population perfectly aligned to the direction of flow at 18 hours, compared to 
only 27% at the start of the experiment. It has been reported that the temporal profiles of 379 shear 
responsive genes, measured at 3, 6, 12, 24, and 48 h after exposure to shear stress, are variable and could 
be classified into eleven clusters [Ando11]. The ability to monitor the temporal dynamics of endothelial cell 
transcriptional profiles under flow conditions, can reveal the sequence of complex cascades that govern the 
endothelial cell responses to shear stress. 
The single-cells analysis pursued in this work is very important for the accuracy of the results since it can 
capture the cell-to-cell variability arising due to the inherent stochasticity in gene expression [Raj08, 
Blake03]. In the context of shear stress responses, it has been suggested that the cell’s micro-environment 
can alter their response to the same shear stress conditions [Davies01]. Further confounding on this 
biological variation, the multi-step  procedure of the RNAi platform results to spots with heterogeneous cell 
population, consisting of a mixture of un-transfected cells, cells transfected to a different extent with reporter 
probes and cells transfected with only siRNA. There are many instances in literature where single-cell 
analysis was beneficial in the interpretation of RNAi screening results [Snijder12, Rajan11, Liberali15]. 
Extending the current software to include individual cell tracking over time, will extend the population 
measurements presented in this chapter and fully address the issue of cell-to-cell variation. 
The work presented herein, is the first study to describe the use of SmartFlare probes in primary endothelial 
cells. We have shown that SmartFlare probes can achieve high transfection efficiency in HUVECs, with no 
observable cytotoxicity. Time-lapsed imaging has demonstrated that the probes remain stable in the 
intracellular environment of static cultures with high signal to noise ratio. Furthermore, KLF4 SmartFlare 
probes have been successfully used for live cell detection of endogenous RNA levels in a sensitive and 
specific manner. Current application papers using SmartFlare probes, are limited to fluorescence activated 
cell sorting analysis to detect subpopulation of cells based on markers genes with present/absence 
behaviour [Halo14, Kratz14, Khare14, Lahm15, Krönig15]. We have demonstrated a statin concentration-
dependent shift in endogenous KLF4 RNA level, which extents the use of SmartFlare probes, beyond the 
detection of marker genes, and demonstrates their applicability for relative quantification of endogenous 
RNA levels. Single-cell analysis has been instrumental in the ability to quantify the gene response, since the 
broad response of RNA hybridisation probes, reported elsewhere [Prigodich12, Chen10] and also observed 
in our results, meant that the average response of the whole population was not representative. 
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We have further attempted to use RNA hybridisation probes for real time quantification of endogenous RNA 
expression, based on the hypothesis that over time the probe measures the synthesis rate of a gene and 
therefore gene up-regulation and down-regulation can be inferred by detecting changes in the rate of 
increase in SmartFlare signal over time. The current data are inconclusive as to the validity of this 
hypothesis. Even though different rates have been observed for cells pre-conditioned at different steady 
states (using varied statin concentrations), it has not been tested whether the rates dynamically change 
during the experiment and if the sensitivity of the SmartFlare probe is sufficient to quantify this. The main 
obstacle encountered in trying to validate this hypothesis has been the loss of SmartFlare signal under flow 
conditions. The cell-associated fluorescence for sheared cells progressively diminished and shifted towards 
the signal observed in scramble negative controls. Contrary, static control conditions had no associated loss 
of signal. The reduction in the signal was observed both in a cell culture incubator and in time-lapsed 
imaging experiments excluding the possibility that it was due to the imaging or the environmental conditions 
under the microscope. 
5.4.2 Future work
The mechanism of SmartFlare signal loss under flow conditions is not fully understood. There are a number 
of possible explanations including: reduced nanoparticle endocytosis or enhanced exocytosis under flow 
conditions, increased metabolic rate and/or production of reactive oxygen species (ROS) in sheared cells 
resulting to faster breakdown of the fluoorophore and photobleaching, respectively. 
Nanoparticle delivery to endothelial cells has been investigated in literature in the context of nanoparticle 
mediated drug delivery. In agreement with our observations these studies report a shear stress and cyclic 
stretch related reduction of nanoparticle signal10 [Freese14, Bhowmick12, Lin10]. The work of Freese et al. 
demonstrated that the loss of signal was due to reduction of endocytosis, as opposed to enhanced 
exocytosis or induction of cellular stress. In the experiments conducted in this study, however, cells were pre-
incubated with SmartFlare probes and the cells were not continuously perfused with probes during the flow 
exposure. Therefore, nanoparticle uptake for static and sheared cells was performed under similar 
experiment conditions and the starting signal was comparable between the two cell populations. This would 
suggest that altered uptake is less likely to play a role in the loss of signal, observed in our study. It is worth 
noting that in order to avoid the activation of endothelial cell shear responses, the cells were not thoroughly 
washed before the onset of flow and therefore it is possible that residual nanoparticles were still present in 
the static conditions. 
The effect of exocytosis on nanoparticle cellular clearance has not been specifically investigated under flow 
conditions. Freeze et al. demonstrated that nanoparticle exocytosis was not affected by cyclic stretch, but its 
importance in the context of shear stress application needs to be investigated [Freese14]. Further, in static 
smooth muscle cells, nanoparticle exocytosis was enhanced in serum rich medium [Panyam03]. In our study 
2% serum medium was used, making it less likely that this is the primary cause of the signal reduction. 
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10 These studies do not specifically use SmartFlare probes. 
SmartFlare probes have been marketed by the manufacturer for their ability to intrinsically clear the cell and 
allow for reuse of the cells in downstream assays. The nanoparticles are either degraded by cellular 
enzymes, or recycled out of the cells by active transport or diffusion [Wu14]. A possible explanation is that 
these mechanisms might be accelerated under flow condition. Prolonged shear stress is normally associated 
with quiescent metabolic state of endothelial cells [Sun15] and low permeability [Warboys10]. The 
observation, however, that loss of signal occurs early after the onset of flow, suggests that this could be 
associated with the adaptive response to shear stress. During this period, the endothelial cells are 
undergoing an active change in phenotype with alteration in gene expression that could contribute to higher 
metabolic rate when compared to static cells. Further, there is a transient increase in NFkB  [Searles06], and 
endothelial cell permeability [Zhang12], which could potentially adversely affect SmartFlare signal.
A final mechanism to consider is the role of reactive oxygen species (ROS) on photobleaching. ROS 
produced as a result of the imaging, have been shown to negatively effect fluorescence signal due to 
photobleaching [Zheng14, Hoebe07]. The stable signal in the static controls suggests that imaging 
acquisition is not a key determinant of photobleaching. Nonetheless, ROS might still play a role in 
photobleaching through an enhanced production, as a result of flow exposure. ROS are known to respond to 
shear stress; steady flow conditions are normally associated with lower concentrations of ROS when 
compared to disturbed flow patterns, but there are reported cases of increased intracellular ROS under 20 
dyne/cm2  [Hsieh14, Chiu97]. 
A series of experiments can be performed to discriminate between these hypotheses. The experiments 
presented in Section 5.3.4 should be repeated in the presence of exocytosis blockers and anti-oxidant 
treatment to determine if these improve signal retention under flow. In addition static control cells should be 
thoroughly washed before the start of experiment to test if prolonged incubation is responsible for the 
differences is signal. Furthermore, in order to exclude other causes aside from flow causing the problem, we 
can investigate if there is a linear relationship  between applied shear stress level and signal retention. A 
better understanding of the mechanism of loss of signal could indicate if this is a specific issue with the 
nanoparticle technology or a general issue with RNA hybridisation probes. To the best of our knowledge 
there are no recorded studies on molecular beacons in live endothelial cells or under the effect of shear 
stress in general. 
Regardless of the loss of signal under flow conditions SmartFlare probes under static conditions can still be 
used to validate the hypothesis that RNA hybridisation probes can be used for real-time detection of gene 
dynamics through monitoring changes in their synthesis rate. To this effect, experiments have been planned 
but not completed on time for the submission of this thesis. In these set of experiments, instead of pre-
conditioning the cells with different concentrations of statins, the statins are added to the media at the same 
time as the SmartFlare probes and time-lapsed imaging is started immediately. The expectation is that at the 
beginning of the experiment, the rate of increase in fluorescence should be comparable between untreated 
and statin treated cells, while statin treated cells should gradually change their rate as more KLF4 is being 
produced. Similarly, in order to test the real-time detection of gene down-regulation, siRNA targeted against 
MEF2, the transcription factor responsible for KLF4 activation, is transfected in endothelial cells and time-
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lapsed imaging is started. The levels of KLF4 should gradually reduce over the period of 24 hours, as the 
knockdown comes into effect. In parallel, to support the experimental efforts, a mathematical model of 
coupled differential equations to describe the relationship  between SmartFlare dynamics and RNA transcript 
concentration should be set up. By establishing the kinetics of the sensor (SmartFlare) deconvolution can be 
used to derive the mRNA synthesis and breakdown rates [de-Leon09].
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5.5 Outlook
In conclusion, in this chapter we have explored the feasibility of using SmartFlare RNA probes as a modality 
for time-resolved quantification of gene responses in live cells. Due to their complex behaviour under flow, 
further investigation is needed for their adaptation as a high-content RNAi screen molecular readouts. 
Moving forward with the integrated platform for network validation more conventional methods such as 
plasmids encoding fluorescent protein constructs might be advisable. Cell arrays in conjunction with 
fluorescent protein reporter genes have previously been used for live cell quantification of expression 
dynamics. Rajan et al. used reverse transfected fluorescent reporter plasmids and drug induced responses 
to monitor single-cell transcriptional activity over time [Rajan11]. King et al. fabricated a live cell array within 
a device capable of seeding multiple cell lines, each stably transfected with a GFP reporter plasmid for a 
different readout [King07]. Finally, Tian et al. generated a viral based reverse transfection array with each 
spot having a different virus construct of transcriptional regulatory elements (promoters) coupled to GFP 
[Tian10]. In the works stated above the use of modified fluorescence constructs with fast maturation and 
degradation times, together with dual-reporter systems for internal signal normalisation (ratiometric) analysis 
was pivotal for quantitative analysis of gene dynamics. The aforementioned studies are a proof of concept 
that GFP constructs can be used for quantification of gene expression dynamics. The studies only analysed 
3-4 constructs, and therefore the issue of high-throughput plasmid production, which was our motivation for 
exploring alternative methods, was not addressed. With the advent of molecular techniques the high 
throughput production and purification of plasmids is possible, and fast plasmid production protocols are 
constantly being improved in our laboratory. Once these are established, we believe that the methods setup 
in Chapter 4 can easily be optimised for co-arraying plasmids together with siRNA. There are reported cases 
of co-arrayed plasmids with siRNA on reverse transfection arrays, using the same protocols as that for 
siRNA alone [Yoshikawa04, Erfle04].
Live cell fluorescence imaging of endogenous RNA/protein molecules is a rapidly advancing field with new 
technologies constantly being developed. Recently, aptamer nucleic acid molecules have been synthesised 
that can form secondary and tertiary structures, similar to those of antibodies. Initial work on adapting these 
for live cell imaging of endogenous molecules is promising [Wang13]. Further, peptide tags (e.g., SNAP-tags) 
have been developed, which are fused to proteins and can catalyse the covalent attachment of fluorophores 
added to cell medium. These tags are not naturally fluorescent, unlike fluorescent proteins, allowing more 
flexibility to signal onset and more accurate detection of protein dynamics through the use of pulse-chase 
analysis [Corrêa14]. There is ongoing work to couple peptide tags with CRISPR-Cas genome manipulation 
system and enable the labeling of endogenous proteins [Dean14]. These emerging technologies offer 
exciting opportunities for high-content molecular readouts. 
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6Concluding remarks
The prevalent pathology leading to high mortality from cardiovascular diseases is atherosclerosis. Despite 
strong evidence for the association of shear stress and atherosclerosis initiation, there has been very little 
potential treatment focusing on directly modulating shear stress-induced phenotypes in endothelial cells. The 
tools presented in this thesis provide the basis for developing qualitative models and uncovering targeted 
therapies, in order to further our pursuit for shear-mediated atherosclerosis prevention.
In the post genomic era system component identification is routinely accomplished through high-throughput 
techniques. The next frontier in Systems biology is the development of strategies for identifying their complex 
interactions. Currently, network inference remains a formidable challenge. This thesis presents a two-step 
approach, which integrates network inference from gene expression data with functional genomics within a 
single framework to set up  an integrated platform for gene network inference and validation. In order to 
achieve this a number of technological innovations were necessary and developed. The success of the 
platform relies on, i) the symbolic learning which is suitable for reasoning over incomplete knowledge and 
makes assumptions to be tested, ii) the use of prior knowledge to infer causal networks, which can be used 
to design informative experiments and iii) an experimental platform, which can be applied on primary cells 
for mechanotransduction studies and allows for multiple loss-of-functions tests to be examined.
The first contribution of the work is a comprehensive software package that integrates a logic-based model 
for gene network inference and a set of complementary bioinformatics methods for microarray data 
processing and feature selection. The methods have been implemented within the open-access R/
Bioconductor environment and can be applied in different contexts and to multiple diseases, thus 
contributing to a set of renewable resources generated by the work conducted in this thesis. 
In Chapter 2, we have presented an approach, named ARNI, to logically model and automatically construct 
through abductive reasoning, regulatory gene networks from experimental data and background prior 
knowledge on gene functions and interactions. The symbolic representation offers a model which allows an 
improvement on performance, applicability and expressiveness of existing methods. A unique contribution of 
our method, is that, while improving topology inference, it is incorporated within a general logical framework 
that is elaboration tolerant and provides support for meta-level reasoning to test hypotheses and design 
informative experiments.
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In Chapter 3, a bioinformatics workflow for the integration of gene expression profiles across platforms and 
species was established and applied for generating an integrated endothelial cell mechanoresponsive gene 
expression profile. The work presented makes key contributions to both, the field of bioinformatics and the 
field of endothelial cell mechanobiology. The bioinformatics pipeline shows for the first time that direct 
integration of Agilent, Affymetrix and Illumina platforms is possible. The endothelial cell integrated dataset 
identified >1600 genes to be shear responsive, more than any other study, and functional analysis suggests 
that the results are consistent with current literature regarding the atheroprotective transcriptional program 
induced by shear stress. The dataset can be used by the scientific community to advance our understanding 
of mechanoresponses in endothelial cells. 
Chapter 4 described the design, fabrication and evaluation of a high-throughput RNAi platform for 
mechanotransduction studies in primary mammalian cells. A challenge in this project was to conceptually 
design the platform in a way that was practical and satisfied all the requirements. Several alternatives were 
pursued and an iterative cycle of designing, testing and re-designing of the components was necessary. The 
methods setup  are practically easy to follow and reduce the risks of experiments failing due to technical 
problems. Each step  of the assemblage was evaluated and effective loss-of-function was demonstrated for 
multiple gene targets. The established RNAi platform is, to our knowledge, the first platform to demonstrate 
successful reverse electroporation of mammalian primacy cell lines and presents the first described system 
that can couple RNAi screening with mechanotransduction studies. Endothelial cell dysfunction has been 
linked to many diseases, for example cancer, renal failure, viral responses and aneurism [Rajendran13]. 
Given that these cells are constantly exposed to shear stress in vivo, any study aiming to understand the 
mechanism of their disease should be associated with flow studies. Further, the highly modular design of the 
platform and the versatility provided by electroporation extends its applicability to a range of cell types 
relevant to human disease. The field of mechanobiology has grown dramatically in the last decade and 
includes a diverse range of disciplines including tissue engineering, regenerative medicine, ageing and 
cancer metastasis [Phillip15, Sun13, Iskratsch14].
Chapter 5 explored the feasibility of using SmartFlare RNA probes as a modality for time-resolved 
quantification of gene responses in live cells. A key contribution of this chapter was the optimisation of 
experimental protocols for time-lapsed flow studies and implementation of associated software for single-cell 
imaging analysis. These were not previously set up in our group and therefore a number of practical 
difficulties had to be overcome. The ability to monitor the temporal dynamics of endothelial cell 
transcriptional profiles under flow conditions can reveal the sequence of complex cascades that govern the 
endothelial cell responses to shear stress. We have further demonstrated SmartFlare probes applicability for 
relative quantification of endogenous RNA levels under static conditions, which extends the use of 
SmartFlare probes beyond the detection of marker genes currently reported in the literature. Due to their 
complex behaviour under flow, further investigation is needed for their adaptation as a high-content 
molecular readout for RNAi screening.
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Having the initial step  of hypotheses generation driven by computational modeling provides a rapid and cost 
effective way to determine the structure of signaling networks as compared to other technologies such as 
large scale genetic interactions (GI) screens. Recent high profile publications in Nature and Science have 
highlighted the power of GI screens for defining gene pathways [Hart13]. Genetic interactions are derived 
from combinatorial RNAi screens, which knockdown two genes simultaneously within the same cell11. The 
pairs of genes that need to be depleted has to be carefully chosen as the number of potential gene pairs in 
the human genome is enormous; in the order of hundreds of millions. For instance, Laufer et al. focused their 
analysis on 323 epigenetic regulators in colon cancer and performed approximately 52,000 tests, Roguev et 
al. analysed a set of 130 genes for chromatic remodeling and had to perform 11,000 tests [Roguev13, 
Laufer13]. Consequently, large scale applications of GI screening have been limited to biological questions 
that have selectable phenotypes (i.e. proliferation, apoptosis), which allows for pooled RNAi screening 
formats12 [Wong15, Kampmann13].  Kampmann et al. first performed a genome-wide pooled RNAi screen to 
identify candidate genes involved in toxin responses, and then performed a combinatorial pooled RNAi 
screen to uncover GI interactions. In our specific biological question, the diversity of mechanotransduction 
makes it difficult to find an appropriate readout for the RNAi screen. A single transcription factor does not 
capture the broadness of the shear stress response, while a phenotypic readout is not useful for network 
inference. Consequently, we have to rely on observational data to initiate the network inference approach. 
Using computational tools to process the vast amount of data already available reduces the experiment 
component, thus making network inference more tractable. In addition, having predicted networks at the 
experiment design stage can help  design RNAi experiments to maximise the discriminatory power of the 
tests and apply combinatorial experiments in cases of predicted redundancy in the networks.
During the project we have carried out an initial investigation of possible ways to achieve the full automation 
of the integrated platform. The integrated platform consists of several software and hardware components. 
The software implementation involves four different computational environments (ImageJ, Matlab, ASP/
Sicstus, R/Bioconductor) embedded within two frameworks: Matlab  for imaging analysis and R/Bioconductor 
for computational inference. Hardware components include the robot dispenser, fluorescent microscope and 
a central computer.  The integration approach involves a central computer connected to the robot dispenser 
and the microscope and Labview software as a master, which controls and steers all other tasks in the cycle. 
Communication between the different software is achieved via the generation of standard files. Initial 
assessment of the controllability of the robot dispenser through scripts written by the R/Bioconductor 
framework looks promising. 
In conclusion, a framework of computational and experimental tools has been developed with a special focus 
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11  Genetic interaction can be predicted by calculating the deviation between the predicted and observed double 
knockdown phenotype. In a situation where two genes are acting in parallel pathways, depletion of any one of the two 
has a moderate effect  on the phenotype since the genes compensate for each other’s role; depletion of both, however 
has a much stronger effect. Contrary, in a situation where genes are acting in linear pathways, depletion of either causes 
the same phenotypic effect. 
12  In a pooled RNAi screen format, siRNAs are delivered at random to a bulk population of cells. The cells with the 
desired phenotype are selected, and the siRNA  molecule that  they had been transfected with is  identified through a bar 
code system. 
on uncovering mechanoresponsive gene networks in endothelial cells. In a fully developed scientific 
approach, the coarse system components of the endothelial cell response to shear stress are identified by 
the methods set up in Chapter 3, the abductive inference method established in Chapter 2 expands these 
based on their topological context, in order to compensate for experimental limitations, and arranges them in 
a set of alternative networks. The experimental procedures developed in Chapter 4 and Chapter 5 lead to a 
final fully validated mechanoresponsive network in endothelial cells, via an iterative cycle of measurement, 
validation and network refinement. 
All available experimental or computational methodologies, including the one developed herein, have their 
strengths and weaknesses; no individual methodology can capture the full complexity of biological systems. 
The central dogma of biology states that DNA is transcripted into RNA which is translated to protein 
[Crick70]. In reality, this simple two-step  process is regulated at multiple levels: DNA itself is regulated by 
epigenetic mechanisms; the transcription process is regulated by transcription factors co-factors; post 
transcription regulation mechanisms such as alternative splicing and microRNA further regulate mRNA levels 
and proteins are subjected to a series of modification via post translational mechanism [Shapiro09]. We 
envisage that our logic based method, through the integrity constraints, which allow for incremental model 
refinement, can form a central platform for the progressive integration of diverse types of data and 
methodologies to improve the final network inference.
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Appendices
Appendix I: ARNI implementation
A.1 Sicstus and Prolog Implementations
Logic Program for clauses (5)-(9) of the logical model of sign directed networks (Section 2.2)
Executable Commands
?-['../src/Asystem.pl'].
:-load_theories(['../src/connectSeeds.pl', '../priors_db_X.pl','ExpX_seeds.pl']).
?-query_all_with_txt_output([get_paths(6)],'../output_file.pl').
Logical program for connectSeeds.pl:
get_paths(M):- call(findall(R, query([connect_seeds(M)],(R,_,_)),Rs)),!
! !    abd_priors(Rs).
connect_seeds(M):- seed(Q1),seed(Q2), path([Q2],Q1,0,M,Z).
path([U|L],Q,N,M,[Q,U|L]):- N < M,temp(Q,U).
path([V|L],Q,N,M,[U,V|L]):- N<M, temp(U,V), \+ seed(U), member(U,[V|L]).
path([V|L],Q,N,M,Z):- ! N<M, temp(U,V), \+seed(U), \+member(U,[V|L]), 
! ! ! ! N1 is N+1, path([U,V|L], Q,N1,M,Z).
abd_priors([]).
abd_priors([H|T]) :- abduce_list(H), abd_priors(T).
abduce_list([]).
abduce_list([temp(G1, G2)|T]) :-  relevant_ip(G1,G2), abduce_list(T).
Abducibles and Integrity constraints
abducible(temp(_,_)).
abducible(relevant_ip(_,_)).
abducible(establish_link(_,_,_)).
abducible(reg_pot(_,_)).
types(temp(G1,G2), [type(ip_db(G1, G2))]).
ic:- relevant_ip(X,Y), known_sign(X,Y,S), \+establish_link(X,Y,S).
ic:- relevant_ip(X,Y), known_sign(X,Y,S), \+establish_link(X,Y,S).
ic:- relevant_ip(X,Y), \+ abdu_reg_pot(X).
 
abdu_reg_pot(X):- known_effect(X,S), reg_pot(X,S).
abdu_reg_pot(X):- known_reg(X), reg_pot(X,1),reg_pot(X,-1)
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ic:- reg_pot(X,1),reg_pot(X,-1),known_effect(X,S).
ic:-establish_link(X,_,S), known_effect(X,S1), S =/= S1.
A.2 Clingo and ASP Implementations
Logic Program for clauses (10)-(33) of the logical model of sign directed networks (Section 2.2)
Executable Commands
./clingo arni_asp.pl  complete_priors_filepath.pl  --opt-all,  &> arni_output_file.txt
Logical program 
% Compatible and Competitive abducibles expressed as choice statement. The domain of r/3 and or/3 is relevant_ip/2 
(abduced using implementation in Sicstus)
0{r(X,Y,1),r(X,Y,-1), or(X,Y,1), or(X,Y,-1)}1:-relevant_ip(Y,X).
% State abducible expressed as choice statement. The domain of state/2 is r/3 and not relevant_ip/2. Otherwise you 
have a state for genes that do not participate in the networks (i.e which do not regulate or are regulated by anything
1{state(X,1), state(X,-1)}1:- r(X,Y,_).
1{state(Y,1), state(Y,-1)}1:- r(X,Y,_).
1{state(X,1), state(X,-1)}1:- or(X,Y,_).
1{state(Y,1), state(Y,-1)}1:- or(X,Y,_).
% State must be consistent with experimental data
:-r(X,Y,1), state(X,S1), state(Y,S2), S1 != S2.
:-r(X,Y,-1), state(X,S),state(Y,S).
:-or(X,Y,1), state(X,S),state(Y,S).
:-or(X,Y,-1), state(X,S1), state(Y,S2), S1 != S2.
:-state(X,S2), exp_data(X,S1), S1!=S2.
:- state(X,S2), exp_data(X,S1), S1!=S2.
% r/or must be consistent with regulatory potentials
:-r(X,Y,S), X != Y, not reg_pot(Y,S).
:-or(X,Y,S), X != Y, not reg_pot(Y,S).
reg_pot(Y,1):-pot_reg(Y).
reg_pot(Y,-1):- pot_reg(Y).
% r/or must be consistent with any known interactions signs (activations, inhibitions)
:- r(X,Y,S), X != Y, establish_link(Y,X,S1), S != S1.
:- or(X,Y,S), X != Y, establish_link(Y,X,S1), S != S1.
% r/or must be along paths of seed genes. Any r/or that does not lead to somewhere of which is not regulated by 
something is not accepted.
:-r(X,Y,_), not keep(X,Y).
keep(X,Y):-connected_in(Y),connected_out(X).
keep(X,Y):-part_ffl(X,Y).
part_ffl(T,R2):- r(T,R,_), or(R2,R,_).
part_ffl(R2,R):- r(T,R,_), or(T,R2,_).
connected_out(X):- r(Z,X,_).
connected_in(X):- r(X,Z,_).
connected_in(X):- seed(X).
connected_out(X):- seed(X).
% Integrity constraints of competitive regulators
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:-or(X,Y,S), not op_exception(X,Y,S).
op_exception(X,Y,S):-overpower(X,Z,Y), r(X,Z,W),effect(S).
op_exception(T,R,S1):- r(T,R2,S3), r(R2,R,S2),iff(S1,S2,S3).
op_exception(T,R2,S3):- r(T,R,S1), r(R2,R,S2),iff(S1,S2,S3).
op_exception(R2,R,S2):- r(T,R,S1), r(T,R2,S3),iff(S1,S2,S3).
iff(1,1,-1). iff(1,-1,1). iff(-1,1,1). iff(-1,-1,-1).
effect(1). effect(-1).
% Optimisation Procedure for maximise number of seeds explained
explain(X):- seed(X),r(X,Y,Z).
#maximize{explain(X)}.
%Optimisation procedure for maximise number of links
answer(r,X,Y,Z):-r(X,Y,Z).
answer(or,X,Y,Z):-or(X,Y,Z).
#maximize[answer(R,X,Y,Z)=1].  
% Output to print in text file
#hide. 
#show answer/4.
#show state/2.
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Appendix II: Gene co-expression network analysis
The bioinformatics workflow set up in Chapter 3 has generated an integrated human endothelial cell 
mechanoresponsive gene expression profile consisting of 14,028 genes and 23 samples. Differential 
expression analysis of this dataset has identified a robust set of 1638 mechanoresponsive genes (FDR 
pvalue < 0.05). Differential expression analysis however, is biased against the detection of differentially 
expressed genes with low fold changes and of weekly expressed genes due to the inherent noise in 
accurately measuring their expression value [Canales06]. In order to address this issue we propose to 
augment the seed genes identified from differential expression analysis with co-expressed genes identified 
via co-expression network analysis to maximise the information gain from the integrated mechanoresponsive 
gene expression profile. The set of co-expressed genes and differential expressed genes do not always 
overlap  as they capture different biological signal [Huan13]. Therefore by merging the two approaches the 
initial set of seed genes is as complete as possible and should result in improved network inference by our 
ARNI approach.
Following the current recommendation by the DREAM consortium, we have decided to generate a 
consensus co-expression network, which statistically integrates the results of multiple network algorithms. 
The following network inference algorithms have been selected for generating the community-based co-
expression network:
• Regression: GENIE3
• Mutual information:  CRL and ARACNE
• Correlation: WGCNA
• Partial Correlation (Graphical Gaussian model): GeneNet
The selection was based on the evaluation data presented in [Marbach12], and the the top  ranked method 
from each of the different methodological categories was included in the analysis.
GENIE network inference on the integrated human datasets has generated a network with 1528 nodes and 
1852 edges (Figure A.1.A). Topological analysis of this network revealed that it has the expected scale-free 
topology, whereby the degree distribution (number of neighbours of nodes) follows a power law (goodness of 
fit  r2 = 0.88), (Figure A.1.B). Functional enrichment analysis on the network genes identified cardiovascular 
diseases as strongly associated with the gene set (p< 0.00001). Further, transcription factor enrichment 
analysis identified amongst other genes, NRF2, NFKb, and MEF2 as strongly associated (p< 0.00001) with 
the network genes. These findings, confirm the biological relevance of the co-expressed genes. A 
comparison between the differentially expressed genes presented in Chapter 3 and genes that participate in 
the network inferred by GENIE3 reveal a ~45% overlap, confirming our intuition that the two methodologies 
capture different biological signal, (Figure A.1.C). 
The rest of the individual networks are currently been generated. Once all the networks have been obtained, 
the statistical merging function provided by the DREAM consortium will be used for computing the 
consensus co-expression network [Marbach12]. 
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Figure A.1: Co-expression network for the integrated human dataset. 
A) Network generated by the GENIE3 algorithm. The network consists of 1528 nodes and 1852 edges. B) Degree 
distribution of the network shown in (A).  The plot shows the number of nodes (Y-axis) having a specified degree value 
(X-axis). The degree refers to the number of  neighbours for a given node.  The degree distribution of a scale-free network 
should follow a power law (shown by the red line). The goodness of fit (r2) to a power law distribution is 0.88. C) Overlap 
between the differentially expressed genes presented in Chapter 3 (blue circle) with the genes that participate in the 
network inferred by GENIE3 ( yellow circe). 
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Appendix III: Experimental supplementary data
Pump Calibration Data
τ: shear stress [dyn/cm2]
µ: dynamic viscosity of the fluid [dyn·s/cm2] Viscocity(Range:(0.007830.01
Q: volumetric flow rate [cm3/s]
h: height of the channel [cm]
w: width of the channel [cm]
A
Speed%RPM Q%%ml/min
Shear%stress%for%
cell%array%
(dyne/cm2)
2 3.5 0.93
4 10 2.67
5 13 3.47
7 17.5 4.67
8 20 5.33
10 30 8.00
15 43 11.47
20 58 15.47
25 80 21.33
30 100 26.67
35 120 32.00
h 0.05
w 1.5
B
Speed%RPM Q%%ml/min
Shear%stress%for%
ibidi%µDslide%VI%
(dyne/cm2)
2 1.8 2.96
3
4 6.75 11.10
6 10.35 17.02
7 13.5 23.77
8 14.25 23.44
9
10 18 29.61
h 0.04
w 0.38
Cobe%Pump
Perista%Pump
cell%array%dimentions:
µDSlide%VI%dimensions
y%=%0.9305x%D%1.6196%
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 RESULTS AND DISCUSSION 3.3
3.3.1 Design of linearly increasing shear stress inducing microfluidics 
device 
In order to efficiently study mechanosensing in endothelial cells, a flow channel in which 
shear stress increases linearly from near 0 to 10 Pa along the flow path is needed. To our 
knowledge, only the parallel plate flow channel designed by Usami et. al. [639] was built to 
satisfy this requirement. However, our flow simulations showed that the lower range on the 
shear stress does not come close to 0 and the shear stress range along the channel length is 
not wide enough, Figure 3.2. Furthermore, shear stress values are not uniform across the 
width of the channel, higher shear stress occurs in the width-wise centre of the channel. 
Because of this non-uniformity of shear stress across the channel width, the sampling area is 
reduced. Due to these, this parallel plate flow channel is not suitable for our applications. 
Thus, we set out to design our own flow channel to fulfil the need for a linear shear stress 
inducing flow channel.      
To design our flow channel, instead of modifying the width of the channel, we decided to 
modify the channel height. For this, we used the mathematical formula derived from the 
Navier–Stokes equations by Usami et. al. [639] to relate shear stress values to the geometry 
of the channel, Equation 3.1. 
𝜏 =
6µ𝑄
ℎଶ𝑤 (1 −
𝑧
𝐿) 
 
Equation 3.1. Mathematical formula derived by Usam  et. al. [639] to deter ine shear stress 
in function of channel geometry.  
Where:   
τ: shear stress along the centre line of the channel floor [dyn/cm2] 
 µ: dynamic viscosity of the fluid [dyn·s/cm2] 
 Q: volumetric flow rate [cm3/s] 
 h: height of the channel [cm] 
 w: width of the channel [cm] 
z: arbitrary position along the channel length measured from the channel entrance,               
    where L=0 [cm] 
Figure A.2: Pump shear stress calibration data.
The tables display the pump setting (column 1), measured flow rate (column 2) and the calculated shear stress based on 
the formula shown. Panel A includes the calibration for the Cobe pump  when using the RNAi platform flow chamber. 
Panel B includes the calibration for the Perista pump  when using the ibidi 6-channel chambers. The width (w) and the 
heigh (h) for each chamber are also shown. 
Appendices
243
Example images from imaging analysis
             
Mock siRNA transfected! Death siRNA transfected!
Figure A.3: Representative images for manual cell counting. 
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siGFP transfected! No pulse control!
Figure A.4: Representative images for manual cell counting of GFP positive cells.
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Flow setup equipment
Below is the design of the media reservoir used for flow studies which can be manufactured from Cambridge 
Glassblowing Ltd (http://www.camglassblowing.co.uk/)
Figure A.5: Specification for the media reservoir used in the flow studies
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